Document:

Exhibit 4.1

    

    
      

      

    

    AQUESTIVE THERAPEUTICS, INC.,

     

    as Issuer,

     

    and any Guarantor that becomes party hereto pursuant to Section 4.10 hereof

     

    12.5% Senior Secured Notes due 2025

     

    
      

     

    INDENTURE

     

    Dated as of July 15, 2019

     

    
      

     

    U.S. BANK NATIONAL ASSOCIATION,

    as Trustee and as Collateral Agent

     

    

    
      
        

    

    
    
      
        TABLE OF CONTENTS

      

    

     

    

    
      	 	Page

            
	 	 
	
              ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE

            	
              1

            
	 	 
	 	
              SECTION 1.01.

            	
              Definitions

            	
              1

            
	 	 	 	 
	 	
              SECTION 1.02.

            	
              Other Definitions

            	
              37

            
	 	 	 	 
	 	
              SECTION 1.03.

            	
              Rules of Construction

            	
              38

            
	 	 	 	 
	
              ARTICLE 2 THE SECURITIES

            	
              39

            
	 	 	 
	 	
              SECTION 2.01.

            	
              Amount of Securities

            	
              39

            
	 	 	 	 
	 	
              SECTION 2.02.

            	
              Form and Dating

            	
              41

            
	 	 	 	 
	 	
              SECTION 2.03.

            	
              Execution and Authentication

            	
              41

            
	 	 	 	 
	 	
              SECTION 2.04.

            	
              Registrar and Paying Agent

            	
              41

            
	 	 	 	 
	 	
              SECTION 2.05.

            	
              Paying Agent to Hold Money in Trust

            	
              42

            
	 	 	 	 
	 	
              SECTION 2.06.

            	
              Holder Lists

            	
              43

            
	 	 	 	 
	 	
              SECTION 2.07.

            	
              Transfer and Exchange

            	
              43

            
	 	 	 	 
	 	
              SECTION 2.08.

            	
              Replacement Securities

            	
              44

            
	 	 	 	 
	 	
              SECTION 2.09.

            	
              Outstanding Securities

            	
              44

            
	 	 	 	 
	 	
              SECTION 2.10.

            	
              Temporary Securities

            	
              45

            
	 	 	 	 
	 	
              SECTION 2.11.

            	
              Cancellation

            	
              45

            
	 	 	 	 
	 	
              SECTION 2.12.

            	
              Defaulted Interest

            	
              45

            
	 	 	 	 
	 	
              SECTION 2.13.

            	
              CUSIP Numbers, ISINs, etc

            	
              45

            
	 	 	 	 
	 	
              SECTION 2.14.

            	
              Calculation of Principal Amount of Securities

            	
              46

            
	 	 	 	 
	 	
              SECTION 2.15.

            	
              Statement to Holders

            	
              46

            
	 	 	 	 
	
              ARTICLE 3 REDEMPTION

            	
              46

            
	 	 	 
	 	
              SECTION 3.01.

            	
              Redemption

            	
              46

            
	 	 	 	 
	 	
              SECTION 3.02.

            	
              Applicability of Article

            	
              46

            
	 	 	 	 
	 	
              SECTION 3.03.

            	
              Notices to Trustee

            	
              47

            
	 	 	 	 
	 	
              SECTION 3.04.

            	
              Selection of Securities to Be Redeemed

            	
              47

            
	 	 	 	 
	 	
              SECTION 3.05.

            	
              Notice of Optional Redemption

            	
              47

            
	 	 	 	 
	 	
              SECTION 3.06.

            	
              Effect of Notice of Redemption

            	
              48

            
	 	 	 	 
	 	
              SECTION 3.07.

            	
              Deposit of Redemption Price

            	
              49

            
	 	 	 	 
	 	
              SECTION 3.08.

            	
              Securities Redeemed in Part

            	
              49

            
	 	 	 	 
	
              ARTICLE 4 COVENANTS

            	
              49

            
	 	 	 
	 	
              SECTION 4.01.

            	
              Payment of Securities

            	
              49

            
	 	 	 	 
	 	
              SECTION 4.02.

            	
              Reports and Other Information

            	
              50

            

      

      

      
        i

        
          

      

      TABLE OF CONTENTS

      (continued)

       

      

      	 	 	 	Page
	 	 	 	 
	 	
              SECTION 4.03.

            	
              Limitation on Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred Stock

            	
              53

            
	 	 	 	 
	 	
              SECTION 4.04.

            	
              Limitation on Restricted Payments

            	
              59

            
	 	 	 	 
	 	
              SECTION 4.05.

            	
              Dividend and Other Payment Restrictions Affecting Subsidiaries

            	
              63

            
	 	 	 	 
	 	
              SECTION 4.06.

            	
              Asset Sales

            	
              65

            
	 	 	 	 
	 	
              SECTION 4.07.

            	
              Transactions with Affiliates

            	
              69

            
	 	 	 	 
	 	
              SECTION 4.08.

            	
              Change of Control

            	
              72

            
	 	 	 	 
	 	
              SECTION 4.09.

            	
              Further Instruments and Acts

            	
              74

            
	 	 	 	 
	 	
              SECTION 4.10.

            	
              Future Guarantors

            	75
	 	 	 	 
	 	
              SECTION 4.11.

            	
              Liens

            	
              75

            
	 	 	 	 
	 	
              SECTION 4.12.

            	
              Maintenance of Office or Agency

            	
              75

            
	 	 	 	 
	 	
              SECTION 4.13.

            	
              After-Acquired Property

            	
              76

            
	 	 	 	 
	 	
              SECTION 4.14.

            	
              Intellectual Property

            	
              77

            
	 	 	 	 
	 	
              SECTION 4.15.

            	
              Line of Business

            	
              77

            
	 	 	 	 
	 	
              SECTION 4.16.

            	
              Use of Proceeds

            	
              77

            
	 	 	 	 
	 	
              SECTION 4.17.

            	
              Tax Matters

            	
              77

            
	 	 	 	 
	 	
              SECTION 4.18.

            	
              Existence

            	78
	 	 	 	 
	 	
              SECTION 4.19.

            	
              Right of First Offer

            	
              78

            
	 	 	 	 
	
              ARTICLE 5 SUCCESSOR COMPANY

            	78

            
	 	 	 
	 	
              SECTION 5.01.

            	
              When Issuer May Merge or Transfer Assets

            	
              78

            
	 	 	 	 
	 	
              SECTION 5.02.

            	
              When Guarantors May Merge or Transfer Assets

            	
              80

            
	 	 	 	 
	
              ARTICLE 6 DEFAULTS AND REMEDIES

            	80
	 	 	 
	 	
              SECTION 6.01.

            	
              Events of Default

            	
              80

            
	 	 	 	 
	 	
              SECTION 6.02.

            	
              Acceleration

            	
              83

            
	 	 	 	 
	 	
              SECTION 6.03.

            	
              Other Remedies

            	
              84

            
	 	 	 	 
	 	
              SECTION 6.04.

            	
              Waiver of Existing Defaults

            	
              84

            
	 	 	 	 
	 	
              SECTION 6.05.

            	
              Control by Majority

            	
              85

            
	 	 	 	 
	 	
              SECTION 6.06.

            	
              Limitation on Suits

            	
              85

            
	 	 	 	 
	 	
              SECTION 6.07.

            	
              Rights of the Holders to Receive Payment

            	
              85

            
	 	 	 	 
	 	
              SECTION 6.08.

            	
              Collection Suit by Trustee

            	
              85

            

      

      

      
        ii

        
          

      

      
        TABLE OF CONTENTS

        (continued)

      

       

      

      	 	 	 	Page
	 	 	 	 
	 	
              SECTION 6.09.

            	
              Trustee May File Proofs of Claim

            	
              86

            
	 	 	 	 
	 	
              SECTION 6.10.

            	
              Priorities

            	
              86

            
	 	 	 	 
	 	
              SECTION 6.11.

            	
              Undertaking for Costs

            	
              86

            
	 	 	 	 
	 	
              SECTION 6.12.

            	
              Waiver of Stay or Extension Laws

            	
              87

            
	 	 	 	 
	 	
              SECTION 6.13.

            	
              Holder Request

            	
              87

            
	 	 	 	 
	
              ARTICLE 7 TRUSTEE

            	87
	 	 	 
	 	
              SECTION 7.01.

            	
              Duties of Trustee

            	
              87

            
	 	 	 	 
	 	
              SECTION 7.02.

            	
              Rights of Trustee

            	
              89

            
	 	 	 	 
	 	
              SECTION 7.03.

            	
              Individual Rights of Trustee

            	
              90

            
	 	 	 	 
	 	
              SECTION 7.04.

            	
              Trustee’s Disclaimer

            	
              90

            
	 	 	 	 
	 	
              SECTION 7.05.

            	
              Notice of Defaults

            	
              90

            
	 	 	 	 
	 	
              SECTION 7.06.

            	
              Compensation and Indemnity

            	
              91

            
	 	 	 	 
	 	
              SECTION 7.07.

            	
              Replacement of Trustee

            	
              92

            
	 	 	 	 
	 	
              SECTION 7.08.

            	
              Successor Trustee by Merger

            	
              93

            
	 	 	 	 
	 	
              SECTION 7.09.

            	
              Eligibility; Disqualification

            	
              93

            
	 	 	 	 
	 	
              SECTION 7.10.

            	
              Preferential Collection of Claims Against the Issuer

            	
              93

            
	 	 	 	 
	 	
              SECTION 7.11.

            	
              Confidential Information

            	94
	 	 	 	 
	
              ARTICLE 8 DISCHARGE OF INDENTURE; DEFEASANCE

            	95
	 	 	 
	 	
              SECTION 8.01.

            	
              Discharge of Liability on Securities; Defeasance

            	
              95

            
	 	 	 	 
	 	
              SECTION 8.02.

            	
              Conditions to Defeasance

            	
              96

            
	 	 	 	 
	 	
              SECTION 8.03.

            	
              Application of Trust Money

            	
              97

            
	 	 	 	 
	 	
              SECTION 8.04.

            	
              Repayment to Issuer

            	
              97

            
	 	 	 	 
	 	
              SECTION 8.05.

            	
              Indemnity for Government Obligations

            	
              98

            
	 	 	 	 
	 	
              SECTION 8.06.

            	
              Reinstatement

            	
              98

            
	 	 	 	 
	
              ARTICLE 9 AMENDMENTS AND WAIVERS

            	98
	 	 	 
	 	
              SECTION 9.01.

            	
              Without Consent of the Holders

            	
              98

            
	 	 	 	 
	 	
              SECTION 9.02.

            	
              With Consent of the Holders

            	
              100

            
	 	 	 	 
	 	
              SECTION 9.03.

            	
              Revocation and Effect of Consents and Waivers

            	
              101

            
	 	 	 	 
	 	
              SECTION 9.04.

            	
              Notation on or Exchange of Securities

            	
              102

            
	 	 	 	 
	 	
              SECTION 9.05.

            	
              Trustee to Sign Amendments

            	
              102

            
	 	 	 	 
	 	
              SECTION 9.06.

            	
              Payment for Consent

            	
              102

            

      

      

      
        iii

        
          

      

      
        
          TABLE OF CONTENTS

          (continued)

        

      

       

      

      	 	 	 	Page

            
	 	 	 	 
	 	
              SECTION 9.07.

            	
              Additional Voting Terms; Calculation of Principal Amount

            	
              102

            
	 	 	 	 
	
              ARTICLE 10 GUARANTEES

            	103
	 	 	 
	 	
              SECTION 10.01.

            	
              Guarantees

            	
              103

            
	 	 	 	 
	 	
              SECTION 10.02.

            	
              Limitation on Liability

            	
              105

            
	 	 	 	 
	 	
              SECTION 10.03.

            	
              Releases

            	
              105

            
	 	 	 	 
	 	
              SECTION 10.04.

            	
              Successors and Assigns

            	
              106

            
	 	 	 	 
	 	
              SECTION 10.05.

            	
              No Waiver

            	
              106

            
	 	 	 	 
	 	
              SECTION 10.06.

            	
              Modification

            	
              106

            
	 	 	 	 
	 	
              SECTION 10.07.

            	
              Execution of Supplemental Indenture for Future Guarantors

            	
              107

            
	 	 	 	 
	 	
              SECTION 10.08.

            	
              No Impairment

            	
              107

            
	 	 	 	 
	 	
              SECTION 10.09.

            	
              Benefits Acknowledged

            	
              107

            
	 	 	 	 
	
              ARTICLE 11 SECURITY DOCUMENTS

            	107
	 	 	 
	 	
              SECTION 11.01.

            	
              Collateral and Security Documents

            	
              107

            
	 	 	 	 
	 	
              SECTION 11.02.

            	
              {Reserved}.

            	
              108

            
	 	 	 	 
	 	
              SECTION 11.03.

            	
              Release of Collateral

            	
              108

            
	 	 	 	 
	 	
              SECTION 11.04.

            	
              Permitted Releases Not To Impair Lien

            	
              109

            
	 	 	 	 
	 	
              SECTION 11.05.

            	
              Suits To Protect the Collateral

            	
              110

            
	 	 	 	 
	 	
              SECTION 11.06.

            	
              Authorization of Receipt of Funds by the Trustee Under the Security Documents

            	
              110

            
	 	 	 	 
	 	
              SECTION 11.07.

            	
              Purchaser Protected

            	
              110

            
	 	 	 	 
	 	
              SECTION 11.08.

            	
              Powers Exercisable by Receiver or Trustee

            	
              110

            
	 	 	 	 
	 	
              SECTION 11.09.

            	
              Release Upon Termination of the Issuer’s Obligations

            	
              111

            
	 	 	 	 
	 	
              SECTION 11.10.

            	
              Collateral Agent

            	
              111

            
	 	 	 	 
	
              ARTICLE 12 MISCELLANEOUS

            	114
	 	 	 
	 	
              SECTION 12.01.

            	
              Notices

            	
              114

            
	 	 	 	 
	 	
              SECTION 12.02.

            	
              Certificate and Opinion as to Conditions Precedent

            	
              115

            
	 	 	 	 
	 	
              SECTION 12.03.

            	
              Statements Required in Certificate or Opinion

            	
              115

            
	 	 	 	 
	 	
              SECTION 12.04.

            	
              When Securities Disregarded

            	
              116

            
	 	 	 	 
	 	
              SECTION 12.05.

            	
              Rules by Trustee, Paying Agent and Registrar

            	
              116

            
	 	 	 	 
	 	
              SECTION 12.06.

            	
              Legal Holidays

            	
              116

            

      

      

      
        iv

        
          

      

      
        
          TABLE OF CONTENTS

          (continued)

        

      

       

      

      	 	 	 	Page
	 	 	 	 
	 	
              SECTION 12.07.

            	
              GOVERNING LAW; SUBMISSION TO JURISDICTION; WAIVER OF IMMUNITY

            	
              116

            
	 	 	 	 
	 	
              SECTION 12.08.

            	
              No Recourse Against Others

            	
              116

            
	 	 	 	 
	 	
              SECTION 12.09.

            	
              Successors

            	
              117

            
	 	 	 	 
	 	
              SECTION 12.10.

            	
              Multiple Originals

            	
              117

            
	 	 	 	 
	 	
              SECTION 12.11.

            	
              Table of Contents; Headings

            	
              117

            
	 	 	 	 
	 	
              SECTION 12.12.

            	
              Indenture Controls

            	
              117

            
	 	 	 	 
	 	
              SECTION 12.13.

            	
              Severability

            	
              117

            
	 	 	 	 
	 	
              SECTION 12.14.

            	
              Currency of Account; Conversion of Currency; Currency Exchange Restrictions

            	
              117

            
	 	 	 	 
	 	
              SECTION 12.15.

            	
              Intercreditor Agreement Governs

            	
              119

            
	 	 	 	 
	 	
              SECTION 12.16.

            	
              Tax Matters.

            	
              120

            
	 	 	 	 
	 	
              SECTION 12.17.

            	
              USA PATRIOT Act

            	
              121

            
	 	 	 	 
	 	
              SECTION 12.18.

            	
              WAIVER OF TRIAL BY JURY

            	
              121

            
	 	 	 	 
	 	
              SECTION 12.19.

            	
              Limited Incorporation of the TIA

            	
              121

            

       

      

       

      

      
        	
                Appendix A

              	
                 -

              	
                Provisions Relating to Securities

              	
                A-1

              
	 	 	 	 
	
                EXHIBIT INDEX

              	 
	 	 	 	 
	
                Exhibit A

              	
                -

              	
                Form of Security and Trustee’s Certificate of Authentication

              	
                A-1

              
	
                Exhibit B

              	
                -

              	
                Form of Transferee Letter of Representation

              	
                B-1

              
	
                Exhibit C

              	
                -

              	
                Form of Supplemental Indenture

              	
                C-1

              
	
                Exhibit D

              	
                -

              	
                Form of Intercreditor Agreement

              	
                D-1

              
	
                Exhibit E

              	
                -

              	
                Form of Confidentiality Agreement

              	
                E-1

              
	
                Exhibit F

              	-

              	
                Payment Subordination Terms

              	
                F-1

              
	
                Exhibit G

              	
                -

              	
                Form of Portfolio Interest Certificate

              	
                G-1

              

        

        

        
          v

          
            

        

      

    

    INDENTURE dated as of July 15, 2019 among Aquestive Therapeutics, Inc., a Delaware corporation with an address at 30 Technology Drive, Warren, New Jersey 07059 (the “Issuer”), any Guarantor that becomes party hereto
      pursuant to Section 4.10, and U.S. Bank National Association, as trustee (as more fully defined in Section 1.01, the “Trustee”) and as collateral agent (as more fully defined in Section 1.01, the “Collateral Agent”).

     

    Each party agrees as follows for the benefit of the other parties and for the equal and ratable benefit of the Holders of the Issuer’s 12.5% Senior Secured Notes due 2025 (as more fully defined in Section 1.01, the
      “Securities”).

     

    ARTICLE 1

     

    DEFINITIONS AND INCORPORATION BY REFERENCE

     

    SECTION 1.01.   Definitions.

     

    “ABL Agreement” means any revolving credit, line of credit or similar agreement, debt facility, commercial paper facility, debt securities, indenture or other form of debt financing (including convertible or exchangeable
      debt instruments or bank guarantees or bankers’ acceptances) or other instruments or agreements evidencing Secured Bank Indebtedness, in each case, with the same or different borrowers, lenders, noteholders or other creditors or agents, as amended,
      extended, renewed, restated, supplemented, waived, replaced (whether or not upon termination), restructured, repaid, refunded, refinanced or otherwise modified from time to time.

     

    “ABL Collateral” means, with respect to ABL Obligations under any ABL Document, any and all of the following assets and properties owned by any Grantor as of the Issue Date or at any time thereafter acquired by any
      Grantor and, in either case, pledged under the related ABL Security Document (but solely to the extent that such Grantor is a party to such ABL Security Document, and solely to the extent such Grantor has granted an ABL Lien on such assets and
      properties that secures such ABL Obligations pursuant to such ABL Security Document): (a) all Inventory; (b) all Accounts arising from the sale of Inventory or the provision of services; (c) to the extent evidencing, governing or securing the items
      referred to in the preceding clauses (a) and (b), all of such Grantor’s (i) General Intangibles, (ii) Chattel Paper, (iii) Instruments, (iv) Documents, (v) Payment Intangibles (including tax refunds), other than any Payment Intangibles that represent
      tax refunds in respect of or otherwise relate to real property, Fixtures, Equipment or any other Noteholder First Lien Collateral and (vi) Supporting Obligations; (d) collection accounts and Deposit Accounts, including any Lockbox Account, and any
      cash or other assets in any such accounts constituting Proceeds of clause (a) or (b) (excluding identifiable cash proceeds in respect of Noteholder First Lien Collateral, including proceeds from the sale of the Securities or any cash, checks or other
      property held therein or credited thereto in respect of Noteholder First Lien Collateral); (e) all Indebtedness that arises from cash advances to enable the obligor or obligors thereon to acquire Inventory; (f) all books and records related to the
      foregoing; and (g) all Products and Proceeds of any and all of the foregoing in whatever form received, including proceeds of insurance policies related to Inventory or Accounts arising from the sale of Inventory of such Grantor or the provision of
      services by such Grantor and business interruption insurance; provided, however, that the following items shall not constitute ABL Collateral and shall be expressly
      excluded from the definition thereof: (x) Proceeds of ABL Collateral described in clauses (c) and (d) above unless such Proceeds would otherwise constitute ABL Collateral in any of the foregoing clauses (a) through (e); and (y) the Collateral
      Account, all funds and other assets or property from time to time deposited therein or credited thereto and the Proceeds thereof. All capitalized terms used in this definition and not otherwise defined herein have the respective meanings assigned to
      them in the Uniform Commercial Code.

     

    
      
        

    

    
    “ABL Documents” means, with respect to any ABL Obligations under an ABL Agreement, such ABL Agreement, any related “Loan Documents” (or similar term) as such term is defined in such ABL Agreement, any related ABL
      Security Documents, each of the other agreements, documents and instruments providing for or evidencing such ABL Obligations, and any other document or instrument executed or delivered at any time in connection with such ABL Obligations, including
      any intercreditor or joinder agreement among holders of such ABL Obligations, in each case, as amended, extended, renewed, restated, supplemented, waived, replaced (whether or not upon termination), restructured, repaid, refunded, refinanced or
      otherwise modified from time to time.

     

    “ABL Liens” means, with respect to ABL Obligations under any ABL Document, Liens on the ABL Collateral created under the related ABL Security Document to secure such ABL Obligations.

     

    “ABL Obligations” means all “Secured Obligations” as such term is defined in each applicable ABL Document (or, if “Secured Obligations” is not defined therein, then all the liabilities and obligations under all ABL
      Documents secured, in whole or in part, pursuant to the related ABL Security Documents), including, if so secured, any hedging obligations and cash management obligations and whether for principal, interest (including interest that, but for the
      filing of a petition in any proceeding under any Bankruptcy Law with respect to any Grantor, would have accrued on any ABL Obligation, whether or not a claim is allowed against such Grantor for such interest in such proceeding), premium, fees,
      expenses, indemnification, performance or otherwise.

     

    “ABL Security Documents” means, with respect to ABL Obligations under an ABL Document, such ABL Document (insofar as the same grants a Lien on any assets or properties of any Grantor to secure any such ABL Obligations)
      and any other documents existing as of the Issue Date or entered into after the Issue Date that grant a Lien on any assets or properties of any Grantor to secure any such ABL Obligations, as amended, extended, renewed, restated, supplemented, waived,
      replaced (whether or not upon termination), restructured, repaid, refunded, refinanced or otherwise modified from time to time.

     

    “Accredited Investors” means “accredited investors” as defined in Rule 501(a)(1), (a)(2), (a)(3) or (a)(7) of Regulation D under the Securities Act.

     

    
      2

      
        

    

    “Acquired Indebtedness” means, with respect to any specified Person:

     

    (1)          Indebtedness of any other Person existing at the time such other Person is merged, amalgamated or consolidated with or into or became a Restricted Subsidiary of such specified Person; and

     

    (2)          Indebtedness secured by a Lien encumbering any asset acquired by such specified Person.

     

    “Affiliate” of any specified Person means any other Person directly or indirectly controlling or controlled by or under common control with such specified Person. For purposes of this definition, “control” (including,
      with correlative meanings, the terms “controlling”, “controlled by” and “under common control with”), as used with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management or
      policies of such Person, whether through the ownership of voting securities, by agreement or otherwise.

     

    “Apomorphine” means the product referred to as APL-130277 (apomorphine) (whether marketed under such name or any other name).

     

    “Apomorphine Disposition” means (i) any Apomorphine Royalty Disposition or (ii) any Apomorphine License Transaction.

     

    “Apomorphine License Transaction” means, directly or indirectly, any license, development or commercialization of any Intellectual Property in respect of Apomorphine resulting in fixed cash payments not based on the
      occurrence (or non-occurrence) of any event (other than solely the passage of time).

     

    “Apomorphine Royalty Disposition” means, directly or indirectly, any Disposition (including via a monetization), including to a Royalty Subsidiary, of the Issuer’s right to receive royalties or milestone payments under
      any license or similar arrangement (whether such arrangement is in existence on the Issue Date or thereafter) in respect of Apomorphine (and any related rights).

     

    “Applicable Premium” means, with respect to any Security (or portion thereof) to be redeemed on any redemption date, the greater of (i) 1.0% of the amount of principal of such Security to be redeemed and (ii) the amount,
      if any, by which (a) the present value at such redemption date of (1) the redemption price of the amount of principal of such Security to be redeemed on the First Call Date (as stated in the table immediately following the second paragraph under
      Paragraph 5 of the form of Security set forth in Exhibit A) plus (2) all required interest payments due on the amount of principal of such Security to be redeemed through the First Call Date (excluding accrued but unpaid interest, if any, to the
      redemption date), computed using a discount rate equal to the Treasury Rate in respect of such redemption date plus 100 basis points, exceeds (b) the amount of principal of such Security to be redeemed. The Trustee shall have no duty to calculate or
      verify the calculation of the Applicable Premium.

     

    “Bank Indebtedness” means any and all amounts payable under or in respect of any Credit Agreement and the other Credit Agreement Documents, as amended, restated, supplemented, waived, replaced, restructured, repaid,
      refunded, refinanced or otherwise modified from time to time (including after termination of such Credit Agreement), including principal, premium (if any), interest (including interest accruing on or after the filing of any petition in bankruptcy or
      for reorganization relating to the Issuer whether or not a claim for post-filing interest is allowed in such proceedings), fees, charges, expenses, reimbursement obligations, guarantees and all other amounts payable thereunder or in respect thereof.

     

    
      3

      
        

    

    “Board of Directors” means, as to any Person, the board of directors, board of managers or similar governing body, as applicable, of such Person (or, if such Person is a partnership, the board of directors or other
      governing body of the general partner of such Person) or any duly authorized committee thereof. References in this Indenture to directors (on a Board of Directors) shall also be deemed to refer to managers (on a Board of Managers).

     

    “Business Day” means a day other than a Saturday, Sunday or other day on which banking institutions are authorized or required by law to close in New York City or the city in which the Corporate Trust Office is located.

     

    “Capital Stock” means:

     

    (1)          in the case of a corporation or company, corporate stock or shares;

     

    (2)          in the case of an association or business entity, any and all shares, interests, participations, rights or other equivalents (however designated) of corporate stock;

     

    (3)          in the case of a partnership or limited liability company, partnership interests (whether general or limited) and membership interests; and

     

    (4)          any other interest or participation that confers on a Person the right to receive a share of the profits and losses of, or distributions of assets of, the issuing Person;

     

    in each case to the extent treated as equity in accordance with GAAP.

     

    “Capitalized Lease Obligation” means, at the time any determination thereof is to be made, the amount of the liability in respect of a capital lease (or a finance lease upon adoption by the Issuer of ASU No. 2016-02, Leases (Topic 842)) that would at such time be required to be capitalized and reflected as a liability on a balance sheet (excluding the footnotes thereto) in accordance with GAAP.

     

    “Cash Equivalents” means:

     

    (1)          U.S. Dollars, Canadian dollars, pounds sterling, euros or the national currency of any member state in the European Union;

     

    (2)          securities issued or directly and fully guaranteed or insured by the U.S. government, Canada, the United Kingdom or any country that is a member of the European Union or any agency or
      instrumentality thereof, in each case maturing not more than two years from the date of acquisition;

     

    
      4

      
        

    

    (3)          certificates of deposit, time deposits and eurodollar time deposits with maturities of one year or less from the date of acquisition, bankers’ acceptances with maturities not exceeding one
      year and overnight bank deposits, in each case with any commercial bank having capital and surplus in excess of $250,000,000 and whose long-term debt is rated “A” or the equivalent thereof by Moody’s or S&P (or reasonably equivalent ratings of
      another nationally recognized statistical rating organization);

     

    (4)          repurchase obligations for underlying securities of the types described in clauses (2) and (3) above and clause (5) below entered into with any financial institution meeting the
      qualifications specified in clause (3) above;

     

    (5)          commercial paper issued by a Person (other than an Affiliate of the Issuer) rated at least “A-1” or the equivalent thereof by Moody’s or S&P (or reasonably equivalent ratings of
      another nationally recognized statistical rating organization), and in each case maturing within one year after the date of acquisition;

     

    (6)          readily marketable direct obligations issued by any state of the United States of America or any political subdivision thereof having one of the two highest rating categories obtainable
      from either Moody’s or S&P (or reasonably equivalent ratings of another nationally recognized statistical rating organization), in each case with maturities not exceeding two years from the date of acquisition;

     

    (7)          Indebtedness issued by Persons (other than an Affiliate of the Issuer) with a rating of “A” or higher from S&P or “A-2” or higher from Moody’s (or reasonably equivalent ratings of
      another nationally recognized statistical rating organization), in each case with maturities not exceeding two years from the date of acquisition;

     

    (8)         marketable short-term money market and similar securities rated at least “A-1” or the equivalent thereof by Moody’s or S&P (or reasonably equivalent ratings of
      another nationally recognized statistical rating organization), and in each case maturing within twelve months after the date of creation thereof; and

     

    (9)          investment funds investing at least 95% of their assets in securities of the types described in clauses (1) through (8) above.

     

    “Change of Control” means the occurrence of any of the following events:

     

    (i)           the sale, lease or transfer, in one or a series of related transactions, of all or substantially all the assets of the Issuer and its Subsidiaries, taken as a whole, to a Person other
      than (x) any of the Permitted Holders or (y) any of the Issuer or its Restricted Subsidiaries;

     

    (ii)          the Issuer becomes aware of (by way of report or any other filing pursuant to Section 13(d) of the Exchange Act, proxy, vote, written notice or otherwise) the
      acquisition by any Person or “group” (within the meaning of Section 13(d)(3) or Section 14(d)(2) of the Exchange Act, or any successor provision), including any “group” acting for the purpose of acquiring, holding or disposing of securities (within
      the meaning of Rule 13d-5(b)(1) under the Exchange Act or any successor provision), other than any of the Permitted Holders, in a single transaction or in a related series of transactions, by way of merger, amalgamation, consolidation or other
      business combination or purchase of beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act, or any successor provision), of more than 50% of the total voting power of the issued and outstanding Voting Stock of the Issuer; or

     

    
      5

      
        

    

    (iii)         the adoption of a plan relating to the Issuer’s dissolution or liquidation in accordance with the Issuer’s organizational documents.

     

    Notwithstanding the foregoing, the acquisition, directly or indirectly, of 100% of the total voting power of the issued and outstanding Voting Stock of the Issuer by any Person who, immediately after such acquisition,
      has no material assets other than the Capital Stock of the Issuer or its direct or indirect parent company will not, by itself, constitute a Change of Control.

     

    “Code” means the United States Internal Revenue Code of 1986, as amended.

     

    “Collateral Agent” means U.S. Bank National Association in its capacity as “Collateral Agent” under this Indenture and under the Security Documents and any successor thereto in such capacity.

     

    “Collateral Agreement” means the Collateral Agreement dated as of the date hereof among the Issuer, the Guarantors party thereto from time to time, the Trustee and the Collateral Agent, as may be amended, extended,
      renewed, restated, supplemented, waived or otherwise modified from time to time.

     

    “Confidentiality Agreement” means a confidentiality agreement substantially in the form of Exhibit E.

     

    “Consolidated Interest Expense” means, with respect to any Person for any period, the sum, without duplication, of:

     

    (1)          consolidated interest expense of such Person and its Restricted Subsidiaries for such period, to the extent such expense was deducted in computing Consolidated Net Income (including
      amortization of original issue discount, the interest component of Capitalized Lease Obligations, and net payments and receipts (if any) pursuant to interest rate Hedging Obligations, amortization of deferred financing fees, debt issuance costs,
      commissions, fees and expenses, non-cash interest expense, all commissions, discounts and other fees and charges owed with respect to letters of credit or bankers acceptances and expensing of any bridge, commitment or other financing fees); plus

     

    (2)          consolidated capitalized interest of such Person and its Restricted Subsidiaries for such period, whether paid or accrued; minus

     

    (3)          interest income for such period.

     

    
      6

      
        

    

    For purposes of this definition, interest on a Capitalized Lease Obligation shall be deemed to accrue at an interest rate reasonably determined by the Issuer to be the rate of interest implicit in such Capitalized Lease
      Obligation in accordance with GAAP.

     

    “Consolidated Leverage Ratio” means, with respect to any Person, at any date (the “Consolidated Leverage Calculation Date”), the ratio of (i) Indebtedness (other than Indebtedness of the kind described in clause 1(c) of
      the definition of Indebtedness) of such Person and its Restricted Subsidiaries as of the Consolidated Leverage Calculation Date (determined on a consolidated basis in accordance with GAAP) to (ii) EBITDA of such Person for the most recent four full
      fiscal quarters ended on the last day of the most recent fiscal quarter for which internal financial statements are available immediately preceding such Consolidated Leverage Calculation Date. In the event that the Issuer or any of its Restricted
      Subsidiaries Incurs, repays, repurchases, defeases or redeems any Indebtedness subsequent to such last day but prior to the Consolidated Leverage Calculation Date, then the Consolidated Leverage Ratio shall be calculated giving pro forma effect to such Incurrence, repayment, repurchase, defeasance or redemption of Indebtedness as if the same had occurred at the beginning of the applicable four-quarter period; provided that the Issuer may elect pursuant to an Officers’ Certificate delivered to the Trustee to treat all or any portion of the commitment under any agreement evidencing Indebtedness as being Incurred on the first day of the
      applicable four-quarter measurement period, in which case any subsequent Incurrence of Indebtedness under such commitment shall not be deemed, for purposes of this calculation, to be an Incurrence at such subsequent time.

     

    For purposes of making the computation referred to above, Investments, acquisitions, Dispositions, mergers, amalgamations, consolidations and discontinued operations (as determined in accordance with GAAP), in each case
      with respect to a business, a division or an operating unit of a business, as applicable, that the Issuer or any of its Restricted Subsidiaries has determined to make or made during the applicable four-quarter measurement period or subsequent to such
      measurement period and on or prior to or simultaneously with the Consolidated Leverage Calculation Date shall be calculated on a pro forma basis assuming that all such Investments, acquisitions, Dispositions,
      mergers, amalgamations, consolidations and discontinued operations (and the change of any associated Indebtedness and the change in EBITDA resulting therefrom) had occurred on the first day of the applicable four-quarter measurement period. If since
      the beginning of such period any Person that subsequently became a Restricted Subsidiary or was merged with or into the Issuer or any Restricted Subsidiary since the beginning of such period shall have made any Investment, acquisition, Disposition,
      merger, amalgamation, consolidation or discontinued operation, in each case, with respect to a business, a division or an operating unit of a business, as applicable, that would have required adjustment pursuant to this definition, then the
      Consolidated Leverage Ratio shall be calculated giving pro forma effect thereto for such period as if such Investment, acquisition, Disposition, merger, amalgamation, consolidation or discontinued operation
      had occurred on the first day of the applicable four-quarter measurement period.

     

    
      7

      
        

    

    For purposes of this definition, whenever pro forma effect is to be given to any event, the pro forma calculations shall be made in good
      faith by a responsible financial or accounting officer of the Issuer in accordance with Regulation S-X under the Securities Act. Any such pro forma calculation may include adjustments appropriate, in the
      reasonable good faith determination of the Issuer in accordance with Regulation S-X under the Securities Act, to reflect operating expense reductions, cost savings and other operating improvements or synergies reasonably expected to result from the
      applicable event; provided, that any such expected operating expense reductions, cost savings, operating improvements or synergies shall not increase EBITDA by more than 10% in the aggregate for the most
      recent four full fiscal quarters ended on the last day of the most recent fiscal quarter for which internal financial statements are available immediately preceding the Consolidated Leverage Calculation Date.

     

    For purposes of this definition, any amount in a currency other than U.S. Dollars will be converted to U.S. Dollars based on the average exchange rate for such currency for the most recent four full fiscal quarters
      immediately prior to the date of determination in a manner consistent with that used in calculating EBITDA for the applicable period.

     

    “Consolidated Net Income” means, with respect to any Person for any period, the aggregate of the Net Income of such Person and its Restricted Subsidiaries for such period, on a consolidated basis; provided, however, that:

     

    (1)          any net after-tax extraordinary, non-recurring or unusual gains or losses (less all fees and expenses relating thereto) shall be excluded;

     

    (2)          effects of purchase accounting adjustments (including the effects of such adjustments pushed down to such Person and such Subsidiaries) in amounts required or permitted by GAAP, resulting
      from the application of purchase accounting in relation to any consummated acquisition or the amortization or write-off of any amounts thereof, net of taxes, shall be excluded;

     

    (3)          the Net Income for such period shall not include the cumulative effect of a change in accounting principles during such period;

     

    (4)          any net after-tax income or loss from Disposed, abandoned, transferred, closed or discontinued operations and any net after-tax gains or losses on Disposal of Disposed, abandoned,
      transferred, closed or discontinued operations shall be excluded;

     

    (5)          any net after-tax gains or losses (less all fees and expenses or charges relating thereto) attributable to business Dispositions or asset Dispositions other than in the ordinary course of
      business (as determined in good faith by the Issuer) shall be excluded;

     

    (6)          any net after-tax gains or losses (less all fees and expenses or charges relating thereto) attributable to the early extinguishment of Indebtedness, and any unrealized gains and losses
      relating to Hedging Obligations or other derivative instruments, shall be excluded;

     

    (7)          the Net Income for such period of any Person that is not a Subsidiary of such Person, or is an Unrestricted Subsidiary, or that is accounted for by the equity method of accounting, shall
      be included only to the extent of the amount of dividends or distributions or other payments paid in cash (or to the extent converted into cash) to the referent Person or a Restricted Subsidiary thereof in respect of such period;

     

    
      8

      
        

    

    (8)          solely for the purpose of determining the amount available for Restricted Payments under clause (1) of the definition of “Cumulative Credit”, the Net Income for such period of any
      Restricted Subsidiary (other than any Guarantor) shall be excluded to the extent that the declaration or payment of dividends or similar distributions by such Restricted Subsidiary of its Net Income is not at the date of determination with respect to
      such Restricted Payment permitted without any prior governmental approval (which has not been obtained) or, directly or indirectly, by the operation of the terms of its charter or any agreement, instrument, judgment, decree, order, statute, rule or
      governmental regulation applicable to that Restricted Subsidiary or its stockholders or equityholders, unless such restrictions with respect to the payment of dividends or similar distributions have been legally waived; provided that the Consolidated Net Income of such Person shall be increased by the amount of dividends or other distributions or other payments actually paid in cash (or converted into cash) by any such Restricted Subsidiary to such
      Person, to the extent not already included therein;

     

    (9)          any impairment charges or asset write-offs, in each case pursuant to GAAP, and the amortization of intangibles arising pursuant to GAAP shall be excluded;

     

    (10)        any non-cash expense realized or resulting from stock option plans, employee benefit plans or post-employment benefit plans, or grants or sales of stock, stock appreciation or similar
      rights, stock options, restricted stock, preferred stock or other rights (including any of the foregoing related to terminated employees) shall be excluded;

     

    (11)        any one-time non-cash compensation charges shall be excluded;

     

    (12)        accruals and reserves that are established or adjusted within 12 months after the Issue Date and that are so required to be established or adjusted in accordance with GAAP or as a result of
      adoption or modification of accounting policies shall be excluded;

     

    (13)        non-cash gains, losses, income and expenses resulting from fair value accounting required by the applicable standard under GAAP and related interpretations shall be excluded;

     

    (14)        any currency translation gains and losses related to currency remeasurements of Indebtedness, and any net loss or gain resulting from Hedging Obligations, shall be excluded;

     

    (15)        solely for the purposes of calculating Restricted Payments, if positive, any permanent difference (but excluding, for the avoidance of doubt, any temporary difference the Issuer reasonably
      expects to be paid in cash in any future tax period) by which (A) the Consolidated Taxes of the Issuer calculated in accordance with GAAP exceeds (B) the actual Consolidated Taxes paid in cash by the Issuer during such period shall be excluded;

     

    
      9

      
        

    

    (16)        any non-cash after-tax interest expense resulting from the application of Accounting Standards Codification Topic 470-20 “Debt — Debt With Conversion and Other Options” shall be excluded;

     

    (17)        to the extent covered by insurance and actually reimbursed, or, so long as such Person has made a determination that there exists reasonable evidence that such amount will in fact be
      reimbursed by the insurer and only to the extent that such amount is (a) not denied by the applicable carrier in writing and (b) in fact reimbursed within 365 days of the date of such evidence (with a deduction for any amount so added back to the
      extent not so reimbursed within 365 days), such loss or expense amounts as are so reimbursed, or reimbursable, by insurance providers in respect of liability or casualty events or business interruption shall be excluded; and

     

    (18)        to the extent covered by fees, costs, expenses and losses that are, or (without duplication) are required to be, covered by contractual indemnities, guaranty obligations, purchase price
      adjustments, insurance policies or other contractual reimbursement obligations of third parties, to the extent actually indemnified or reimbursed or with respect to which the Issuer has determined that a reasonable basis exists for indemnification or
      reimbursement, but only to the extent that such amount is actually indemnified or reimbursed within 365 days of such determination (with a deduction in the applicable future period of any amount so added back to the extent not so indemnified or
      reimbursed within such 365 days), shall be excluded.

     

    Notwithstanding the foregoing, for the purpose of Section 4.04 only, there shall be excluded from Consolidated Net Income any dividends, repayments of loans or advances or other transfers of assets from Unrestricted
      Subsidiaries of the Issuer or a Restricted Subsidiary of the Issuer to the extent such dividends, repayments or transfers increase the amount of Restricted Payments permitted under Section 4.04 pursuant to clauses (5) and (6) of the definition of
      “Cumulative Credit”.

     

    “Consolidated Non-cash Charges” means, with respect to any Person for any period, the aggregate depreciation, amortization and other non-cash expenses of such Person and its Restricted Subsidiaries reducing Consolidated
      Net Income of such Person for such period on a consolidated basis and otherwise determined in accordance with GAAP, but excluding any such charge that consists of or requires an accrual of, or cash reserve for, anticipated cash charges for any future
      period.

     

    “Consolidated Taxes” means, with respect to any Person for any period, the provision for taxes for such Person and its Restricted Subsidiaries based on income, profits or capital, including state, franchise, property and
      similar taxes and foreign withholding taxes (including penalties and interest related to such taxes or arising from tax examinations).

     

    “Contingent Obligations” means, with respect to any Person, any obligation of such Person guaranteeing any leases, dividends or other obligations that do not constitute Indebtedness (“primary obligations”) of any other
      Person (the “primary obligor”) in any manner, whether directly or indirectly, including any obligation of such Person, whether or not contingent:

     

    
      10

      
        

    

    (1)          to purchase any such primary obligation or any property constituting direct or indirect security therefor;

     

    (2)          to advance or supply funds:

     

    (a)          for the purchase or payment of any such primary obligation; or

     

    (b)          to maintain working capital or equity capital of the primary obligor or otherwise to maintain the net worth or solvency of the primary obligor; or

     

    (3)          to purchase property, securities or services primarily for the purpose of assuring the owner of any such primary obligation of the ability of the primary obligor to make payment of such
      primary obligation against loss in respect thereof.

     

    “Corporate Trust Office” means the address of the Trustee specified in Section 12.01 or such other address as to which the Trustee may give notice to the Holders and the Issuer.

     

    “Credit Agreement” means (i) if designated by the Issuer to be included in the definition of “Credit Agreement”, any revolving credit, line of credit or similar agreement, as amended, restated, supplemented, waived,
      replaced (whether or not upon termination, and whether with the original lenders or otherwise), restructured, repaid, refunded, refinanced or otherwise modified from time to time, including any agreement or instrument extending the maturity thereof,
      refinancing, replacing or otherwise restructuring all or any portion of the Indebtedness under such agreement or instrument or any successor or replacement agreement or agreements or instrument or instruments or increasing the amount loaned or issued
      thereunder or altering the maturity thereof and (ii) whether or not the agreements or instruments referred to in clause (i) above remain outstanding, and if designated by the Issuer to be included in the definition of “Credit Agreement”, one or more
      (a) debt facilities or commercial paper facilities, providing for revolving credit loans, term loans, receivables financing (including through the sale of receivables to lenders or to special purpose entities formed to borrow from lenders against
      such receivables) or letters of credit, or (b) debt securities, indentures or other forms of debt financing (including convertible or exchangeable debt instruments or bank guarantees or bankers’ acceptances), in each case, with the same or different
      borrowers or issuers and, in each case, as amended, supplemented, modified, extended, restructured, renewed, refinanced, restated, replaced or refunded in whole or in part from time to time.

     

    “Credit Agreement Documents” means any Credit Agreement, any notes issued pursuant thereto and the guarantees thereof, and the collateral documents relating thereto, as amended, supplemented, restated, renewed, refunded,
      replaced, restructured, repaid, refinanced or otherwise modified from time to time.

     

    “Cumulative Credit” means the sum of (without duplication):

     

    (1)         50% of the Consolidated Net Income for the period (taken as one accounting period, the “Reference Period”) from July 1, 2019 to the end of the Issuer’s most recently ended fiscal quarter
      for which internal financial statements are available at the time of such Restricted Payments (or, in the case such Consolidated Net Income for such Reference Period is a deficit, minus 100% of such deficit); plus

     

    
      11

      
        

    

    (2)         100% of the aggregate net proceeds, including cash and the Fair Market Value (as determined in good faith by the Issuer) of property other than cash, received by the Issuer on or after July
      1, 2019 from the issue or sale of Equity Interests of the Issuer (excluding Refunding Capital Stock, Designated Preferred Stock and Disqualified Stock), including Equity Interests issued upon conversion of Indebtedness or Disqualified Stock or upon
      exercise of warrants or options (other than an issuance or sale to a Restricted Subsidiary of the Issuer or to an employee stock ownership plan or trust established by the Issuer or any of its Subsidiaries); plus

     

    (3)         100% of the aggregate amount of contributions to the capital of the Issuer received in cash and the Fair Market Value (as determined in good faith by the Issuer) of property other than cash
      after the Issue Date (other than Refunding Capital Stock, Designated Preferred Stock and Disqualified Stock); plus

     

    (4)          the principal amount of any Indebtedness, or the liquidation preference or maximum fixed repurchase price, as the case may be, of any Disqualified Stock of the Issuer or any Restricted
      Subsidiary thereof issued after the Issue Date (other than Indebtedness or Disqualified Stock issued to a Restricted Subsidiary) that has been converted into or exchanged for Equity Interests in the Issuer (other than Disqualified Stock) or any
      direct or indirect parent of the Issuer (provided in the case of any such parent, such Indebtedness or Disqualified Stock is retired or extinguished); plus

     

    (5)         100% of the aggregate amount received by the Issuer or any Restricted Subsidiary after the Issue Date in cash and the Fair Market Value (as determined in good faith by the Issuer) of
      property other than cash received by the Issuer or any Restricted Subsidiary after the Issue Date from:

     

    (A)          the Disposition (other than to the Issuer or a Restricted Subsidiary of the Issuer) of Restricted Investments made by the Issuer and its Restricted Subsidiaries and from repurchases and
      redemptions of such Restricted Investments from the Issuer and its Restricted Subsidiaries by any Person (other than the Issuer or any of its Restricted Subsidiaries) and from repayments of loans or advances that constituted Restricted Investments
      (other than in each case to the extent that the Restricted Investment was made pursuant to clause (vii) of Section 4.04(b));

     

    (B)          the sale (other than to the Issuer or a Restricted Subsidiary of the Issuer) of the Capital Stock of an Unrestricted Subsidiary; or

     

    (C)          a distribution or dividend from an Unrestricted Subsidiary; plus

     

    (6)          in the event any Unrestricted Subsidiary of the Issuer has been redesignated as a Restricted Subsidiary or has been merged, amalgamated or consolidated with or into, or transfers or
      conveys its assets to, or is liquidated into, the Issuer or a Restricted Subsidiary of the Issuer, the Fair Market Value (as determined in good faith by the Issuer) of the Investment of the Issuer or a Restricted Subsidiary in such Unrestricted
      Subsidiary at the time of such redesignation, combination or transfer (or of the assets transferred or conveyed, as applicable), after taking into account any Indebtedness associated with the Unrestricted Subsidiary so designated or combined or any
      Indebtedness associated with the assets so transferred or conveyed (other than in each case to the extent that the designation of such Subsidiary as an Unrestricted Subsidiary was made pursuant to clause (vii) of Section 4.04(b) or constituted a
      Permitted Investment), which Fair Market Value shall not exceed the amount invested in such Unrestricted Subsidiary by the Issuer and its Restricted Subsidiaries.

     

    
      12

      
        

    

    “Default” means any event that is, or after notice or passage of time or both would be, an Event of Default.

     

    “Designated Preferred Stock” means Preferred Stock of the Issuer or any direct or indirect parent of the Issuer, as applicable (other than Disqualified Stock), that is issued for cash (other than to the Issuer or any of
      its Subsidiaries or an employee stock ownership plan or trust established by the Issuer or any of its Subsidiaries) and is so designated as Designated Preferred Stock, pursuant to an Officers’ Certificate, on the issuance date thereof.

     

    “Disposition” means the sale, assignment, conveyance, transfer, license or other disposition (whether in a single transaction or a series of related transactions) of property or assets (including by way of a
      Sale/Leaseback Transaction) of the Issuer or any Restricted Subsidiary of the Issuer.

     

    “Disqualified Stock” means, with respect to any Person, any Capital Stock of such Person that, by its terms (or by the terms of any security into which it is convertible or for which it is redeemable or exchangeable), or
      upon the happening of any event:

     

    (1)          matures or is mandatorily redeemable, pursuant to a sinking fund obligation or otherwise (other than as a result of a change of control; provided
      that the relevant change of control provisions, taken as a whole, are no more favorable in any material respect to holders of such Capital Stock than the provisions of Section 4.08 and any purchase requirement triggered thereby may not become
      operative until after compliance with the provisions of Section 4.08 (including the purchase of any Securities tendered pursuant thereto));

     

    (2)          is convertible or exchangeable at the option of the holder thereof for Indebtedness or Disqualified Stock of such Person; or

     

    (3)          is redeemable at the option of the holder thereof, in whole or in part (other than solely as a result of a change of control),

     

    in each case, prior to 91 days after the earlier of the Stated Maturity of the Securities and the date the Securities are no longer outstanding; provided, however,
      that only the portion of Capital Stock that so matures or is mandatorily redeemable, is so convertible or exchangeable or is so redeemable at the option of the holder thereof prior to such date shall be deemed to be Disqualified Stock; provided, further, however, that if such Capital Stock is issued to any employee or to any plan for the benefit of employees of
      the Issuer or its Subsidiaries or by any such plan to such employees, such Capital Stock shall not constitute Disqualified Stock solely because it may be required to be repurchased by the Issuer in order to satisfy applicable statutory or regulatory
      obligations or as a result of such employee’s termination, death or disability; provided, further, that any class of Capital Stock of such Person that by its terms
      authorizes such Person to satisfy its obligations thereunder by delivery of Capital Stock that is not Disqualified Stock shall not be deemed to be Disqualified Stock.

     

    
      13

      
        

    

    “EBITDA” means, with respect to any Person for any period, the Consolidated Net Income of such Person for such period plus, without duplication, to the extent the same was deducted (or otherwise not included) in
      calculating Consolidated Net Income:

     

    (1)          Consolidated Taxes; plus

     

    (2)          Consolidated Interest Expense plus all cash dividend payments (excluding items eliminated in consolidation) on a series of Preferred Stock or Disqualified Stock of such Person and its
      Subsidiaries that are Restricted Subsidiaries; plus

     

    (3)          Consolidated Non-cash Charges; plus

     

    (4)          any costs or expenses incurred pursuant to any management equity plan or stock option plan or any other management or employee benefit plan or agreement or any stock subscription or
      shareholder agreement, to the extent that such costs or expenses are funded with cash proceeds contributed to the capital of the Issuer or a Guarantor or net cash proceeds of an issuance of Equity Interests of the Issuer (other than Disqualified
      Stock) solely to the extent that such net cash proceeds are excluded from the calculation of the Cumulative Credit; plus

     

    (5)          any expenses in connection with earn-out obligations of such Person and its Restricted Subsidiaries for such period; plus

     

    (6)          Consolidated Net Income attributable to, or adding to the losses attributable to, the minority equity interests of third parties in any Restricted Subsidiary that is not a Wholly Owned
      Restricted Subsidiary of such Person, except to the extent of dividends declared or paid with respect to such period or any prior period on the shares of Capital Stock of such Restricted Subsidiary held by such third parties; plus

     

    (7)          any ordinary course dividend or distribution or other payment paid in cash and received from any Person, in each case in excess of amounts included in clause (7) of
      the definition of Consolidated Net Income;

     

    less, without duplication,

     

    (8)          non-cash items increasing Consolidated Net Income for such period (excluding the recognition of deferred revenue or any items that represent the reversal of any accrual of, or cash reserve
      for, anticipated cash charges that reduced EBITDA in any prior period and any items for which cash was received in a prior period).

     

    
      14

      
        

    

    “Equity Interests” means Capital Stock and all warrants, options or other rights to acquire Capital Stock (but excluding any debt security that is convertible into, or exchangeable for, Capital Stock).

     

    “Exchange Act” means the United States Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC promulgated thereunder.

     

    “Excluded Assets” means, subject to Section 4.11, (i) any license, contract, permit or agreement of the Issuer or any of the Guarantors, if and only for so long as and to the extent that the grant of a security interest
      therein under the Security Documents would result in a breach or default under, or abandonment, invalidation or unenforceability of, that license, contract, permit or agreement (except (a) to the extent the relevant term that would result in such
      breach, default, abandonment, invalidation or unenforceability is rendered ineffective pursuant to Section 9-406, 9-407, 9-408 or 9-409 of the Uniform Commercial Code (or equivalent statutes of any jurisdiction) or any other applicable law or (b) any
      such license, contract, permit or agreement between the Issuer and any Subsidiary of the Issuer or between Subsidiaries of the Issuer), (ii) (a) any fee interest in real property (excluding fixtures) if the greater of the cost and the book value of
      such interest is less than $500,000 or (b) any leasehold interest in real property if the annual base rent is less than $500,000, (iii) any asset or property to the extent that the grant of a security interest in such asset or property is prohibited
      by any applicable law or requires a consent not obtained of any Governmental Authority pursuant to applicable law (except to the extent the law prohibiting such grant or requiring such consent is rendered ineffective pursuant to Section 9-406, 9-407,
      9-408 or 9-409 of the Uniform Commercial Code (or equivalent statutes of any jurisdiction) or any other applicable law), (iv) any assets or property as to which the Issuer or the Collateral Agent (at the direction of the Holders of a majority in
      principal amount of the Securities then outstanding) reasonably determines in good faith that the costs of obtaining such a security interest are excessive in relation to the value of the security to be afforded thereby, (v) any Equity Interests of
      any Unrestricted Subsidiaries and any Royalty Subsidiaries, (vi) any tax accounts, trust accounts, wage and benefit accounts, fiduciary accounts, zero balance accounts, payroll accounts, payroll withholding tax accounts, pension and pension reserve
      accounts and employee benefit accounts to the extent funded or maintained in accordance with prudent business practice or as required by law, (vii) any trademark or service mark applications filed in the United States Patent and Trademark Office on
      the basis of the intent of the Issuer or any Guarantor to use such trademark or service mark, unless and until evidence of use of such mark acceptable to the United States Patent and Trademark Office has been filed with the United States Patent and
      Trademark Office pursuant to Section 1(c) or Section 1(d) of the Lanham Act (15 U.S.C., et seq.), to the extent that granting a security interest in such application prior to such filing would adversely affect the validity or enforceability of such
      trademark application, (viii) any motor vehicle or other equipment that is (a) subject to a certificate of title and (b) obtained and used in the ordinary course of business and (ix) any Lockbox Account to the extent such Lockbox Account is pledged
      as collateral to secure any First Priority Lien Obligations.

     

    “Fair Market Value” means, at the time of any given transaction, with respect to any asset or property, the price (after taking into account any liabilities related to such asset or property) that could be negotiated in
      an arm’s-length transaction, for cash, between a willing seller and a willing and able buyer, neither of whom is under undue pressure or compulsion to complete the transaction.

     

    
      15

      
        

    

    “FATCA” means Sections 1471 through 1474 of the Code, as of the date of this Indenture (or any amended or successor version that is substantively comparable and not materially more onerous to comply with), any current or
      future regulations thereunder or official interpretations thereof, any agreements entered into pursuant to Section 1471(b)(1) of the Code and any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental
      agreement, treaty or convention among Governmental Authorities and implementing such Sections of the Code.

     

    “FDA” means the United States Food and Drug Administration (including any of its successor agencies or departments).

     

    “Federal Deposit Insurance Corporation” means the Federal Deposit Insurance Corporation or any successor thereto.

     

    “Financial Officer” of any Person shall mean the Chief Financial Officer and/or principal financial officer, Chief Accounting Officer and/or principal accounting officer, Treasurer, Assistant Treasurer or Controller of
      such Person.

     

    “First Additional Securities” means the Issuer’s 12.5% Senior Secured Notes due 2025 that may be issued after the Issue Date pursuant to Section 2.01(c).

     

    “First Additional Securities Triggering Event” means the filing of a new drug application for Libervant by the Issuer with the FDA.

     

    “First Amortization Date” means, with respect to any security, the date specified in such security as the fixed date on which the first payment of principal of such security is due and payable.

     

    “First Lien Agent” means the Representative(s) of the holders of the First Priority Lien Obligations to the extent designated as such in an Intercreditor Agreement.

     

    “First Priority Lien Obligations” means (i) all Secured Bank Indebtedness and (ii) all other Obligations (not constituting Indebtedness) of the Issuer and its Restricted Subsidiaries under the agreements governing
      Secured Bank Indebtedness, to the extent that, in the case of each of clause (i) or (ii), such Indebtedness or other Obligations are secured, in whole or in part, by the ABL Collateral and have otherwise been incurred in accordance with this
      Indenture.

     

    “GAAP” means generally accepted accounting principles in the United States set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and
      statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other entity as have been approved by a significant segment of the accounting profession, in each case, as in effect on the Issue Date,
      other than reports and financial information required to be delivered under Section 4.02, which shall be prepared in accordance with GAAP in effect as of the date thereof.

     

    “Governmental Authority” means the government of the United States or any other nation, or of any political subdivision thereof, whether state or local, and any agency, authority, instrumentality, regulatory body, court,
      central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government (including any supra-national bodies such as the European Union or the European Central
      Bank).

     

    
      16

      
        

    

    “Grantor” means any Person that shall have granted any Lien in favor of an ABL Collateral Agent (as defined in the Intercreditor Agreements) or the Collateral Agent on any of its assets or properties to secure any of the
      Obligations, including any such Person as debtor-in-possession and any receiver or trustee for such Person (or any similar officer under any Bankruptcy Law) in any proceeding under any Bankruptcy Law.

     

    “guarantee” means a guarantee or other provision of credit support (other than by endorsement of negotiable instruments for collection in the ordinary course of business), direct or indirect, in any manner (including
      letters of credit and reimbursement agreements in respect thereof), of all or any part of any Indebtedness or other obligations, including by providing security therefor or by becoming a co-obligor with respect thereto. The term “guarantee,” when
      used as a verb, shall mean to provide a guarantee.

     

    “Guarantee” means any guarantee of the obligations of the Issuer under this Indenture and the Securities by any Person in accordance with the provisions of this Indenture.

     

    “Guarantor” means any Person that Incurs a Guarantee pursuant to Section 4.10; provided, however, that upon the release or discharge of
      such Person from its Guarantee in accordance with this Indenture, such Person ceases to be a Guarantor.

     

    “Hedging Obligations” means, with respect to any Person, the obligations of such Person under:

     

    (1)          currency exchange, interest rate or commodity swap agreements, currency exchange, interest rate or commodity cap agreements and currency exchange, interest rate or commodity collar
      agreements; and

     

    (2)          other agreements or arrangements designed to protect such Person against fluctuations in currency exchange, interest rates or commodity prices or to otherwise manage interest rate risk or
      currency exchange risk.

     

    “Holder” means the Person in whose name a Security is registered on the Registrar’s books.

     

    “Immaterial Subsidiary” means, at any time, any Subsidiary of the Issuer that (x) has not Incurred any Indebtedness and (y) has, excluding its Subsidiaries, (i) total assets that are individually less than 2.5% of the
      consolidated total assets of the Issuer and its Subsidiaries in the aggregate and (ii) gross revenues that are individually less than 2.5% of the consolidated gross revenues of the Issuer and its Subsidiaries in the aggregate; provided, however, that if, at any time, the aggregate amount of the consolidated total assets or consolidated gross revenues attributable to all Subsidiaries of the Issuer
      that would otherwise be Immaterial Subsidiaries exceeds 5.0% in the aggregate of the consolidated total assets or consolidated gross revenues, respectively, of the Issuer and its Subsidiaries, only those Immaterial Subsidiaries with the smallest
      percentage of assets (not exceeding 5.0% in the aggregate of the consolidated total assets of the Issuer and its Subsidiaries) shall constitute Immaterial Subsidiaries.

     

    
      17

      
        

    

    “Incur” means issue, assume, guarantee, incur or otherwise become liable for; provided, however, that any Indebtedness or Capital Stock
      of a Person existing at the time such Person becomes a Subsidiary (whether by merger, amalgamation, consolidation, acquisition or otherwise) shall be deemed to be Incurred by such Person at the time it becomes a Subsidiary; and “Incurrence” has a
      correlative meaning.

     

    “Indebtedness” means, with respect to any Person:

     

    (1)          the principal and premium (if any) of any indebtedness of such Person, whether or not contingent, (a) in respect of borrowed money, (b) evidenced by bonds, notes, debentures or similar
      instruments or letters of credit or bankers’ acceptances (or, without duplication, reimbursement agreements in respect thereof), (c) representing the deferred and unpaid purchase price of any property (except (i) any such balance that constitutes a
      trade payable or similar obligation to a trade creditor Incurred in the ordinary course of business and (ii) any liabilities accrued in the ordinary course of business), which purchase price is due more than twelve months after the date of placing
      the property in service or taking delivery and title thereto, (d) in respect of Capitalized Lease Obligations or (e) representing any Hedging Obligations, if and solely to the extent that any of the foregoing indebtedness (other than letters of
      credit and Hedging Obligations) would appear as a liability on a balance sheet (excluding the footnotes thereto) of such Person prepared in accordance with GAAP;

     

    (2)          to the extent not otherwise included under clause (1) above and without duplication, any obligation of such Person to be liable for, or to pay, as obligor, guarantor or otherwise, on the
      Indebtedness of another Person (other than by endorsement of negotiable instruments for collection in the ordinary course of business); and

     

    (3)          to the extent not otherwise included under clause (1) above and without duplication, Indebtedness of another Person secured by a Lien on any asset owned by such Person (whether or not such
      Indebtedness is assumed by such Person); provided, however, that the amount of such Indebtedness will be the lesser of: (a) the Fair Market Value (as determined in
      good faith by such Person) of such asset at such date of determination; and (b) the amount of such Indebtedness of such other Person;

     

    provided, however, that notwithstanding the foregoing, Indebtedness shall be deemed not to
        include: (i) Contingent Obligations incurred in the ordinary course of business and not in respect of borrowed money; (ii) deferred or prepaid revenues; (iii) purchase price holdbacks in respect of a portion of the purchase price of an asset to
        satisfy warranty or other unperformed obligations of the respective seller; (iv) any earn-out obligations, contingent consideration, purchase price adjustments, deferred purchase money amounts, repayment obligations, milestone or bonus payments
        (whether performance or time-based), and royalty, licensing, revenue or profit sharing arrangements, in each case, characterized as such and arising expressly out of purchase and sale contracts, development arrangements or licensing arrangements;
        (v) deferred compensation; (vi) accrued expenses; or (vii) obligations in respect of Preferred Stock that does not have any of the features set forth in the definition of “Disqualified Stock”.

     

    
      18

      
        

    

    Notwithstanding anything in this Indenture to the contrary, Indebtedness shall not include, and shall be calculated without giving effect to, the effects of Accounting Standards Codification section 815 and related
      interpretations to the extent such effects would otherwise increase or decrease the amount of Indebtedness deemed outstanding for purposes of this Indenture (so that such outstanding amount differs from the principal amount of such Indebtedness
      payable at maturity) as a result of accounting for any embedded derivatives created by the terms of such Indebtedness; and any such amounts that would have constituted Indebtedness under this Indenture but for the application of this sentence shall
      not be deemed an Incurrence of Indebtedness under this Indenture.

     

    “Indenture” means this Indenture, as amended, restated or supplemented from time to time.

     

    “Independent Financial Advisor” means an accounting, appraisal or investment banking firm or consultant, in each case of recognized standing in the United States, that is, in the good faith determination of the Issuer,
      qualified to perform the task for which it has been engaged.

     

    “Intellectual Property” means, with respect to any Person, all intellectual property and proprietary rights in any jurisdiction throughout the world, and all corresponding rights, presently or hereafter existing,
      including: (i) all inventions (whether or not patentable or reduced to practice), all improvements thereto, and all patents, patent applications, industrial designs, industrial design applications, and patent disclosures, together with all reissues,
      continuations, continuations-in-part, revisions, divisionals, extensions, and reexaminations in connection therewith; (ii) all trademarks, trademark applications, tradenames, servicemarks, servicemark applications, trade dress, logos and designs,
      business names, company names, Internet domain names, and all other indicia of origin, all applications, registrations, and renewals in connection therewith, and all goodwill associated with any of the foregoing; (iii) all copyrights and other works
      of authorship, mask works, database rights and moral rights, and all applications, registrations, and renewals in connection therewith; (iv) all trade secrets, know-how, technologies, processes, techniques, new drug applications, abbreviated new drug
      applications, biologic license applications or 351(k) biologic license applications (or equivalent non-U.S. applications of any of the foregoing), protocols, methods, industrial models, designs, drawings, plans, specifications, research and
      development, biological, chemical, pharmacological, biochemical, toxological, pharmaceutical, physical and analytical, safety, quality control, manufacturing, technical, preclinical and clinical data (in each case, whether or not included in any
      regulatory filing) and confidential information (including technical information, customer and supplier lists, manufacturing processes, protocols and methods, pricing and cost information, and business and marketing plans and proposals); (v) all
      software (including source code, executable code, data, databases, and related documentation); (vi) all rights of privacy and publicity, including rights to the use of names, likenesses, images, voices, signatures and biographical information of real
      persons; and (vii) all copies and tangible embodiments or descriptions of any of the foregoing (in whatever form or medium).

     

    
      19

      
        

    

    “Intercreditor Agreement” means any intercreditor agreement, substantially in the form of Exhibit D, among the holders of First Priority Lien Obligations or their Representative(s), the Trustee or the Collateral Agent,
      the Issuer and each Guarantor that may be party thereto from time to time, as it may be amended from time to time in accordance with this Indenture.

     

    “Intercreditor Collateral” means ABL Collateral in which the Noteholder Secured Parties have a Lien.

     

    “Investment Grade Securities” means:

     

    (1)          securities issued or directly and fully guaranteed or insured by the U.S. government or any agency or instrumentality thereof (other than Cash Equivalents);

     

    (2)          securities that have a rating equal to or higher than “Baa3” (or equivalent) by Moody’s or “BBB-” (or equivalent) by S&P, or an equivalent rating by any other Rating Agency, but
      excluding any debt securities or loans or advances between and among the Issuer and its Subsidiaries;

     

    (3)          investments in any fund that invests exclusively in investments of the type described in clauses (1) and (2) above, which fund may also hold immaterial amounts of cash pending investment
      or distribution; and

     

    (4)          corresponding instruments in countries other than the United States customarily utilized for high quality investments and in each case with maturities not exceeding two years from the date
      of acquisition.

     

    “Investments” means, with respect to any Person, all investments by such Person in other Persons (including Affiliates) in the form of loans (including guarantees), advances or capital contributions (excluding accounts
      receivable, trade credit and advances to customers and commission, travel and similar advances to officers, employees and consultants made in the ordinary course of business), purchases or other acquisitions for consideration of Indebtedness, Equity
      Interests or other securities issued by any other Person and investments that are required by GAAP to be classified on the balance sheet of the Issuer in the same manner as the other investments included in this definition to the extent such
      transactions involve the transfer of cash or other property. Except as otherwise provided in this Indenture, the outstanding amount of any Investment shall be deemed to be the initial cost of such Investment when made, purchased or acquired (without
      giving effect to any adjustments for subsequent increases or decreases in value), but giving effect to any repayments, interest, returns, profits, dividends, distributions, proceeds, fees, income and other amounts actually received by the Issuer or
      any Restricted Subsidiary of the Issuer in respect of such Investment and determined without regard to any write-downs or write-offs of any investments, loans or advances in connection therewith. For purposes of the definition of “Unrestricted
      Subsidiary” and Section 4.04:

     

    (1)          “Investments” shall include the portion (proportionate to the Issuer’s equity interest in such Subsidiary) of the Fair Market Value (as determined in good faith by the Issuer) of the net
      assets of a Subsidiary of the Issuer at the time that such Subsidiary is designated an Unrestricted Subsidiary or ceases to be a Subsidiary (to the extent the Issuer retains an Investment in such Person); and

     

    
      20

      
        

    

    (2)          any property transferred to or from an Unrestricted Subsidiary shall be valued at its Fair Market Value (as determined in good faith by the Issuer) at the time of such transfer, in each
      case as determined in good faith by the Board of Directors of the Issuer.

     

    “IRS” means the U.S. Internal Revenue Service.

     

    “Issue Date” means July 15, 2019.

     

    “Issuer” has the meaning set forth in the preamble hereof but, for the avoidance of doubt, shall not include any of its Subsidiaries.

     

    “Libervant” means the product referred to as Libervant (whether marketed under such name or any other name).

     

    “Libervant License” means an exclusive license of (or similar arrangement with respect to) the Issuer’s Intellectual Property to a Person (other than any Affiliate of the Issuer) for the development or commercialization
      of Libervant in the United States.

     

    “Lien” means, with respect to any asset, any mortgage, lien, pledge, charge, security interest or encumbrance of any kind in respect of such asset, whether or not filed, recorded or otherwise perfected under applicable
      law (including any conditional sale or other title retention agreement, any lease in the nature thereof, any option or other agreement to sell, or give a security interest in, such asset and any filing of or agreement to give any financing statement
      under the Uniform Commercial Code (or equivalent statutes of any jurisdiction)); provided that in no event shall an operating lease be deemed to constitute a Lien.

     

    “Lockbox Account” means any Deposit Account maintained at a depository institution whose customer deposits are insured by the Federal Deposit Insurance Corporation (to the extent required by law) or a similar institution
      in a jurisdiction other than the United States of America, into which account are paid solely the Proceeds of Inventory and Accounts that constitute ABL Collateral. All capitalized terms used in this definition and not defined elsewhere herein have
      the meanings assigned to them in the Uniform Commercial Code.

     

    “Moody’s” means Moody’s Investors Service, Inc. or any successor to the rating agency business thereof.

     

    “Net Income” means, with respect to any Person, the net income (loss) of such Person and its Subsidiaries, determined in accordance with GAAP and before any reduction in respect of Preferred Stock dividends.

     

    
      21

      
        

    

    “Non-Recourse Debt” means Indebtedness as to which (i) neither the Issuer nor any of its Subsidiaries (other than any Royalty Subsidiary) (a) provides credit support of any kind (other than unsecured undertakings in
      respect of representations and warranties and covenants in connection with an Apomorphine Royalty Disposition that are usual and customary in transactions of that kind) or collateral security to secure such Indebtedness, (b) is directly or indirectly
      liable as an obligor, guarantor or otherwise or (c) constitutes the lender or counterparty thereto, (ii) no default with respect to such Indebtedness (including any rights that the holders of the Indebtedness may have to take enforcement action
      against a Royalty Subsidiary) would permit, upon notice, lapse of time or both, any holder of any other Indebtedness (other than the Securities) of the Issuer or its Subsidiaries to declare a default on such other Indebtedness or cause the payment of
      the Indebtedness to be accelerated or payable prior to its stated maturity date and (iii) the lenders have been notified in writing that they will not have any recourse to the stock or assets of the Issuer or any of its Subsidiaries (other than such
      Royalty Subsidiary).

     

    “Noteholder First Lien Collateral” means any and all Notes Collateral other than Intercreditor Collateral.

     

    “Noteholder Obligations” means the Obligations under this Indenture, the Securities and the Security Documents, whether for principal, interest (including interest that, but for the filing of a petition in any proceeding
      under any Bankruptcy Law, would have accrued on any Obligation, whether or not a claim is allowed or allowable for such interest in such proceeding), premium, fees, expenses, indemnification, performance or otherwise.

     

    “Noteholder Secured Parties” means, at any time, the Trustee, the Collateral Agent, each Holder and each other holder of, or obligee in respect of, any Noteholder Obligations outstanding at such time.

     

    “Notes Collateral” means all property subject, or purported to be subject from time to time, to a Lien under any Security Documents, including all Intellectual Property of the Issuer and the Collateral Account; provided, however, that (i) the Notes Collateral does not include the Excluded Assets and (ii) any funds released to the Issuer by the Trustee or other Paying Agent, as
      applicable, from the Collateral Account in accordance with Section 4.06(c)(iii) shall not constitute Notes Collateral and shall be expressly excluded from the definition thereof.

     

    “Obligations” means any principal, interest, penalties, fees, indemnifications, reimbursements (including reimbursement obligations with respect to letters of credit and bankers’ acceptances), damages and other
      liabilities payable under the documentation governing any Indebtedness; provided, however, that Obligations with respect to the Securities shall not include fees,
      expenses or indemnifications in favor of the Trustee and the Collateral Agent or any other third party (other than any Holder).

     

    “Officer” means the Chairman of the Board of Directors, the Chief Executive Officer, the Chief Financial Officer, the President, any Executive Vice President, any Senior Vice President, any Vice President, the
      Controller, the Treasurer or the Secretary or Assistant Secretary of the Issuer.

     

    “Officers’ Certificate” means a certificate signed on behalf of the Issuer by two Officers of the Issuer, one of whom must be the principal executive officer, the principal financial officer, the treasurer or the
      principal accounting officer of the Issuer that meets the requirements set forth in this Indenture.

     

    
      22

      
        

    

    “Opinion of Counsel” means a written opinion from legal counsel who is acceptable to the Trustee and may be an employee of or counsel to the Issuer or the Trustee.

     

    “Original Securities” means the Issuer’s 12.5% Senior Secured Notes due 2025 issued on the Issue Date pursuant to Section 2.01(b).

     

    “Patent and Trademark Agreements” means each patent collateral agreement and trademark collateral agreement executed (and, if necessary, notarized) and delivered by a Grantor to the Collateral Agent to evidence or
      perfect the Collateral Agent’s Lien in such Grantor’s Intellectual Property.

     

    “Permitted Asset Sale” means:

     

    (1)          a Disposition of (i) Cash Equivalents or Investment Grade Securities, (ii) obsolete, damaged or worn-out assets, property or equipment in the ordinary course of business (including the
      abandonment or other Disposition of Intellectual Property that is, in the reasonable judgment of the Issuer, no longer economically practicable or commercially reasonable to maintain or useful in any material respect, taken as a whole, in the conduct
      of the business of the Issuer and its Restricted Subsidiaries taken as a whole), (iii) Inventory (as defined in the Uniform Commercial Code) or goods (or other assets) held for sale in the ordinary course of business or (iv) equipment or other assets
      as part of a trade-in for replacement equipment;

     

    (2)          the Disposition of all or substantially all of the assets of the Issuer in a manner permitted pursuant to Section 5.01 or any Disposition that constitutes a Change of Control;

     

    (3)          any Restricted Payment that is permitted to be made, and is made, under Section 4.04 or any Permitted Investment;

     

    (4)          any Disposition of assets or issuance or sale of Equity Interests of the Issuer or any Restricted Subsidiary, which assets or Equity Interests so Disposed or issued have an aggregate Fair
      Market Value (as determined in good faith by the Issuer) of less than $250,000;

     

    (5)          any Disposition of property or assets, or the issuance of securities, (i) by a Restricted Subsidiary to the Issuer or (ii) by the Issuer or a Restricted Subsidiary to a Guarantor (or to an
      entity that contemporaneously therewith becomes a Guarantor);

     

    (6)          any exchange of assets (including a combination of assets and Cash Equivalents) (other than Intellectual Property) for assets related to a Similar Business of comparable or greater market
      value or usefulness to the business of the Issuer and its Restricted Subsidiaries as a whole, as determined in good faith by the Issuer, which in the event of an exchange of assets with a Fair Market Value in excess of (A) $250,000 shall be evidenced
      by an Officers’ Certificate and (B) $500,000 shall be set forth in a resolution approved by a majority of the Board of Directors of the Issuer, evidenced by an Officers’ Certificate certifying as to such approval;

     

    
      23

      
        

    

    (7)          any sale of Equity Interests in, or Indebtedness or other securities of, an Unrestricted Subsidiary;

     

    (8)          the lease, assignment or sublease of any real or personal property in the ordinary course of business;

     

    (9)          any license, collaboration agreement, strategic alliance or similar arrangement in the ordinary course of business providing for the licensing of Intellectual Property or the development
      or commercialization of Intellectual Property (except in each case for a Libervant License, unless the Issuer has received the written consent of the Holders of a majority in principal amount of the Securities then outstanding, it being understood
      that the Holders shall respond in a reasonably timely manner to any written request for such consent and such consent shall not otherwise be unreasonably withheld, conditioned or delayed) that, at the time of such license, collaboration agreement,
      strategic alliance or similar arrangement, does not materially and adversely affect the Issuer’s business, condition (financial or otherwise) or prospects or the value of the Notes Collateral, taken as a whole; provided,
      that no Event of Default has occurred and is continuing;

     

    (10)        any surrender or waiver of contract rights or the settlement of, release of, recovery on or surrender of contract, tort or other claims of any kind;

     

    (11)        in the ordinary course of business, any swap of assets, or lease, assignment or sublease of any real or personal property, in each case, other than Intellectual Property, in exchange for
      services (including in connection with any outsourcing arrangements) of comparable or greater value or usefulness to the business of the Issuer and its Restricted Subsidiaries taken as a whole, as determined in good faith by the Issuer;

     

    (12)        the incurrence of Permitted Liens;

     

    (13)        any Disposition of Capital Stock of any Restricted Subsidiary pursuant to an agreement or other obligation with or to a Person (other than the Issuer or a Restricted Subsidiary of the
      Issuer) from whom such Restricted Subsidiary was acquired or from whom such Restricted Subsidiary acquired its business and assets (having been newly formed in connection with such acquisition), made as part of such acquisition and in each case
      comprising all or a portion of the consideration in respect of such sale or acquisition;

     

    (14)        Dispositions of receivables in connection with the compromise, settlement or collection thereof in the ordinary course of business or in bankruptcy or similar proceedings and exclusive of
      factoring or similar arrangements;

     

    (15)        the issuance of Disqualified Stock pursuant to Section 4.03;

     

    (16)        the Disposition resulting from any involuntary loss of title or damage to, involuntary loss or destruction of, or condemnation or other taking of, any property or assets of the Issuer or
      any Restricted Subsidiary; and

     

    
      24

      
        

    

    (17)        voluntary terminations, transitions, sales or other dispositions of Hedging Obligations.

     

    “Permitted Holders” means, at any time, each of Mr. Douglas Bratton, Bratton Capital Management L.P., MRX Partners, LLC, Monoline R.X., L.P., Monoline II R.X., L.P. and Monoline III R.X., L.P.

     

    “Permitted Investments” means:

     

    (1)          any Investment in the Issuer or any Restricted Subsidiary; provided, that any Notes Collateral may be transferred pursuant to this clause (1) only
      to a Restricted Subsidiary that is a Guarantor;

     

    (2)          any Investment in Cash Equivalents or Investment Grade Securities;

     

    (3)          any Investment by the Issuer or any Restricted Subsidiary of the Issuer in a Person if as a result of such Investment (a) such Person becomes a Guarantor or (b) such Person, in one
      transaction or a series of related transactions, is merged, amalgamated or consolidated with or into, or transfers or conveys all or substantially all of its assets to, or is liquidated into, the Issuer or a Guarantor;

     

    (4)          any Investment in securities or other assets not constituting Cash Equivalents and received in connection with a Permitted Asset Sale;

     

    (5)          any Investment existing on, or made pursuant to binding commitments existing on, the Issue Date or an Investment consisting of any extension, modification or renewal of any Investment
      existing on the Issue Date; provided that the amount of any such Investment may be increased as required by the terms of such Investment as in existence on the Issue Date;

     

    (6)          advances to employees not in excess of $100,000 outstanding at any one time in the aggregate;

     

    (7)          any Investment acquired by the Issuer or any of its Restricted Subsidiaries (a) in exchange for any other Investment or accounts receivable held by the Issuer or any such Restricted
      Subsidiary in connection with or as a result of a bankruptcy, workout, reorganization or recapitalization of the issuer of such other Investment or accounts receivable, (b) as a result of a foreclosure by the Issuer or any of its Restricted
      Subsidiaries with respect to any secured Investment or other transfer of title with respect to any secured Investment in default or (c) in settlement of or other resolution of claims or disputes, and, in each case, extensions, modifications and
      renewals thereof;

     

    (8)          Hedging Obligations permitted under Section 4.03(b)(x);

     

    (9)          Investments by the Issuer or any of its Restricted Subsidiaries having an aggregate Fair Market Value, taken together with all other Investments made pursuant to this clause (9) that are
      at that time outstanding, not to exceed $1,000,000 (with the Fair Market Value of each Investment being measured at the time made and without giving effect to subsequent changes in value); provided, however, that if any Investment pursuant to this clause (9) is made in any Person that is not a Restricted Subsidiary at the date of the making of such Investment and such Person becomes a Restricted Subsidiary
      after such date, such Investment shall thereafter be deemed to have been made pursuant to clause (1) above and shall cease to have been made pursuant to this clause (9) for so long as such Person continues to be a Restricted Subsidiary;

     

    
      25

      
        

    

    (10)        loans and advances to officers, directors and employees for business-related travel expenses, moving expenses and other similar expenses, in each case Incurred in the ordinary course of
      business or consistent with past practice or to fund such person’s purchase of Equity Interests of the Issuer or any direct or indirect parent of the Issuer, not to exceed $500,000 at any one time outstanding pursuant to this clause (10);

     

    (11)        Investments the payment for which consists of Equity Interests of the Issuer (other than Disqualified Stock) or any direct or indirect parent of the Issuer, as applicable; provided, however, that such Equity Interests will not increase the amount available for Restricted Payments under clause (3) of the definition of “Cumulative Credit”;

     

    (12)        any transaction to the extent it constitutes an Investment that is permitted by and made in accordance with the provisions of Section 4.07(b) (except transactions described in clauses (ii),
      (iv), (v), (viii)(B) or (ix) of such Section);

     

    (13)        Investments consisting of the licensing of Intellectual Property or collaboration agreements, strategic alliances or similar arrangements in respect of Intellectual Property, in each case,
      for the development or commercialization of Intellectual Property (except in each case for a Libervant License, unless the Issuer has received the written consent of the Holders of a majority in principal amount of the Securities then outstanding, it
      being understood that the Holders shall respond in a reasonably timely manner to any written request for such consent and such consent shall not otherwise be unreasonably withheld, conditioned or delayed) that, at the time such license, collaboration
      agreement, strategic alliance or similar arrangement is entered into, does not materially and adversely affect the Issuer’s business, condition (financial or otherwise) or prospects or the value of the Notes Collateral, taken as a whole; provided, that no Event of Default has occurred and is continuing;

     

    (14)        guarantees issued in accordance with Sections 4.03 and 4.10, including any guarantee or other obligation Incurred under any Credit Agreement in connection with any letter of credit issued
      for the account of the Issuer or any of its Subsidiaries (including with respect to the issuance of, or payments in respect of drawings under, such letters of credit);

     

    (15)        Investments consisting of or to finance purchases and acquisitions of inventory, supplies, materials, services or equipment or purchases of contract rights or licenses or leases of
      Intellectual Property (except in each case for a Libervant License, unless the Issuer has received the written consent of the Holders of a majority in principal amount of the Securities then outstanding, it being understood that the Holders shall
      respond in a reasonably timely manner to any written request for such consent and such consent shall not otherwise be unreasonably withheld, conditioned or delayed); provided, in the case of such a license or
      lease of Intellectual Property, that no Event of Default has occurred and is continuing;

     

    
      26

      
        

    

    (16)        loans and advances relating to indemnification or reimbursement of any officers, directors or employees in respect of liabilities relating to their serving in such capacity;

     

    (17)        (i) lease, utility and other similar deposits and (ii) prepaid expenses, negotiable instruments held for collection and lease, utility and workers’
        compensation, performance and other similar deposits, in each case, in the ordinary course of business;

     

    (18)        any redemption or repurchase of the Securities permitted and made in accordance with the terms of this Indenture;

     

    (19)        Investments consisting of earnest money deposits required in connection with a purchase agreement, or letter of intent, or other acquisitions to the extent not otherwise prohibited by this
      Indenture;

     

    (20)        Investments of a Restricted Subsidiary of the Issuer acquired after the Issue Date or of an entity merged into, amalgamated with, or consolidated with a Restricted Subsidiary of the Issuer
      in a transaction that is not prohibited by Article 5 after the Issue Date to the extent that such Investments were not made in contemplation of such acquisition, merger, amalgamation or consolidation and were in existence on the date of such
      acquisition, merger, amalgamation or consolidation;

     

    (21)        any Investment in any Restricted Subsidiary of the Issuer or any joint venture in connection with intercompany cash management arrangements or related activities arising in the ordinary
      course of business;

     

    (22)        Investments by the Issuer and its Restricted Subsidiaries consisting of deposits, prepayments and other credits to suppliers or landlords, and guaranties of business obligations owed to
      landlords, suppliers, customers, franchisees and licensees of the Issuer and its Subsidiaries; and

     

    (23)        any Investment in connection with a Sale/Leaseback Transaction not prohibited by this Indenture.

     

    In the event that any Investment (or any portion thereof) meets the criteria of more than one
        of the categories of Permitted Investments described in clauses (1) through (23) above, or is entitled to be Incurred or made pursuant to Section 4.04, the Issuer shall, in its sole discretion, classify or reclassify, or later divide, classify or
        reclassify, such Investment (or any portion thereof) in any manner that complies with such categories above or Section 4.04. In addition, at the time of Incurrence or making of any Investment, the Issuer shall be entitled to divide and classify
        such Investment in more than one of the categories of Permitted Investments described above or described in Section 4.04.

     

    
      27

      
        

    

    “Permitted Liens” means, with respect to any Person:

     

    (1)          pledges or deposits by such Person under workmen’s compensation laws, unemployment insurance laws or similar legislation, or good faith deposits in connection with bids, tenders, contracts
      (other than for the payment of Indebtedness) or leases to which such Person is a party, or deposits to secure public or statutory obligations of such Person or deposits of cash or U.S. government bonds to secure surety or appeal bonds to which such
      Person is a party, or deposits as security for taxes, assessments or other governmental charges being contested in good faith by appropriate proceedings or for the payment of rent, in each case Incurred in the ordinary course of business;

     

    (2)          Liens imposed by law, such as carriers’, warehousemen’s and mechanics’ Liens, in each case for sums not overdue for more than 30 days or being contested in good faith by appropriate
      proceedings or other Liens arising out of judgments or awards against such Person with respect to which such Person shall then be proceeding with an appeal or other proceedings for review;

     

    (3)          Liens for taxes, assessments or other governmental charges not yet due or payable or subject to penalties for nonpayment or that are being contested in good faith by appropriate
      proceedings if adequate reserves with respect thereto are maintained on the books of such Person in accordance with GAAP;

     

    (4)          Liens in favor of issuers of performance and surety bonds or bid bonds or with respect to other regulatory requirements or letters of credit issued pursuant to the request of and for the
      account of such Person in the ordinary course of its business (including any Liens securing Indebtedness permitted to be Incurred pursuant to Section 4.03(b)(v) and Section 4.03(b)(xi));

     

    (5)          minor survey exceptions, minor encumbrances, easements or reservations of, or rights of others for, licenses, rights-of-way, sewers, electric lines, telegraph and telephone lines and other
      similar purposes, or zoning or other restrictions as to the use of real properties or title defects or Liens incidental to the conduct of the business of such Person or to the ownership of its properties that were not Incurred in connection with
      Indebtedness and that do not in the aggregate materially adversely affect the value of said properties or materially impair their use in the operation of the business of such Person;

     

    (6)          (A) Liens on the ABL Collateral securing Indebtedness permitted to be Incurred pursuant to Section 4.03(b)(i) and ABL Obligations related thereto, which Liens shall be subject to the
      Intercreditor Agreements, and (B) Liens securing Indebtedness permitted to be Incurred pursuant to Section 4.03(b)(iv) and Section 4.03(b)(xv) (provided that in the case of such Section 4.03(b)(xv) such Lien
      applies solely to acquired property or assets of the acquired entity, as the case may be);

     

    (7)          (A) Liens existing on the Issue Date, (B) Liens securing the Securities or the Guarantees, including Liens arising under or relating to the Security Documents, and (C) the Lien securing
      the Issuer’s and the Guarantors’ payment obligations under Section 7.06;

     

    
      28

      
        

    

    (8)          Liens on assets, property or shares of stock of a Person at the time such Person becomes a Subsidiary; provided, however, that such Liens are not created or Incurred in connection with, or in contemplation of, such other Person becoming such a Subsidiary; provided, further,
      however, that such Liens may not extend to any other property owned by the Issuer or any Restricted Subsidiary of the Issuer;

     

    (9)          Liens on assets or property at the time the Issuer or a Restricted Subsidiary of the Issuer acquired the assets or property, including any acquisition by means of a merger, amalgamation or
      consolidation with or into the Issuer or any Restricted Subsidiary of the Issuer; provided, however, that such Liens are not created or Incurred in connection with,
      or in contemplation of, such acquisition; provided, further, however, that the Liens may not extend to any other property
      owned by the Issuer or any Restricted Subsidiary of the Issuer;

     

    (10)        Liens securing Indebtedness or other obligations of a Restricted Subsidiary owing to the Issuer or a Guarantor permitted to be Incurred in accordance with Section 4.03;

     

    (11)        Liens securing Hedging Obligations not Incurred in violation of this Indenture; provided that with respect to Hedging Obligations relating to
      Indebtedness, such Lien extends only to the property securing such Indebtedness;

     

    (12)        Liens on specific items of inventory or other goods and proceeds of any Person securing such Person’s obligations in respect of bankers’ acceptances issued or created for the account of
      such Person to facilitate the purchase, shipment or storage of such inventory or other goods;

     

    (13)        leases and subleases of real property that do not materially interfere with the ordinary conduct of the business of the Issuer or any of its Restricted Subsidiaries;

     

    (14)        Liens arising from Uniform Commercial Code financing statement filings regarding operating leases entered into by the Issuer and its Restricted Subsidiaries in the ordinary course of
      business;

     

    (15)        Liens in favor of the Issuer or any Guarantor;

     

    (16)        deposits made in the ordinary course of business to secure liability to insurance carriers;

     

    (17)        Liens on the Equity Interests of Unrestricted Subsidiaries;

     

    (18)        any license, collaboration agreement, strategic alliance or similar arrangement providing for the licensing of Intellectual Property or the development or commercialization of Intellectual
      Property (except in each case for a Libervant License, unless the Issuer has received the written consent of the Holders of a majority in principal amount of the Securities then outstanding, it being understood that the Holders shall respond in a
      reasonably timely manner to any written request for such consent and such consent shall not otherwise be unreasonably withheld, conditioned or delayed) that, at the time of the grant thereof, does not materially and adversely affect the Issuer’s
      business, condition (financial or otherwise) or prospects or the value of the Notes Collateral taken as a whole; provided, that no Event of Default has occurred and is continuing;

     

    
      29

      
        

    

    (19)        Liens to secure any refinancing, refunding, extension, renewal or replacement (or successive refinancings, refundings, extensions, renewals or replacements) as a whole, or in part, of any
      Indebtedness (“Refinancing Secured Indebtedness”) secured by any Lien referred to in the foregoing clauses (6)(B) (in the case of Liens to secure any Refinancing Secured Indebtedness under such clause (6)(B), such Liens shall be deemed to have also
      been incurred under such clause (6)(B), and not this clause (19), for purposes of determining amounts outstanding under such clause (6)(B)), (7), (8) and (9); provided, however,
      that (w) such new Lien shall be limited to all or part of the same property that secured (or, under the written arrangements under which the original Lien arose, could secure) the Lien then securing such Indebtedness being refinanced, refunded,
      extended, renewed or replaced (plus improvements, accessions, proceeds, dividends or distributions in respect thereof), (x) the Indebtedness secured by such Lien at such time is not increased to any amount greater than the sum of (a) the outstanding
      principal amount or, if greater, committed amount of the Indebtedness described under such clauses (6)(B), (7), (8) and (9) at the time the original Lien became a Permitted Lien under this Indenture, and (b) an amount necessary to pay any fees and
      expenses, including premiums, related to such refinancing, refunding, extension, renewal or replacement, (y) any refinancing, refunding, extension, renewal or replacement (or successive refinancings, refundings, extensions, renewals or replacements)
      as a whole, or in part, of any Indebtedness secured by any Lien referred to in clause 7(B) above shall, at the election of the Issuer, be secured by and entitled to the benefits of the Security Documents and rank pari
        passu with the Indebtedness that is refinanced, refunded, extended, renewed or replaced and (z) any Lien securing the Refinancing Secured Indebtedness shall have a priority relative to the Liens securing the Securities and the Guarantees
      that is not greater than the relative priority of the Lien securing the Indebtedness that is refinanced, refunded, extended, renewed or replaced;

     

    (20)        Liens on equipment of the Issuer or any Restricted Subsidiary granted in the ordinary course of business to the Issuer’s or such Restricted Subsidiary’s client at which such equipment is
      located;

     

    (21)        judgment and attachment Liens not giving rise to an Event of Default and notices of lis pendens and associated rights related to litigation being contested in good faith by appropriate
      proceedings and for which adequate reserves have been made;

     

    (22)        Liens arising out of conditional sale, title retention, consignment or similar arrangements for the sale of goods entered into in the ordinary course of business;

     

    (23)        Liens Incurred to secure cash management services or to implement cash pooling arrangements in the ordinary course of business that do not, individually or in the aggregate, materially
      impair the value of the Notes Collateral;

     

    
      30

      
        

    

    (24)        any encumbrance or restriction (including put and call arrangements) with respect to Capital Stock of any joint venture or similar arrangement pursuant to any joint venture or similar
      agreement; provided, however, that this clause (24) shall not apply to any Liens securing Indebtedness;

     

    (25)        any amounts held by a trustee in the funds and accounts under an indenture securing any revenue bonds issued for the benefit of the Issuer or any Restricted Subsidiary;

     

    (26)        Liens arising by virtue of any statutory or common law provisions relating to banker’s Liens, rights of set-off or similar rights and remedies as to Deposit Accounts (as defined in the
      Uniform Commercial Code) or other funds maintained with a depository or financial institution;

     

    (27)        Liens on property subject to any Sale/Leaseback Transactions not prohibited under this Indenture;

     

    (28)        Liens that secure Indebtedness Incurred in the ordinary course of business not to exceed $250,000 at any one time outstanding;

     

    (29)        any interest of title of a lessor under any lease of real or personal property;

     

    (30)        Liens on the identifiable proceeds of any property or asset subject to a Lien otherwise constituting a Permitted Lien;

     

    (31)        Apomorphine License Transactions that comply with Section 4.06(b); and

     

    (32)        Liens arising on any real property as a result of eminent domain, condemnation or similar proceedings against such property.

     

    For purposes of determining compliance with this definition, (a) Permitted Liens need not be incurred solely by reference to one category of Permitted Liens described above but are permitted to be incurred in part under
      any combination thereof and (b) in the event that a Lien (or any portion thereof) meets the criteria of one or more categories of Permitted Liens described above, the Issuer shall, in its sole discretion, classify (or later reclassify) such item of
      Permitted Liens (or any portion thereof) in any manner that complies with this definition and will only be required to include the amount and type of such item of Permitted Liens in one of the above clauses and such Lien will be treated as having
      been incurred pursuant to only one of such clauses.

     

    “Person” means any individual, corporation, company, partnership, limited liability company, joint venture, association, joint-stock company, trust, unincorporated organization, government or any agency or political
      subdivision thereof or any other entity.

     

    “Preferred Stock” means any Equity Interest with preferential right of payment of dividends or upon liquidation, dissolution or winding up.

     

    
      31

      
        

    

    “Rating Agency” means (i) Moody’s, (ii) S&P or (iii) any “nationally recognized statistical rating organization” within the meaning of Section 3(a)(62) of the Exchange Act selected by the Issuer or any direct or
      indirect parent of the Issuer as a replacement agency for Moody’s or S&P, as the case may be.

     

    “Representative” means the trustee(s), agent(s) or representative(s) (if any) for an issue of Indebtedness; provided, however, that if,
      and for so long as, such Indebtedness lacks such a Representative, then, unless otherwise provided for in the document governing such Indebtedness, the Representative for such Indebtedness shall at all times constitute the holder or holders of a
      majority in outstanding principal amount of obligations under such Indebtedness.

     

    “Restricted Investment” means an Investment other than a Permitted Investment.

     

    “Restricted Subsidiary” means, with respect to any Person, any Subsidiary of such Person other than an Unrestricted Subsidiary of such Person. Unless otherwise indicated in this Indenture, all references to Restricted
      Subsidiaries shall mean Restricted Subsidiaries of the Issuer.

     

    “Royalty Subsidiary” means any Subsidiary of the Issuer that is designated by the Board of Directors of the Issuer as a Royalty Subsidiary pursuant to a resolution of such Board of Directors, but only to the extent that
      such Subsidiary (i) has no Indebtedness other than Non-Recourse Debt, (ii) has no assets other than the assets that are the subject of an Apomorphine Royalty Disposition and is not engaged in any activities other than those related or incidental to
      an Apomorphine Royalty Disposition, (iii) is a Person with respect to which neither the Issuer nor any of its other Subsidiaries has any direct or indirect obligation (a) to subscribe for additional Equity Interests or (b) to maintain or preserve
      such Person’s financial condition or to cause such Person to achieve any specified levels of operating results and (iv) has not guaranteed or otherwise directly or indirectly provided credit support for any Indebtedness of the Issuer or any of its
      other Subsidiaries.

     

    “Royalty Subsidiary Liens” means Liens (i) solely on assets owned by a Royalty Subsidiary that are the subject of an Apomorphine Royalty Disposition securing the Non-Recourse Debt of such Royalty Subsidiary in connection
      with an Apomorphine Royalty Disposition and (ii) solely on the Equity Interests of a Royalty Subsidiary securing the Non-Recourse Debt of such Royalty Subsidiary in connection with an Apomorphine Royalty Disposition; provided that there is no recourse (whether as an obligor, guarantor or otherwise) to, or other credit support provided by, the Issuer or any other Subsidiary (other than unsecured undertakings in respect of representations and
      warranties and covenants in connection with such Apomorphine Royalty Disposition that are usual and customary in transactions of that kind).

     

    “S&P” means S&P Global Ratings or any successor to the rating agency business thereof.

     

    “Sale/Leaseback Transaction” means an arrangement relating to property now owned or acquired after the Issue Date by the Issuer or a Restricted Subsidiary whereby the Issuer or such Restricted Subsidiary transfers such
      property to a Person and the Issuer or such Restricted Subsidiary leases it from such Person, other than leases between the Issuer and a Restricted Subsidiary of the Issuer or between Restricted Subsidiaries of the Issuer.

     

    
      32

      
        

    

    “SEC” means the United States Securities and Exchange Commission or any successor thereto.

     

    “Second Additional Securities” means the Issuer’s 12.5% Senior Secured Notes due 2025 that may be issued after the Issue Date pursuant to Section 2.01(d).

     

    “Second Additional Securities Triggering Event” means the approval of Libervant by the FDA for sale in the United States.

     

    “Secured Bank Indebtedness” means any Bank Indebtedness that is secured, in whole or in part, by a Lien Incurred or deemed Incurred pursuant to clause (6)(A) of the definition of “Permitted Liens”.

     

    “Secured Indebtedness” means any Indebtedness secured, in whole or in part, by a Lien.

     

    “Securities” means the Issuer’s 12.5% Senior Secured Notes due 2025 and shall include, for the avoidance of doubt, the Original Securities issued on the Issue Date and the First Additional Securities and the Second
      Additional Securities that may be issued after the Issue Date, in each case, as and to the extent issued pursuant to the terms and conditions of this Indenture.

     

    “Securities Act” means the United States Securities Act of 1933, as amended, and the rules and regulations of the SEC promulgated thereunder.

     

    “Security Documents” means the security agreements, pledge agreements, mortgages, collateral assignments and related agreements, as amended, supplemented, restated, renewed, refunded, replaced, restructured, repaid,
      refinanced or otherwise modified from time to time, creating, perfecting or otherwise evidencing the security interests granted by the Issuer or any Guarantor in favor of the Collateral Agent in the Notes Collateral as contemplated by this Indenture,
      including the Collateral Agreement and the Patent and Trademark Agreements.

     

    “Similar Business” means a business, the majority of whose revenues are derived from the activities of the Issuer and its Subsidiaries as of the Issue Date or any business or activity that is reasonably similar or
      complementary thereto or a reasonable extension, development or expansion thereof or ancillary or complementary thereto.

     

    “Stated Maturity” means, with respect to any security, the date specified in such security as the fixed date on which the final payment of principal of such security is due and payable, including pursuant to any
      mandatory redemption provision (but excluding any provision providing for the repurchase of such security at the option of the holder thereof upon the happening of any contingency beyond the control of the issuer unless such contingency has
      occurred).

     

    
      33

      
        

    

    “Subordinated Indebtedness” means (a) with respect to the Issuer, any Indebtedness of the Issuer that is (i) unsecured, (ii) by its terms subordinated in right of payment to the Securities or (iii) secured by Liens on
      Notes Collateral ranking junior to the Liens securing the Securities or (b) with respect to any Guarantor, any Indebtedness of such Guarantor that is (i) unsecured, (ii) by its terms subordinated in right of payment to its Guarantee or (iii) secured
      by Liens on Notes Collateral ranking junior to the Liens securing its Guarantee. For the avoidance of doubt, Subordinated Indebtedness shall be deemed to include any Indebtedness reflecting the payment subordination terms set forth in Exhibit F.

     

    “Subsidiary” means, with respect to any Person, (i) any corporation, association or other business entity (other than a partnership, joint venture, limited liability company or similar entity) of which more than 50% of
      the total voting power of shares of Capital Stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at the time of determination owned or controlled, directly or
      indirectly, by such Person or one or more of the other Subsidiaries of that Person or a combination thereof, and (ii) any partnership, joint venture, limited liability company or similar entity of which (a) more than 50% of the capital accounts,
      distribution rights, total equity and voting interests or general and limited partnership interests, as applicable, are owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of that Person or a
      combination thereof, whether in the form of membership, general, special or limited partnership interests or otherwise, or (b) such Person or any Subsidiary of such Person is a controlling general partner or otherwise controls such entity. For
      purposes of clarity, a Subsidiary of a Person shall not include any Person that is under common control with the first Person solely by virtue of having directors, managers or trustees in common and shall not include any Person that is solely under
      common control with the first Person (i.e., a sister company with a common parent).

     

    “TIA” means the Trust Indenture Act of 1939 (15 U.S.C. Sections 77aaa-77bbbb) as interpreted and in effect on the Issue Date; provided, however,
      that in the event the Trust Indenture Act of 1939 is amended or there is a change in its interpretation after the Issue Date, the term “TIA” shall mean, to the extent required by such amendment or such change in interpretation, the Trust Indenture
      Act of 1939, as so amended or interpreted. It is acknowledged that this Indenture will not be qualified under the TIA.

     

    “Treasury Rate” means, in respect of any redemption date, the yield to maturity as of such redemption date of United States Treasury securities with a constant maturity (as compiled and published in the most recent
      Federal Reserve Statistical Release H.15 that has become publicly available at least two Business Days prior to such redemption date (or, if such Federal Reserve Statistical Release H.15 is no longer published, any publicly available source of
      similar market data)) most nearly equal to the period from such redemption date to the First Call Date; provided, that if the period from such redemption date to the First Call Date is less than one year, the
      weekly average yield on actually traded United States Treasury securities adjusted to a constant maturity of one year will be used.

     

    
      34

      
        

    

    “Trust Officer” means:

     

    (1)          any officer within the Corporate Trust Office of the Trustee, including any vice president, assistant vice president, assistant secretary, assistant treasurer, trust officer or any other
      officer of the Trustee to whom any corporate trust matter relating to this Indenture is referred because of such Person’s knowledge of and familiarity with the particular subject; and

     

    (2)          who shall have direct responsibility for the administration of this Indenture.

     

    “Trustee” means the party named as such in this Indenture until a successor replaces it in accordance with the applicable provisions of this Indenture and, thereafter, means such successor.

     

    “Uniform Commercial Code” means the Uniform Commercial Code as in effect from time to time in the State of New York.

     

    “Unrestricted Subsidiary” means:

     

    (1)          any Subsidiary of the Issuer that at the time of determination shall be designated an Unrestricted Subsidiary by the Board of Directors of such Person in the manner provided below; and

     

    (2)          any Subsidiary of an Unrestricted Subsidiary;

     

    provided, however, that, in each case, such Subsidiary does not own, acquire or license any
        Intellectual Property.

     

    The Issuer may designate any Subsidiary of the Issuer (including any newly acquired or newly formed Subsidiary of the Issuer) to be an Unrestricted Subsidiary unless such Subsidiary or any of its Subsidiaries owns any
      Equity Interests or Indebtedness of, or owns or holds any Lien on any property of, the Issuer or any other Subsidiary of the Issuer that is not a Subsidiary of the Subsidiary to be so designated; provided, however, that the Subsidiary to be so designated and its Subsidiaries (i) do not at the time of designation have and do not thereafter Incur any Indebtedness that is guaranteed by the Issuer or any of its
      Restricted Subsidiaries (or that otherwise has recourse to the property or assets of the Issuer or any of its Restricted Subsidiaries) and (ii) do not at the time of designation and do not thereafter guarantee any other Indebtedness of the Issuer or
      any of its Restricted Subsidiaries; provided, further, however, that either:

     

    (a)          the Subsidiary to be so designated has total consolidated assets of $1,000 or less; or

     

    (b)          if such Subsidiary has consolidated assets greater than $1,000, then such designation would be permitted under Section 4.04.

     

    
      35

      
        

    

    The Issuer may designate any Unrestricted Subsidiary to be a Restricted Subsidiary; provided, however, that immediately after giving
      effect to such designation:

     

    (x)          (1) the Issuer could Incur $1.00 of additional Indebtedness pursuant to the Consolidated Leverage Ratio test set forth in Section 4.03(a) or (2) the Consolidated Leverage Ratio for the
      Issuer and its Restricted Subsidiaries would be less than such ratio for the Issuer and its Restricted Subsidiaries immediately prior to such designation, in each case on a pro forma basis taking into account
      such designation; and

     

    (y)          no Event of Default shall have occurred and be continuing.

     

    Any such designation by the Issuer shall be evidenced to the Trustee by promptly filing with the Trustee a copy of the resolution of the Board of Directors of the Issuer or any committee thereof giving effect to such
      designation and an Officers’ Certificate certifying that such designation complied with the foregoing provisions.

     

    “U.S. Government Obligations” means securities that are:

     

    (1)          direct obligations of the United States of America for the timely payment of which its full faith and credit is pledged; or

     

    (2)          obligations of a Person controlled or supervised by and acting as an agency or instrumentality of the United States of America, the timely payment of which is unconditionally guaranteed as
      a full faith and credit obligation by the United States of America,

     

    which, in each case, are not callable or redeemable at the option of the issuer thereof, and shall also include a depository receipt issued by a bank (as defined in Section 3(a)(2) of the Securities Act) as custodian with respect to any such U.S.
      Government Obligations or a specific payment of principal of or interest on any such U.S. Government Obligations held by such custodian for the account of the holder of such depository receipt; provided that
      (except as required by law) such custodian is not authorized to make any deduction from the amount payable to the holder of such depository receipt from any amount received by the custodian in respect of the U.S. Government Obligations or the
      specific payment of principal of or interest on the U.S. Government Obligations evidenced by such depository receipt.

     

    “Voting Stock” of any Person as of any date means the Capital Stock of such Person that is at the time entitled to vote in the election of the Board of Directors of such Person.

     

    “Weighted Average Life to Maturity” means, when applied to any Indebtedness or Disqualified Stock, as the case may be, at any date, the quotient obtained by dividing (i) the sum of the products of the number of years
      from the date of determination to the date of each successive scheduled principal payment of such Indebtedness or redemption or similar payment with respect to such Disqualified Stock multiplied by the amount of such payment, by (ii) the sum of all
      such payments.

     

    “Wholly Owned Restricted Subsidiary” means any Wholly Owned Subsidiary that is a Restricted Subsidiary.

     

    “Wholly Owned Subsidiary” of any Person means a Subsidiary of such Person 100% of the outstanding Capital Stock or other ownership interests of which (other than directors’ qualifying shares or shares required to be held
      by foreign nationals or Subsidiaries not organized or existing under the laws of the United States of America or any state or territory thereof or the District of Columbia) is owned by such Person or by one or more Wholly Owned Subsidiaries of such
      Person.

     

    
      36

      
        

    

    SECTION 1.02.          Other Definitions.

     

    	
            Term

          	
            Defined in Section

          
	
            “Acceleration”

          	
            6.02

          
	
            “Affiliate Transaction”

          	
            4.07(a)

          
	
            “After-Acquired Property”

          	
            4.13

          
	
            “Apomorphine Asset Sale Offer”

          	
            4.06(b)(ii)

          
	
            “Bankruptcy Law”

          	
            6.01

          
	
            “Base Currency”

          	
            12.14(b)(i)

          
	
            “Change of Control Offer”

          	
            4.08(b)

          
	
            “Collateral Account”

          	
            4.06(c)(i)

          
	
            “Confidential Information”

          	
            7.11

          
	
            “Confidential Parties”

          	
            7.11

          
	
            “Consolidated Leverage Calculation Date”

          	
            “Consolidated Leverage Ratio” definition

          
	
            “covenant defeasance option”

          	
            8.01(c)

          
	
            “Custodian”

          	
            6.01

          
	
            “Definitive Security”

          	
            Appendix A

          
	
            “Depository”

          	
            Appendix A

          
	
            “Event of Default”

          	
            6.01

          
	
            “First Call Date”

          	
            Exhibit A

          
	
            “Global Security”

          	
            Appendix A

          
	
            “Guaranteed Obligations”

          	
            10.01(a)

          
	
            “Increased Amount”

          	
            4.11

          
	
            “Judgment Currency”

          	
            12.14(b)(i)

          
	
            “legal defeasance option”

          	
            8.01(c)

          
	
            “Paying Agent”

          	
            2.04(a)

          
	
            “Payment Date”

          	
            Exhibit A

          
	
            “primary obligations”

          	
            “Contingent Obligations” definition

          
	
            “primary obligor”

          	
            “Contingent Obligations” definition

          
	
            “protected purchaser”

          	
            2.08

          
	
            “Purchase Agreements”

          	
            Appendix A

          
	
            “QIB”

          	
            Appendix A

          
	
            “rate(s) of exchange”

          	
            12.14(d)

          
	
            “Record Date”

          	
            Exhibit A

          
	
            “Reference Period”

          	
            “Cumulative Credit” definition

          
	
            “Refinancing Indebtedness”

          	
            4.03(b)(xiv)

          
	
            “Refinancing Secured Indebtedness”

          	
            “Permitted Liens” definition

          
	
            “Refunding Capital Stock”

          	
            4.04(b)(ii)

          
	
            “Registrar”

          	
            2.04(a)

          
	
            “Restricted Payments”

          	
            4.04(a)

          
	
            “Retired Capital Stock”

          	
            4.04(b)(ii)

          
	
            “Second Additional Securities Triggering Event Officers’ Certificate”

          	
            2.01(d)

          
	
            “Securities”

          	
            Preamble

          
	
            “Securities Custodian”

          	
            Appendix A

          
	
            “Security Document Order”

          	
            11.10(i)

          
	
            “Successor Company”

          	
            5.01(a)(i)

          
	
            “Successor Guarantor”

          	
            5.02(a)(i)

          

     

    

    
      37

      
        

    

    SECTION 1.03.   Rules of Construction. Unless the context otherwise requires:

     

    (a)          a term has the meaning assigned to it;

     

    (b)          except as otherwise set forth in this Indenture, all accounting terms used herein shall be interpreted, all accounting determinations hereunder shall be made, and all financial statements
      required to be delivered hereunder shall be prepared in accordance with GAAP as defined herein, and an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP as defined herein;

     

    (c)          the word “or” is not exclusive;

     

    (d)          the word “including” means including without limitation, and any item or list of items set forth following the word “including”, “include” or “includes” in this Indenture is set forth only
      for the purpose of indicating that, regardless of whatever other items are in the category in which such item or items are “included”, such item or items are in such category and shall not be construed as indicating the items in the category in which
      such item or items are “included” are limited to such item or items similar to such items;

     

    (e)          all references in this Indenture to any designated “Article”, “Section”, “Appendix”, “Exhibit”, definition and other subdivision are to the designated Article, Section, Appendix, Exhibit,
      definition and other subdivision, respectively, of this Indenture;

     

    (f)          all references in this Indenture to (i) the words “herein”, “hereof” and “hereunder” and other words of similar import refer to this Indenture as a whole and not to any particular Article,
      Section, Appendix, Exhibit and other subdivision, respectively, and (ii) the term “this Indenture” means this Indenture as a whole, including the Appendix and Exhibits;

     

    (g)          words in the singular include the plural and words in the plural include the singular;

     

    (h)          the principal amount of any non-interest bearing or other discount security at any date shall be the principal amount thereof that would be shown on a balance sheet of the issuer dated
      such date prepared in accordance with GAAP as defined herein;

     

    
      38

      
        

    

    (i)          the principal amount of any Preferred Stock shall be (i) the maximum liquidation value of such Preferred Stock or (ii) the maximum mandatory redemption or mandatory repurchase price with
      respect to such Preferred Stock, whichever is greater;

     

    (j)          “$” and “U.S. Dollars” each refers to United States dollars, or such other money of the United States of America that at the time of payment is legal tender for payment of public and
      private debts;

     

    (k)          the words “asset” or “property” shall be construed to have the same meaning and effect and to refer to any and all tangible and intangible assets and properties, including cash,
      securities, accounts and contract rights;

     

    (l)          unless otherwise specified, all references to an agreement or other document include references to such agreement or document as from time to time amended, restated, reformed, supplemented
      or otherwise modified in accordance with the terms thereof (subject to any restrictions on such amendments, restatements, reformations, supplements or modifications set forth herein);

     

    (m)         all references to any Person shall be construed to include such Person’s successors and permitted assigns (subject to any restrictions on assignment, transfer or delegation set forth
      herein), and any reference to a Person in a particular capacity excludes such Person in other capacities; and

     

    (n)          the word “will” shall be construed to have the same meaning and effect as the word “shall”.

     

    ARTICLE 2

     

    THE SECURITIES

     

    SECTION 2.01.          Amount of Securities.

     

    (a)          The aggregate principal amount of Securities that may be authenticated and delivered under this Indenture is limited to $100,000,000.

     

    (b)          On the Issue Date, the Issuer shall issue and deliver, in accordance with this Article 2, Original Securities in an aggregate principal amount of $70,000,000.

     

    
      39

      
        

    

    (c)          On any Business Day on or prior to March 31, 2021 that does not fall between a Record Date and its related Payment Date (but, for the avoidance of doubt, only one Business Day, but not more than one Business
      Day), the Issuer may issue and deliver, in accordance with this Article 2, with the written consent of the Holders of a majority in principal amount of the Original Securities then outstanding, upon five Business Days’ written notice to the Trustee,
      First Additional Securities in an aggregate principal amount of $10,000,000; provided, that, as of such Business Day, as conditions to the issuance of such First Additional Securities, (i) no Event of Default
      has occurred and is continuing, (ii) the First Additional Securities Triggering Event has occurred and (iii) the Issuer shall deliver to the Trustee, in addition to the written order of the Issuer pursuant to Section 2.03, Officers’ Certificates of
      the Issuer (A) certifying as to the receipt of such written consent of the Holders and the satisfaction of the foregoing clause (i) and clause (ii) and (B) stating that the representations and warranties of the Issuer in the Purchase Agreements are
      true and correct in all material respects on and as of such Business Day with the same force and effect as if expressly made on and as of such Business Day (except for such representations and warranties qualified by materiality or material adverse
      effect, which are true and correct in all respects). Such First Additional Securities shall have the same terms as the Original Securities, except that the issue date, the issue price, the initial Payment Date and the initial date from which interest
      shall accrue may vary. If the Issuer determines that such First Additional Securities are issued as part of a “qualified reopening” for U.S. federal income tax purposes, such First Additional Securities will have the same CUSIP number as the Original
      Securities and for U.S. federal income tax purposes will have the same issue date and issue price as the Original Securities. If the Issuer determines that such First Additional Securities are not issued as part of a “qualified reopening” for U.S.
      federal income tax purposes, such First Additional Securities will be required to have a CUSIP number that is different than the CUSIP number of the Original Securities.

     

    (d)          On any Business Day on or prior to March 31, 2021 that does not fall between a Record Date and its related Payment Date (but, for the avoidance of doubt, only one Business Day, but not more than one Business
      Day), the Issuer may issue and deliver, in accordance with this Article 2, without the consent of any Holder of or any holder of beneficial interests in the Original Securities or any First Additional Securities, upon five Business Days’ written
      notice to the Trustee, Second Additional Securities in an aggregate principal amount of up to $30,000,000; provided, that, as of such Business Day, if the Issuer has issued the First Additional Securities,
      the Issuer may only issue and deliver such Second Additional Securities in an aggregate principal amount of up to $20,000,000; provided, further, that, as of such
      Business Day, as conditions to the issuance of such Second Additional Securities, (i) no Event of Default has occurred and is continuing, (ii) the Second Additional Securities Triggering Event has occurred and (iii) the Issuer shall deliver to the
      Trustee, in addition to the written order of the Issuer pursuant to Section 2.03, Officers’ Certificates of the Issuer (A) certifying as to the satisfaction of the foregoing clause (i) and clause (ii) (the “Second Additional Securities Triggering
      Event Officers’ Certificate”) and (B) stating that the representations and warranties of the Issuer in the Purchase Agreements are true and correct in all material respects on and as of such Business Day with the same force and effect as if expressly
      made on and as of such Business Day (except for such representations and warranties qualified by materiality or material adverse effect, which are true and correct in all respects). Such Second Additional Securities shall have the same terms as the
      Original Securities and any First Additional Securities, except that the issue date, the issue price, the initial Payment Date and the initial date from which interest shall accrue may vary. If the Issuer determines that such Second Additional
      Securities are issued as part of a “qualified reopening” for U.S. federal income tax purposes, such Second Additional Securities will have the same CUSIP number as the Original Securities or any First Additional Securities, as the case may be, and
      for U.S. federal income tax purposes will have the same issue date and issue price as the Original Securities or such First Additional Securities, as the case may be. If the Issuer determines that such Second Additional Securities are not issued as
      part of a “qualified reopening” for U.S. federal income tax purposes, such Second Additional Securities will be required to have a CUSIP number that is different than the CUSIP number of the Original Securities and any First Additional Securities.

     

    
      40

      
        

    

    (e)          The Securities shall be treated as a single class for all purposes under this Indenture, including directions provided to the Trustee pursuant to Section 6.05, waivers, amendments, redemptions and offers to
      purchase, and shall rank on a parity basis in right of payment and security.

     

    SECTION 2.02.   Form and Dating. Provisions relating to the Securities are set forth in Appendix A hereto, which is hereby incorporated in and expressly made a part of this Indenture. The Securities and the
      Trustee’s certificate of authentication shall each be substantially in the form of Exhibit A, which is hereby incorporated in and expressly made a part of this Indenture. The Securities may have notations, legends or endorsements required by law,
      stock exchange rule, agreements to which the Issuer or any Guarantor is subject, if any, or usage (provided that any such notation, legend or endorsement is in a form acceptable to the Issuer). Each Security
      shall be dated the date of its authentication. The Securities shall be issuable only in registered form, without interest coupons, and in minimum denominations of $250,000 and any integral multiple of $1,000 in excess thereof.

     

    SECTION 2.03.   Execution and Authentication. The Trustee shall authenticate and make available for delivery upon a written order of the Issuer signed by one Officer (i) Original Securities for original issue on
      the Issue Date in an aggregate principal amount of $70,000,000, (ii) First Additional Securities for original issue pursuant to Section 2.01(c) and (iii) Second Additional Securities for original issue pursuant to Section 2.01(d). Such order shall
      specify the amount of the Securities to be authenticated, the form in which the Securities are to be authenticated and the date on which the original issue of Securities is to be authenticated.

     

    One Officer shall sign the Securities for the Issuer by manual or facsimile signature.

     

    If an Officer whose signature is on a Security no longer holds that office at the time the Trustee authenticates the Security, the Security shall be valid nevertheless.

     

    A Security shall not be valid until an authorized signatory of the Trustee manually signs the certificate of authentication on the Security. The signature shall be conclusive evidence that the Security has been
      authenticated under this Indenture.

     

    The Trustee may appoint one or more authenticating agents reasonably acceptable to the Issuer to authenticate the Securities. Any such appointment shall be evidenced by an instrument signed by a Trust Officer, a copy of
      which shall be furnished to the Issuer. Unless limited by the terms of such appointment, an authenticating agent may authenticate Securities whenever the Trustee may do so. Each reference in this Indenture to authentication by the Trustee includes
      authentication by such agent. An authenticating agent has the same rights as any Registrar, Paying Agent or agent for service of notices and demands.

     

    SECTION 2.04.   Registrar and Paying Agent.

    

    

    (a)          The Issuer shall maintain (i) an office or agency where Securities may be presented for registration of transfer or for exchange (the “Registrar”) and (ii) an office or agency where Securities may be
      presented for payment (the “Paying Agent”). The Registrar shall keep a register of the Securities and of their transfer and exchange. The Issuer may have one or more co-registrars and one or more additional paying agents. The term “Registrar”
      includes any co-registrars. The term “Paying Agent” includes the Paying Agent and any additional paying agents. The Issuer initially appoints the Trustee as Registrar, Paying Agent and the Securities Custodian with respect to the Global Securities
      and as Registrar and Paying Agent with respect to the Definitive Securities.

     

    
      41

      
        

    

    (b)          The Issuer may enter into an appropriate agency agreement with any Registrar or Paying Agent not a party to this Indenture. The agreement shall implement the provisions of this Indenture that relate to such
      agent. The Issuer shall notify the Trustee of the name and address of any such agent. If the Issuer fails to maintain a Registrar or Paying Agent, the Trustee shall act as such and shall be entitled to appropriate compensation therefor pursuant to
      Section 7.06. The Issuer or any of its domestically organized Wholly Owned Restricted Subsidiaries may act as Paying Agent or Registrar. Upon any Event of Default as described in Section 6.01(e), Section 6.01(f) or Section 6.01(g), the Trustee shall
      automatically be the Paying Agent.

     

    (c)          The Issuer may remove any Registrar or Paying Agent upon written notice to such Registrar or Paying Agent and to the Trustee; provided, however, that no such removal shall become effective until (i) if applicable, acceptance of an appointment by a successor as evidenced by an appropriate agreement entered into by the Issuer and such successor Registrar or Paying
      Agent, as the case may be, and delivered to the Trustee or (ii) notification to the Trustee that the Trustee shall serve as Registrar or Paying Agent until the appointment of a successor in accordance with clause (i) above. The Registrar or Paying
      Agent may resign at any time upon written notice to the Issuer and the Trustee; provided, however, that the Trustee may resign as Paying Agent or Registrar only if
      the Trustee also resigns as Trustee in accordance with Section 7.07.

     

    (d)          The Issuer shall promptly deliver to the Trustee (and any Holder upon written request) following the end of each calendar year a written notice specifying the amount of original issue discount, if any,
      accrued on the outstanding Securities for the previous calendar year, including daily rates and accrual periods, and such other information relating to original issue discount as may be required under the Code and applicable regulations, as amended
      from time to time.

     

    SECTION 2.05.   Paying Agent to Hold Money in Trust. On or prior to each due date of the principal of and interest on any Security, the Issuer shall deposit with each Paying Agent (or if the Issuer or a Wholly
      Owned Restricted Subsidiary is acting as Paying Agent, segregate and hold in trust for the benefit of the Persons entitled thereto) a sum sufficient to pay such principal and interest when so becoming due. The Issuer shall require each Paying Agent
      (other than the Trustee) to agree in writing that a Paying Agent shall act as an agent for or representative of the Trustee, and act solely as directed by the Trustee, in the administration of the Collateral Account. The Issuer shall require each
      Paying Agent (other than the Trustee) to agree in writing that a Paying Agent shall hold in trust for the benefit of Holders or the Trustee all money held by a Paying Agent or in the Collateral Account for the payment of principal of and interest on
      the Securities, and shall notify the Trustee of any default by the Issuer in making any such payment. While any such default continues, the Trustee may require a Paying Agent to pay all money held by it to the Trustee. If the Issuer or a Wholly Owned
      Restricted Subsidiary of the Issuer acts as Paying Agent, it shall segregate the money held by it as Paying Agent and hold it in trust for the benefit of the Persons entitled thereto. Upon any bankruptcy or reorganization proceedings relating to the
      Issuer, the Trustee will serve as Paying Agent if not otherwise so acting. The Issuer at any time may require a Paying Agent to pay all money held by it to the Trustee and to account for any funds disbursed by such Paying Agent. Upon complying with
      this Section 2.05, a Paying Agent shall have no further liability for the money delivered to the Trustee.

     

    
      42

      
        

    

    SECTION 2.06.   Holder Lists. The Trustee shall preserve in as current a form as is reasonably practicable the most recent list available to it of the names and addresses of Holders. If the Trustee is not the
      Registrar, the Issuer shall furnish, or cause the Registrar to furnish, to the Trustee, in writing at least five Business Days before each Payment Date and at such other times as the Trustee may request in writing, a list in such form and as of such
      date as the Trustee may reasonably require of the names and addresses of Holders. The Issuer shall also maintain a copy of such list of the names and addresses of Holders at its registered office.

     

    SECTION 2.07.   Transfer and Exchange. The Securities shall be issued in registered form and shall be transferable only upon the surrender of a Security for registration of transfer and in compliance with
      Appendix A. When a Security is presented to the Registrar with a request to register a transfer, the Registrar shall register the transfer as requested if its requirements therefor are met. When Securities are presented to the Registrar with a
      request to exchange them for an equal principal amount of Securities of other denominations, the Registrar shall make the exchange as requested if the same requirements are met. To permit registration of transfers and exchanges, the Issuer shall
      execute and the Trustee shall authenticate Securities at the Registrar’s request. No service charge will be made for any registration of transfer or exchange of the Securities, but the Issuer may require payment from the Holder of a sum sufficient to
      pay all taxes (including transfer taxes), assessments or other governmental charges in connection with any transfer or exchange pursuant to this Section 2.07. Upon any transfer or exchange, the Registrar and the Trustee may require a Holder, among
      other things, to furnish appropriate endorsements and transfer documents. The Issuer shall not be required to make, and the Registrar need not register, transfers or exchanges of Securities selected for redemption (except, in the case of Securities
      to be redeemed in part, the portion thereof not to be redeemed) or of any Securities for a period of 15 days prior to a selection of Securities to be redeemed.

     

    Prior to the due presentation for registration of transfer of any Security, the Issuer, the Guarantors, the Trustee, the Paying Agent and the Registrar may deem and treat the Person in whose name a Security is registered
      as the absolute owner of such Security for the purpose of receiving payment of principal of and interest, if any, on such Security and for all other purposes whatsoever, whether or not such Security is overdue, and none of the Issuer, any Guarantor,
      the Trustee, the Paying Agent or the Registrar shall be affected by notice to the contrary.

     

    Any holder of a beneficial interest in a Global Security shall, by acceptance of such beneficial interest, agree that transfers of beneficial interests in such Global Security may be effected only through a book-entry
      system maintained by (a) the Holder of such Global Security (or its agent) or (b) any holder of a beneficial interest in such Global Security, and that ownership of a beneficial interest in such Global Security shall be required to be reflected in a
      book entry.

     

    
      43

      
        

    

    All Securities issued upon any transfer or exchange pursuant to the terms of this Indenture shall evidence the same debt and shall be entitled to the same benefits under this Indenture as the Securities surrendered upon
      such transfer or exchange.

     

    SECTION 2.08.   Replacement Securities. If a mutilated Security is surrendered to the Registrar or if the Holder of a Security claims that the Security has been lost, destroyed or wrongfully taken, the Issuer
      shall issue and the Trustee shall authenticate a replacement Security if the requirements of Section 8‐405 of the Uniform Commercial Code are met, such that the Holder (a) satisfies the Issuer or the Trustee within a reasonable time after such Holder
      has notice of such loss, destruction or wrongful taking and the Registrar does not register a transfer prior to receiving such notification, (b) makes such request to the Issuer or the Trustee prior to the Security being acquired by a protected
      purchaser as defined in Section 8‐303 of the Uniform Commercial Code (a “protected purchaser”) and (c) satisfies any other reasonable requirements of the Issuer and the Trustee. If required by the Trustee or the Issuer, such Holder shall furnish an
      indemnity bond sufficient in the judgment of the Trustee to protect the Trustee, the Paying Agent and the Registrar (if the Registrar also serves as the Paying Agent) and of the Issuer to protect the Issuer, each Guarantor, the Paying Agent and the
      Registrar (if the Trustee is not serving in the role of Paying Agent or Registrar, as the case may be) from any loss that any of them may suffer if a Security is replaced. The Issuer and the Trustee may charge the Holder for their expenses in
      replacing a Security (including attorneys’ fees and disbursements in replacing such Security). In the event any such mutilated, lost, destroyed or wrongfully taken Security has become or is about to become due and payable, the Issuer in its
      discretion may pay such Security instead of issuing a new Security in replacement thereof.

     

    Upon its due issuance, every replacement Security will be an obligation of the Issuer evidencing the same debt, and entitled to the same benefits under this Indenture, as the Security surrendered therefor or replaced
      thereby.

     

    The provisions of this Section 2.08 are exclusive and shall preclude (to the extent lawful) all other rights and remedies with respect to the replacement or payment of mutilated, lost, destroyed or wrongfully taken
      Securities.

     

    SECTION 2.09.   Outstanding Securities. Securities outstanding at any time are all Securities authenticated by the Trustee except for those canceled by it, those delivered to it for cancellation and those
      described in this Section 2.09 as not outstanding. Subject to Section 12.04, a Security does not cease to be outstanding because the Issuer or an Affiliate of the Issuer holds the Security.

     

    If a Security is replaced pursuant to Section 2.08 (other than a mutilated Security surrendered for replacement), it ceases to be outstanding unless the Trustee and the Issuer receive proof satisfactory to them that the
      replaced Security is held by a protected purchaser. A mutilated Security ceases to be outstanding upon surrender of such Security and replacement thereof pursuant to Section 2.08.

     

    If the principal amount of any Securities (or portions thereof) is considered paid under Section 4.01, such Securities (or portions thereof) cease to be outstanding and interest on them ceases to accrue.

     

    
      44

      
        

    

    If a Paying Agent segregates and holds in trust, in accordance with this Indenture, on a redemption date or maturity date money sufficient to pay all principal and interest payable on that date with respect to the
      Securities (or portions thereof) to be redeemed or maturing, as the case may be, and no Paying Agent is prohibited from paying such money to the Holders on that date pursuant to the terms of this Indenture, then on and after that date such Securities
      (or portions thereof) cease to be outstanding and interest on them ceases to accrue.

     

    SECTION 2.10.   Temporary Securities. In the event that Definitive Securities are to be issued under the terms of this Indenture, until such Definitive Securities are ready for delivery, the Issuer may prepare
      and the Trustee shall authenticate temporary Securities. Temporary Securities shall be substantially in the form of Definitive Securities but may have variations that the Issuer considers appropriate for temporary Securities. Without unreasonable
      delay, the Issuer shall prepare and the Trustee shall authenticate Definitive Securities and make them available for delivery in exchange for temporary Securities upon surrender of such temporary Securities at the office or agency of the Issuer,
      without charge to the Holder. Until such exchange, temporary Securities shall be entitled to the same rights, benefits and privileges as Definitive Securities under this Indenture.

     

    SECTION 2.11.   Cancellation. The Issuer at any time may deliver Securities to the Trustee for cancellation. The Registrar and each Paying Agent shall forward to the Trustee any Securities surrendered to them for
      registration of transfer, exchange, payment or cancellation. The Trustee and no one else shall cancel all Securities surrendered for registration of transfer, exchange, payment or cancellation and shall dispose of canceled Securities in accordance
      with its customary procedures. Certification of the destruction of all cancelled Securities shall be delivered to the Issuer. The Issuer may not issue new Securities to replace Securities it has redeemed, paid or delivered to the Trustee for
      cancellation. The Trustee shall not authenticate Securities in place of canceled Securities other than pursuant to the terms of this Indenture.

     

    SECTION 2.12.   Defaulted Interest. If the Issuer defaults in a payment of interest on the Securities, the Issuer shall pay the defaulted interest then borne by the Securities (plus interest on such defaulted
      interest to the extent lawful) in any lawful manner. The Issuer may pay the defaulted interest to the Persons who are Holders on a subsequent special record date. The Issuer shall fix or cause to be fixed any such special record date and payment date
      and shall promptly provide or cause to be provided to each affected Holder a written notice that states the special record date, the payment date and the amount of defaulted interest to be paid. The special record date for the payment of such
      defaulted interest shall not be more than 15 days and shall not be less than 10 days prior to the proposed payment date and shall not be less than 10 days after the receipt by the Trustee of the notice of the proposed payment.

     

    SECTION 2.13.   CUSIP Numbers, ISINs, etc. The Issuer in issuing the Securities may use CUSIP numbers, ISINs and “Common Code”
        numbers (if then generally in use) and, if so, the Trustee shall use CUSIP numbers, ISINs and “Common Code” numbers in notices (including notices of redemption) as a convenience to Holders; provided, however, that any such notice may state that no representation is made as to the correctness of such numbers, either as printed on the Securities or as contained in any notice that reliance may be placed only on
        the other identification numbers printed on the Securities and that any such notice shall not be affected by any defect in or omission of such numbers. The Issuer shall advise the Trustee of any change in the CUSIP numbers, ISINs and “Common Code”
        numbers.

     

    
      45

      
        

    

    SECTION 2.14.   Calculation of Principal Amount of Securities. The aggregate principal amount of the Securities, at any date of determination, shall be the aggregate principal amount of the Securities outstanding
      at such date of determination. With respect to any matter requiring consent, waiver, approval or other action of the Holders of a specified percentage of the principal amount of all the Securities, such percentage shall be calculated, on the relevant
      date of determination, by dividing (a) the principal amount, as of such date of determination, of Securities, the Holders of which have so consented, waived, approved or taken other action by (b) the aggregate principal amount, as of such date of
      determination, of the Securities then outstanding, in each case, as determined in accordance with the preceding sentence, Section 2.09 and Section 12.04. Any such calculation made pursuant to this Section 2.14 shall be made by the Issuer and
      delivered to the Trustee pursuant to an Officers’ Certificate. The Issuer and the Trustee agree that any action of the Holders may be evidenced by the Depository applicable procedures or by such other procedures as the Issuer and Trustee may agree.

     

    SECTION 2.15.   Statement to Holders. After the end of each calendar year but not later than the latest date permitted by applicable law, the Trustee shall (or shall instruct any Paying Agent to) furnish to each
      Person who at any time during such calendar year was a Holder a statement (for example, a Form 1099 or any other means required by applicable law) prepared by the Trustee containing the interest and original issue discount paid (based solely upon
      information provided by the Issuer) with respect to the Securities for such calendar year or, in the event such Person was a Holder during only a portion of such calendar year, for the applicable portion of such calendar year, and such other items as
      may be (a) required pursuant to the then-applicable regulations under the Code or (b) readily available to the Trustee and that a Holder shall reasonably request as necessary for the purpose of such Holder’s preparation of its U.S. federal income or
      other tax returns. In the event that any such information has been provided by any Paying Agent directly to such Person through other tax-related reports or otherwise, the Trustee in its capacity as Paying Agent shall not be obligated to comply with
      such request for information.

     

    ARTICLE 3

     

    REDEMPTION

     

    SECTION 3.01.   Redemption. The Securities may be redeemed by the Issuer at its option, in whole, or from time to time in part, on any Business Day specified by the Issuer, subject to the conditions and at the
      redemption prices set forth in Paragraph 5 of the form of Security set forth in Exhibit A, which is hereby incorporated by reference and made a part of this Indenture, together with accrued and unpaid interest to the redemption date.

     

    SECTION 3.02.   Applicability of Article. Redemption of Securities at the election of the Issuer or otherwise, as permitted or required by any provision of this Indenture, shall be made in accordance with such
      provision and this Article 3.

     

    
      46

      
        

    

    SECTION 3.03.   Notices to Trustee. If the Issuer elects to redeem Securities pursuant to the optional redemption provisions of Paragraph 5 of the Security, it shall notify the Trustee and the Holders in writing
      of (i) the Section of this Indenture and the Paragraph of the Security (if any) pursuant to which the redemption shall occur, (ii) the redemption date, (iii) the principal amount of Securities to be redeemed and (iv) the redemption price (if then
      ascertainable).

     

    The Issuer shall provide written notice to the Trustee provided for in this Section 3.03 at least 30 days (or such shorter period as may be acceptable to the Trustee) but not more than 60 days before a redemption date if
      the redemption is pursuant to Paragraph 5 of the Security. Such notice shall be accompanied by an Officers’ Certificate from the Issuer to the effect that such redemption will comply with the conditions herein. If fewer than all the Securities are to
      be redeemed, the record date relating to such redemption shall be selected by the Issuer and given to the Trustee, which record date shall be not fewer than 15 days after the date of notice to the Trustee. Any such notice may be canceled at any time
      prior to written notice of such redemption being provided to any Holder and shall thereby be void and of no effect.

     

    SECTION 3.04.   Selection of Securities to Be Redeemed. In the case of any partial redemption, and if the Securities are Global Securities held by the Depository, the particular Securities or portions thereof to
      be redeemed shall be allocated on a pro rata pass-through distribution of principal basis in accordance with Depository procedures; provided, that, so long as the Securities are held in book-entry form, the
      selection for redemption of such Securities shall be made in accordance with the operational arrangements of the Depository then in effect, and if the Depository operational arrangements do not allow for redemption on a pro rata pass-through
      distribution of principal basis, the Securities will be selected for redemption, in accordance with Depository procedures, by lot. If the Securities are not Global Securities held by the Depository, selection of the Securities for redemption will be
      made by the Trustee on a pro rata basis to the extent practicable or such other method the Trustee deems fair and appropriate; provided that no Securities of $1,000 or less shall be redeemed in part. The
      Trustee shall make the selection from outstanding Securities not previously called for redemption. The Trustee may select for redemption portions of the principal of Securities that have denominations larger than $1,000. Securities and portions of
      them the Trustee selects shall be in amounts of $1,000 or any integral multiple of $1,000 in excess thereof. Provisions of this Indenture that apply to Securities called for redemption also apply to portions of Securities called for redemption. The
      Trustee shall notify the Issuer promptly of the Securities or portions of Securities to be redeemed and the principal amount thereof.

     

    SECTION 3.05.   Notice of Optional Redemption.

     

    (a)          At least 30 days but not more than 60 days before a redemption date pursuant to Paragraph 5 of the Security, the Issuer shall provide or cause to be provided a written notice of redemption to each Holder
      whose Securities are to be redeemed.

     

    Any such notice shall identify the Securities to be redeemed and shall state:

     

    (i)          the redemption date;

     

    
      47

      
        

    

    (ii)         the redemption price (or manner of calculation thereof if not then known) and the amount of accrued and unpaid interest to the redemption date;

     

    (iii)        the name and address of the Paying Agent;

     

    (iv)        that Securities called for redemption must be surrendered to the Paying Agent to collect the redemption price, plus accrued and unpaid interest;

     

    (v)          that all outstanding Securities are to be redeemed or, if fewer than all the outstanding Securities are to be redeemed, the certificate numbers and principal amounts of the particular
      Securities to be redeemed, the aggregate principal amount of Securities to be redeemed and the aggregate principal amount of Securities to be outstanding after such partial redemption;

     

    (vi)        that, unless the Issuer defaults in making such redemption payment or the Paying Agent is prohibited from making such payment pursuant to the terms of this Indenture, interest on Securities
      (or portion thereof) called for redemption ceases to accrue on and after the redemption date;

     

    (vii)       the CUSIP number, ISIN or “Common Code” number, if any, printed on the Securities being redeemed;

     

    (viii)      that no representation is made as to the correctness or accuracy of the CUSIP number or ISIN or “Common Code” number, if any, listed in such notice or printed on the Securities; and

     

    (ix)        such other matters as the Issuer deems desirable or appropriate.

     

    Notice of any redemption pursuant to this Section 3.05 may, at the Issuer’s direction, be revocable and be subject to one or more conditions precedent, including the receipt by the Trustee, on or prior to the redemption
      date, of money sufficient to pay the principal of, and premium, if any, and interest on, the Securities being redeemed.

     

    (b)          At the Issuer’s request, the Trustee shall give the notice of redemption in the Issuer’s name and at the Issuer’s expense. In such event, the Issuer shall provide the Trustee a notice containing the
      information required by this Section 3.05 at least five Business Days (unless the Trustee consents to a shorter period) prior to the date such notice is to be provided to Holders and such notice may not be canceled but may be subject to such
      conditions precedent as shall be set forth in such notice.

     

    SECTION 3.06.   Effect of Notice of Redemption. Once written notice of redemption is provided in accordance with Section 3.05, Securities called for redemption become due and payable on the redemption date and at
      the redemption price stated in the notice, subject to the satisfaction or waiver of any conditions precedent in the notice of redemption. Upon surrender to the Paying Agent, such Securities shall be paid at the redemption price stated in the notice,
      plus accrued and unpaid interest, to, but not including, the redemption date; provided, however, that if the redemption date is after a Record Date and on or prior to
      the related Payment Date, the accrued and unpaid interest shall be payable to the Holder of the redeemed Securities registered on such Record Date. Failure to give notice or any defect in the notice to any Holder shall not affect the validity of the
      notice to any other Holder.

     

    
      48

      
        

    

    SECTION 3.07.   Deposit of Redemption Price.With respect to any Securities, prior to 10:00 a.m., New York City time, on the redemption date (provided that the Issuer shall have confirmed in writing to the Trustee
      the satisfaction or waiver of all conditions to such redemption pursuant to Section 3.05(a)), the Issuer shall deposit with the Paying Agent (or, if the Issuer or a Wholly Owned Restricted Subsidiary is the Paying Agent, shall segregate and hold in
      trust) money sufficient to pay the redemption price of and accrued and unpaid interest on all Securities or portions thereof to be redeemed on that date other than Securities or portions of Securities called for redemption that have been delivered by
      the Issuer to the Trustee for cancellation. On and after the redemption date, interest shall cease to accrue on Securities or portions thereof called for redemption so long as the Issuer has deposited with the Paying Agent funds sufficient to pay the
      principal of, plus accrued and unpaid interest on, the Securities to be redeemed, unless the Paying Agent is prohibited from making such payment pursuant to the terms of this Indenture, provided that, if
      necessary, the Issuer has provided an Officers’ Certificate to the Trustee stating that all conditions precedent (if any) to which such redemption has been made subject have been satisfied. Upon redemption of any
        Securities by the Issuer, such redeemed Securities will be cancelled.

     

    SECTION 3.08.   Securities Redeemed in Part. Upon surrender of a Security that is redeemed in part, the Issuer shall execute and the Trustee shall authenticate for the Holder (at the Issuer’s expense) a new
      Security equal in principal amount to the unredeemed portion of the Security surrendered.

     

    ARTICLE 4

     

    COVENANTS

     

    SECTION 4.01.   Payment of Securities.

     

    (a)          The Issuer shall promptly pay the principal of and interest on the Securities on the dates and in the manner provided in the Securities and in this Indenture. An installment of principal or interest shall be
      considered paid on the date due if on such date the Trustee or the Paying Agent holds as of 12:00 noon New York City time money sufficient to pay all principal and interest then due and the Trustee or the Paying Agent, as the case may be, is not
      prohibited from paying such money to the Holders on that date pursuant to the terms of this Indenture. The Issuer shall pay, during the continuance of an Event of Default, interest on the outstanding principal amount of the Securities at the rate
      borne by the Securities plus 4.00% per annum, and the Issuer shall pay interest on overdue installments of interest at the rate borne by the Securities plus 4.00% per annum to the extent lawful. All payments of interest shall be rounded to two
      decimal places.

     

    
      49

      
        

    

    (b)          On each Payment Date, commencing on September 30, 2021, or on the succeeding Business Day if any such date is not a Business Day, the Issuer shall pay to the Holders an installment of principal of the
      Securities in accordance with the table below corresponding to the applicable Payment Date, where the applicable percentage is the percentage of (i) the initial aggregate principal amount of Original Securities issued on the Issue Date plus (ii) the
      initial aggregate principal amount of any First Additional Securities issued on their date of issuance plus (iii) the initial aggregate principal amount of any Second Additional Securities issued on their date of issuance minus (iv) the aggregate
      principal amount of Securities redeemed or repurchased pursuant to this Indenture prior to such Payment Date:

     

    

    
      	
              Payment Date

            	
              Applicable Percentage

            
	
              September 30, 2021

            	
              2.5%

            
	
              December 30, 2021

            	
              2.5%

            
	
              March 30, 2022

            	
              2.5%

            
	
              June 30, 2022

            	
              2.5%

            
	
              September 30, 2022

            	
              5.0%

            
	
              December 30, 2022

            	
              5.0%

            
	
              March 30, 2023

            	
              5.0%

            
	
              June 30, 2023

            	
              5.0%

            
	
              September 30, 2023

            	
              7.5%

            
	
              December 30, 2023

            	
              7.5%

            
	
              March 30, 2024

            	
              7.5%

            
	
              June 30, 2024

            	
              7.5%

            
	
              September 30, 2024

            	
              10.0%

            
	
              December 30, 2024

            	
              10.0%

            
	
              March 30, 2025

            	
              10.0%

            
	
              June 30, 2025

            	
              All remaining outstanding principal of the Securities at such date

            

    

     

    

    All payments calculated from the principal installment percentages set forth above shall be rounded to two decimal places.

     

    SECTION 4.02.   Reports and Other Information.

     

    (a)          Annual Financials. The Issuer shall deliver to the Trustee, as soon as available, but in any event within 120 days (or such earlier date on which the Issuer is required to file a Form 10-K under the
      Exchange Act, if applicable) after the end of each fiscal year of the Issuer, beginning with the fiscal year ending December 31, 2019, a consolidated balance sheet of the Issuer and its Subsidiaries as of the end of such fiscal year, and the related
      consolidated statements of income, cash flows and stockholders’ equity for such fiscal year, setting forth in each case in comparative form the figures for the previous fiscal year, all prepared in accordance with GAAP, with such consolidated
      financial statements to be audited and accompanied by (i) a report and opinion of the Issuer’s independent certified public accounting firm of recognized standing in the United States (which report and opinion shall be prepared in accordance with
      GAAP), stating that such financial statements fairly present, in all material respects, the consolidated financial condition, results of operations and cash flows of the Issuer as of the dates and for the periods specified in accordance with GAAP,
      and (ii) (if and only if the Issuer is required to comply with the internal control provisions pursuant to Section 404 of the Sarbanes-Oxley Act of 2002 requiring an attestation report of such independent certified public accounting firm) an
      attestation report of such independent certified public accounting firm as to the Issuer’s internal controls pursuant to Section 404 of the Sarbanes-Oxley Act of 2002 attesting that such internal controls meet the requirements of the Sarbanes-Oxley
      Act of 2002; provided, however, that the Issuer shall be deemed to have made such delivery of such consolidated financial statements if such consolidated financial
      statements shall have been made available for free within the time period specified above on the SEC’s EDGAR system (or any successor system adopted by the SEC); provided, further,
      however, that the Trustee shall have no obligation whatsoever to determine whether or not such information, documents or reports have been filed pursuant to EDGAR (or its successor). Such consolidated
      financial statements shall be certified by a Financial Officer as, to his or her knowledge, fairly presenting, in all material respects, the consolidated financial condition, results of operations and cash flows of the Issuer and its Subsidiaries as
      of the dates and for the periods specified in accordance with GAAP consistently applied.

     

    
      50

      
        

    

    (b)          Quarterly Financials. The Issuer shall deliver to the Trustee, as soon as available, but in any event within 60 days (or such earlier date on which the Issuer is required to file a Form 10-Q under the
      Exchange Act, if applicable) after the end of each of the first three fiscal quarters of each fiscal year of the Issuer, beginning with the fiscal quarter ending June 30, 2019, a consolidated balance sheet of the Issuer and its Subsidiaries as of the
      end of such fiscal quarter, and the related consolidated statements of income, cash flows and stockholders’ equity for such fiscal quarter and (in respect of the second and third fiscal quarters of such fiscal year) for the then-elapsed portion of
      the Issuer’s fiscal year, setting forth in each case in comparative form the figures for the comparable period or periods in the previous fiscal year, all prepared in accordance with GAAP; provided, however, that the Issuer shall be deemed to have made such delivery of such consolidated financial statements if such consolidated financial statements shall have been made available for free within the time
      period specified above on the SEC’s EDGAR system (or any successor system adopted by the SEC); provided, further, however,
      that the Trustee shall have no obligation whatsoever to determine whether or not such information, documents or reports have been filed pursuant to EDGAR (or its successor). Such consolidated financial statements shall be certified by a Financial
      Officer as, to his or her knowledge, fairly presenting, in all material respects, the consolidated financial condition, results of operations and cash flows of the Issuer and its Subsidiaries as of the dates and for the periods specified in
      accordance with GAAP consistently applied, and on a basis consistent with the audited consolidated financial statements referred to under Section 4.02(a), subject to normal year-end audit adjustments and the absence of footnotes. Notwithstanding the
      foregoing, if the Issuer or any of its Subsidiaries have made an acquisition, the financial statements with respect to an acquired entity need not be included in the consolidated quarterly financial statements required to be delivered pursuant to
      this Section 4.02(b) until the first date upon which such quarterly financial statements are required to be so delivered that is at least 90 days after the date such acquisition is consummated.

     

    (c)          Compliance with Indenture. The Issuer shall deliver to the Trustee, within 120 days after the end of each fiscal year of the Issuer, commencing with respect to the fiscal year ending December 31,
      2019, an Officers’ Certificate certifying that to each such Officer’s actual knowledge there is no Default or Event of Default that has occurred and is continuing or, if either such Officer does know of any such Default or Event of Default, such
      Officer shall include in such certificate a description of such Default or Event of Default and its status with particularity.

     

    
      51

      
        

    

    (d)          Information During Event of Default. The Issuer shall deliver to the Trustee and the Holders, promptly, such additional information regarding the business or financial affairs of the Issuer or any of
      its Subsidiaries, or compliance with the terms of this Indenture, as the Trustee, any Holder or any holder of beneficial interests in the Securities may from time to time reasonably request during the existence of any Event of Default (subject to
      reasonable requirements of confidentiality, including requirements imposed by law or contract; and provided that the Issuer shall not be obligated to disclose any information that is reasonably subject to the
      assertion of attorney-client privilege).

     

    (e)          Information Filed with SEC or Exchanges. The Issuer shall deliver to the Trustee, promptly after the same are available, copies of any periodic and other reports, registration statements and other
      non-confidential, final materials filed by the Issuer or any of its Subsidiaries with the SEC, any U.S. securities exchange or any securities exchange in any applicable non-U.S. jurisdiction, and in any case not otherwise required to be delivered to
      the Trustee pursuant to this Indenture; provided, however, that the Issuer shall be deemed to have made such delivery of such reports or other materials if such
      reports or other materials shall have been made available for free within the time period specified above on the SEC’s EDGAR system (or any successor system adopted by the SEC); provided, further, however, that the Trustee shall have no obligation whatsoever to determine whether or not such reports or other materials have been filed pursuant to EDGAR (or
      its successor).

     

    (f)          Rule 144A Information. So long as the Issuer is not subject to either Section 13 or 15(d) of the Exchange Act, the Issuer shall deliver to the Holders, any holder of beneficial interests in the
      Securities and any prospective purchaser of the Securities or a beneficial interest therein designated by a Holder or such other Person, promptly upon the request of any such Person, the information required to be delivered pursuant to Rule
      144A(d)(4) under the Securities Act.

     

    (g)          Communication of Information.

     

    (i)          The Issuer shall make available to the Holders (and holders of beneficial interests in the Securities), who shall have executed and delivered a Confidentiality Agreement in accordance with
      the terms of this Indenture, the information required to be delivered under this Section 4.02 by posting such information on IntraLinks or another similar electronic system, and the Issuer shall administer and maintain IntraLinks or such other
      similar electronic system for the Holders (and holders of beneficial interests in the Securities). Access by a Holder (or holder of beneficial interests in the Securities) to IntraLinks or such other similar electronic system shall be subject to the
      condition that such Holder (or such holder of beneficial interests in the Securities) shall have executed and delivered a Confidentiality Agreement in accordance with the terms of this Indenture. The Issuer shall maintain all such information posted
      on IntraLinks or such other similar electronic system for as long as the Securities are outstanding.

     

    
      52

      
        

    

    (ii)         Delivery of information under this Section 4.02 to the Trustee shall be for informational purposes only, and the Trustee’s receipt thereof shall not constitute constructive notice of any
      information contained therein or determinable from any information contained therein, including compliance by the Issuer or any of its Subsidiaries with any of its covenants hereunder (as to which the Trustee is entitled to rely exclusively on
      Officers’ Certificates or certificates or statements delivered to the Trustee pursuant to Section 4.02(c)). Neither the Issuer nor the Guarantors shall be obligated to deliver any confidential reports or other confidential information to any Holder
      (or any holder of beneficial interests in the Securities) who has not executed a Confidentiality Agreement in accordance with the terms of this Indenture. The Issuer shall provide the Trustee with a list of such Holders (or holders of beneficial
      interests in the Securities) and shall update such list after the execution and delivery to the Issuer of a Confidentiality Agreement by any Person not already party to such a Confidentiality Agreement with the Issuer. The Trustee shall have no duty
      to monitor the IntraLinks site.

     

    (h)          Late Filings. To the extent any information required to be delivered pursuant to subsection (a) or (b) above is not delivered within the time periods specified
        therein and such information is subsequently filed or furnished, as applicable, on the SEC’s EDGAR system (or any successor system adopted by the SEC), the Issuer will be deemed to have satisfied its
        obligations with respect thereto at such time and any Default or Event of Default with respect thereto shall be deemed to have been cured unless the Securities have previously been accelerated in accordance with Section 6.02.

     

    SECTION 4.03.   Limitation on Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred Stock.

     

    (a)          The Issuer (i) shall not, and shall not permit any of its Restricted Subsidiaries to, directly or indirectly, Incur any Indebtedness (including Acquired Indebtedness) or issue any shares of Disqualified
      Stock and (ii) shall not permit any of its Restricted Subsidiaries to issue any shares of Preferred Stock; provided, however, that the Issuer and any Guarantor may
      Incur Indebtedness (including Acquired Indebtedness) or issue shares of Disqualified Stock, in each case if the Consolidated Leverage Ratio of the Issuer would have been less than or equal to 4.0 to 1.0 determined on a pro forma basis (including a pro forma application of the net proceeds therefrom), as if the additional Indebtedness had been Incurred, or the Disqualified Stock had been issued, as the case
      may be, and the application of proceeds therefrom had occurred at the beginning of the period for which the EBITDA component of the Consolidated Leverage Ratio calculation is being measured.

     

    (b)          The limitations set forth in Section 4.03(a) shall not apply to:

     

    (i)          the Incurrence by the Issuer or any Guarantor of Indebtedness under a Credit Agreement and the issuance and creation of letters of credit and bankers’ acceptances thereunder (with letters
      of credit and bankers’ acceptances being deemed to have a principal amount equal to the face amount thereof) in the aggregate principal amount outstanding at any one time not to exceed $10,000,000; provided,
      that (A) if such Indebtedness is Secured Indebtedness, such Indebtedness shall be secured only by ABL Collateral, (B) such Credit Agreement shall be with a lender or lenders satisfactory to the Holders in their sole discretion, (C) at each time when
      such a Credit Agreement is entered into and for so long as any such Credit Agreement remains outstanding, the Issuer (on a consolidated basis) has $75,000,000 of net revenues for the most recently completed twelve calendar month period determined in
      accordance with GAAP, (D) the Issuer shall deliver an Officers’ Certificate to the Trustee (upon entering into such a Credit Agreement and each month thereafter that such Credit Agreement remains outstanding) certifying as to the satisfaction of the
      foregoing clause (C), (E) advances under any such Credit Agreement shall be subject to a customary borrowing base formula and (F) the Issuer shall only use the proceeds from the borrowings under any such Credit Agreement for short-term working
      capital requirements and treasury-related activities such as customary hedging activities permitted by this Indenture;

     

    
      53

      
        

    

    (ii)         the Incurrence by any of the Issuer and the Guarantors of Indebtedness represented by the Securities and the Guarantees;

     

    (iii)        Indebtedness existing on the Issue Date;

     

    (iv)        Indebtedness (including Capitalized Lease Obligations) Incurred by the Issuer or any Guarantor, and Disqualified Stock issued by the Issuer or any Guarantor, to finance (whether prior to or
      within 270 days after) the acquisition, lease, construction, repair, replacement or improvement of property (real or personal) or equipment (whether through the direct purchase of assets or the Capital Stock of any Person owning such assets) that (A)
      is without recourse to any property or assets of the Issuer or any Restricted Subsidiary other than the assets so acquired, leased, constructed, repaired, replaced or improved and (B) is in an aggregate principal amount that, when aggregated with the
      principal amount of all other Indebtedness and Disqualified Stock then outstanding that was Incurred pursuant to this clause (iv), does not exceed $2,000,000;

     

    (v)          Indebtedness Incurred by the Issuer or any of its Restricted Subsidiaries constituting reimbursement obligations with respect to letters of credit and bank guarantees issued in the
      ordinary course of business, including letters of credit in respect of workers’ compensation claims, health, disability or other benefits to employees or former employees or their families or property, casualty or liability insurance or
      self-insurance, and letters of credit in connection with the maintenance of, or pursuant to the requirements of, environmental or other permits or licenses from Governmental Authorities, or other Indebtedness with respect to reimbursement type
      obligations regarding workers’ compensation claims;

     

    (vi)        Indebtedness arising from agreements of the Issuer or a Restricted Subsidiary providing for indemnification, adjustment of purchase price or similar obligations (including earn-out
      obligations or other contingent consideration), in each case, Incurred in connection with any acquisition or Disposition of any business, any assets or a Subsidiary of the Issuer in accordance with the terms of this Indenture, other than guarantees
      of Indebtedness Incurred by any Person acquiring all or any portion of such business, assets or Subsidiary for the purpose of financing such acquisition;

     

    
      54

      
        

    

    (vii)       Indebtedness of the Issuer to a Restricted Subsidiary; provided that any such Indebtedness owed to a Restricted Subsidiary that is not a Guarantor
      is subordinated in right of payment to the obligations of the Issuer under the Securities; provided, further, that any subsequent issuance or transfer of any Capital
      Stock or any other event that results in any such Restricted Subsidiary ceasing to be a Restricted Subsidiary or any other subsequent transfer of any such Indebtedness (except to the Issuer or another Restricted Subsidiary or any pledge of such
      Indebtedness constituting a Permitted Lien) shall be deemed, in each case, to be an Incurrence of such Indebtedness not permitted by this clause (vii);

     

    (viii)      shares of Preferred Stock of a Restricted Subsidiary issued to the Issuer or a Guarantor; provided that any subsequent issuance or transfer of any
      Capital Stock or any other event that results in any Guarantor that holds such shares of Preferred Stock of a Restricted Subsidiary ceasing to be a Guarantor or any other subsequent transfer of any such shares of Preferred Stock (except to the Issuer
      or a Guarantor) shall be deemed, in each case, to be an issuance of shares of Preferred Stock not permitted by this clause (viii);

     

    (ix)        Indebtedness of a Restricted Subsidiary to the Issuer or a Guarantor; provided, that any subsequent issuance or transfer of any Capital Stock or
      any other event that results in any such Guarantor holding such Indebtedness ceasing to be a Guarantor or any other subsequent transfer of any such Indebtedness (except to the Issuer or another Guarantor or any pledge of such Indebtedness
      constituting a Permitted Lien) shall be deemed, in each case, to be an Incurrence of such Indebtedness not permitted by this clause (ix);

     

    (x)         Hedging Obligations of the Issuer or any Guarantor that are not Incurred for speculative purposes but: (1) for the purpose of fixing or hedging interest rate risk with respect to any
      Indebtedness that is permitted by the terms of this Indenture to be outstanding; (2) for the purpose of fixing or hedging currency exchange rate risk with respect to any currency exchanges; or (3) for the purpose of fixing or hedging commodity price
      risk with respect to any commodity purchases or sales;

     

    (xi)        obligations (including reimbursement obligations with respect to letters of credit and bank guarantees) in respect of performance, bid, appeal and surety bonds, completion guarantees,
      worker’s compensation claims, self-insurance obligations, bankers’ acceptances, export or import, indemnities, customs, revenue bonds or other similar instruments provided by the Issuer or any Restricted Subsidiary in the ordinary course of business
      or consistent with past practice or industry practice;

     

    
      55

      
        

    

    (xii)       Indebtedness or Disqualified Stock of the Issuer or any Guarantor not otherwise permitted under this Indenture in an aggregate principal amount or liquidation preference, which when
      aggregated with the principal amount or liquidation preference of all other Indebtedness and Disqualified Stock then outstanding and Incurred pursuant to this clause (xii), does not exceed $2,000,000 at any one time outstanding (it being understood
      that any Indebtedness Incurred pursuant to this clause (xii) shall cease to be deemed Incurred or outstanding for purposes of this clause (xii) but shall be deemed Incurred for purposes of Section 4.03(a) from and after the first date on which the
      Issuer, or the Guarantor, as the case may be, could have Incurred such Indebtedness under Section 4.03(a) without reliance upon this clause (xii));

     

    (xiii)      any guarantee by the Issuer or a Guarantor of Indebtedness or other obligations of the Issuer or any other Guarantor so long as the Incurrence of such Indebtedness Incurred by the Issuer or
      such other Guarantor is permitted under the terms of this Indenture; provided that if such Indebtedness is by its express terms unsecured and subordinated in right of payment to the Securities or the
      Guarantee of such other Guarantor, as applicable, any such guarantee of such Guarantor with respect to such Indebtedness shall be unsecured and subordinated in right of payment to such Guarantor’s Guarantee with respect to the Securities
      substantially to the same extent as such Indebtedness is subordinated to the Securities or the Guarantee of such other Guarantor, as applicable;

     

    (xiv)      the Incurrence by the Issuer or any Guarantor of Indebtedness or Disqualified Stock of a Guarantor that serves to refund, refinance or defease any Indebtedness Incurred or Disqualified Stock
      issued as permitted under Section 4.03(a) and clauses (ii), (iii), (iv), (xii), (xiv) and (xv) of this Section 4.03(b) or any Indebtedness or Disqualified Stock Incurred to so refund or refinance such Indebtedness or Disqualified Stock, including any
      additional Indebtedness or Disqualified Stock Incurred to pay premiums (including tender premiums and paid-in-kind interest), fees, expenses and defeasance costs in connection therewith (subject to the following proviso, “Refinancing Indebtedness”)
      prior to its respective maturity; provided that such Refinancing Indebtedness:

     

    (1)          has a Weighted Average Life to Maturity at the time such Refinancing Indebtedness is Incurred that is not less than the remaining Weighted Average Life to Maturity of the Indebtedness or
      Disqualified Stock being refunded, refinanced or defeased;

     

    (2)          has a Stated Maturity that is not earlier than the earlier of (x) the Stated Maturity of the Indebtedness being refunded or refinanced and (y) 91 days following the Stated Maturity of the
      Securities;

     

    (3)          to the extent such Refinancing Indebtedness refunds, refinances or defeases (a) Indebtedness junior in right of payment to the Securities or a Guarantee, as applicable, such Refinancing
      Indebtedness is junior in right of payment to the Securities or a Guarantee to the same extent as such Indebtedness being refunded, refinanced or defeased, as applicable, or (b) Disqualified Stock, such Refinancing Indebtedness is Disqualified Stock;

     

    
      56

      
        

    

    (4)          is Incurred in an aggregate principal amount (or if issued with original issue discount, an aggregate issue price) that is equal to or less than the aggregate principal amount (or if
      issued with original issue discount, the aggregate accreted value) then outstanding of the Indebtedness being refunded, refinanced or defeased plus premium (including tender premiums and paid-in-kind interest), fees, expenses and defeasance costs
      Incurred in connection with such refinancing;

     

    (5)          shall not include Indebtedness of the Issuer or a Guarantor that refunds, refinances or defeases Indebtedness of an Unrestricted Subsidiary; and

     

    (6)          in the case of any Refinancing Indebtedness Incurred to refund, refinance or defease Indebtedness outstanding under clause (iv) or (xii) of this Section 4.03(b), shall be deemed to have
      been Incurred and to be outstanding under such clause (iv) or (xii) of this Section 4.03(b), as applicable, and not this clause (xiv) for purposes of determining amounts outstanding under such clause (iv) or (xii) of this Section 4.03(b);

     

    (xv)       Indebtedness or Disqualified Stock of (x) the Issuer or any Guarantor Incurred to finance an acquisition of any property or assets or (y) Persons that are acquired by the Issuer or any
      Guarantor or merged, amalgamated or consolidated with or into the Issuer or a Guarantor in accordance with the terms of this Indenture; provided that, in each case, immediately after giving effect to such
      acquisition or merger, amalgamation or consolidation, the Issuer would be permitted to Incur at least $1.00 of additional Indebtedness pursuant to the Consolidated Leverage Ratio test set forth in Section 4.03(a); provided,
      further, that if, with respect to any Indebtedness Incurred under this clause (xv), either (A) the property or assets so acquired are held in a Restricted Subsidiary that is not a Guarantor or (B) the Person
      so acquired does not become, upon acquisition, a Guarantor, then, in each case, the Issuer and the Guarantors shall not guarantee any such Indebtedness, and such Indebtedness shall have no recourse to any assets or property of the Issuer or the
      Guarantors;

     

    (xvi)      Indebtedness arising from the honoring by a bank or other financial institution of a check, draft or similar instrument drawn against insufficient funds in the ordinary course of business; provided that such Indebtedness is extinguished within five Business Days of receipt by the Issuer or the applicable Restricted Subsidiary of notice of its Incurrence;

     

    (xvii)     Indebtedness of the Issuer or any Guarantor supported by a letter of credit or bank guarantee issued pursuant to a Credit Agreement, in a principal amount not in excess of the stated amount
      of such letter of credit, to the extent such letter of credit or bank guarantee issued pursuant to such Credit Agreement is otherwise permitted by this Section 4.03;

     

    (xviii)    Indebtedness of the Issuer or any Restricted Subsidiary consisting of (x) the financing of insurance premiums or (y) take-or-pay obligations contained in supply arrangements, in each case,
      in the ordinary course of business;

     

    
      57

      
        

    

    (xix)      Indebtedness of the Issuer or any Guarantor issued to (x) any joint venture (regardless of the form of legal entity) that is not a Subsidiary or (y) any Unrestricted Subsidiary, in each case
      arising in the ordinary course of business in connection with the cash management operations (including with respect to intercompany self-insurance arrangements) of the Issuer or any Guarantor;

     

    (xx)       Non-Recourse Debt of a Royalty Subsidiary;

     

    (xxi)      Indebtedness related to unfunded pension fund and other employee benefit plan obligations and liabilities to the extent they are permitted to remain unfunded under applicable law; and

     

    (xxii)     Indebtedness of the Issuer or any Restricted Subsidiary to the extent the net proceeds thereof are substantially concurrently (i) used to purchase all of the Securities pursuant to a Change
      of Control Offer, a tender offer or pursuant to Section 3.01 or (ii) deposited to defease all of the Securities as described in Article 8.

     

    (c)          For purposes of determining compliance with this Section 4.03, in the event that an item of Indebtedness or Disqualified Stock (or any portion thereof) meets the criteria of more than one of the categories
      of permitted Indebtedness described in clauses (i) through (xxii) of Section 4.03(b) or is entitled to be Incurred pursuant to Section 4.03(a), the Issuer shall, in its sole discretion, classify or reclassify, or later divide, classify or reclassify,
      such item of Indebtedness or Disqualified Stock (or any portion thereof) in any manner that complies with this Section 4.03; provided, that any Indebtedness outstanding under the Credit Agreement on the Issue
      Date shall be allocated to Section 4.03(b)(i) and shall not be reallocated.

     

    (d)          Accrual of interest, the accretion of accreted value, the payment of interest in the form of additional Indebtedness with the same terms, the payment of dividends on Disqualified Stock or Preferred Stock in
      the form of additional shares of Disqualified Stock or Preferred Stock of the same class, amortization or accretion of original issue discount or liquidation preference and increases in the amount of Indebtedness outstanding solely as a result of
      fluctuations in the exchange rate of currencies shall not be deemed to be an Incurrence of Indebtedness, Disqualified Stock or Preferred Stock for purposes of this Section 4.03. Guarantees of, or obligations in respect of letters of credit relating
      to, Indebtedness that is otherwise included in the determination of a particular amount of Indebtedness shall not be included in the determination of such amount of Indebtedness; provided that the Incurrence
      of the Indebtedness represented by such guarantee or letter of credit, as the case may be, was in compliance with this Section 4.03.

     

    (e)          For purposes of determining compliance with any U.S. Dollar-denominated restriction on the Incurrence of Indebtedness, the U.S. Dollar-equivalent principal amount of Indebtedness denominated in a non-U.S.
      currency shall be calculated based on the relevant currency exchange rate in effect on the date such Indebtedness was Incurred, in the case of term debt, or first committed or first Incurred (whichever yields the higher U.S. Dollar equivalent), in
      the case of revolving credit debt.

     

    
      58

      
        

    

    (f)          Notwithstanding any other provision of this Section 4.03, the maximum amount of Indebtedness that the Issuer or any Restricted Subsidiary of the Issuer may Incur pursuant to this Section 4.03 shall not be
      deemed to be exceeded solely as a result of fluctuations in exchange rates or currency values following the Incurrence of such Indebtedness.

     

    SECTION 4.04.   Limitation on Restricted Payments.

      

     

    (a)          The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, directly or indirectly:

     

    (i)          declare or pay any dividend or make any distribution on account of the Issuer’s or any of its Restricted Subsidiaries’ Equity Interests, including any payment made in connection with any
      merger, amalgamation or consolidation involving the Issuer (other than (A) dividends or distributions by the Issuer payable solely in Equity Interests (other than Disqualified Stock) of the Issuer or (B) dividends or distributions by a Restricted
      Subsidiary, provided that, in the case of any dividend or distribution payable on or in respect of any class or series of securities issued by a Restricted Subsidiary other than a Wholly Owned Restricted
      Subsidiary, the Issuer or a Restricted Subsidiary receives at least its pro rata share of such dividend or distribution in accordance with its Equity Interests in such class or series of securities);

     

    (ii)         purchase or otherwise acquire or retire for value any Equity Interests (other than Disqualified Stock) of the Issuer or any direct or indirect parent of the Issuer;

     

    (iii)        purchase or otherwise acquire or retire for value any Disqualified Stock of the Issuer or any direct or indirect parent of the Issuer;

     

    (iv)        make any principal payment on, or redeem, repurchase, defease or otherwise acquire or retire for value, in each case prior to any scheduled repayment or scheduled maturity, any Subordinated
      Indebtedness of the Issuer or any of its Restricted Subsidiaries (other than the payment, redemption, repurchase, defeasance, acquisition or retirement of (A) Subordinated Indebtedness in anticipation of satisfying a sinking fund obligation,
      principal installment or final maturity, in each case due within one year of the date of such payment, redemption, repurchase, defeasance, acquisition or retirement, unless such sinking fund obligation, principal installment or final maturity occurs
      within one year of the Stated Maturity of the Securities, and (B) Indebtedness permitted under clauses (vii) and (ix) of Section 4.03(b)); or

     

    (v)          make any Restricted Investment

     

    (all such payments and other actions set forth in clauses (i) through (v) above being collectively referred to as “Restricted Payments”), unless, at the time of such Restricted Payment (other than a Restricted Payment under clause (iii) above, for
      which the following exception shall not be applicable):

     

    
      59

      
        

    

    (1)          no Default shall have occurred and be continuing or would occur as a consequence thereof;

     

    (2)          immediately after giving effect to such Restricted Payment on a pro forma basis, the Issuer could Incur $1.00 of additional Indebtedness under
      Section 4.03(a); and

     

    (3)          such Restricted Payment, together with the aggregate amount of all other Restricted Payments made by the Issuer and its Restricted Subsidiaries after the Issue Date (including Restricted
      Payments permitted by clauses (i), (iv), (v) (to the extent such dividends did not reduce Consolidated Net Income) and (xi) of Section 4.04(b), but excluding all other Restricted Payments permitted by Section 4.04(b)), is less than the amount equal
      to the Cumulative Credit (with the amount of any Restricted Payment made under this Section 4.04 in any property other than cash being equal to the Fair Market Value (as determined in good faith by the Issuer) of such property at the time such
      Restricted Payment is made).

     

    (b)          The provisions of Section 4.04(a) shall not prohibit:

     

    (i)          the payment of any dividend or distribution within 60 days after the date of declaration thereof, if at the date of declaration such payment would have complied with the provisions of this
      Indenture;

     

    (ii)         (A) the redemption, repurchase, retirement or other acquisition of any Equity Interests (“Retired Capital Stock”) of the Issuer or any direct or indirect parent of the Issuer or
      Subordinated Indebtedness of the Issuer, any direct or indirect parent of the Issuer or any Guarantor in exchange for, or out of the proceeds of, the substantially concurrent sale of, Equity Interests of the Issuer or any direct or indirect parent of
      the Issuer or contributions to the equity capital of the Issuer (other than any Disqualified Stock or any Equity Interests sold to a Subsidiary of the Issuer or to an employee stock ownership plan or any trust established by the Issuer or any of its
      Subsidiaries) (collectively, including any such contributions, “Refunding Capital Stock”); and (B) the declaration and payment of accrued dividends on the Retired Capital Stock out of the proceeds of the substantially concurrent sale (other than to a
      Subsidiary of the Issuer or to an employee stock ownership plan or any trust established by the Issuer or any of its Subsidiaries) of Refunding Capital Stock;

     

    (iii)        the redemption, repurchase, defeasance or other acquisition or retirement of Subordinated Indebtedness of the Issuer or any Guarantor made by exchange for, or out of the proceeds of the
      substantially concurrent sale of, (x) Equity Interests of the Issuer or any direct or indirect parent of the Issuer (which Equity Interests shall be deemed to be Refunding Capital Stock) or (y) new Indebtedness of the Issuer or a Guarantor that is
      Incurred in accordance with Section 4.03 so long as, with respect to this clause (y):

     

    
      60

      
        

    

    (A)         the principal amount (or accreted value, if applicable) of such new Indebtedness does not exceed the principal amount (or accreted value, if applicable), plus any accrued and unpaid
      interest, of the Subordinated Indebtedness being so redeemed, repurchased, acquired or retired for value (plus the amount of any premium required to be paid under the terms of the instrument governing the Subordinated Indebtedness being so redeemed,
      repurchased, acquired or retired, plus any paid-in-kind interest, any tender premiums or any defeasance costs, fees and expenses Incurred in connection therewith);

     

    (B)         such Indebtedness by its terms is subordinated to the Securities or the related Guarantee, as the case may be, in right of payment and either unsecured or secured by a Lien junior as to
      priority with respect to the Notes Collateral, at least to the same extent as such Subordinated Indebtedness so purchased, exchanged, redeemed, repurchased, defeased, acquired or retired for value;

     

    (C)         such Indebtedness has a Stated Maturity and, if applicable, a First Amortization Date equal to or later than the earlier of (x) the Stated Maturity of the Subordinated Indebtedness being so
      redeemed, repurchased, acquired or retired and (y) 91 days following the Stated Maturity of any Securities then outstanding; and

     

    (D)         such Indebtedness has a Weighted Average Life to Maturity at the time Incurred that is not less than the remaining Weighted Average Life to Maturity of the Subordinated Indebtedness being
      so redeemed, repurchased, defeased, acquired or retired;

     

    (iv)         the repurchase, retirement or other acquisition (or dividends to any direct or indirect parent of the Issuer to finance any such repurchase, retirement or other acquisition) for value of
      Equity Interests of the Issuer or any direct or indirect parent of the Issuer held by any future, present or former employee, director or consultant of the Issuer or any direct or indirect parent of the Issuer or any Subsidiary of the Issuer pursuant
      to any management equity plan or stock option plan or any other management or employee benefit plan or other agreement or arrangement; provided that the aggregate amounts paid under this clause (iv) do not
      exceed $250,000 in any calendar year; provided, further, that such amount in any calendar year may be increased by an amount not to exceed:

     

    (A)         the cash proceeds received by the Issuer or any of its Restricted Subsidiaries from the sale of Equity Interests (other than Disqualified Stock) of the Issuer or any direct or indirect
      parent of the Issuer (to the extent contributed to the Issuer) to members of management, directors or consultants of the Issuer and its Restricted Subsidiaries or any direct or indirect parent of the Issuer that occurs after the Issue Date (provided that the amount of such cash proceeds utilized for any such repurchase, retirement, other acquisition or dividend shall not increase the amount available for Restricted Payments under clause (3) of
      Section 4.04(a)); plus

     

    
      61

      
        

    

    (B)         the cash proceeds of key man life insurance policies received by the Issuer or any direct or indirect parent of the Issuer (to the extent contributed to the Issuer) or the Issuer’s
      Restricted Subsidiaries after the Issue Date;

     

    provided that the Issuer may elect to apply all or any portion of the aggregate increase contemplated by clauses (A) and (B) above in
        any one or more calendar years; and provided, further, that cancellation of Indebtedness owing to the Issuer or any Restricted Subsidiary from any present or former
        employees, directors, officers or consultants of the Issuer or any Restricted Subsidiary or the direct or indirect parent of the Issuer will not be deemed to constitute a Restricted Payment for purposes of this Section 4.04 or any other provision
        of this Indenture;

     

    (v)          the declaration and payment of dividends or distributions to holders of any class or series of Disqualified Stock of the Issuer or any Guarantor Incurred in accordance with Section 4.03;

     

    (vi)         payments or distributions to dissenting stockholders or equityholders pursuant to applicable law, pursuant to or in connection with a merger, amalgamation, consolidation or transfer of all
      or substantially all of the assets of the Issuer and the Restricted Subsidiaries, taken as a whole, that complies with Article 5, provided that as a result of such merger, amalgamation, consolidation or
      transfer of assets, the Issuer shall have made a Change of Control Offer (if required by this Indenture) and that all Securities tendered by Holders in connection with such Change of Control Offer have been repurchased, redeemed or acquired for
      value;

     

    (vii)       other Restricted Payments in an aggregate amount not to exceed $100,000;

     

    (viii)      the distribution, as a dividend or otherwise, of (i) shares of Capital Stock of, or (ii) Indebtedness owed to the Issuer or a Restricted Subsidiary of the Issuer by, Unrestricted
      Subsidiaries (other than Unrestricted Subsidiaries the primary assets of which are Cash Equivalents);

     

    (ix)        the repurchase of Equity Interests deemed to occur upon the exercise or vesting of stock options, warrants or phantom stock, in each case, to the extent such Equity Interests (i) represent
      all or a portion of the exercise price of those stock options, warrants or phantom stock or (ii) are surrendered in connection with satisfying any federal or state tax obligation incurred in connection with such exercise or vesting;

     

    (x)          (A) Restricted Payments by the Issuer or any Restricted Subsidiary to allow the payment of cash in lieu of the issuance of fractional shares upon the exercise of options or warrants or
      upon the conversion or exchange of Capital Stock or Indebtedness convertible into the Capital Stock of any such Person (or the direct or indirect parent of the Issuer) (including dividends, splits, combinations and business combinations) or (B) the
      issuance of Capital Stock upon conversion of Indebtedness convertible into the Capital Stock of the Issuer (or the direct or indirect parent of the Issuer) or the exercise of stock options or warrants (including dividends, splits, combinations and
      business combinations); and

     

    
      62

      
        

    

    (xi)        the repurchase, redemption or other acquisition or retirement for value of any Subordinated Indebtedness pursuant to provisions similar to those described under Section 4.08; provided that all Securities tendered by Holders in connection with a Change of Control Offer have been repurchased, redeemed or acquired for value;

     

    provided, that at the time of, and after giving effect to, any Restricted Payment permitted under clauses (vii), (viii) and (xi) of
        this Section 4.04(b), no Default shall have occurred and be continuing or would occur as a consequence thereof.

     

    (c)          For purposes of designating any Restricted Subsidiary as an Unrestricted Subsidiary, all outstanding Investments by the Issuer and its Restricted Subsidiaries (except to the extent repaid) in the Subsidiary
      so designated shall be deemed to be Restricted Payments in an amount determined as set forth in the last sentence of the definition of “Investments”. Such designation shall only be permitted if a Restricted Payment or Permitted Investment in such
      amount would be permitted at such time and if such Subsidiary otherwise meets the definition of “Unrestricted Subsidiary”.

     

    (d)          For purposes of determining compliance with this Section 4.04, in the event that a Restricted Payment (or any portion thereof) meets the criteria of more than one of the categories described in Section
      4.04(b) or is entitled to be made pursuant to Section 4.04(a), the Issuer may, in its sole discretion, classify or reclassify, or later divide, classify or reclassify, such Restricted Payment (or any portion thereof) in any manner that complies with
      this Section 4.04.

     

    SECTION 4.05.   Dividend and Other Payment Restrictions Affecting Subsidiaries

     

    The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, directly or indirectly, create or otherwise cause or suffer to exist or become effective any consensual encumbrance or consensual
      restriction on the ability of any Restricted Subsidiary to:

     

    (a)          (i) pay dividends or make any other distributions to the Issuer or any of its Restricted Subsidiaries (1) on its Capital Stock or (2) with respect to any other interest or participation in, or measured by,
      its profits or (ii) pay any Indebtedness owed to the Issuer or any of its Restricted Subsidiaries;

     

    (b)          make loans or advances to the Issuer or any of its Restricted Subsidiaries; or

     

    

    
      (c)          sell, lease or transfer any of its properties or assets to the Issuer or any of its Restricted Subsidiaries,

       

      

      except in each case for such encumbrances or restrictions existing under or by reason of:
       

      

    

    
      63

      
        

    

    (1)          contractual encumbrances or restrictions in effect on the Issue Date;

     

    (2)          this Indenture, the Guarantees, the Securities, the Security Documents or the Intercreditor Agreements;

     

    (3)          applicable law or any applicable rule, regulation or order;

     

    (4)          any agreement or other instrument relating to Indebtedness of a Person acquired by the Issuer or any Restricted Subsidiary that was in existence at the time of such acquisition (but not
      created in contemplation thereof or to provide all or any portion of the funds or guarantees utilized to consummate such acquisition), which encumbrance or restriction is not applicable to any Person, or the properties or assets of any Person, other
      than the Person, or the property or assets of the Person, so acquired;

     

    (5)          contracts or agreements for the sale of assets, including any restriction with respect to a Restricted Subsidiary imposed pursuant to an agreement entered into for the Disposition of the
      Capital Stock or assets of such Restricted Subsidiary pending the closing of such Disposition;

     

    (6)          documents relating to any Secured Indebtedness otherwise permitted to be Incurred pursuant to Sections 4.03 and 4.11, which restrictions are restrictions on the transfer of assets securing
      such Secured Indebtedness;

     

    (7)          restrictions on cash or other deposits or net worth imposed by customers under contracts entered into in the ordinary course of business;

     

    (8)          customary provisions in joint venture agreements, collaboration agreements, intellectual property licenses and other similar agreements entered into in the ordinary course of business;

     

    (9)          purchase money obligations for property acquired and Capitalized Lease Obligations in the ordinary course of business;

     

    (10)        customary provisions contained in leases, contracts, licenses and other similar agreements entered into in the ordinary course of business (including non-assignment provisions);

     

    (11)        other Indebtedness, Disqualified Stock or Preferred Stock (a) of the Issuer or any Restricted Subsidiary of the Issuer that is a Guarantor or (b) of any Restricted Subsidiary that is not a
      Guarantor so long as such encumbrances and restrictions contained in any agreement or instrument will not materially affect the Issuer’s ability to make anticipated principal or interest payments on the Securities (as determined in good faith by the
      Issuer), provided that in the case of each of clauses (a) and (b) above, such Indebtedness, Disqualified Stock or Preferred Stock is permitted to be Incurred subsequent to the Issue Date under Section 4.03;

     

    
      64

      
        

    

    (12)        any Permitted Investment (to the extent such encumbrance or restriction was not made in contemplation of such Permitted Investment and was in existence on the date of such Permitted
      Investment);

     

    (13)        customary provisions imposed on the transfer of copyrighted or patented materials;

     

    (14)        any encumbrances or restrictions of the type referred to in clauses (a), (b) and (c) above imposed by any amendments, modifications, restatements, renewals, increases, supplements,
      refundings, replacements or refinancings of the contracts, instruments or obligations referred to in clauses (1) through (13) above; provided that such amendments, modifications, restatements, renewals,
      increases, supplements, refundings, replacements or refinancings are, in the good faith judgment of the Issuer, no more restrictive with respect to such dividend and other payment restrictions than those contained in the dividend or other payment
      restrictions prior to such amendment, modification, restatement, renewal, increase, supplement, refunding, replacement or refinancing; or

     

    (15)        any Apomorphine Royalty Disposition to a Royalty Subsidiary.

     

    For purposes of determining compliance with this Section 4.05, (i) the priority of any Preferred Stock in receiving dividends or liquidating distributions prior to dividends or liquidating distributions being paid on
      other Capital Stock shall not be deemed a restriction on the ability to make distributions on Capital Stock and (ii) the subordination of loans or advances made to the Issuer or a Restricted Subsidiary of the Issuer to other Indebtedness Incurred by
      the Issuer or any such Restricted Subsidiary shall not be deemed a restriction on the ability to make loans or advances.

     

    SECTION 4.06.   Asset Sales.

     

    (a)          General. The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, directly or indirectly, (i) make a Disposition or (ii) issue or sell Equity Interests (other than directors’
      qualifying shares and shares issued to foreign nationals or other third parties to the extent required by applicable law) of any Restricted Subsidiary (other than to the Issuer or another Restricted Subsidiary of the Issuer) (whether in a single
      transaction or a series of related transactions), in each case except for (A) Apomorphine Dispositions that comply with Section 4.06(b) and (B) Permitted Asset Sales.

     

    (b)          Apomorphine Dispositions.

     

    (i)          Upon the occurrence of any Apomorphine Disposition, each Holder shall have the right to require the Issuer to repurchase all or any part of such Holder’s then outstanding Securities at a
      repurchase price in cash equal to 112.5000% of the principal amount thereof, plus accrued and unpaid interest, if any, thereon to the repurchase date (subject to the right of the Holders of record on the relevant Record Date to receive interest due
      on the related Payment Date), in accordance with the terms contemplated in this Section 4.06(b); provided, however, that notwithstanding the occurrence of an
      Apomorphine Disposition, the Issuer shall not be obligated to repurchase any Securities pursuant to this Section 4.06(b) in the event that it has exercised (x) its unconditional right to redeem such Securities in accordance with Article 3 or (y) its
      legal defeasance option or covenant defeasance option in accordance with Article 8; provided, further, that the Issuer shall not repurchase more than $40,000,000 in
      aggregate principal amount of Securities from the cash proceeds from all such Apomorphine Dispositions (or $50,000,000 in aggregate principal amount of Securities if the First Additional Securities have been issued) (and, in the event that the
      aggregate principal amount of Securities so requested to be repurchased pursuant to this Section 4.06(b) exceeds $40,000,000 (or $50,000,000 if the First Additional Securities have been issued), then the Issuer shall repurchase the Securities from
      such Holders on a pro rata basis).

     

    
      65

      
        

    

    (ii)          Within 30 days following any Apomorphine Disposition, except to the extent that the Issuer has exercised (x) its unconditional right to redeem the Securities by delivery of a notice of
      redemption in accordance with Article 3 or (y) its legal defeasance option or covenant defeasance option in accordance with Article 8, the Issuer shall provide a written notice (an “Apomorphine Asset Sale Offer”) to each Holder with a copy to the
      Trustee stating:

     

    (A)          that an Apomorphine Disposition has occurred and that such Holder has the right to require the Issuer to repurchase (subject to the second proviso of Section 4.06(b)(i)) all or any part
      of such Holder’s then outstanding Securities at a repurchase price in cash equal to 112.5000% of the principal amount thereof, plus accrued and unpaid interest, if any, thereon to the repurchase date (subject to the right of the Holders of record on
      the relevant Record Date to receive interest due on the related Payment Date);

     

    (B)          the amount of cash proceeds from such Apomorphine Disposition;

     

    (C)          the amount of cash proceeds from any prior Apomorphine Dispositions;

     

    (D)          the repurchase date (which shall be no earlier than 30 days nor later than 60 days from the date such written notice is provided); and

     

    (E)          the instructions determined by the Issuer, consistent with this Section 4.06(b), that a Holder must follow in order to have its Securities repurchased.

     

    (iii)        At any time prior to the Second Additional Securities Triggering Event, to the extent that the aggregate principal amount of Securities repurchased by the Issuer pursuant to this Section
      4.06(b), taken together with any prior repurchases by the Issuer pursuant to this Section 4.06(b), is less than $40,000,000 (or $50,000,000 if the First Additional Securities have been issued), the difference between (x) the cash proceeds in respect
      of all Apomorphine Dispositions, limited to the first $40,000,000 of all such cash proceeds (or $50,000,000 if the First Additional Securities have been issued) and (y) the aggregate principal amount of Securities so repurchased shall be deposited
      into the Collateral Account.

     

    
      66

      
        

    

    (iv)        Holders electing to have a Security repurchased pursuant to this Section 4.06(b) shall be required to surrender the Security, with an appropriate form duly completed, to the Issuer at the
      address specified in the Apomorphine Asset Sale Offer (or otherwise in accordance with the applicable procedures of the Depository) at least three Business Days prior to the repurchase date. The Holders shall be entitled to withdraw their election if
      the Issuer receives not later than one Business Day prior to the repurchase date a facsimile transmission or letter setting forth the name of the Holder, the principal amount of the Security that was delivered for repurchase by the Holder and a
      statement that such Holder is withdrawing its election to have such Security repurchased. Holders whose Securities are repurchased only in part shall be issued new Securities equal in principal amount to the portion of the Securities surrendered but
      not repurchased. If the Securities are Global Securities held by the Depository, then the applicable operational procedures of the Depository for tendering and withdrawing securities will apply.

     

    (v)         On the repurchase date, all Securities repurchased by the Issuer under this Section 4.06(b) shall be delivered to the Trustee for cancellation, and the Issuer shall pay the repurchase price
      plus accrued and unpaid interest to the Holders entitled thereto.

     

    (vi)        Securities repurchased by the Issuer pursuant to this Section 4.06(b) will have the status of Securities issued but not outstanding or will be retired and canceled at the option of the
      Issuer.

     

    (vii)       At the time the Issuer delivers (or causes to be delivered) Securities to the Trustee that are to be accepted for repurchase, the Issuer shall also deliver an Officers’ Certificate stating
      that such Securities are to be accepted by the Issuer pursuant to and in accordance with the terms of this Section 4.06(b) and confirming whether the Securities will be considered issued but not outstanding or including orders to cancel the
      repurchased Securities. A Security shall be deemed to have been accepted for repurchase at the time the Trustee, directly or through an agent, provides payment therefor upon receipt from or on behalf of the Issuer to the surrendering Holder.

     

    (viii)      Prior to providing written notice to the Holders of any Apomorphine Asset Sale Offer pursuant to Section 4.06(b)(ii), the Issuer shall deliver to the Trustee an Officers’ Certificate
      stating that all conditions precedent contained herein to the right of the Issuer to make such offer have been complied with.

     

    
      67

      
        

    

    (ix)        The Issuer shall comply, to the extent applicable, with the requirements of Section 14(e) of the Exchange Act and any other securities laws or regulations in connection with the repurchase
      of Securities pursuant to this Section 4.06(b). To the extent that the provisions of any securities laws or regulations conflict with provisions of this Section 4.06(b), the Issuer shall comply with the applicable securities laws and regulations and
      shall not be deemed to have breached its obligations under this Section 4.06(b) by virtue thereof.

     

    (c)          Administration of Collateral Account.

     

    (i)          The Issuer shall establish and maintain a segregated account held with U.S. Bank National Association (or another segregated account in replacement thereof held with another U.S. federally
      insured depositary financial institution that is acting as the Trustee or other Paying Agent) in the name of the Trustee or other Paying Agent (acting in either case as an agent for or representative of the Collateral Agent), or in the name of the
      Issuer, in each case, subject to the Liens established under the Collateral Agreement and the other Security Documents (such account, the “Collateral Account”). The Collateral Account shall be established and maintained so as to create, perfect and
      establish the priority of the Liens established under the Collateral Agreement and the other Security Documents in such Collateral Account and all funds and other assets or property from time to time deposited therein or credited thereto and
      otherwise to effectuate the Liens under the Security Documents. The Collateral Account shall bear a designation clearly indicating that the funds and other assets or property deposited therein or credited thereto are held for the benefit of the
      Holders and the Trustee.

     

    (ii)         The Trustee or other Paying Agent, as applicable, shall have sole dominion and control over the Collateral Account (including, among other things, the sole power to direct withdrawals or
      transfers from the Collateral Account). The Trustee or other Paying Agent, as applicable, shall make withdrawals and transfers from the Collateral Account in accordance with the terms of this Indenture. Each of the Issuer and the Trustee, any other
      Paying Agent and the Collateral Agent acknowledges and agrees that the Collateral Account is a “securities account” within the meaning of Section 8-501 of the Uniform Commercial Code and that the Trustee or other Paying Agent, as applicable, has
      “control”, for purposes of Section 9-314 of the Uniform Commercial Code, of the Collateral Account that is maintained with the Trustee or other Paying Agent. The Trustee hereby confirms that it has established account number 217428010 in the name of
      the Issuer for the benefit of the Holders and the Trustee as the Collateral Account. The Issuer and the Trustee, any other Paying Agent and the Collateral Agent further agree that the jurisdiction of the Trustee, such other Paying Agent or the
      Collateral Agent, as applicable, for purposes of the Uniform Commercial Code shall be the State of New York. The crediting by the Trustee or other Paying Agent, as applicable, to the Collateral Account of any asset or property that is not otherwise a
      financial asset by virtue of Section 8-102(a)(9)(i) of the Uniform Commercial Code or Section 8-102(a)(9)(ii) of the Uniform Commercial Code, including cash, shall constitute the “express agreement” of the Trustee or such other Paying Agent, as
      applicable, under Section 8-102(a)(9)(iii) of the Uniform Commercial Code that such property is a financial asset under such Section 8-102(a)(9)(iii) of the Uniform Commercial Code.

     

    
      68

      
        

    

    (iii)        The funds in the Collateral Account shall be released to the Issuer in whole or in part (free and clear of any Liens established under the Collateral Agreement and any other applicable
      Security Document) only upon (A) the occurrence of the Second Additional Securities Triggering Event and receipt by the Trustee or other applicable Paying Agent of the Second Additional Securities Triggering Event Officers’ Certificate or (B) the
      written consent of the Holders of a majority in principal amount of the Securities. The funds in the Collateral Account may not otherwise be withdrawn except (x) upon the occurrence and during the continuance of an Event of Default at the direction
      of the Holders of a majority in principal amount of the Securities as further described in Article 6, (y) to the Issuer following the discharge of this Indenture or (z) solely to be used in connection with the Issuer’s (A) unconditional right to
      redeem the Securities in whole in accordance with Article 3 or (B) legal defeasance option or covenant defeasance option in accordance with Article 8. Funds in the Collateral Account may be invested by the Trustee or such Paying Agent in Cash
      Equivalents available to the Trustee or other Paying Agent, as applicable, at the written direction of the Issuer absent the occurrence and continuance of an Event of Default. Promptly following the occurrence of an Event of Default and during the
      continuation thereof, the Trustee or other Paying Agent, as applicable (acting as an agent for or representative of the Collateral Agent), shall direct such funds to be invested pursuant to the direction of the Holders of a majority in principal
      amount of the Securities that are available to the Trustee or other Paying Agent, as applicable. In the absence of written instructions, no investments shall be made using the funds in the Collateral Account.

     

    (iv)         The cash proceeds in respect of any Apomorphine Disposition in excess of the first $40,000,000 of cash proceeds from all Apomorphine Dispositions (or $50,000,000 if the First Additional
      Securities have been issued) may be used by the Issuer for any purpose that is not prohibited by this Indenture. At any time following the Second Additional Securities Triggering Event, after any repurchase of Securities by the Issuer pursuant to
      Section 4.06(b), any cash proceeds in respect of the related Apomorphine Disposition not used for such repurchase may be used by the Issuer for any purpose that is not prohibited by this Indenture.

     

    SECTION 4.07.   Transactions with Affiliates.

     

    (a)          The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, directly or indirectly, make any payment to, or lease or Dispose of any of its properties or assets to, or purchase any
      property or assets from, or enter into or make or amend any transaction or series of transactions, contract, agreement, understanding, loan, advance or guarantee with, or for the benefit of, any Affiliate of the Issuer (each of the foregoing, an
      “Affiliate Transaction”) involving aggregate consideration in excess of $250,000, unless:

     

    
      69

      
        

    

    (i)          such Affiliate Transaction is on terms that are not materially less favorable to the Issuer or the relevant Restricted Subsidiary than those that could have been obtained in a comparable
      transaction by the Issuer or such Restricted Subsidiary with an unrelated Person; and

     

    (ii)         with respect to any Affiliate Transaction or series of related Affiliate Transactions involving aggregate consideration in excess of $500,000, the Issuer delivers to the Trustee a
      resolution adopted by the majority of the disinterested members of the Board of Directors of the Issuer, approving such Affiliate Transaction, evidenced by an Officers’ Certificate certifying that such Affiliate Transaction complies with clause (i)
      above.

     

    (b)          The provisions of Section 4.07(a) shall not apply to the following:

     

    (i)          (A) any transaction or series of transactions between or among any of the Issuer and its Restricted Subsidiaries (or an entity that becomes a Restricted Subsidiary as a result of such
      transaction), including any payment to, or lease or Disposition of any properties or assets to, or purchase of any property or assets from, or any contract, agreement, amendment, understanding, loan, advance or guarantee with, or for the benefit of,
      any of the Issuer and its Restricted Subsidiaries (or an entity that becomes a Restricted Subsidiary as a result of such transaction), or (B) any merger, amalgamation or consolidation of the Issuer and any direct parent of the Issuer; provided that such parent shall have no material liabilities and no material assets other than cash, Cash Equivalents and the Capital Stock of the Issuer and such merger, amalgamation or consolidation is otherwise
      not prohibited by the terms of this Indenture and is effected for a bona fide business purpose;

     

    (ii)         Restricted Payments permitted by Section 4.04 and Permitted Investments (without giving effect to clause (12) of the definition of “Permitted Investments”);

     

    (iii)        the payment of reasonable and customary compensation, benefits, fees and reimbursement of expenses paid to, and indemnity, contribution and insurance provided on behalf of, officers,
      directors, employees, agents or consultants of the Issuer or any Restricted Subsidiary;

     

    (iv)        transactions in which the Issuer or any of its Restricted Subsidiaries, as the case may be, delivers to the Trustee a letter from an Independent Financial Advisor stating that such
      transaction is fair to the Issuer or such Restricted Subsidiary from a financial point of view or meets the requirements of Section 4.07(a)(i);

     

    (v)          payments, advances or loans (or cancellation of loans) to officers, directors, employees or consultants of the Issuer or any of the Restricted Subsidiaries of the Issuer and employment
      agreements, stock option plans, consulting agreements, restrictive covenant agreements, expense reimbursement arrangements, indemnification agreements, severance and separation agreements and other similar arrangements with such officers, directors,
      employees, agents or consultants that, in each case, are entered into in the ordinary course of business (including, in each case, payments pursuant thereto);

     

    
      70

      
        

    

    (vi)        any agreement as in effect as of the Issue Date or any amendment thereto (so long as any such agreement together with all amendments thereto, taken as a whole, is not more disadvantageous
      to the Holders of the Securities in any material respect than the original agreement as in effect on the Issue Date) or any transaction contemplated thereby as determined in good faith by the Issuer;

     

    (vii)        the existence of, or the performance by the Issuer or any of its Restricted Subsidiaries of its obligations under the terms of, any stockholders or equityholders agreement (including any
      registration rights agreement or purchase agreement related thereto) to which it is a party as of the Issue Date and any amendment thereto or similar transactions, agreements or arrangements that it may enter into thereafter; provided that the existence of, or the performance by the Issuer or any of its Restricted Subsidiaries of its obligations under, any future amendment to any such existing transaction, agreement or arrangement or
      under any similar transaction, agreement or arrangement entered into after the Issue Date shall only be permitted by this clause (vii) to the extent that the terms of any such existing transaction, agreement or arrangement together with all
      amendments thereto, taken as a whole, or new transaction, agreement or arrangement are not otherwise more disadvantageous to the Holders of the Securities in any material respect than the original transaction, agreement or arrangement as in effect on
      the Issue Date;

     

    (viii)      (A) transactions with customers, clients, suppliers or purchasers or sellers of goods or services, or transactions otherwise relating to the purchase or sale of goods or services, in each
      case in the ordinary course of business and otherwise in compliance with the terms of this Indenture, which are fair to the Issuer and its Restricted Subsidiaries in the reasonable determination of the Board of Directors or the senior management of
      the Issuer, or are on terms at least as favorable as might reasonably have been obtained at such time from an unaffiliated party or (B) transactions with joint ventures or Unrestricted Subsidiaries entered into in the ordinary course of business that
      are not otherwise prohibited by this Indenture;

     

    (ix)        the issuance of Equity Interests (other than Disqualified Stock) of the Issuer to any Person;

     

    (x)          the issuances of securities or other payments, awards or grants in cash, securities or otherwise pursuant to, or the funding of, employment arrangements, stock option and stock ownership
      plans or similar employee or director benefit plans approved by the Board of Directors of the Issuer or any direct or indirect parent of the Issuer or of a Restricted Subsidiary of the Issuer, as appropriate, in good faith;

     

    
      71

      
        

    

    (xi)        any contribution to the capital of the Issuer;

     

    (xii)       transactions permitted by, and complying with, Article 5;

     

    (xiii)      pledges of Equity Interests of Unrestricted Subsidiaries and Royalty Subsidiaries;

     

    (xiv)      intercompany transactions undertaken in good faith for the purpose of improving the consolidated tax efficiency of the Issuer and its Restricted Subsidiaries and not for the purpose of
      circumventing compliance with any covenant set forth in this Indenture;

     

    (xv)        the formation and maintenance of any consolidated group or subgroup for tax, accounting or cash pooling or management purposes in the ordinary course of business;

     

    (xvi)      any Apomorphine Royalty Disposition to a Royalty Subsidiary; and

     

    (xvii)     transactions between the Issuer or any of its Restricted Subsidiaries and any Person, a director of which is also a director of the Issuer or any direct or indirect parent of the Issuer; provided, however, that such director abstains from voting as a director of the Issuer or such direct or indirect parent, as the case may be, on any matter involving such other Person.

     

    SECTION 4.08.   Change of Control.

     

    (a)          Upon a Change of Control, each Holder shall have the right to require the Issuer to repurchase all or any part of such Holder’s then outstanding Securities at a repurchase price in cash equal to 101% of the
      principal amount thereof, plus accrued and unpaid interest, if any, thereon to the repurchase date (subject to the right of the Holders of record on the relevant Record Date to receive interest due on the related Payment Date), in accordance with the
      terms contemplated in this Section 4.08; provided, however, that notwithstanding the occurrence of a Change of Control, the Issuer shall not be obligated to
      repurchase any Securities pursuant to this Section 4.08 in the event that it has exercised (i) its unconditional right to redeem such Securities in accordance with Article 3 or (ii) its legal defeasance option or covenant defeasance option in
      accordance with Article 8.

     

    (b)          Within 30 days following any Change of Control, except to the extent that the Issuer has exercised (x) its unconditional right to redeem the Securities by delivery of a notice of redemption in accordance
      with Article 3 or (y) its legal defeasance option or covenant defeasance option in accordance with Article 8, the Issuer shall provide a written notice (a “Change of Control Offer”) to each Holder with a copy to the Trustee stating:

     

    
      72

      
        

    

    (i)          that a Change of Control has occurred and that such Holder has the right to require the Issuer to repurchase such Holder’s then outstanding Securities at a repurchase price in cash equal
      to 101% of the principal amount thereof, plus accrued and unpaid interest, if any, thereon to the repurchase date (subject to the right of the Holders of record on the relevant Record Date to receive interest due on the related Payment Date);

     

    (ii)         the circumstances and relevant facts and financial information regarding such Change of Control (provided, that such information may be provided by
      making reference to such information available for free on the SEC’s EDGAR system (or any successor system adopted by the SEC));

     

    (iii)        the repurchase date (which shall be no earlier than 30 days nor later than 60 days from the date such written notice is provided, other than as may be required by law); and

     

    (iv)        the instructions determined by the Issuer, consistent with this Section 4.08, that a Holder must follow in order to have its Securities repurchased.

     

    (c)          Holders electing to have a Security repurchased pursuant to this Section 4.08 shall be required to surrender the Security, with an appropriate form duly completed, to the Issuer at the address specified in
      the Change of Control Offer (or otherwise in accordance with the applicable procedures of the Depository) at least three Business Days prior to the repurchase date. The Holders shall be entitled to withdraw their election if the Issuer receives not
      later than one Business Day prior to the repurchase date a facsimile transmission or letter setting forth the name of the Holder, the principal amount of the Security that was delivered for repurchase by the Holder and a statement that such Holder is
      withdrawing its election to have such Security repurchased. Holders whose Securities are repurchased only in part shall be issued new Securities equal in principal amount to the portion of the Securities surrendered but not repurchased. If the
      Securities are Global Securities held by the Depository, then the applicable operational procedures of the Depository for tendering and withdrawing securities will apply.

     

    (d)          On the repurchase date, all Securities repurchased by the Issuer under this Section 4.08 shall be delivered to the Trustee for cancellation, and the Issuer shall pay the repurchase price plus accrued and
      unpaid interest to the Holders entitled thereto.

     

    (e)          A Change of Control Offer may be made in advance of a Change of Control, and conditioned upon the consummation of such Change of Control, if a definitive agreement is in place for the Change of Control at
      the time of making of the Change of Control Offer.

     

    (f)          Notwithstanding the foregoing provisions of this Section 4.08, the Issuer shall not be required to make a Change of Control Offer upon a Change of Control if a third party makes the Change of Control Offer
      in the manner, at the times and otherwise in compliance with the requirements set forth in this Section 4.08 applicable to a Change of Control Offer made by the Issuer and purchases all Securities validly tendered and not withdrawn under such Change
      of Control Offer.

     

    
      73

      
        

    

    (g)          Securities repurchased by the Issuer pursuant to a Change of Control Offer will have the status of Securities issued but not outstanding or will be retired and canceled at the option of the Issuer.
      Securities purchased by a third party pursuant to Section 4.08(f) will have the status of Securities issued and outstanding.

     

    (h)          At the time the Issuer delivers (or causes to be delivered) Securities to the Trustee that are to be accepted for repurchase, the Issuer shall also deliver an Officers’ Certificate stating that such
      Securities are to be accepted by the Issuer pursuant to and in accordance with the terms of this Section 4.08 and confirming whether the Securities will be considered issued but not outstanding or including orders to cancel the repurchased
      Securities. A Security shall be deemed to have been accepted for repurchase at the time the Trustee, directly or through an agent, provides payment therefor upon receipt from or on behalf of the Issuer to the surrendering Holder.

     

    (i)           Prior to providing written notice to the Holders of any Change of Control Offer pursuant to Section 4.08(b), the Issuer shall deliver to the Trustee an Officers’ Certificate and an Opinion of Counsel
      stating that all conditions precedent contained herein to the right of the Issuer to make such offer have been complied with.

     

    (j)           The Issuer shall comply, to the extent applicable, with the requirements of Section 14(e) of the Exchange Act and any other securities laws or regulations in connection with the repurchase of Securities
      pursuant to this Section 4.08. To the extent that the provisions of any securities laws or regulations conflict with provisions of this Section 4.08, the Issuer shall comply with the applicable securities laws and regulations and shall not be deemed
      to have breached its obligations under this Section 4.08 by virtue thereof.

     

    (k)          In the event that Holders of at least 90% of the aggregate principal amount of the outstanding Securities accept and do not withdraw their acceptance of a Change of Control
        Offer and the Issuer or a third party purchases all of the Securities held by such Holders, the Issuer will have the right, on not less than 10 nor more than 60 days’ prior notice to the Holders (with a copy to the Trustee), and not more than 30
        days following the purchase pursuant to such Change of Control Offer, to redeem all of the Securities that remain outstanding following such purchase at a purchase price equal to the Change of Control payment set forth in clause (b)(i) of this
        Section 4.08 plus, to the extent not included in such Change of Control payment, accrued and unpaid interest, if any, on the Securities that remain outstanding, to such later repurchase date.

     

    SECTION 4.09.   Further Instruments and Acts. The Issuer shall execute and deliver such further instruments and do such further acts as may be reasonably necessary or proper to carry out more effectively the
      purpose of this Indenture.

     

    

    
      74

      
        

    

    
      
      SECTION 4.10.   Future Guarantors. The Issuer shall cause each Restricted Subsidiary, within ten Business Days of becoming a Restricted Subsidiary, to
        execute and deliver to the Trustee a supplemental indenture substantially in the form of Exhibit C pursuant to which such Restricted Subsidiary shall guarantee the Issuer’s Obligations under the Securities and this Indenture; provided, however, that no Immaterial Subsidiary or Royalty Subsidiary shall be required to become a Guarantor; provided, further, however, that if a Restricted Subsidiary ceases to be an Immaterial Subsidiary (and is not at that time a Royalty Subsidiary) or ceases to be a Royalty
        Subsidiary (and is not at that time an Immaterial Subsidiary), the Issuer shall cause such Restricted Subsidiary, within ten Business Days of ceasing to be an Immaterial Subsidiary or a Royalty Subsidiary, as applicable, to execute and deliver to
        the Trustee a supplemental indenture substantially in the form of Exhibit C pursuant to which such Restricted Subsidiary shall guarantee the Issuer’s Obligations under the Securities and this Indenture.

       

      SECTION 4.11.   Liens. The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, directly or indirectly, create, Incur or suffer to
        exist (a) any Lien (except Permitted Liens and Royalty Subsidiary Liens) on any asset or property of the Issuer or such Restricted Subsidiary or (b) any Lien on ABL Collateral securing any First Priority Lien Obligation of the Issuer or any
        Guarantor without effectively providing that the Securities or the applicable Guarantee, as the case may be, shall be secured by a junior security interest (subject to Permitted Liens) upon the assets or property constituting such ABL Collateral
        for such First Priority Lien Obligations; provided, however, that (x) all such Liens on the ABL Collateral shall be subject to the Intercreditor Agreements and (y)
        no such junior security interest upon any Lockbox Account constituting ABL Collateral shall be required.

       

      Except with respect to clause (viii) and clause (ix) of the definition of “Excluded Asset”, no property or asset shall constitute an Excluded Asset to the extent it is pledged to secure any Indebtedness of the Issuer
        or a Restricted Subsidiary of the Issuer.

       

      For purposes of determining compliance with this Section 4.11, in the event that a Lien securing an item of Indebtedness (or any portion thereof) meets the criteria of more than one of the categories of Liens described
        in the foregoing paragraph or permitted by clauses (1) through (32) of the definition of “Permitted Liens”, then the Issuer shall, in its sole discretion, classify or reclassify, or later divide, classify or reclassify, such Lien securing an item
        of Indebtedness (or any portion thereof) in any manner that complies with this Section 4.11.

       

      With respect to any Lien securing Indebtedness that was permitted to secure such Indebtedness at the time of the Incurrence of such Indebtedness, such Lien shall also be permitted to secure any Increased Amount of such
        Indebtedness. The “Increased Amount” of any Indebtedness shall mean any increase in the amount of such Indebtedness in connection with any accrual of interest, the accretion of accreted value, the payment of interest or dividends in the form of
        additional Indebtedness, amortization of original issue discount and increases in the amount of Indebtedness outstanding solely as a result of fluctuations in the exchange rate of currencies, in each case in respect of such Indebtedness.

       

      SECTION 4.12.   Maintenance of Office or Agency.

       

      (a)          The Issuer shall maintain an office or agency (which may be an office of the Trustee or an Affiliate of the Trustee or Registrar) where Securities may be surrendered for registration of transfer or for
        exchange and where notices and demands to or upon the Issuer in respect of the Securities and this Indenture may be made. The Issuer shall give prompt written notice to the Trustee of the location, and any change in the location, of such office or
        agency. If at any time the Issuer shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such presentations and surrenders may be made at the corporate trust place of payment and
        notices and demands may be made at the Corporate Trust Office of the Trustee as set forth in Section 12.01.

       

      

      
        75

        
          

      

      (b)          The Issuer may also from time to time designate one or more other offices or agencies where the Securities may be presented or surrendered for any or all such purposes and may from time to time rescind
        such designations; provided, however, that no such designation or rescission shall in any manner relieve the Issuer of its obligation to maintain an office or
        agency for such purposes. The Issuer shall give prompt written notice to the Trustee of any such designation or rescission and of any change in the location of any such other office or agency.

       

      (c)          The Issuer hereby designates the Corporate Trust Office of the Trustee or its agent as such office or agency of the Issuer in accordance with Section 2.04.

       

      SECTION 4.13.   After-Acquired Property. Upon the acquisition by any Issuer or any Guarantor of any assets or property,
        including any Equity Interests issued by a new Subsidiary of the Issuer or any Guarantor (in each case, other than Excluded Assets) (“After-Acquired Property”), the Issuer or such Guarantor shall promptly execute and deliver such mortgages, deeds
        of trust, security instruments, pledge agreements, financing statements and certificates and opinions of counsel as shall be reasonably necessary to vest in the Collateral Agent a perfected security interest or other Lien, subject only to Permitted
        Liens, in such After-Acquired Property and to have such After-Acquired Property (but subject to certain limitations, if applicable, including as described under Article 11) added to the Notes Collateral, and shall promptly deliver such Officers’
        Certificates and Opinions of Counsel as are customary in secured financing transactions in the relevant jurisdictions or as are reasonably requested by the Trustee or the Collateral Agent (subject to customary assumptions, exceptions and
        qualifications), and thereupon all provisions of this Indenture relating to the Notes Collateral shall be deemed to relate to such After-Acquired Property to the same extent and with the same force and effect; provided
        that if granting a security interest or Lien in such After-Acquired Property requires the consent of a third party, the Issuer shall use commercially reasonable efforts to obtain such consent with respect to the security interest or Lien for the
        benefit of the Collateral Agent on behalf of the Holders of the Securities; provided, further, that if such third party does not consent to the granting of such
        security interest or Lien after the use of such commercially reasonable efforts, the Issuer or such Guarantor, as the case may be, will not be required to provide such security interest or Lien (so long as no other Person is granted a Lien on such
        After-Acquired Property securing any Indebtedness following such acquisition or in contemplation thereof); and provided, further, that with respect to the security
        interest in After-Acquired Property that constitutes ABL Collateral securing First Priority Lien Obligations, such security interest securing the Securities and the Guarantees shall be subject to the Intercreditor Agreements. Notwithstanding the
        foregoing, if any property or assets of the Issuer or any Guarantor originally deemed to be an Excluded Asset at any point ceases to be an Excluded Asset pursuant to the definition of “Excluded Asset”, all or the applicable portion of such property
        and assets shall be deemed to be After-Acquired Property and shall be added to the Notes Collateral in accordance with the previous sentence.

       

      

      
        76

        
          

      

      SECTION 4.14.   Intellectual Property. The Issuer shall, at its sole expense, either directly or by using commercially reasonable efforts to cause
          any Restricted Subsidiary or any licensee to do so, take any and all commercially reasonable actions to (a) diligently maintain the Intellectual Property owned or otherwise controlled by the Issuer or any Restricted Subsidiary and (b) to the
          extent the Issuer, any Restricted Subsidiary or any licensee in good faith determines such action to be appropriate, diligently defend or assert the Intellectual Property against infringement or interference by any other Persons and against any
          claims of invalidity or unenforceability by any other Persons (including by bringing any legal action for infringement or defending any counterclaim of invalidity or action for declaratory judgment of non-infringement) in each case where the
          failure to so act, prepare, execute, deliver or file would reasonably be expected to have a material adverse effect on the Intellectual Property or the results of operations or financial condition of the Issuer and its Restricted Subsidiaries, in
          each case, taken as a whole. The Issuer shall not, and shall use its commercially reasonable efforts to cause any Restricted Subsidiary or any licensee not to, disclaim or abandon, or fail to take any action the Issuer in good faith determines
          appropriate to prevent the disclaimer or abandonment of, the Intellectual Property, in each case where such disclaimer, abandonment or failure to take any such action would reasonably be expected to have a material adverse effect on the
          Intellectual Property or the results of operations or financial condition of the Issuer and its Restricted Subsidiaries.

       

      SECTION 4.15.   Line of Business. The Issuer shall not, and shall not permit any of its Restricted Subsidiaries to, principally engage in any line of
        business other than those businesses engaged in on the Issue Date and businesses reasonably related thereto, including in other aspects of the pharmaceutical and biotechnology businesses.

       

      SECTION 4.16.   Use of Proceeds. The Issuer shall use, or will cause its Restricted Subsidiaries to use, the net proceeds from the issuance and sale of the
        Securities and the related warrants issued and sold concurrently therewith to repay all outstanding obligations under that certain Credit Agreement and Guaranty dated as of August 16, 2016, as amended to date, among the Issuer (formerly MonoSol Rx,
        LLC), the subsidiary guarantors from time to time party thereto, the lenders from time to time party thereto and Perceptive Credit Holdings, LP, as administrative agent and collateral agent, to finance the Issuer’s strategic pipeline programs, to
        pay fees, costs and expenses arising in connection with the issuance of the Securities and such warrants and for general corporate purposes.

       

      SECTION 4.17.   Tax Matters. The Issuer shall (a) timely file all material tax returns and reports as required by applicable law and such returns and
        reports shall be true and correct in all material respects, (b) pay all material taxes, assessments or other governmental charges when due and payable, (c) not file any tax return or report under any name other than its exact legal name and (d) use
        commercially reasonable efforts to file any form (or comply with any administrative formalities) required for an exemption from or a reduction of any withholding tax for which it is eligible with respect to any payments received or receivable by
        the Issuer.

       

      

      
        77

        
          

      

      SECTION 4.18.   Existence. Subject to Article 5, each of the Issuer and each Guarantor will do or cause to be done all things necessary to preserve and keep
        in full force and effect its respective corporate existence, rights (charter and statutory), license and franchises in accordance with its respective organizational documents (as the same may be amended from time
          to time); provided that this provision shall not require the Issuer to maintain any right, license or franchise or to preserve the corporate
          existence of any Guarantor if the Issuer or such Guarantor determines in good faith that the maintenance or preservation thereof is no longer necessary or desirable in the conduct of its business, taken as a whole; provided, further, that any such failure to
          maintain any right, license or franchise or to preserve the corporate existence of any Guarantor shall not adversely affect the value of the Notes Collateral in any material respect.

       

      SECTION 4.19.   Right of First Offer. Upon each proposed issuance, if any, of First Additional Securities or Second Additional Securities, the Issuer will grant to the initial
        purchasers of the Original Securities the right to purchase an aggregate amount of such First Additional Securities or Second Additional Securities, as applicable, in an amount equal to the same proportion that the principal amount of Original
        Securities each such purchaser initially purchased bears to the aggregate principal amount of Original Securities issued on the Issue Date and at a purchase price specified by the Issuer (which purchase price shall not be more than the purchase
        price being offered to other investors), with such right to purchase being exercised by each such purchaser by written notice to the Issuer no later than 15 days after being notified of such proposed issuance by the Issuer. To the extent that any
        of the initial purchasers of the Original Securities decline to exercise their right to purchase any First Additional Securities or Second Additional Securities, as applicable (in whole or in part), the Issuer will promptly notify the other initial
        purchasers of the Original Securities that have exercised such right in full, in which case such other initial purchasers will have the right to purchase such remaining First Additional Securities or Second Additional Securities, as applicable
        (subject to proportional reduction to the extent of the relative initial principal amount of First Additional Securities or Second Additional Securities, as applicable, purchased by other initial purchasers exercising the same right), on the same
        terms as any First Additional Securities or Second Additional Securities, as applicable, it previously exercised the right to purchase pursuant to the preceding sentence, with such right to purchase being exercised by each such purchaser by written
        notice to the Issuer no later than two days after being notified of the opportunity to purchase such remaining First Additional Securities or Second Additional Securities, as applicable, by the Issuer.

       

      

      ARTICLE 5

        

       

      

      SUCCESSOR COMPANY

       

      SECTION 5.01.   When Issuer May Merge or Transfer Assets.

       

      (a)          The Issuer shall not, directly or indirectly, merge, amalgamate or consolidate with or into or wind up or convert into (whether or not the Issuer is the surviving Person), or lease or Dispose of all or
        substantially all of its properties or assets in one or more related transactions to, any Person unless:

       

      

      
        78

        
          

      

      (i)           (x) the Issuer is the surviving Person or the Person formed by or surviving any such merger, amalgamation, consolidation, winding up or conversion (if other than the Issuer) or to which
        such lease or Disposition shall have been made is a corporation, partnership or limited liability company organized or existing under the laws of the United States, any state thereof or the District of Columbia (the Issuer or such Person, as the
        case may be, being herein called the “Successor Company”); and (y) the Successor Company (if other than the Issuer) expressly assumes all the obligations of the Issuer under this Indenture, the Securities, the Intercreditor Agreements and the
        Security Documents pursuant to supplemental indentures or other documents or instruments in form reasonably satisfactory to the Trustee;

       

      (ii)          immediately after giving effect to such transaction (and treating any Indebtedness that becomes an obligation of the Successor Company or any of its Restricted Subsidiaries as a result
        of such transaction as having been Incurred by the Successor Company or such Restricted Subsidiary at the time of such transaction) no Default shall have occurred and be continuing;

       

      (iii)         immediately after giving pro forma effect to such transaction, as if such transaction had occurred at the beginning of the applicable
        four-quarter period (and treating any Indebtedness that becomes an obligation of the Successor Company or any of its Restricted Subsidiaries as a result of such transaction as having been Incurred by the Successor Company or such Restricted
        Subsidiary at the time of such transaction), the Successor Company would be permitted to Incur at least $1.00 of additional Indebtedness pursuant to Section 4.03(a);

       

      (iv)         each Guarantor, unless it is the other party to the transactions described above, shall have by supplemental indenture confirmed that its Guarantee shall apply to such Person’s
        obligations under this Indenture and the Securities; and

       

      (v)          the Successor Company shall have delivered to the Trustee (A) an Officers’ Certificate and an Opinion or Opinions of Counsel, each stating (to the extent applicable with respect to such
        Opinion or Opinions of Counsel) that such transaction and such supplemental indentures (if any) comply with this Indenture and the obligations of the Issuer under this Indenture, the Securities, the Intercreditor Agreements and the Security
        Documents remain obligations of the Successor Company and confirming the necessary actions to continue the perfection and priority of the Collateral Agent’s Lien in the Notes Collateral and of the preservation of its rights therein and (B) an
        Officers’ Certificate stating that such necessary actions have been taken (together with evidence thereof) promptly and in any event no later than 30 days following such transaction.

       

      (b)          The Successor Company (if other than the Issuer) shall succeed to, and be substituted for, the Issuer under this Indenture, the Securities, the Intercreditor Agreements and the Security Documents, and in
        such event the Issuer will automatically be released and discharged from its obligations under this Indenture, the Securities and the Security Documents. Notwithstanding the foregoing clauses (ii) and (iii) of Section 5.01(a), any Guarantor may
        merge, amalgamate or consolidate with or transfer all or substantially all of its properties and assets to the Issuer.

       

      

      
        79

        
          

      

      SECTION 5.02.   When Guarantors May Merge or Transfer Assets.

       

      (a)          Subject to the provisions of Section 10.03 (which govern the release of a Guarantee upon the Disposition or exchange of the Capital Stock of a Guarantor), none of the Guarantors shall, and the Issuer shall
        not permit any Guarantor to, directly or indirectly, merge, amalgamate or consolidate with or into or wind up or convert into (whether or not such Guarantor is the surviving Person), or lease or Dispose of all or substantially all of its properties
        or assets in one or more related transactions to, any Person unless:

       

      (i)           either (A) such Guarantor is the surviving Person or the Person formed by or surviving any such merger, amalgamation, consolidation, winding up or conversion (if other than such
        Guarantor) or to which such lease or Disposition shall have been made is a corporation, partnership or limited liability company organized or existing under the laws of the jurisdiction of its formation (such Guarantor or such Person, as the case
        may be, being herein called the “Successor Guarantor”) and the Successor Guarantor (if other than such Guarantor) expressly assumes all the obligations of such Guarantor under this Indenture and, if applicable, such Guarantors’ Guarantee and the
        Security Documents pursuant to a supplemental indenture or other documents or instruments in form reasonably satisfactory to the Trustee or (B) (x) such Disposition or merger, amalgamation or consolidation is made to a Person that is not the Issuer
        or a Restricted Subsidiary and is not in violation of Section 4.06 and (y) after giving effect to such Disposition, such Guarantor is no longer a Restricted Subsidiary; and

       

      (ii)          the Successor Guarantor (if other than such Guarantor) or the Issuer shall have delivered or caused to be delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel,
        each stating that such merger, amalgamation, consolidation, winding up, conversion, lease or Disposition and such supplemental indenture (if any) comply with this Indenture.

       

      (b)          Except as otherwise provided in this Indenture, the Successor Guarantor (if other than such Guarantor) will succeed to, and be substituted for, such Guarantor under this Indenture, such Guarantor’s
        Guarantee and the Security Documents, and in such event such Guarantor will automatically be released and discharged from its obligations under this Indenture, such Guarantor’s Guarantee and the Security Documents.

       

      (c)          Notwithstanding the foregoing, any Guarantor may merge, amalgamate or consolidate with or into or wind up or convert into, or lease or Dispose of all or substantially all of its properties or assets to,
        the Issuer or any other Guarantor.

       

      ARTICLE 6

        

        DEFAULTS AND REMEDIES

       

      SECTION 6.01.   Events of Default. An “Event of Default” occurs if:

       

      

      
        80

        
          

      

      (a)          there is a default in any payment of interest on any Security when the same becomes due and payable, and such default continues for a period of 30 days;

       

      (b)          there is a default in the payment of principal of or premium, if any, on any Security when due at its Stated Maturity, upon scheduled payment thereof, upon optional redemption, upon required repurchase,
        upon declaration of acceleration or otherwise (including pursuant to Section 4.01(b));

       

      (c)          the Issuer or any Guarantor fails to comply with any of its agreements in the Securities or this Indenture (other than those referred to in clause (a) or (b) above) and such failure continues for 30 days
        after the notice specified below;

       

      (d)          the Issuer or any Restricted Subsidiary fails to pay any Indebtedness within any applicable grace period after such payment is due and payable (including at final maturity) or the acceleration of any such
        Indebtedness by the holders thereof occurs because of a default, in each case, if the total principal amount of such Indebtedness unpaid or accelerated exceeds $1,000,000 or its non-U.S. currency equivalent;

       

      (e)          the Issuer or any Restricted Subsidiary pursuant to or within the meaning of any Bankruptcy Law:

       

      (i)          commences a voluntary case;

       

      (ii)         consents to the entry of an order for relief against it in an involuntary case;

       

      (iii)        consents to the appointment of a Custodian of it or for any substantial part of its property; or

       

      (iv)        makes a general assignment for the benefit of its creditors or takes any comparable action under any non-U.S. laws relating to insolvency;

       

      (f)          a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that:

       

      (i)          is for relief against the Issuer or any Restricted Subsidiary of the Issuer in an involuntary case;

       

      (ii)         appoints a Custodian of the Issuer or any Restricted Subsidiary of the Issuer or for any substantial part of its property; or

       

      (iii)        orders the winding up or liquidation of the Issuer or any Restricted Subsidiary of the Issuer;

       

      or any similar relief is granted under any non-U.S. laws and the order or decree remains unstayed and in effect for 60 days;

       

      

      
        81

        
          

      

      (g)          the Issuer or any Restricted Subsidiary submits to any extrajudicial restructuring or similar proceeding;

       

      (h)          the Issuer or any Restricted Subsidiary fails to pay final judgments entered against the Issuer or such Restricted Subsidiaries to the extent aggregating in excess of $1,000,000 or its non-U.S. currency
        equivalent (net of any amounts that are covered by enforceable insurance policies issued by solvent carriers or indemnities or payable from any escrow arrangement that is available to the Issuer or such Restricted Subsidiaries for payment of such
        liabilities), which judgments are not discharged, waived or stayed for a period of 60 days following the entry thereof;

       

      (i)           any representation or warranty made in writing by or on behalf of the Issuer or any Guarantor in connection with the issuance and sale of the Securities or made in writing by or on behalf of the Issuer or
        any Guarantor furnished in connection with the transactions contemplated by this Indenture and the Security Documents proves to have been false or incorrect in any material respect on the date as of which made (or, if such representation or
        warranty is given as of a specific time, as of such time);

       

      (j)           the Collateral Agent fails to have a perfected security interest in any portion of the Notes Collateral with a value greater than $1,000,000, except (i) as contemplated by this Indenture and the Security
        Documents or (ii) due to the failure on the part of the Collateral Agent to maintain custody of the Notes Collateral within its control;

       

      (k)          any Guarantee ceases to be in full force and effect (except as contemplated by the terms thereof in accordance with this Indenture) or any Guarantor denies or disaffirms in writing its obligations under
        this Indenture or any Guarantee and such Default continues for 10 days;

       

      (l)           unless all of the Notes Collateral has been released from the Liens in accordance with the provisions of the Security Documents with respect to the Securities, the Issuer shall assert or any Guarantor
        shall assert, in any pleading in any court of competent jurisdiction, that any such security interest is invalid or unenforceable;

       

      (m)         the Issuer or any Guarantor fails to comply for 30 days after notice with its obligations contained in the Security Documents, except for a failure with respect to assets or property with an aggregate value
        of less than $1,000,000; or

       

      (n)          the occurrence of (i) any material adverse change, or any development that would be expected to result in a material adverse change, in or affecting the business, condition (financial or otherwise),
        operations, performance, property or prospects of the Issuer and its Subsidiaries taken as a whole since the Issue Date or (ii) any event that results in, or is reasonably expected to result in, a material adverse effect on the ability of each of
        the Issuer and each Guarantor to perform its obligations (including its payment obligations) under the Securities and this Indenture.

       

      The foregoing shall constitute Events of Default whatever the reason for any such Event of Default and whether it is voluntary or involuntary or is effected by operation of law or pursuant to any judgment, decree or
        order of any court or any order, rule or regulation of any administrative or governmental body.

       

      

      
        82

        
          

      

      The term “Bankruptcy Law” means Title 11, United States Code, or any similar U.S. federal or state law for the relief of debtors (or their non-U.S. equivalents). The term “Custodian” means any receiver, trustee,
        assignee, liquidator, custodian or similar official under any Bankruptcy Law.

       

      A Default under clause (c) or (m) above shall not constitute an Event of Default until the Trustee or the Holders of at least 25% in principal amount of the outstanding Securities notify the Issuer (and also the
        Trustee if given by the Holders) of the Default and the Issuer does not cure such Default within the time specified in such clause (c) or (m) after receipt of such notice or after such date, as applicable. Such notice must specify the Default,
        demand that it be remedied and state that such notice is a “Notice of Default”. The Issuer shall deliver to the Trustee, within 30 days after the occurrence thereof, written notice in the form of an Officers’ Certificate of any event that is, or
        with the giving of notice or the lapse of time or both would become, an Event of Default, its status and what action the Issuer is taking or proposes to take in respect thereof.

       

      SECTION 6.02.   Acceleration. If an Event of Default (other than an Event of Default specified in Section 6.01(e), 6.01(f) or 6.01(g)) occurs and is
        continuing, the Trustee or the Holders of at least 25% in principal amount of outstanding Securities by written notice to the Issuer may, and if such notice is given by the Holders such notice shall be given to the Issuer and the Trustee, declare
        that the principal of, and the premium and accrued but unpaid interest on, all the Securities is due and payable. Upon such a declaration, such principal, premium and interest shall be due and payable immediately. If an Event of Default specified
        in Section 6.01(e), 6.01(f) or 6.01(g) occurs, the principal of, and the premium and accrued but unpaid interest on, all the Securities shall ipso facto become and be immediately due and payable, without
        any declaration or other act on the part of the Trustee or any Holders. The Holders of a majority in principal amount of the outstanding Securities by notice to the Trustee may rescind an acceleration and its consequences with respect to all
        outstanding Securities if the rescission would not conflict with any judgment or decree and if all existing Events of Default (except nonpayment of principal, interest or premium that has become due solely because of the acceleration) have been (or
        are concurrently with such rescission) cured or waived.

       

      If the principal of, or premium or accrued and unpaid interest on, the Securities becomes due and payable as provided above (an “Acceleration”), the principal of, and the premium and accrued but unpaid interest on, the
        Securities that becomes due and payable shall equal the optional redemption price in effect on the date of such declaration (or the date set forth in the third sentence of this Section 6.02), as if such Acceleration were an optional redemption of
        the Securities effected thereby on such date of declaration (or the date set forth in the third sentence of this Section 6.02). The amounts described in the preceding sentence are intended to be liquidated damages and not unmatured interest or a
        penalty, and the Issuer agrees that such liquidated damages are reasonable under the circumstances. THE ISSUER EXPRESSLY WAIVES THE PROVISIONS OF ANY PRESENT OR FUTURE STATUTE OR LAW THAT PROHIBITS OR MAY PROHIBIT THE COLLECTION OF THE FOREGOING
        PREMIUM IN CONNECTION WITH ANY SUCH ACCELERATION, INCLUDING IN CONNECTION WITH ANY VOLUNTARY OR INVOLUNTARY ACCELERATION OF THE OBLIGATIONS PURSUANT TO ANY PROCEEDING PURSUANT TO ANY BANKRUPTCY LAW OR PURSUANT TO A PLAN OF REORGANIZATION. The
        Issuer expressly agrees that: (a) such premium is reasonable and is the product of an arm’s-length transaction between sophisticated business people, ably represented by counsel; (b) such premium shall be payable notwithstanding the then prevailing
        market rates at the time payment is made; (c) there has been a course of conduct between the Holders and the Issuer giving specific consideration in this transaction for such agreement to pay such premium; and (d) the Issuer shall be estopped
        hereafter from claiming differently than as agreed to in this paragraph. The Issuer expressly acknowledges that its agreement to pay such premium to the Holders described in this Section 6.02 is a material inducement to the Holders to purchase the
        Securities.

       

      

      
        83

        
          

      

      In the event of any Event of Default specified in Section 6.01(d), such Event of Default and all consequences thereof (excluding, however, any resulting payment default) shall be annulled, waived and rescinded,
        automatically and without any action by the Trustee or the Holders of the Securities, if within 20 days after such Event of Default arose the Issuer delivers an Officers’ Certificate to the Trustee stating that (x) the Indebtedness or guarantee
        that is the basis for such Event of Default has been discharged, (y) the Holders thereof have rescinded or waived the acceleration, notice or action (as the case may be) giving rise to such Event of Default or (z) the default that is the basis for
        such Event of Default has been cured, it being understood that in no event shall an acceleration of the principal amount of the Securities as described above be annulled, waived or rescinded upon the happening of any such events.

       

      SECTION 6.03.   Other Remedies. If an Event of Default occurs and is continuing, the Trustee or the Collateral Agent, as applicable, may, but only, in the
        case of the Trustee, at the written direction of Holders of a majority in principal amount of the then outstanding Securities, pursue any available remedy at law or in equity to collect the payment of principal of or interest or premium on the
        Securities or to enforce the performance of any provision of the Securities or this Indenture.

       

      The Trustee or the Collateral Agent, as applicable, may maintain a proceeding even if it does not possess any of the Securities or does not produce any of them in the proceeding. A delay or omission by the Trustee or
        the Collateral Agent, as applicable, or any Holder in exercising any right or remedy accruing upon an Event of Default shall not impair the right or remedy or constitute a waiver of or acquiescence in the Event of Default. No remedy is exclusive of
        any other remedy. To the extent required by law, all available remedies are cumulative.

       

      SECTION 6.04.   Waiver of Existing Defaults. Provided the Securities are not then due and payable by reason of a declaration of acceleration, the Holders
        of a majority in principal amount of the then outstanding Securities by written notice to the Trustee may waive an existing Default or Event of Default and its consequences except (a) an uncured Default in the payment of the principal of or
        interest on a Security, (b) a Default arising from the failure to redeem or purchase any Security when required pursuant to the terms of this Indenture or (c) a Default in respect of a provision that under Section 9.02 cannot be amended without the
        consent of each Holder affected. When a Default or Event of Default is waived, it is deemed cured and the Issuer, the Trustee and the Holders will be restored to their former positions and rights under this Indenture, but no such waiver shall
        extend to any subsequent or other Default or impair any consequent right.

       

      

      
        84

        
          

      

      SECTION 6.05.   Control by Majority. The Holders of a majority in principal amount of the then outstanding Securities may direct the time, method and place
        of conducting any proceeding for any remedy available to the Trustee or of exercising any trust or power conferred on the Trustee. However, the Trustee may refuse to follow any direction that conflicts with law or this Indenture or, subject to
        Section 7.01, that the Trustee determines is unduly prejudicial to the rights of any other Holder or that would involve the Trustee in personal liability. Prior to taking any action under this Indenture, the Trustee shall be entitled to
        indemnification satisfactory to it in its sole discretion against all losses and expenses caused by taking or not taking such action.

       

      SECTION 6.06.   Limitation on Suits.

       

      (a)          Except to enforce the right to receive payment of principal, premium (if any) or interest when due, no Holder may pursue any remedy with respect to this Indenture or the Securities unless:

       

      (i)           the Holder gives the Trustee written notice stating that an Event of Default is continuing;

       

      (ii)          the Holders of at least 25% in principal amount of the then outstanding Securities make a written request to the Trustee to pursue the remedy;

       

      (iii)         such Holder or Holders offer to the Trustee security or indemnity satisfactory to it against any loss, liability or expense;

       

      (iv)         the Trustee does not comply with the request within 60 days after receipt of the request and the offer of security or indemnity; and

       

      (v)          the Holders of a majority in principal amount of the then outstanding Securities do not give the Trustee a direction inconsistent with the request during such 60-day period.

       

      (b)          A Holder may not use this Indenture to prejudice the rights of another Holder or to obtain a preference or priority over another Holder.

       

      SECTION 6.07.   Rights of the Holders to Receive Payment. Notwithstanding any other provision of this Indenture, the right of any Holder to receive payment
        of principal of and interest on the Securities held by such Holder, on or after the respective due dates expressed or provided for in this Indenture or in the Securities, or to bring suit for the enforcement of any such payment on or after such
        respective dates, shall not be impaired or affected without the consent of such Holder.

       

      SECTION 6.08.   Collection Suit by Trustee. If an Event of Default specified in Section 6.01(a) or Section 6.01(b) occurs and is continuing, the Trustee
        may recover judgment in its own name and as trustee of an express trust against the Issuer or any other obligor on the Securities for the whole amount then due and owing (together with interest on overdue principal and (to the extent lawful) on any
        unpaid interest at the rate provided for in the Securities) and the amounts provided for in Section 7.06.

       

      

      
        85

        
          

      

      SECTION 6.09.   Trustee May File Proofs of Claim. The Trustee may file such proofs of claim and other papers or documents as may be necessary or advisable
        in order to have the claims of the Trustee (including any claim for reasonable compensation, expenses disbursements and advances of the Trustee (including counsel, accountants, experts or such other professionals as the Trustee deems necessary,
        advisable or appropriate)) and the Holders allowed in any judicial proceedings relative to the Issuer or any Guarantor, their creditors or their property, shall be entitled to participate as a member, voting or otherwise, of any official committee
        of creditors appointed in such matters and, unless prohibited by law or applicable regulations, may vote on behalf of the Holders in any election of a trustee in bankruptcy or other Person performing similar functions and be a member of a
        creditors’ or other similar committee, and any Custodian in any such judicial proceeding is hereby authorized by each Holder to make payments to the Trustee and, in the event that the Trustee shall consent to the making of such payments directly to
        the Holders, to pay to the Trustee any amount due it for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and its counsel, and any other amounts due the Trustee under Section 7.06.

       

      SECTION 6.10.   Priorities. If the Trustee collects any money or property pursuant to this Article 6 or any Security Document, the Trustee (after giving
        effect to Section 5.3 of the Collateral Agreement) shall pay out the money or property in the following order:

       

      FIRST: to the Trustee for amounts then due and payable under Section 7.06;

       

      SECOND: to the Holders for amounts due and unpaid on the Securities for principal, premium, if any, and interest, ratably, without preference or priority of any kind, according to the amounts then due and payable on
        the Securities for principal, premium, if any, and interest, respectively; and

       

      THIRD: to the Issuer or, to the extent the Trustee collects any amount for any Guarantor, to such Guarantor.

       

      The Trustee may fix a record date and payment date for any payment to the Holders pursuant to this Section 6.10. At least 15 days before such record date, the Trustee shall provide to each Holder and the Issuer a
        written notice that states the record date, the payment date and amount to be paid.

       

      SECTION 6.11.   Undertaking for Costs. In any suit for the enforcement of any right or remedy under this Indenture or in any suit against the Trustee for
        any action taken or omitted by it as Trustee, a court in its discretion may require the filing by any party litigant in the suit of an undertaking to pay the costs of the suit, and the court in its discretion may assess reasonable costs, including
        reasonable and documented attorneys’ fees and expenses, against any party litigant in the suit, having due regard to the merits and good faith of the claims or defenses made by the party litigant. This Section 6.11 does not apply to a suit by the
        Trustee, a suit by a Holder pursuant to Section 6.07 or a suit by Holders of more than 10% in principal amount of the Securities.

       

      

      
        86

        
          

      

      SECTION 6.12.   Waiver of Stay or Extension Laws. Neither the Issuer nor any Guarantor (to the extent it may lawfully do so) shall at any time insist upon,
        or plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay or extension law wherever enacted, now or at any time hereafter in force, that may affect the covenants or the performance of this Indenture; and the Issuer
        and each Guarantor (to the extent that it may lawfully do so) hereby expressly waive all benefit or advantage of any such law, and shall not hinder, delay or impede the execution of any power herein granted to the Trustee, but shall suffer and
        permit the execution of every such power as though no such law had been enacted.

       

      SECTION 6.13.   Holder Request. At the written request of the Issuer or any Holder (or any holder of beneficial interests in the Securities that certifies to the Trustee that it is a
        holder of such beneficial interests or is actually known by the Trustee to be such a holder of beneficial interests as evidenced by a Confidentiality Agreement that has previously been delivered to the Trustee), the Trustee shall, as soon as
        practicable after receipt of such request and at the Issuer’s sole cost and expense, (a) contact each Holder or each other Holder (and each other holder of beneficial interests in the Securities) to request each such other Holder or other Holder
        (and each such other holder of beneficial interests in the Securities) to provide its written permission to being identified to the Issuer or the requesting Holder (or holder of beneficial interests in the Securities) by the Trustee, to the extent
        the Trustee has actual knowledge of the identity of such Holder or other Holder (or other holder of beneficial interests in the Securities), including pursuant to Section 4.02(g) and (b) disclose to the Issuer or the requesting Holder (or other
        holder of beneficial interests in the Securities) the identity of any such Holder or other Holder (and any such other holder of beneficial interests in the Securities) who provides such written permission to the Trustee. The Trustee shall have no
        liability if it contacts any Person that it believes to be a beneficial holder of the Securities that is not a beneficial holder of the Securities.

       

      ARTICLE 7

        

        TRUSTEE

       

      SECTION 7.01.   Duties of Trustee.

       

      (a)          If an Event of Default has occurred and is continuing, the Trustee shall exercise the rights and powers vested in it by this Indenture and use the same degree of care and skill in their exercise as a
        prudent person would exercise or use under the circumstances in the conduct of such person’s own affairs, except with respect to the obligation to exercise rights and remedies following an Event of Default, which right and remedies shall be
        performed by the Trustee acting solely upon the direction of Holders of a majority in principal amount of the Securities in accordance with Section 6.03 and Section 6.05.

       

      (b)          Except during the continuance of an Event of Default:

       

      

      
        87

        
          

      

      (i)           the Trustee undertakes to perform such duties and only such duties as are specifically set forth in this Indenture and no implied covenants or obligations shall be read into this
        Indenture against the Trustee (it being agreed that the permissive right of the Trustee to do things enumerated in this Indenture shall not be construed as a duty); and

       

      (ii)          in the absence of bad faith on its part, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon certificates or
        opinions furnished to the Trustee and conforming to the requirements of this Indenture. The Trustee shall be under no duty to make any investigation as to any statement contained in any such instance, but may accept the same as conclusive evidence
        of the truth and accuracy of such statement or the correctness of such opinions. However, in the case of certificates or opinions required by any provision hereof to be provided to it, the Trustee shall examine the certificates and opinions to
        determine whether or not they conform to the requirements of this Indenture.

       

      (c)          The Trustee may not be relieved from liability for its own negligent action, its own negligent failure to act or its own willful misconduct, except that:

       

      (i)           this paragraph does not limit the effect of Section 7.01(b);

       

      (ii)          the Trustee shall not be liable for any error of judgment made in good faith by a Trust Officer unless it is proved that the Trustee was negligent in ascertaining the pertinent facts;

       

      (iii)         the Trustee shall not be liable with respect to any action it takes or omits to take in good faith in accordance with a direction received by it pursuant to Section 6.05; and

       

      (iv)         no provision of this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur financial liability in the performance of any of its duties hereunder or in
        the exercise of any of its rights or powers.

       

      (d)          Every provision of this Indenture that in any way relates to the Trustee is subject to paragraphs (a), (b) and (c) of this Section 7.01.

       

      (e)          The Trustee shall not be liable for interest on any money received by it except as the Trustee may agree in writing with the Issuer.

       

      (f)          Money held in trust by the Trustee need not be segregated from other funds except to the extent required by law.

       

      (g)          The Trustee shall not be liable to any Person for special, punitive, indirect, consequential or incidental loss or damage of any kind whatsoever (including lost profits), even if the Trustee has been
        advised of the likelihood of such loss or damage.

       

      

      
        88

        
          

      

      (h)          Every provision of this Indenture relating to the conduct or affecting the liability of or affording protection to the Trustee shall be subject to the provisions of this Section 7.01 and, to the extent
        made expressly applicable by the terms of this Indenture, to the provisions of the TIA.

       

      SECTION 7.02.   Rights of Trustee.

       

      (a)          The Trustee may conclusively rely on any document believed by it to be genuine and to have been signed or presented by the proper person. The Trustee need not investigate any fact or matter stated in the
        document.

       

      (b)          Before the Trustee acts or refrains from acting, it may require an Officers’ Certificate or an Opinion of Counsel or both. The Trustee shall not be liable for any action it takes or omits to take in good
        faith in reliance on the Officers’ Certificate or Opinion of Counsel.

       

      (c)          The Trustee may act through agents and shall not be responsible for the misconduct or negligence of any agent appointed with due care.

       

      (d)          The Trustee shall not be liable for any action it takes or omits to take in good faith that it believes to be authorized or within its rights or powers; provided,
        however, that the Trustee’s conduct does not constitute willful misconduct or negligence.

       

      (e)          The Trustee may consult with counsel of its own selection and the advice or opinion of counsel with respect to legal matters relating to this Indenture and the Securities or any Opinion of Counsel shall be
        full and complete authorization and protection from liability in respect of any action taken, omitted or suffered by it hereunder in good faith and in accordance with the advice or opinion of such counsel or Opinion of Counsel.

       

      (f)          The Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, consent, order, approval,
        bond, debenture, note or other paper or document unless requested in writing to do so by the Holders of a majority in principal amount of the Securities at the time outstanding, but the Trustee, in its discretion, may make such further inquiry or
        investigation into such facts or matters as it may see fit, and, if the Trustee shall determine to make such further inquiry or investigation, it shall be entitled to examine the books, records and premises of the Issuer, personally or by agent or
        attorney, at the expense of the Issuer and shall incur no liability of any kind by reason of such inquiry or investigation.

       

      (g)          The Trustee shall be under no obligation to exercise any of the rights or powers vested in it by this Indenture at the request or direction of any of the Holders pursuant to this Indenture, unless such
        Holders shall have offered to the Trustee security or indemnity satisfactory to the Trustee in its sole discretion against the costs, expenses and liabilities that might be incurred by it in compliance with such request or direction.

       

      (h)          The rights, privileges, protections, immunities and benefits given to the Trustee, including its right to be compensated, reimbursed and indemnified as provided in Section 7.06, are extended to, and shall
        be enforceable by, the Trustee in each of its capacities hereunder (including as Collateral Agent), and each agent, custodian and other Person employed to act hereunder.

       

      

      
        89

        
          

      

      (i)           The Trustee shall not be liable for any action taken or omitted by it in good faith at the direction of the Holders of a majority in principal amount of the Securities as to the time, method and place of
        conducting any proceedings for any remedy available to the Trustee or the exercising of any power conferred by this Indenture.

       

      (j)           Any action taken, or omitted to be taken, by the Trustee in good faith pursuant to this Indenture upon the request or authority or consent of any person who, at the time of making such request or giving
        such authority or consent, is the Holder of any Security shall be conclusive and binding upon future Holders of Securities and upon Securities executed and delivered in exchange therefor or in place thereof.

       

      (k)          In no event shall the Trustee be responsible or liable for any failure or delay in the performance of its obligations hereunder arising out of or caused by, directly or indirectly, forces beyond its
        control, including strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, and interruptions, loss or malfunctions of utilities, communications or computer
        (software and hardware) services; it being understood that the Trustee shall use reasonable efforts that are consistent with accepted practices in the banking industry to resume performance as soon as practicable under the circumstances.

       

      SECTION 7.03.   Individual Rights of Trustee. The Trustee in its individual or any other capacity may become the owner or pledgee of Securities and may
        otherwise deal with the Issuer or its Affiliates with the same rights it would have if it were not Trustee. The Trustee and its Affiliates have engaged, currently are engaged and may in the future engage in financial or other transactions with the
        Issuer and its Affiliates in the ordinary course of their respective businesses, subject to the TIA (to the extent this Indenture has been qualified thereunder). Any Paying Agent or Registrar may do the same with like rights. However, the Trustee
        must comply with Sections 7.09 and 7.10.

       

      SECTION 7.04.   Trustee’s Disclaimer. The Trustee shall not be responsible for and makes no representation as to the validity or adequacy of this
        Indenture, any Guarantee, the Securities or any Security Documents, it shall not be accountable for the Issuer’s use of the proceeds from the Securities, and it shall not be responsible for any statement of the Issuer or any Guarantor in this
        Indenture or in any document issued in connection with the sale of the Securities or in the Securities other than the Trustee’s certificate of authentication. The Trustee shall not be charged with knowledge of any Default or Event of Default under
        Section 6.01(c), 6.01(d), 6.01(e), 6.01(f), 6.01(g), 6.01(h), 6.01(i), 6.01(j), 6.01(k), 6.01(l), 6.01(m) or 6.01(n) unless either (a) a Trust Officer shall have actual knowledge thereof or (b) the Trustee shall have received written notice thereof
        in accordance with Section 12.01 from the Issuer, any Guarantor or any Holder.

       

      SECTION 7.05.   Notice of Defaults. If a Default occurs and is continuing and if it is actually known to the Trustee, the Trustee shall provide to each
        Holder written notice of the Default within 30 days after it is actually known to a Trust Officer or written notice referring to this Indenture, describing such Default or Event of Default and stating that such notice is a “notice of default”, is
        received by the Trustee in accordance with Section 12.01. Except in the case of a Default in the payment of principal of or premium (if any) or interest on any Security, the Trustee may withhold the notice if and so long as a committee of its Trust
        Officers in good faith determines that withholding the notice is in the interests of the Holders.

       

      

      
        90

        
          

      

      SECTION 7.06.   Compensation and Indemnity. The Issuer shall pay to the Trustee from time to time reasonable compensation for its services, as agreed
        between the Issuer and the Trustee. The Trustee’s compensation shall not be limited by any law on compensation of a trustee of an express trust. The Issuer shall reimburse the Trustee upon request for all reasonable and documented out-of-pocket
        expenses incurred or made by it, including costs of collection, in addition to the compensation for its services. Such expenses shall include the reasonable compensation and expenses, disbursements and advances of the Trustee’s agents, counsel,
        accountants and experts. The Issuer and each Guarantor, jointly and severally, shall indemnify the Trustee against any and all loss, liability, claim, damage or expense (including reasonable and documented attorneys’ fees and expenses) incurred by
        or in connection with the acceptance or administration of this trust and the performance of its duties hereunder, including the costs and expenses of enforcing this Indenture or a Guarantee against the Issuer or a Guarantor (including this Section
        7.06) and defending itself against or investigating any claim (whether asserted by the Issuer, any Guarantor, any Holder or any other Person). The obligation to pay such amounts shall survive the discharge of this Indenture, the payment in full or
        defeasance of the Securities or the removal or resignation of the Trustee. The Trustee shall notify the Issuer of any claim for which it may seek indemnity promptly upon obtaining actual knowledge thereof; provided,
        however, that any failure so to notify the Issuer shall not relieve the Issuer or any Guarantor of its indemnity obligations hereunder. The Issuer shall have the opportunity to assume the defense of the
        claim and the indemnified party shall provide reasonable cooperation at the Issuer’s expense in the defense. Such indemnified parties may have separate counsel and the Issuer and the Guarantors, as applicable, shall pay the reasonable and
        documented fees and expenses of such counsel; provided, however, that the Issuer shall not be required to pay such fees and expenses if it assumes such indemnified
        parties’ defense and, in such indemnified parties’ reasonable judgment, there is no conflict of interest between the Issuer and the Guarantors, as applicable, and such parties in connection with such defense. The Issuer need not reimburse any
        expense or indemnify against any loss, liability or expense Incurred by an indemnified party through such party’s own willful misconduct or gross negligence (as determined by a final, non-appealable order of a court of competent jurisdiction), or
        with respect to any settlement made without its consent.

       

      To secure the Issuer’s and the Guarantors’ payment obligations in this Section 7.06, the Trustee shall have a Lien prior to the Securities on all money or property held or collected by the Trustee other than money or
        property held in trust to pay principal of, and premium, if any, and interest on, particular Securities.

       

      The Issuer’s and the Guarantors’ payment obligations pursuant to this Section 7.06 shall survive the satisfaction or discharge of this Indenture, any rejection or termination of this Indenture under any bankruptcy law
        or the resignation or removal of the Trustee. Without prejudice to any other rights available to the Trustee under applicable law, when the Trustee incurs expenses after the occurrence of a Default specified in Section 6.01(e), Section 6.01(f) or
        Section 6.01(g), the expenses are intended to constitute expenses of administration under the Bankruptcy Law.

       

      

      
        91

        
          

      

      No provision of this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder, or in the exercise of any of its
        rights or powers, if repayment of such funds or adequate indemnity against such risk or liability is not assured to its satisfaction.

       

      SECTION 7.07.   Replacement of Trustee.

       

      (a)          A resignation or removal of the Trustee and appointment of a successor Trustee will become effective only upon the successor Trustee’s acceptance of appointment as provided in this Section 7.07.

       

      (b)          The Trustee may resign in writing at any time upon 30 days’ prior written notice to the Issuer by so notifying the Issuer. The Holders of a majority in aggregate principal amount of the then outstanding
        Securities may remove the Trustee upon 30 days’ written notice to the Trustee and the Issuer and may appoint a successor Trustee. The Issuer may remove the Trustee if upon 30 days’ written notice:

       

      (i)           the Trustee fails to comply with Section 7.09;

       

      (ii)          the Trustee is adjudged bankrupt or insolvent or an order for relief is entered with respect to the Trustee under any Bankruptcy Law;

       

      (iii)         a receiver or other public officer takes charge of the Trustee or its property; or

       

      (iv)         the Trustee otherwise becomes incapable of acting.

       

      (c)          If the Trustee resigns or is removed by the Issuer or by the Holders of a majority in aggregate principal amount of the then outstanding Securities and such Holders do not reasonably promptly appoint a
        successor Trustee, or if a vacancy exists in the office of Trustee for any reason (the Trustee in such event being referred to herein as the retiring Trustee), the Issuer shall, as promptly as practicable, appoint a successor Trustee.

       

      (d)          A successor Trustee shall deliver a written acceptance of its appointment to the retiring Trustee and to the Issuer. Thereupon the resignation or removal of the retiring Trustee shall become effective, and
        the successor Trustee shall have all the rights, powers and duties of the Trustee under this Indenture. The successor Trustee shall provide a written notice of its succession to the Holders. The retiring Trustee shall promptly transfer all property
        held by it as Trustee to the successor Trustee, subject to the Lien provided for in Section 7.06.

       

      (e)          If a successor Trustee does not take office within 60 days after the retiring Trustee is notified that it is to be removed or has notified the Issuer that it wishes to resign, in each case, in accordance
        with paragraph (b) above, the retiring Trustee, the Issuer or the Holders of at least 10% in aggregate principal amount of the then outstanding Securities, at the expense of the Issuer, may petition any court of competent jurisdiction for the
        appointment of a successor Trustee.

       

      

      
        92

        
          

      

      (f)          If the Trustee fails to comply with Section 7.09, unless the Trustee’s duty to resign is stayed as provided in Section 310(b) of the TIA, any Holder who has been a bona fide holder of a Security for at
        least six months may petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee.

       

      (g)          Notwithstanding the replacement of the Trustee pursuant to this Section 7.07, the obligations of the Issuer and the Guarantors under Section 7.06 shall continue for the benefit of the retiring Trustee.

       

      SECTION 7.08.   Successor Trustee by Merger. If the Trustee merges, amalgamates or consolidates with or into, or transfers all or substantially all its
        corporate trust business or assets to, another corporation or banking association, the resulting, surviving or transferee corporation or banking association without any further act shall be the successor Trustee.

       

      In case at the time such successor or successors by merger, amalgamation or consolidation to the Trustee shall succeed to the trusts created by this Indenture any of the Securities shall have been authenticated but not
        delivered, any such successor to the Trustee may adopt the certificate of authentication of any predecessor trustee, and deliver such Securities so authenticated; and in case at that time any of the Securities shall not have been authenticated, any
        successor to the Trustee may authenticate such Securities either in the name of any predecessor hereunder or in the name of the successor to the Trustee; and in all such cases such certificates shall have the full force that it is anywhere in the
        Securities or in this Indenture provided that the certificate of the Trustee shall have.

       

      SECTION 7.09.   Eligibility; Disqualification. The Trustee shall at all times satisfy the requirements of Section 310(a) of the TIA. The Trustee shall have
        a combined capital and surplus of at least $100,000,000 as set forth in its most recent published annual report of condition. The Trustee shall comply with Section 310(b) of the TIA, subject to its right to apply for a stay of its duty to resign
        under the penultimate paragraph of Section 310(b) of the TIA; provided, however, that there shall be excluded from the operation of Section 310(b)(1) of the TIA any
        series of securities issued under this Indenture and any indenture or indentures under which other securities or certificates of interest or participation in other securities of the Issuer is outstanding if the requirements for such exclusion set
        forth in Section 310(b)(1) of the TIA are met.

       

      SECTION 7.10.   Preferential Collection of Claims Against the Issuer. The Trustee shall comply with Section 311(a) of the TIA, excluding any creditor
        relationship listed in Section 311(b) of the TIA. A Trustee who has resigned or been removed shall be subject to Section 311(a) of the TIA to the extent indicated.

       

      

      
        93

        
          

      

      SECTION 7.11.   Confidential Information. The Trustee, in its individual capacity and as Trustee, agrees and acknowledges that all confidential information
        (“Confidential Information”) provided to the Trustee by the Issuer or any Subsidiary (or any direct or indirect equityholder of the Issuer or such Subsidiary) or any Holder (or holder of a beneficial interest in the Securities) may be considered to
        be proprietary and confidential information. The Trustee agrees to take reasonable precautions to keep Confidential Information confidential, which precautions shall be no less stringent than those that the Trustee employs to protect its own
        confidential information. The Trustee shall not disclose to any third party other than as set forth herein, and shall not use for any purpose other than the exercise of the Trustee’s rights and the performance of its obligations under this
        Indenture, any Confidential Information without the prior written consent of the Issuer or such Holder (or such holder of a beneficial interest in the Securities), as applicable. The Trustee shall limit access to Confidential Information received
        hereunder to (a) its directors, officers, managers and employees and (b) its legal advisors, to each of whom disclosure of Confidential Information is necessary for the purposes described above; provided, however, that in each case such party has expressly agreed to maintain such information in confidence under terms and conditions substantially identical to the terms of this Section 7.11.

       

      The Trustee agrees that the Issuer or any Holder (or any holder of a beneficial interest in the Securities), as applicable, does not have any responsibility whatsoever for any reliance on Confidential Information by
        the Trustee or by any Person to whom such information is disclosed in connection with this Indenture, whether related to the purposes described above or otherwise. Without limiting the generality of the foregoing, the Trustee agrees that the Issuer
        or any Holder (or any holder of a beneficial interest in the Securities), as applicable, makes no representation or warranty whatsoever to it with respect to Confidential Information or its suitability for such purposes. The Trustee further agrees
        that it shall not acquire any rights against the Issuer or any of its Subsidiaries or any employee, officer, director, manager, representative or agent of the Issuer or any of its Subsidiaries or any Holder (or any holder of a beneficial interest
        in the Securities), as applicable (together with the Issuer, “Confidential Parties”) as a result of the disclosure of Confidential Information to the Trustee and that no Confidential Party has any duty, responsibility, liability or obligation to
        any Person as a result of any such disclosure.

       

      In the event the Trustee is legally compelled to disclose any Confidential Information received hereunder in order to comply with any laws, regulations or court orders, it may disclose such information only to the
        extent necessary for such compliance; provided, however, that it shall give the Issuer or any Holder (or any holder of a beneficial interest in the Securities), as
        applicable, reasonable advance written notice of any court proceeding in which such disclosure may be required pursuant to a court order so as to afford the Issuer or any Holder (or any holder of a beneficial interest in the Securities), as
        applicable, full and fair opportunity to oppose the issuance of such order and to appeal therefrom and shall cooperate reasonably with the Issuer or any Holder (or any holder of a beneficial interest in the Securities), as applicable, in opposing
        such court order and in securing confidential treatment of any such information to be disclosed or obtaining a protective order narrowing the scope of such disclosure.

       

      Each of the Paying Agent and the Registrar agrees to be bound by this Section 7.11 to the same extent as the Trustee.

       

      

      
        94

        
          

      

      ARTICLE 8

        

        DISCHARGE OF INDENTURE; DEFEASANCE

       

      SECTION 8.01.          Discharge of Liability on Securities; Defeasance.

       

      (a)          This Indenture shall be discharged and shall cease to be of further effect (except as to surviving rights of registration of transfer or exchange of Securities, as expressly provided for in this Indenture)
        as to all outstanding Securities when:

       

      (i)           either (1) all the Securities theretofore authenticated and delivered (other than Securities pursuant to Section 2.08 that have been replaced or paid and Securities for whose payment
        money has theretofore been deposited in trust or segregated and held in trust by the Issuer and thereafter repaid by the Issuer or discharged from such trust) have been delivered to the Trustee for cancellation or (2) all of the Securities (x) have
        become due and payable, (y) will become due and payable at their Stated Maturity within one year or (z) if redeemable at the option of the Issuer, are to be called for redemption within one year under arrangements satisfactory to the Trustee for
        the giving of notice of redemption by the Trustee in the name, and at the expense, of the Issuer, and the Issuer has irrevocably deposited or caused to be deposited with the Trustee funds in an amount sufficient to pay and discharge the entire
        Indebtedness on the Securities not theretofore delivered to the Trustee for cancellation, for principal of, and premium, if any, and interest on, the Securities to the date of deposit, together with irrevocable instructions from the Issuer
        directing the Trustee to apply such funds to the payment thereof at maturity or redemption, as the case may be;

       

      (ii)          the Issuer or the Guarantors have paid all other sums payable under this Indenture; and

       

      (iii)         the Issuer has delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel stating that all conditions precedent under this Indenture relating to the satisfaction and
        discharge of this Indenture have been complied with.

       

      (b)          Notwithstanding clauses (a)(i) and (a)(ii) above, the Issuer’s obligations in Sections 2.04, 2.05, 2.06, 2.07, 2.08, 2.09, 6.07, 7.06 and 7.07 and in this Article 8 shall survive until the Securities have
        been paid in full. Thereafter, the Issuer’s obligations in Sections 7.06, 8.05 and 8.06 shall survive such satisfaction and discharge.

       

      (c)          Subject to Section 8.01(b) and Section 8.02, the Issuer at any time may terminate (i) all its obligations under the Securities and this Indenture (with respect to such Securities) (“legal defeasance
        option”) or (ii) its obligations under Sections 4.02, 4.03, 4.04, 4.05, 4.06, 4.07, 4.10, 4.11, 4.13, 4.14, 4.15, 4.16, 4.17, 4.18 and 4.19 and the operation of Sections 4.06 and 4.08, Article 5 and Sections 6.01(c), 6.01(d), 6.01(e) (with respect
        to Restricted Subsidiaries of the Issuer only), 6.01(f) (with respect to Restricted Subsidiaries of the Issuer only), 6.01(g) (with respect to Restricted Subsidiaries of the Issuer only), 6.01(h), 6.01(i), 6.01(j), 6.01(k), 6.01(l), 6.01(m) or
        6.01(n) (“covenant defeasance option”). The Issuer may exercise its legal defeasance option notwithstanding its prior exercise of its covenant defeasance option. In the event that the Issuer terminates all of its obligations under the Securities
        and this Indenture (with respect to such Securities) by exercising its legal defeasance option or its covenant defeasance option, the obligations of each Guarantor under its Guarantee of such Securities and the Security Documents shall be
        terminated simultaneously with the termination of such obligations.

       

      

      
        95

        
          

      

      If the Issuer exercises its legal defeasance option, payment of the Securities so defeased may not be accelerated because of an Event of Default. If the Issuer exercises its covenant defeasance option, payment of the
        Securities so defeased may not be accelerated because of an Event of Default specified in Section 6.01(c), 6.01(d), 6.01(e) (to the extent such Section 6.01(e) applies to Restricted Subsidiaries), 6.01(f) (to the extent such Section 6.01(f) applies
        to Restricted Subsidiaries), 6.01(g) (to the extent such Section 6.01(g) applies to Restricted Subsidiaries), 6.01(h), 6.01(i), 6.01(j), 6.01(k), 6.01(l), 6.01(m) or 6.01(n) or because of the failure of the Issuer to comply with Article 5.

       

      Upon satisfaction of the conditions set forth herein and upon request of the Issuer, the Trustee shall acknowledge in writing the discharge of those obligations that the Issuer terminates.

       

      SECTION 8.02.   Conditions to Defeasance.

       

      (a)          The Issuer may exercise its legal defeasance option or its covenant defeasance option only if:

       

      (i)           the Issuer irrevocably deposits in trust with the Trustee cash in U.S. Dollars, U.S. Government Obligations or a combination thereof in an amount sufficient, or U.S. Government
        Obligations, the principal of and the interest on which will be sufficient, or a combination thereof sufficient, to pay the principal of and premium (if any) and interest on the Securities when due at maturity or redemption, as the case may be,
        including interest thereon to maturity or such redemption date;

       

      (ii)          the Issuer delivers to the Trustee a certificate from a firm of independent accountants expressing its opinion that the payments of principal and interest when due and without
        reinvestment on the deposited U.S. Government Obligations plus any deposited money without investment will provide cash at such times and in such amounts as will be sufficient to pay principal, premium, if any, and interest when due on all the
        Securities to maturity or redemption, as the case may be;

       

      (iii)        123 days pass after the deposit is made and during the 123-day period no Default specified in Section 6.01(e), Section 6.01(f) or Section 6.01(g) occurs that is continuing at the end of
        the period;

       

      (iv)         the deposit does not constitute a default under any other agreement binding on the Issuer;

       

      

      
        96

        
          

      

      (v)          in the case of the legal defeasance option, the Issuer shall have delivered to the Trustee an opinion of tax counsel of recognized standing in the United States stating that (1) the
        Issuer has received from, or there has been published by, the IRS a ruling, or (2) since the date of this Indenture there has been a change in the applicable U.S. federal income tax law, in either case to the effect that, and based thereon such
        opinion of tax counsel of recognized standing in the United States shall confirm that, the Holders will not recognize income, gain or loss for U.S. federal income tax purposes as a result of such deposit and defeasance and will be subject to U.S.
        federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such deposit and defeasance had not occurred;

       

      (vi)         in the case of the covenant defeasance option, the Issuer shall have delivered to the Trustee an opinion of tax counsel of recognized standing in the United States to the effect that the
        Holders will not recognize income, gain or loss for U.S. federal income tax purposes as a result of such deposit and defeasance and will be subject to U.S. federal income tax on the same amounts, in the same manner and at the same times as would
        have been the case if such deposit and defeasance had not occurred;

       

      (vii)        the right of any Holder to receive payment of principal of, and premium, if any, and interest on, such Holder’s Securities on or after the due dates therefor or to institute suit for the
        enforcement of any payment on or with respect to such Holder’s Securities shall not be impaired; and

       

      (viii)        the Issuer delivers to the Trustee an Officers’ Certificate and an Opinion of Counsel (which may be subject to customary assumptions and exclusions), each stating that all conditions
        precedent to the defeasance and discharge of the Securities to be so defeased and discharged as contemplated by this Article 8 have been complied with.

       

      (b)          Before or after a deposit, the Issuer may make arrangements satisfactory to the Trustee for the redemption of such Securities at a future date in accordance with Article 3.

       

      SECTION 8.03.   Application of Trust Money. The Trustee shall hold in trust money or U.S. Government Obligations (including proceeds thereof) deposited
        with it pursuant to this Article 8. It shall apply the deposited money and the money from U.S. Government Obligations through each Paying Agent and in accordance with this Indenture to the payment of principal of and interest on the Securities so
        discharged or defeased.

       

      SECTION 8.04.   Repayment to Issuer. Each of the Trustee and each Paying Agent shall promptly turn over to the Issuer upon request any money or U.S.
        Government Obligations held by it as provided in this Article 8 that, in the written opinion of a firm of independent public accountants recognized in the United States delivered to the Trustee (which delivery shall only be required if U.S.
        Government Obligations have been so deposited), are in excess of the amount thereof that would then be required to be deposited to effect an equivalent discharge or defeasance in accordance with this Article 8.

       

      

      
        97

        
          

      

      Subject to any applicable abandoned property law, the Trustee and each Paying Agent shall pay to the Issuer upon written request any money held by them for the payment of principal or interest that remains unclaimed
        for two years, and, thereafter, Holders entitled to the money must look to the Issuer for payment as general creditors, and the Trustee and each Paying Agent shall have no further liability with respect to such monies.

       

      SECTION 8.05.   Indemnity for Government Obligations. The Issuer shall pay and shall indemnify the Trustee against any tax, fee or other charge imposed on
        or assessed against deposited U.S. Government Obligations or the principal and interest received on such U.S. Government Obligations.

       

      SECTION 8.06.   Reinstatement. If the Trustee or any Paying Agent is unable to apply any money or U.S. Government Obligations in accordance with this
        Article 8 by reason of any legal proceeding or by reason of any order or judgment of any Governmental Authority enjoining, restraining or otherwise prohibiting such application, the Issuer’s obligations under this Indenture and the Securities so
        discharged or defeased shall be revived and reinstated as though no deposit had occurred pursuant to this Article 8 until such time as the Trustee or any Paying Agent is permitted to apply all such money or U.S. Government Obligations in accordance
        with this Article 8; provided, however, that, if the Issuer has made any payment of principal of or interest on any such Securities because of the reinstatement of
        its obligations, the Issuer shall be subrogated to the rights of the Holders of such Securities to receive such payment from the money or U.S. Government Obligations held by the Trustee or any Paying Agent.

       

      ARTICLE 9

        

        AMENDMENTS AND WAIVERS

       

      SECTION 9.01.   Without Consent of the Holders. Notwithstanding Section 9.02, the Issuer, the Collateral Agent, the Guarantors and the Trustee may amend or
        supplement this Indenture, the Securities, the Security Documents or the Intercreditor Agreements, and may waive any provision thereof, without notice to or consent of any Holder:

       

      (i)           to cure any ambiguity, omission, mistake, defect or inconsistency;

       

      (ii)          to provide for the assumption by a Successor Company of the obligations of the Issuer under this Indenture and the Securities in accordance with the terms of this Indenture;

       

      (iii)        to provide for the assumption by a Successor Guarantor of the obligations of a Guarantor under this Indenture and its Guarantee;

       

      (iv)         to provide for uncertificated Securities in addition to or in place of certificated Securities; provided, however,
        that the uncertificated Securities are issued in registered form for purposes of Sections 871(h)(2)(B) and 881(c)(2)(B) of the Code and United States Treasury Regulation Section 5f.103-1(c);

       

      (v)          to add additional Guarantees or co-obligors with respect to the Securities in accordance with the terms of this Indenture;

       

      

      
        98

        
          

      

      (vi)         to add to the covenants of the Issuer for the benefit of the Holders or to surrender any right or power conferred herein upon the Issuer in accordance with the terms of this Indenture;

       

      (vii)        to comply with any requirement of the SEC in connection with qualifying or maintaining the qualification of this Indenture under the TIA (to the extent any such qualification is
        required);

       

      (viii)       to make any change that does not adversely affect the rights of any Holder;

       

      (ix)         to add additional assets as Notes Collateral to secure the Securities;

       

      (x)          to provide for or confirm the issuance of Second Additional Securities;

       

      (xi)         to release a Guarantor in accordance with the provisions of this Indenture, the Security Documents and the Intercreditor Agreement or to release Notes Collateral from the Lien pursuant
        to this Indenture, the Security Documents and the Intercreditor Agreements when permitted or required by this Indenture, the Security Documents or the Intercreditor Agreements; or

       

      (xii)        to modify the Security Documents or the Intercreditor Agreements (a) to secure additional extensions of credit and add additional secured creditors holding First Priority Lien
        Obligations so long as the Incurrence of such First Priority Lien Obligations and related Liens are not prohibited by the provisions of this Indenture, (b) as provided for in provisions comparable to Section 2.11(b) of the form of Intercreditor
        Agreement attached as Exhibit D, (c) to add the Issuer or any Guarantor as a party to any Intercreditor Agreement to the extent such party Incurs any Secured Indebtedness that constitutes First Priority Lien Obligations in accordance with the terms
        of this Indenture or to remove the Issuer or any Guarantor as a party to any Intercreditor Agreement to the extent such party ceases to be bound by any and all First Priority Lien Obligations or (d) to accommodate and implement the Liens permitted
        by clause (19)(z) of the definition of “Permitted Liens”.

       

      Upon the request of the Issuer, and upon receipt by the Trustee of the documents described in Section 9.05, the Trustee shall join with the Issuer in the execution of any amended or supplemental Indenture authorized or
        permitted by the terms of this Indenture and to make any further appropriate agreements and stipulations that may be therein contained, but the Trustee shall not be obligated to enter into such modified or amended indenture that affects its own
        rights, duties or immunities under this Indenture or otherwise. After an amendment under this Section 9.01 becomes effective, the Issuer shall provide to the Holders a written notice briefly describing such amendment. The failure to give such
        notice to all Holders, or any defect therein, shall not impair or affect the validity of an amendment under this Section 9.01.

       

      

      
        99

        
          

      

      SECTION 9.02.   With Consent of the Holders.

       

      (a)          The Issuer, the Collateral Agent, the Guarantors and the Trustee may amend or supplement this Indenture, the Securities, the Security Documents and the Intercreditor Agreements, and may waive any provision
        thereof (including the provisions of Section 4.08), with the written consent of the Holders of a majority in principal amount of the Securities then outstanding voting as a single class (including consents obtained in connection with a tender offer
        or exchange offer for the Securities). However, without the consent of each Holder of an outstanding Security affected, an amendment, supplement or waiver may not:

       

      (i)           reduce the amount of Securities whose Holders must consent to an amendment;

       

      (ii)          reduce the rate of or extend the time for payment of interest on any Security;

       

      (iii)         reduce the principal of or change the Stated Maturity of any Security (or reduce the amount of any payment of any installment of principal or change the due date in respect of the
        payment of any installment of principal);

       

      (iv)         reduce the premium payable upon the redemption or repurchase of any Security or change the time at which any Security may be redeemed or repurchased in accordance with Article 3, Section
        4.06 or Section 4.08;

       

      (v)          make any Security payable in currency other than that stated in such Security;

       

      (vi)         expressly subordinate the Securities or any Guarantees in right of payment to any other Indebtedness of the Issuer or any Guarantor or adversely affect the priority of any Liens securing
        the Securities and the Guarantees, except as provided in the Intercreditor Agreements;

       

      (vii)        impair the right of any Holder to receive payment of principal of or premium, if any, and interest on such Holder’s Securities on or after the due dates (or the due date in respect of
        the payment of any installment of principal) therefor or to institute suit for the enforcement of any payment on or with respect to such Holder’s Securities;

       

      (viii)       make any change in Section 6.04 or the second sentence of this Section 9.02;

       

      (ix)         modify any Guarantees in any manner adverse to the Holders; or

       

      (x)          make any change in the provisions in this Indenture or the Intercreditor Agreements dealing with the application of proceeds of Notes Collateral that would adversely affect the
        non-consenting Holders of the Securities.

       

      

      
        100

        
          

      

      Without the consent of the Holders of at least two-thirds in aggregate principal amount of the Securities then outstanding or as otherwise provided in the Intercreditor Agreements, no amendment, supplement or waiver
        may release all or substantially all of the Notes Collateral from the Lien of this Indenture and the Security Documents with respect to the Securities.

       

      It shall not be necessary for the consent of the Holders under this Section 9.02 to approve the particular form of any proposed amendment, supplement or waiver if such consent approves the substance thereof.

       

      (b)          Upon the request of the Issuer, and upon receipt by the Trustee of the documents described in Section 9.05, the Trustee shall join with the Issuer in the execution of any
          amended or supplemental Indenture authorized or permitted by the terms of this Indenture and to make any further appropriate agreements and stipulations that may be therein contained, but the Trustee shall not be obligated to enter into such
          modified or amended indenture that affects its own rights, duties or immunities under this Indenture or otherwise. After an amendment under this Section 9.02 becomes effective, the Issuer shall provide to the Holders a written notice
        briefly describing such amendment. The failure to give such notice to all Holders, or any defect therein, shall not impair or affect the validity of an amendment under this Section 9.02.

       

      SECTION 9.03.   Revocation and Effect of Consents and Waivers.

       

      (a)          A consent to an amendment, supplement or a waiver by a Holder of a Security shall bind the Holder and every subsequent Holder of that Security or portion of the Security that evidences the same debt as the
        consenting Holder’s Security, even if notation of the consent, supplement or waiver is not made on the Security. However, any such Holder or subsequent Holder may revoke the consent, supplement or waiver as to such Holder’s Security or portion of
        the Security if the Trustee receives the notice of revocation before the date on which the Trustee receives an Officers’ Certificate from the Issuer certifying that the requisite principal amount of Securities have consented. After an amendment,
        supplement or waiver becomes effective, it shall bind every Holder. An amendment, supplement or waiver becomes effective upon the (i) receipt by the Issuer or the Trustee of consents by the Holders of the requisite principal amount of Securities,
        (ii) satisfaction of conditions to effectiveness as set forth in this Indenture and any indenture supplemental hereto containing such amendment, supplement or waiver, (iii) execution of such amendment or waiver (or supplemental indenture) by the
        Issuer and the Trustee and (iv) delivery to the Trustee of the Officers’ Certificate and Opinion of Counsel required under Article 12.

       

      (b)          The Issuer may, but shall not be obligated to, fix a record date for the purpose of determining the Holders entitled to give their consent or take any other action described above or required or permitted
        to be taken pursuant to this Indenture. If a record date is fixed, then notwithstanding Section 9.03(a), those Persons who were Holders at such record date (or their duly designated proxies), and only those Persons, shall be entitled to give such
        consent or to revoke any consent previously given or to take any such action, whether or not such Persons continue to be Holders after such record date. No such consent shall be valid or effective for more than 120 days after such record date.

       

      

      
        101

        
          

      

      (c)          Upon the execution of any amended or supplemental indenture pursuant to the provisions hereof, this Indenture and the Securities subject thereto shall be and shall be deemed to be modified and amended in
        accordance therewith and the respective rights, limitations of rights, obligations, duties and immunities under this Indenture of the Trustee, the Issuer and the Holders of Securities shall thereafter be determined, exercised and enforced hereunder
        subject in all respects to such modifications and amendments, and all the terms and conditions of any such supplemental indenture shall be and shall be deemed to be part of the terms and conditions of this Indenture for any and all purposes.

       

      SECTION 9.04.   Notation on or Exchange of Securities. If an amendment, supplement or waiver changes the terms of a Security, the Issuer may require the
        Holder of the Security to deliver it to the Trustee. The Trustee may place an appropriate notation on the Security regarding the changed terms and return it to the Holder. Alternatively, if the Issuer or the Trustee so determines, the Issuer in
        exchange for the Security shall issue and the Trustee shall authenticate a new Security that reflects the changed terms. Failure to make the appropriate notation or to issue a new Security shall not affect the validity of such amendment, supplement
        or waiver.

       

      SECTION 9.05.   Trustee to Sign Amendments. The Trustee shall sign any amendment, supplement or waiver authorized pursuant to this Article 9 if the
        amendment does not adversely affect the rights, duties, liabilities or immunities of the Trustee. If it does, the Trustee may but need not sign it. In signing such amendment, the Trustee shall be entitled to receive indemnity satisfactory to it and
        shall be provided with, and (subject to Section 7.01) shall be fully protected in relying upon, an Officers’ Certificate and an Opinion of Counsel stating that such amendment, supplement or waiver is authorized or permitted by this Indenture and
        that such amendment, supplement or waiver is the legal, valid and binding obligation of the Issuer and the Guarantors, enforceable against them in accordance with its terms, subject to customary exceptions, and complies with the provisions hereof
        (including Section 9.03).

       

      SECTION 9.06.   Payment for Consent. Neither the Issuer nor any Affiliate of the Issuer shall, directly or indirectly, pay or cause to be paid any
        consideration, whether by way of interest, fee or otherwise, to any Holder for or as an inducement to any consent, waiver or amendment of any of the terms or provisions of this Indenture or the Securities unless such consideration is offered to be
        paid to all Holders that so consent, waive or agree to amend in the time frame set forth in solicitation documents relating to such consent, waiver or agreement.

       

      SECTION 9.07.   Additional Voting Terms; Calculation of Principal Amount. All Securities issued under this Indenture shall vote and consent together on all
        matters (as to which any of such Securities may vote) as one class. Determinations as to whether Holders of the requisite aggregate principal amount of Securities have concurred in any direction, waiver or consent shall be made in accordance with
        this Article 9 and Section 2.14.

       

      

      
        102

        
          

      

      ARTICLE 10

        

        GUARANTEES

       

      SECTION 10.01. Guarantees.

       

      (a)          Subject to the provisions of this Article 10, each Guarantor hereby jointly and severally with each other Guarantor irrevocably and unconditionally guarantees as a primary obligor and not merely as a
        surety on a senior basis to each Holder, the Trustee, the Collateral Agent and their respective successors and assigns (i) the full and punctual payment when due, whether at Stated Maturity, by acceleration, by redemption or otherwise, of all
        Obligations of the Issuer under this Indenture (including obligations to the Trustee) and the Securities, whether for payment of principal of, or premium or interest on, the Securities and all other monetary obligations of the Issuer under this
        Indenture and the Securities, and (ii) the full and punctual performance within applicable grace periods of all other obligations of the Issuer, whether for fees, expenses, indemnification or otherwise under this Indenture and the Securities, on
        the terms set forth in this Indenture by becoming a party to this Indenture (all the foregoing being hereinafter collectively called the “Guaranteed Obligations”).

       

      (b)          Each Guarantor further agrees that (to the extent permitted by law) the Guaranteed Obligations may be extended or renewed, in whole or in part, without notice or further assent from each such Guarantor,
        and that each such Guarantor shall remain bound under this Article 10 notwithstanding any extension or renewal of any Guaranteed Obligation. The Guaranteed Obligations of a Guarantor will be secured by security interests (subject to Permitted
        Liens) in the Notes Collateral owned by such Guarantor to the extent provided for in the Security Documents and as required pursuant to Sections 4.11 and 4.13.

       

      (c)          Each Guarantor waives presentation to, demand of payment from and protest to the Issuer of any of the Guaranteed Obligations and also waives notice of protest for nonpayment. Each Guarantor waives notice
        of any default under the Securities or the Guaranteed Obligations. The obligations of each Guarantor hereunder shall not be affected by (i) the failure of any Holder, the Trustee or the Collateral Agent to assert any claim or demand or to enforce
        any right or remedy against the Issuer or any other Person under this Indenture, the Securities, any Security Document, or any other agreement or otherwise; (ii) any extension or renewal of this Indenture, the Securities, any Security Document or
        any other agreement; (iii) any rescission, waiver, amendment or modification of any of the terms or provisions of this Indenture, the Securities, any Security Document or any other agreement; (iv) the release of any security held by any Holder, the
        Trustee or the Collateral Agent for the Guaranteed Obligations or any Guarantor; (v) the failure of any Holder, the Trustee or the Collateral Agent to exercise any right or remedy against any other guarantor of the Guaranteed Obligations; or (vi)
        any change in the ownership of such Guarantor, except as provided in Section 10.03.

       

      (d)          Each Guarantor hereby waives any right to which it may be entitled to (i) have its obligations hereunder divided among the Guarantors, such that such Guarantor’s obligations would be less than the full
        amount claimed, (ii) have the assets of the Issuer or any other Guarantor first be used and depleted as payment of the Issuer’s or such Guarantor’s obligations hereunder prior to any amounts being claimed from or paid by such Guarantor hereunder
        and (iii) require that the Issuer be sued prior to an action being initiated against such Guarantor.

       

      

      
        103

        
          

      

      (e)          Each Guarantor further agrees that its Guarantee herein constitutes a guarantee of payment, performance and compliance when due (and not a guarantee of collection) and waives any right to require that any
        resort be had by any Holder, the Trustee or the Collateral Agent to any security held for payment of the Guaranteed Obligations.

       

      (f)          Except as expressly set forth in Sections 8.01, 10.02, 10.03 and 10.06, the obligations of each Guarantor hereunder shall not be subject to any reduction, limitation, impairment or termination for any
        reason, including any claim of waiver, release, surrender, alteration or compromise, and shall not be subject to any defense of setoff, counterclaim, recoupment or termination whatsoever or by reason of the invalidity, illegality or
        unenforceability of the Guaranteed Obligations or otherwise. Without limiting the generality of the foregoing, the obligations of each Guarantor herein shall not be discharged or impaired or otherwise affected by (i) the failure of any Holder, the
        Trustee or the Collateral Agent to assert any claim or demand or to enforce any remedy under this Indenture, the Securities, any Security Document or any other agreement, (ii) any waiver or modification of any thereof, (iii) any default, failure or
        delay, willful or otherwise, in the performance of the obligations or (iv) any other act or thing or omission or delay to do any other act or thing that may or might in any manner or to any extent vary the risk of any Guarantor or would otherwise
        operate as a discharge of any Guarantor as a matter of law or equity.

       

      (g)          Except as expressly set forth in Sections 8.01 and 10.03, each Guarantor agrees that its Guarantee shall remain in full force and effect until payment in full of its Guaranteed Obligations. Except as
        expressly set forth in Sections 8.01 and 10.03, each Guarantor further agrees that its Guarantee herein shall continue to be effective or be reinstated, as the case may be, if at any time payment, or any part thereof, of principal of or interest on
        any Guaranteed Obligation is rescinded or must otherwise be restored by any Holder or the Trustee upon the bankruptcy or reorganization of the Issuer or otherwise.

       

      (h)          In furtherance of the foregoing and not in limitation of any other right that any Holder, the Trustee or the Collateral Agent has at law or in equity against any Guarantor by virtue hereof, upon the
        failure of the Issuer to pay the principal of or interest on any Guaranteed Obligation when and as the same shall become due, whether at maturity, by acceleration, by redemption or otherwise, or to perform or comply with any other Guaranteed
        Obligation, each Guarantor hereby promises to and shall, upon receipt of written demand by the Trustee in accordance with this Indenture, forthwith pay, or cause to be paid, in cash, to the Holders, the Trustee or the Collateral Agent an amount
        equal to the sum of (i) the unpaid principal amount of such Guaranteed Obligations, (ii) accrued and unpaid interest on such Guaranteed Obligations (but only to the extent not prohibited by applicable law) and (iii) all other monetary obligations
        of the Issuer then due to the Holders, the Trustee and the Collateral Agent in respect of the Guaranteed Obligations.

       

      

      
        104

        
          

      

      (i)           Each Guarantor agrees that it shall not be entitled to any right of subrogation in relation to the Holders in respect of any Guaranteed Obligations guaranteed hereby until payment in full of all
        Guaranteed Obligations. Each Guarantor further agrees that, as between it, on the one hand, and the Holders, the Trustee and the Collateral Agent, on the other hand, (i) the maturity of the Guaranteed Obligations guaranteed hereby may be
        accelerated as provided in Article 6 for the purposes of any Guarantee herein, notwithstanding any stay, injunction or other prohibition preventing such acceleration in respect of the Guaranteed Obligations guaranteed hereby, and (ii) in the event
        of any declaration of acceleration of such Guaranteed Obligations as provided in Article 6, such Guaranteed Obligations (whether or not due and payable) shall forthwith become due and payable by such Guarantor for the purposes of this Section
        10.01.

       

      (j)           Each Guarantor also agrees to pay any and all costs and expenses (including reasonable and documented attorneys’ fees and expenses) incurred by the Trustee, the Collateral Agent or any Holder in enforcing
        any rights under this Section 10.01.

       

      (k)          Each Guarantor shall execute and deliver such further instruments and do such further acts as may be reasonably necessary or proper to carry out more effectively the purpose of this Indenture.

       

      SECTION 10.02. Limitation on Liability. Each Guarantor hereby confirms that it is its intention that the Guarantee of such Guarantor does not constitute a fraudulent transfer or
        conveyance for purposes of Bankruptcy Law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar U.S. federal or state law to the extent applicable to any Guarantee. To effectuate the foregoing intention, the
        Trustee, the Holders and the Guarantors hereby irrevocably agree that, any term or provision of this Indenture to the contrary notwithstanding, the maximum aggregate amount of the Guaranteed Obligations guaranteed hereunder by any Guarantor shall
        not exceed the maximum amount that, after giving effect to all other contingent and fixed liabilities of such Guarantor and after giving effect to any collections from or payments made by or on behalf of any other Guarantor in respect of the
        obligations of such other Guarantor under its Guarantee or pursuant to its contribution obligations under this Indenture, can be guaranteed hereby without rendering the Guarantee, as it relates to such Guarantor, void or voidable under applicable
        laws relating to fraudulent conveyance or fraudulent transfer or similar laws affecting the rights of creditors generally. Each Guarantor that makes a payment under its Guarantee shall be entitled upon payment in full of all Guaranteed Obligations
        under this Indenture to a contribution from each other Guarantor in an amount equal to such other Guarantor’s pro rata portion of such payment based on the respective maximum liability of all the Guarantors at the time of such payment.

       

      SECTION 10.03. Releases. A Guarantee as to any Guarantor shall terminate and be of no further force or effect and such Guarantor shall be deemed to be automatically released from all
        obligations under this Article 10 upon:

       

      (a)          the Disposition or exchange (including through merger, amalgamation, consolidation or otherwise) of the Capital Stock of the applicable Guarantor if (i) such Disposition or exchange is made to a Person
        that is not the Issuer or a Restricted Subsidiary in a manner not in violation of this Indenture and (ii) after giving effect to such Disposition or exchange, such Guarantor is no longer a Restricted Subsidiary;

       

      

      
        105

        
          

      

      (b)          the Issuer designating such Guarantor to be an Unrestricted Subsidiary in accordance with the provisions set forth in Section 4.04 and the definition of “Unrestricted Subsidiary”;

       

      (c)          the merger, amalgamation or consolidation of any Guarantor with and into the Issuer or another Guarantor that is the surviving Person in such merger, amalgamation or consolidation or upon the liquidation
        of such Guarantor following the Disposition of all of its assets to the Issuer or another Guarantor; or

       

      (d)          the Issuer’s exercise of the Issuer’s legal defeasance option or covenant defeasance option in accordance with Section 8.01 or if the obligations of the Issuer and such Guarantor under this Indenture are
        discharged in accordance with the terms of this Indenture.

       

      Notwithstanding the foregoing, neither the consent nor the acknowledgement of the Trustee, the Collateral Agent or the Holders (or any of them) shall be necessary to effect any such release. None of the Trustee, the
        Issuer or any Guarantor will be required to make a notation on the Securities or any Guarantee to reflect any such release, termination or discharge. Upon request of the Issuer and delivery by the Issuer to the Trustee of an Officers’ Certificate
        to the effect that one of the foregoing requirements has been satisfied and the conditions to the release of a Guarantor under this Section 10.03 has been met, the Trustee will execute any documents reasonably requested by the Issuer or such
        Guarantor in order to evidence the release of a Guarantor from its obligations under its Guarantee hereunder.

       

      SECTION 10.04. Successors and Assigns. This Article 10 shall be binding upon each Guarantor and its successors and assigns and shall inure to the benefit
        of the Trustee, the Collateral Agent and the Holders and their successors and assigns and, in the event of any transfer or assignment of rights by any Holder, the Collateral Agent or the Trustee, the rights and privileges conferred upon that party
        in this Indenture and in the Securities shall automatically extend to and be vested in such transferee or assignee, all subject to the terms and conditions of this Indenture.

       

      SECTION 10.05. No Waiver. Neither a failure nor a delay on the part of the Trustee, the Collateral Agent or the Holders in exercising any right, power or
        privilege under this Article 10 shall operate as a waiver thereof, nor shall a single or partial exercise thereof preclude any other or further exercise of any right, power or privilege. The rights, remedies and benefits of the Trustee, the
        Collateral Agent and the Holders herein expressly specified are cumulative and not exclusive of any other rights, remedies or benefits that any of them may have under this Article 10 at law, in equity, by statute or otherwise.

       

      SECTION 10.06. Modification. No modification, amendment or waiver of any provision of this Article 10, nor the consent to any departure by any Guarantor
        therefrom, shall in any event be effective unless the same shall be in writing and signed by the Trustee, and then such waiver or consent shall be effective only in the specific instance and for the purpose for which given. No notice to or demand
        on any Guarantor in any case shall entitle such Guarantor to any other or further notice or demand in the same, similar or other circumstances.

       

      

      
        106

        
          

      

      SECTION 10.07. Execution of Supplemental Indenture for Future Guarantors. Each Person that is required to become a Guarantor after the Issue Date pursuant
        to Section 4.10 shall promptly execute and deliver to the Trustee a supplemental indenture in the form of Exhibit C pursuant to which such Person shall become a Guarantor under this Article 10 and shall guarantee the Guaranteed Obligations.
        Concurrently with the execution and delivery of such supplemental indenture, the Issuer shall deliver to the Trustee an Opinion of Counsel and an Officers’ Certificate to the effect that such supplemental indenture has been duly authorized,
        executed and delivered by such Person and that, subject to the application of Bankruptcy Laws relating to creditors’ rights generally and to the principles of equity, whether considered in a proceeding at law or in equity, the Guarantee of such
        Guarantor is a legal, valid and binding obligation of such Guarantor, enforceable against such Guarantor in accordance with its terms or to such other matters as the Trustee may reasonably request.

       

      SECTION 10.08. No Impairment. The failure to endorse a Guarantee on any Security shall not affect or impair the validity thereof. If an Officer whose
        signature is on this Indenture or the notation of Guarantee no longer holds that office at the time the Trustee authenticates the Securities, the Guarantee shall be valid nevertheless.

       

      SECTION 10.09. Benefits Acknowledged. Each Guarantor acknowledges that it will receive direct and indirect benefits from the financing arrangements contemplated by this Indenture and
        that the guarantee and waivers made by it pursuant to its Guarantee are knowingly made in contemplation of such benefits.

       

      

      ARTICLE 11

        

        SECURITY DOCUMENTS

       

      

      SECTION 11.01. Collateral and Security Documents. The due and punctual payment of the principal of and interest on the Securities when and as the same
        shall be due and payable, whether on an Payment Date, at Stated Maturity, or by acceleration, repurchase, redemption or otherwise, and interest on the overdue principal of and interest on the Securities and performance of all other Guaranteed
        Obligations of the Issuer and the Guarantors to the Holders, the Trustee or the Collateral Agent under this Indenture, the Securities, the Intercreditor Agreements and the Security Documents, according to the terms hereunder or thereunder, shall be
        secured as provided in the Security Documents, which define the terms of the Liens that secure the Guaranteed Obligations, subject to the terms of the Intercreditor Agreements. The Trustee and the Issuer hereby acknowledge and agree that the
        Collateral Agent holds the Notes Collateral in trust for the benefit of the Trustee and the Holders, in each case pursuant to the terms of the Security Documents and the Intercreditor Agreements. Each Holder, by accepting a Security, appoints U.S.
        Bank National Association as Collateral Agent and consents and agrees to the terms of the Security Documents (including the provisions providing for the possession, use, release and foreclosure of Notes Collateral) and the Intercreditor Agreements
        as the same may be in effect or may be amended from time to time in accordance with their respective terms and this Indenture, and authorizes and directs the Trustee to enter into the Security Documents and the Intercreditor Agreements and to bind
        the Holders to the terms thereof and to perform its obligations and exercise its rights thereunder in accordance therewith. The Issuer shall deliver to the Trustee (if it is not then also appointed and serving as Collateral Agent) copies of all
        documents delivered to the Collateral Agent pursuant to the Security Documents, and will do or cause to be done all such acts and things as may be reasonably required by the next sentence of this Section 11.01, to assure and confirm to the Trustee
        and the Collateral Agent the Liens on the Notes Collateral contemplated hereby, by the Security Documents or by any part thereof, as from time to time constituted, so as to render the same available for the security and benefit of this Indenture
        and of the Securities secured hereby, according to the intent and purposes herein expressed. The Issuer shall take, and shall cause the Guarantors to take, any and all actions reasonably required to cause the Security Documents to create and
        maintain at all times, as security for the Obligations of the Issuer and the Guarantors hereunder, a valid and enforceable perfected Lien on all of the Notes Collateral (subject to the terms of the Security Documents and the Intercreditor
        Agreements), in favor of the Collateral Agent for the benefit of the Trustee and the Holders under the Security Documents. Notwithstanding anything to the contrary in this Indenture or any Security Document, in no event shall the Collateral Agent
        be responsible for, or have any duty or obligation with respect to, the recording, filing, registering, perfection, protection or maintenance of the security interests or other Liens intended to be created by this Indenture or the Security
        Documents (including the filing or continuation of any Uniform Commercial Code financing or continuation statements or similar documents or instruments), nor shall the Collateral Agent be responsible for, and the Collateral Agent makes no
        representation regarding, the validity, effectiveness or priority of any of the Security Documents or the security interests or other Liens intended to be created thereby.

       

      

      
        107

        
          

      

      SECTION 11.02. {Reserved}.

       

      SECTION 11.03. Release of Collateral.

       

      (a)          Subject to Sections 11.03(b) and 11.04, the Notes Collateral may be released from the Lien and security interest created by the Security Documents at any time or from time to time in accordance with the
        provisions of the Security Documents or the Intercreditor Agreements or as provided hereby. The Issuer and the Guarantors will be entitled to a release of assets included in the Notes Collateral from the Liens securing the Securities, and the
        Trustee shall release, or instruct the Collateral Agent to release, as applicable, the same from such Liens at the Issuer’s sole cost and expense, in accordance with Section 4.06(c) or under one or more of the following circumstances:

       

      (1)          to enable the Issuer or any Restricted Subsidiary to exchange or Dispose of any of the Notes Collateral to any Person other than the Issuer or any Guarantor (but excluding any
        transaction subject to Article 5 where the recipient is required to become the obligor on the Securities or a Guarantee) to the extent not prohibited by this Indenture, including Section 4.06, and only to the extent that
        such exchange or Disposal results in a legal transfer of title of such Notes Collateral (except in connection with an Apomorphine Disposition that complies with Section 4.06(b));

       

      (2)          in the case of a Guarantor that is released from its Guarantee with respect to the Securities in accordance with this Indenture, the release of the Notes Collateral owned by such
        Guarantor;

       

      

      
        108

        
          

      

      (3)          in respect of the Notes Collateral owned by a Guarantor, upon the designation of such Guarantor to be an Unrestricted Subsidiary in accordance with Section 4.04 and the definition of
        “Unrestricted Subsidiary”;

       

      (4)          in respect of the ABL Collateral (x) to the extent any first-priority liens on such ABL Collateral are released by the First Lien Agent in connection with a Disposition of ABL Collateral
        to the extent not prohibited under Section 4.06 (except with respect to any proceeds of such Disposition that remain after satisfaction in full of the First Priority Lien Obligations secured by such ABL Collateral) or (y) in accordance with an
        Intercreditor Agreement;

       

      (5)          pursuant to an amendment, supplement or waiver in accordance with Article 9; or

       

      (6)          if the Securities have been defeased pursuant to Section 8.01 or if this Indenture is discharged pursuant to Section 8.01.

       

      Notwithstanding the existence of any Event of Default, the junior lien on the ABL Collateral securing the Securities shall terminate and be released automatically to the extent the first-priority liens on the ABL
        Collateral are released by the First Lien Agent in connection with a Disposition of ABL Collateral that is either not prohibited under this Indenture or occurs in connection with the foreclosure of, or other exercise of remedies with respect to,
        such ABL Collateral by the First Lien Agent (except with respect to any proceeds of such Disposition that remain after satisfaction in full of the First Priority Lien Obligations).

       

      Upon receipt of an Officers’ Certificate certifying that all conditions precedent under this Indenture and the Security Documents, if any, to such release have been met and any necessary or proper (as determined by the
        Issuer) instruments of termination, satisfaction or release have been prepared by the Issuer, the Collateral Agent shall execute, deliver or acknowledge (at the Issuer’s expense) such instruments or releases to evidence the release of any Notes
        Collateral permitted to be released pursuant to this Indenture or the Security Documents or the Intercreditor Agreements.

       

      (b)          At any time when a Default or Event of Default has occurred and is continuing and the maturity of the Securities has been accelerated (whether by declaration or otherwise) and the Trustee (if not then also
        appointed and serving as Collateral Agent) has delivered a notice of acceleration to the Collateral Agent, no release of Notes Collateral pursuant to the provisions of this Indenture or the Security Documents will be effective as against the
        Holders, except as otherwise provided in the Intercreditor Agreements.

       

      SECTION 11.04. Permitted Releases Not To Impair Lien. The release of any Notes Collateral from the terms hereof and of the Security Documents or the
        release of, in whole or in part, the Liens created by the Security Documents, will not be deemed to impair the security under this Indenture in contravention of the provisions hereof if and to the extent the Notes Collateral or Liens are released
        pursuant to (x) the applicable Security Documents and the terms of this Article 11 or (y) the Intercreditor Agreements. Each of the Holders acknowledges that a release of Notes Collateral or a Lien in accordance with the terms of the Security
        Documents and the Intercreditor Agreements and of this Article 11 will not be deemed for any purpose to be in contravention of the terms of this Indenture.

       

      

      
        109

        
          

      

      SECTION 11.05. Suits To Protect the Collateral. Subject to the provisions of Article 7 and the Intercreditor Agreements, the Trustee in its sole discretion
        and without the consent of the Holders, on behalf of the Holders, may or may direct the Collateral Agent to take all actions it deems necessary or appropriate in order to:

       

      (a)          enforce any of the terms of the Security Documents; and

       

      (b)          collect and receive any and all amounts payable in respect of the Guaranteed Obligations of the Issuer hereunder.

       

      Subject to the provisions of the Security Documents and the Intercreditor Agreements, the Trustee shall have the power (but not the obligation) to institute and to maintain such suits and proceedings as it may deem
        expedient to prevent any impairment of the Notes Collateral by any acts that may be unlawful or in violation of any of the Security Documents or this Indenture, and such suits and proceedings as the Trustee, in its sole discretion, may deem
        expedient to preserve or protect its interests and the interests of the Holders in the Notes Collateral (including the power to institute and maintain suits or proceedings to restrain the enforcement of or compliance with any legislative or other
        governmental enactment, rule or order that may be unconstitutional or otherwise invalid if the enforcement of, or compliance with, such enactment, rule or order would impair the Lien on the Notes Collateral or be prejudicial to the interests of the
        Holders or the Trustee).

       

      SECTION 11.06. Authorization of Receipt of Funds by the Trustee Under the Security Documents. Subject to the provisions of the Intercreditor Agreements,
        the Trustee is authorized (a) to receive any funds for the benefit of the Holders distributed under the Security Documents and (b) to make further distributions of such funds to the Holders according to the provisions of this Indenture.

       

      SECTION 11.07. Purchaser Protected. In no event shall any purchaser in good faith of any property purported to be released hereunder be bound to ascertain
        the authority of the Collateral Agent or the Trustee to execute the release or to inquire as to the satisfaction of any conditions required by the provisions hereof for the exercise of such authority or to see to the application of any
        consideration given by such purchaser or other transferee; nor shall any purchaser or other transferee of any property or rights permitted by this Article 11 to be sold be under any obligation to ascertain or inquire into the authority of the
        Issuer or the applicable Guarantor to make any such sale or other transfer.

       

      SECTION 11.08. Powers Exercisable by Receiver or Trustee. In case the Notes Collateral shall be in the possession of a receiver or trustee, lawfully
        appointed, the powers conferred in this Article 11 upon the Issuer or a Guarantor with respect to the release or Disposition of such property may be exercised by such receiver or trustee, and an instrument signed by such receiver or trustee shall
        be deemed the equivalent of any similar instrument of the Issuer or a Guarantor or of any officer or officers thereof required by the provisions of this Article 11; and if the Trustee shall be in the possession of the Notes Collateral under any
        provision of this Indenture, then such powers may be exercised by the Trustee.

       

      

      
        110

        
          

      

      SECTION 11.09. Release Upon Termination of the Issuer’s Obligations.

       

      In the event that the Issuer delivers to the Trustee an Officers’ Certificate certifying that (i) payment in full of the principal of, together with premium, if any, and accrued and unpaid interest on, the Securities
        and all other Obligations with respect to the Securities under this Indenture, the Guarantees and the Security Documents that are due and payable at or prior to the time such principal, together with premium, if any, and accrued and unpaid interest
        (including additional interest, if any), are paid, (ii) all the Obligations under this Indenture, the Securities and the Security Documents have been satisfied and discharged by complying with the provisions of Article 8 or (iii) the Issuer shall
        have exercised its legal defeasance option or its covenant defeasance option, in each case in compliance with the provisions of Article 8, the Trustee shall deliver to the Issuer and the Collateral Agent a notice stating that the Trustee, on behalf
        of the Holders, disclaims and gives up any and all rights it has in or to the Notes Collateral (other than with respect to funds held by the Trustee pursuant to Article 8), and any rights it has under the Security Documents, and upon receipt by the
        Collateral Agent of such notice, the Collateral Agent shall be deemed not to hold a Lien in the Notes Collateral on behalf of the Trustee and shall do or cause to be done all acts reasonably requested by the Issuer to release such Lien as soon as
        is reasonably practicable.

       

      SECTION 11.10. Collateral Agent.

       

      (a)          U.S. Bank National Association shall initially act as Collateral Agent and shall be authorized to appoint co-Collateral Agents as necessary in its sole discretion. Except as otherwise explicitly provided
        herein or in the Security Documents or the Intercreditor Agreements, neither the Collateral Agent nor any of its officers, directors, employees or agents shall be liable for failure to demand, collect or realize upon any of the Notes Collateral or
        for any delay in doing so or shall be under any obligation to Dispose of any Notes Collateral upon the request of any other Person or to take any other action whatsoever with regard to the Notes Collateral or any part thereof. Notwithstanding any
        provision to the contrary contained elsewhere in this Indenture, the Intercreditor Agreements or the Security Documents, the duties of the Collateral Agent shall be ministerial and administrative in nature, and the Collateral Agent shall not have
        any duties or responsibilities, except those expressly set forth in this Indenture, in the Intercreditor Agreements and in the Security Documents to which the Collateral Agent is a party, nor shall the Collateral Agent have or be deemed to have any
        trust or other fiduciary relationship with the Trustee, any Holder, the Issuer or any Guarantor, and no implied covenants, functions, responsibilities, duties, obligations or liabilities shall be read into this Indenture, the Intercreditor
        Agreements or the Security Documents or shall otherwise exist against the Collateral Agent. Without limiting the generality of the foregoing sentence, the use of the term “agent” or “Agent” in this Indenture, the Intercreditor Agreements and the
        Security Documents with reference to the Collateral Agent is not intended to connote any fiduciary or other implied (or express) obligations arising under agency doctrine of any applicable law. Instead, such term is used merely as a matter of
        market custom and is intended to create or reflect only an administrative relationship between independent contracting parties. The Collateral Agent shall be accountable only for amounts that it actually receives as a result of the exercise of such
        powers, and neither the Collateral Agent nor any of its officers, directors, employees or agents shall be responsible for any act or failure to act hereunder, except for its own willful misconduct or gross negligence (as determined by a final,
        non-appealable order of a court of competent jurisdiction).

       

      

      
        111

        
          

      

      (b)          The Collateral Agent is authorized and directed to (i) enter into the Security Documents, (ii) enter into the Intercreditor Agreements, (iii) bind the Holders on the terms as set forth in the Security
        Documents and the Intercreditor Agreements and (iv) perform and observe its obligations under the Security Documents and the Intercreditor Agreements.

       

      (c)          If the Issuer or any Guarantors Incur any obligations in respect of any First Priority Lien Obligations at any time when no intercreditor agreement with respect thereto is in effect or at any time when
        Indebtedness constituting First Priority Lien Obligations entitled to the benefit of an existing intercreditor agreement is concurrently retired, the Issuer shall deliver to the Collateral Agent an Officers’ Certificate so stating and requesting
        the Collateral Agent to enter into an Intercreditor Agreement in favor of a designated agent or representative for the holders of the First Priority Lien Obligations so Incurred, and the Trustee and the Collateral Agent shall (and are hereby
        authorized and directed to) enter into such Intercreditor Agreement, bind the Holders on the terms set forth therein and perform and observe their obligations thereunder.

       

      (d)          The Collateral Agent shall act pursuant to the instructions of the Holders and the Trustee with respect to the Security Documents and the Notes Collateral. For the avoidance of doubt, the Collateral Agent
        shall have no discretion under this Indenture, the Intercreditor Agreements or the Security Documents and shall not be required to make or give any determination, consent, approval, request or direction without the written direction of the
        requisite Holders or the Trustee, as applicable. After the occurrence of an Event of Default, the Trustee may direct the Collateral Agent in connection with any action required or permitted by this Indenture, the Security Documents or the
        Intercreditor Agreements.

       

      (e)          The Collateral Agent shall not be deemed to have knowledge or notice of the occurrence of any Default or Event of Default, unless the Collateral Agent shall have received written notice from the Trustee, a
        Holder or the Issuer referring to this Indenture, describing such Default or Event of Default and stating that such notice is a “notice of default”. The Collateral Agent shall take such action with respect to such Default or Event of Default as may
        be requested by the Trustee or the Holders of a majority in aggregate principal amount of the Securities subject to this Article 11.

       

      (f)          No provision of this Indenture or any Security Document shall require the Collateral Agent (or the Trustee) to expend or risk its own funds or otherwise incur any financial liability in the performance of
        any of its duties hereunder or thereunder or to take or omit to take any action hereunder or thereunder or take any action at the request or direction of Holders (or the Trustee in the case of the Collateral Agent) if it shall have reasonable
        grounds for believing that repayment of such funds is not assured to it. Notwithstanding anything to the contrary contained in this Indenture, the Intercreditor Agreements or the Security Documents, in the event the Collateral Agent is entitled or
        required to commence an action to foreclose or otherwise exercise its remedies to acquire control or possession of the Notes Collateral, the Collateral Agent shall not be required to commence any such action, exercise any remedy, inspect or conduct
        any studies of any property or take any such other action if the Collateral Agent has determined that the Collateral Agent may incur personal liability as a result of the presence at, or release on or from, the Notes Collateral or such property of
        any hazardous substances unless the Collateral Agent has received security or indemnity from the Holders in an amount and in a form all satisfactory to the Collateral Agent in its sole discretion, protecting the Collateral Agent from all such
        liability. The Collateral Agent shall at any time be entitled to cease taking any action described in this Section 11.10(f) if it no longer reasonably deems any indemnity, security or undertaking from the Issuer or the Holders to be sufficient.

       

      

      
        112

        
          

      

      (g)          The Collateral Agent shall not be responsible in any manner to any of the Trustee or any Holder for the validity, effectiveness, genuineness, enforceability or sufficiency of this Indenture, the Security
        Documents or the Intercreditor Agreements or for any failure of the Issuer, any Guarantor or any other party to this Indenture, the Security Documents or the Intercreditor Agreements to perform its obligations hereunder or thereunder. The
        Collateral Agent shall not be under any obligation to the Trustee or any Holder to ascertain or to inquire as to the observance or performance of any of the agreements contained in, or conditions of, this Indenture, the Security Documents or the
        Intercreditor Agreements or to inspect the properties, books or records of the Issuer or the Guarantors.

       

      (h)          The parties hereto and the Holders hereby agree and acknowledge that the Collateral Agent shall not assume, be responsible for or otherwise be obligated for any liabilities, claims, causes of action,
        suits, losses, allegations, requests, demands, penalties, fines, settlements, damages (including foreseeable and unforeseeable), judgments, expenses and costs (including any remediation, corrective action, response, removal or remedial action, or
        investigation, operations and maintenance or monitoring costs, for personal injury or property damages, real or personal) of any kind whatsoever, pursuant to any environmental law as a result of this Indenture, the Intercreditor Agreements or the
        Security Documents or any actions taken pursuant hereto or thereto. Further, the parties hereto and the Holders hereby agree and acknowledge that, in the exercise of its rights under this Indenture, the Intercreditor Agreements and the Security
        Documents, the Collateral Agent may hold or obtain indicia of ownership primarily to protect the security interest of the Collateral Agent in the Notes Collateral and that any such actions taken by the Collateral Agent shall not be construed as or
        otherwise constitute any participation in the management of such Notes Collateral.

       

      (i)           Upon the receipt by the Collateral Agent of a written request of the Issuer signed by two Officers pursuant to this Section 11.10(i) (a “Security Document Order”), the Collateral Agent is hereby
        authorized to execute and enter into, and shall execute and enter into, without the further consent of any Holder or the Trustee, any Security Document to be executed after the Issue Date. Such Security Document Order shall (i) state that it is
        being delivered to the Collateral Agent pursuant to, and is a Security Document Order referred to in, this Section 11.10(i) and (ii) instruct the Collateral Agent to execute and enter into such Security Document. Any such execution of a Security
        Document shall be at the direction and expense of the Issuer, upon delivery to the Collateral Agent of an Officers’ Certificate and an Opinion of Counsel stating that all conditions precedent to the execution and delivery of such Security Document
        have been satisfied. The Holders, by their acceptance of the Securities, hereby authorize and direct the Collateral Agent to execute such Security Documents.

       

      

      
        113

        
          

      

      (j)           The Collateral Agent’s resignation or removal shall be governed by provisions equivalent to Section 7.07(b), Section 7.07(c), Section 7.07(d), Section 7.07(e) and Section 7.07(g).

       

      (k)          The Collateral Agent shall be entitled to all of the protections, immunities, indemnities, rights and privileges of the Trustee set forth in this Indenture, and all such protections, immunities,
        indemnities, rights and privileges shall apply to the Collateral Agent in its roles under any Security Document or the Intercreditor Agreements, whether or not expressly stated therein.

       

      ARTICLE 12

        

        MISCELLANEOUS

       

      

      SECTION 12.01. Notices.

       

      (a)          Any notice or communication required or permitted hereunder shall be in writing and delivered in person, via facsimile, via electronic mail, via overnight courier or via first-class mail addressed as
        follows:

       

      if to the Issuer or a Guarantor:

       

      Aquestive Therapeutics, Inc.

        30 Technology Drive

      Warren, New Jersey 07059

        Attention: Chief Financial Officer & General Counsel

        Facsimile: 908-561-1209

       

      if to the Trustee or to the Collateral Agent:

       

      U.S. Bank National Association

      Corporate Trust Services

      One Federal Street, 3rd Floor

      Boston, Massachusetts 02110

      Attention: Alison Nadeau (Aquestive Indenture)

      Facsimile: 617-603-6683

       

      The Issuer or the Trustee by notice to the other may designate additional or different addresses for subsequent notices or communications. Any notice, direction, request or demand hereunder to or upon the Trustee or the Collateral Agent shall be
        deemed to have been sufficiently given or made, for all purposes, upon actual receipt by the Trustee or the Collateral Agent if given or served by being deposited postage prepaid by registered or certified mail in a post office letter box addressed
        to the Corporate Trust Office or sent electronically in PDF format.

       

      (b)          Any notice or communication mailed to a Holder shall be mailed, first-class mail, to the Holder at the Holder’s address as it appears on the registration books of the Registrar and shall be sufficiently
        given if so mailed within the time prescribed. Any notice or communication to be delivered to a Holder of Global Securities shall be delivered in accordance with the applicable procedures of the Depository and shall be sufficiently given to such
        Holder if so delivered to the Depository within the time prescribed.

       

      

      
        114

        
          

      

      (c)          Failure to provide a notice or communication to a Holder or any defect in it shall not affect its sufficiency with respect to other Holders. If a notice or communication is mailed in the manner provided
        above, it is duly given and provided, whether or not the addressee receives it, except that notices to the Trustee are effective only if received.

       

      (d)          Notwithstanding any other provision of this Indenture or any Security, where this Indenture or any Security provides for notice of any event (including any notice of repurchase) to a Holder (whether by
        mail or otherwise), such notice shall be sufficiently given (in the case of a Global Security) if given to the Depository (or its designee) pursuant to the standing instructions from the Depository or its designee, including by electronic mail in
        accordance with accepted practices or procedures at the Depository.

       

      SECTION 12.02. Certificate and Opinion as to Conditions Precedent. Upon any request or application by the Issuer to the Trustee to take or refrain from
        taking any action under this Indenture, the Issuer shall furnish to the Trustee at the request of the Trustee:

       

      (a)          an Officers’ Certificate to the Trustee stating that, in the opinion of the signers, all conditions precedent, if any, provided for in this Indenture relating to the proposed action have been complied
        with; and

       

      (b)          an Opinion of Counsel to the Trustee stating that, in the opinion of such counsel, all such conditions precedent have been complied with.

       

      SECTION 12.03. Statements Required in Certificate or Opinion. Each Officers’ Certificate or Opinion of Counsel with respect to compliance with a covenant
        or condition provided for in this Indenture (other than pursuant to Section 4.02(c)) shall include:

       

      (a)          a statement that the Person making such certificate or opinion has read such covenant or condition;

       

      (b)          a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based;

       

      (c)          a statement that, in the opinion of such Person, he or she has made such examination or investigation as is necessary to enable him or her to express an informed opinion as to whether or not such covenant
        or condition has been complied with (and, in the case of an Opinion of Counsel, may be limited to reliance on an Officers’ Certificate as to matters of fact); and

       

      (d)          a statement as to whether or not, in the opinion of such Person, such covenant or condition has been complied with; provided, however,
        that with respect to matters of fact an Opinion of Counsel may rely on an Officers’ Certificate or certificates of public officials.

       

      

      
        115

        
          

      

      SECTION 12.04. When Securities Disregarded. In determining whether the Holders of the required principal amount of Securities have concurred in any
        direction, waiver or consent, Securities owned by the Issuer, any Guarantor or by any Person directly or indirectly controlling or controlled by or under direct or indirect common control with the Issuer or any Guarantor shall be disregarded and
        deemed not to be outstanding, except that, for the purpose of determining whether the Trustee shall be protected in relying on any such direction, waiver or consent, only Securities that the Trustee knows are so owned shall be so disregarded.
        Subject to the foregoing, only Securities outstanding at the time shall be considered in any such determination. Notwithstanding the foregoing, if any such Person or Persons owns 100% of the Securities, such Securities shall not be so disregarded
        as aforesaid.

       

      SECTION 12.05. Rules by Trustee, Paying Agent and Registrar. The Trustee may make reasonable rules for action by or a meeting of the Holders. The Registrar
        and a Paying Agent may make reasonable rules for their functions.

       

      SECTION 12.06. Legal Holidays. If a Payment Date is not a Business Day, payment shall be made on the next succeeding day that is a Business Day, and no
        interest shall accrue on any amount that would have been otherwise payable on such Payment Date if it were a Business Day for the intervening period. If a Record Date is not a Business Day, the Record Date shall not be affected.

       

      SECTION 12.07. GOVERNING
            LAW; SUBMISSION TO JURISDICTION; WAIVER OF IMMUNITY. THIS INDENTURE, THE SECURITIES, THE SECURITY DOCUMENTS AND THE INTERCREDITOR AGREEMENTS SHALL BE GOVERNED BY AND CONSTRUED IN
          ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAW (OTHER THAN SECTIONS 5-1401 AND 5-1402 OF THE NEW YORK GENERAL OBLIGATIONS LAW) EXCEPT TO THE EXTENT THAT LOCAL LAW GOVERNS THE CREATION,
          PERFECTION, PRIORITY OR ENFORCEMENT OF SECURITY INTERESTS. The Issuer, the Guarantors, the Trustee and, by its acceptance of a Security, each Holder (and holder of beneficial interests in a Security) hereby
          submit to the non-exclusive jurisdiction of the federal and state courts of competent jurisdiction in the Borough of Manhattan in The City of New York in any suit or proceeding arising out of or relating to this Indenture or the transactions
          contemplated hereby. To the extent that the Issuer or any Guarantor may in any jurisdiction claim for itself or its assets immunity (to the extent such immunity may now or hereafter exist, whether on the grounds of sovereign immunity or
          otherwise) from suit, execution, attachment (whether in aid of execution, before judgment or otherwise) or other legal process (whether through service of notice or otherwise), and to the extent that in any such jurisdiction there may be
          attributed to itself or its assets such immunity (whether or not claimed), such Issuer or Guarantor, as applicable, irrevocably agrees with respect to any matter arising under this Indenture for the benefit of the Holders not to claim, and
          irrevocably waives, such immunity to the full extent permitted by the laws of such jurisdiction.

       

      SECTION 12.08. No Recourse Against Others. No director, officer, employee, manager, incorporator or holder of any Equity Interests in the Issuer or in any
        Guarantor, as such, shall have any liability for any obligations of the Issuer or the Guarantors under the Securities, this Indenture or the Guarantees or for any claim based on, in respect of, or by reason of, such obligations or their creation.
        Each Holder of Securities by accepting a Security waives and releases all such liability. The waiver and release are part of the consideration for issuance of the Securities.

       

      

      
        116

        
          

      

      SECTION 12.09. Successors. All agreements of the Issuer and each Guarantor in this Indenture and the Securities shall bind its successors. All agreements
        of the Trustee in this Indenture shall bind its successors.

       

      SECTION 12.10. Multiple Originals. The parties may sign any number of copies of this Indenture. Each signed copy shall be an original, but all of them
        together represent the same agreement. One signed copy is enough to prove this Indenture. The exchange of copies of this Indenture and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of this
        Indenture as to the parties hereto and may be used in lieu of the original Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes.

       

      SECTION 12.11. Table of Contents; Headings. The table of contents and headings of the Articles and Sections of this Indenture have been inserted for
        convenience of reference only, are not intended to be considered a part hereof and shall not modify or restrict any of the terms or provisions hereof.

       

      SECTION 12.12. Indenture Controls. If and to the extent that any provision of the Securities limits, qualifies or conflicts with a provision of this
        Indenture, such provision of this Indenture shall control.

       

      SECTION 12.13. Severability. In case any provision in this Indenture shall be invalid, illegal or unenforceable, the validity, legality and enforceability
        of the remaining provisions shall not in any way be affected or impaired thereby and such provision shall be ineffective only to the extent of such invalidity, illegality or unenforceability.

       

      SECTION 12.14. Currency of Account; Conversion of Currency; Currency Exchange Restrictions.

       

      (a)          U.S. Dollars are the sole currency of account and payment for all sums payable by the Issuer and the Guarantors under or in connection with the Securities, the Guarantees and this Indenture, including
        damages related thereto. Any amount received or recovered in a currency other than U.S. Dollars by a Holder (whether as a result of, or as a result of the enforcement of, a judgment or order of a court of any jurisdiction, in the winding-up or
        dissolution of the Issuer or otherwise) in respect of any sum expressed to be due to it from the Issuer or a Guarantor shall only constitute a discharge to the Issuer or any such Guarantor to the extent of the U.S. Dollar amount, which the
        recipient is able to purchase with the amount so received or recovered in that other currency on the date of that receipt or recovery (or, if it is not practicable to make that purchase on that date, on the first date on which it is practicable to
        do so). If that U.S. Dollar amount is less than the U.S. Dollar amount expressed to be due to the recipient under the applicable Securities, the Issuer and the Guarantors shall indemnify it against any loss sustained by it as a result as set forth
        in Section 12.14(b). In any event, the Issuer and the Guarantors shall indemnify the recipient against the cost of making any such purchase. For the purposes of this Section 12.14, it will be sufficient for the Holder of a Security to certify in a
        satisfactory manner (indicating sources of information used) that it would have suffered a loss had an actual purchase of U.S. Dollars been made with the amount so received in that other currency on the date of receipt or recovery (or, if a
        purchase of U.S. Dollars on such date had not been practicable, on the first date on which it would have been practicable, it being required that the need for a change of date be certified in the manner mentioned above).

       

      

      
        117

        
          

      

      (b)          The Issuer and the Guarantors, jointly and severally, covenant and agree that the following provisions shall apply to conversion of currency in the case of the Securities, the Guarantees and this
        Indenture:

       

      (i)           if for the purpose of obtaining judgment in, or enforcing the judgment of, any court in any country, it becomes necessary to convert into a currency (the “Judgment Currency”) an amount
        due in any other currency (the “Base Currency”), then the conversion shall be made at the rate of exchange prevailing on the Business Day before the day on which the judgment is given or the order of enforcement is made, as the case may be (unless
        a court shall otherwise determine);

       

      (ii)          if there is a change in the rate of exchange prevailing between the Business Day before the day on which the judgment is given or an order of enforcement is made, as the case may be (or
        such other date as a court shall determine), and the date of receipt of the amount due, the Issuer and the Guarantors will pay such additional (or, as the case may be, such lesser) amount, if any, as may be necessary so that the amount paid in the
        Judgment Currency when converted at the rate of exchange prevailing on the date of receipt will produce the amount in the Base Currency originally due; and

       

      (iii)         in the event of the winding-up of the Issuer or any Guarantor at any time while any amount or damages owing under the Securities, the Guarantees and this Indenture, or any judgment or
        order rendered in respect thereof, shall remain outstanding, the Issuer and the Guarantors shall indemnify and hold the Holders and the Trustee harmless against any deficiency arising or resulting from any variation in rates of exchange between (A)
        the date as of which the non-U.S. currency equivalent of the amount due or contingently due under the Securities, the Guarantees and this Indenture (other than under this subsection (b)(iii)) is calculated for the purposes of such winding-up and
        (B) the final date for the filing of proofs of claim in such winding-up (which shall be the date fixed by the liquidator or otherwise in accordance with the relevant provisions of applicable law as being the latest practicable date as at which
        liabilities of the Issuer or such Guarantor may be ascertained for such winding-up prior to payment by the liquidator or otherwise in respect thereof).

       

      

      
        118

        
          

      

      (c)          The obligations contained in this Section 12.14 shall constitute separate and independent obligations from the other obligations of the Issuer and the Guarantors under this Indenture, shall give rise to
        separate and independent causes of action against the Issuer and the Guarantors, shall apply irrespective of any waiver or extension granted by any Holder or the Trustee or either of them from time to time and shall continue in full force and
        effect notwithstanding any judgment or order or the filing of any proof of claim in the winding-up of the Issuer or any Guarantor for a liquidated sum in respect of amounts due hereunder (other than under subsection (b)(iii) above) or under any
        such judgment or order. Any such deficiency as aforesaid shall be deemed to constitute a loss suffered by the Holders or the Trustee, as the case may be, and no proof or evidence of any actual loss shall be required by the Issuer or any Guarantor
        or the liquidator or otherwise or any of them. In the case of subsection (b)(iii) above, the amount of such deficiency shall not be deemed to be reduced by any variation in rates of exchange occurring between the said final date and the date of any
        liquidating distribution.

       

      (d)          For purposes of this Section 12.14, the term “rate(s) of exchange” shall mean the rate of exchange quoted by Reuters at 10:00 a.m. (New York City time) for spot purchases of the Base Currency with the
        Judgment Currency other than the Base Currency and includes any premiums and costs of exchange payable.

       

      SECTION 12.15. Intercreditor Agreement Governs.

       

      (a)          The terms of this Indenture are subject to the Intercreditor Agreements. Each Holder, by its acceptance of a Security, (i) consents to the subordination of Liens provided for in the Intercreditor
        Agreements, (ii) agrees that it will be bound by and will take no actions contrary to the provisions of the Intercreditor Agreements and (iii) authorizes and instructs the Trustee to enter into the Intercreditor Agreements and the Collateral Agent
        to enter into the Intercreditor Agreements as Noteholder Collateral Agent (as defined therein) and to bind such Holder to the terms thereof, and, in each case, on behalf of such Holder. The foregoing provisions are intended as an inducement to the
        other lenders to the Issuer or any Guarantors acting as a secured party under the Intercreditor Agreements to extend credit and such lenders are intended third party beneficiaries of such provisions and the provisions of the Intercreditor
        Agreements. Pursuant to the authorization of each Holder, the Trustee and the Collateral Agent hereby agree to enter into Intercreditor Agreements substantially in the form of Exhibit D from time to time upon the request of the Issuer, when
        accompanied by an Officers’ Certificate and Opinion of Counsel confirming compliance with all conditions precedent set forth herein. To the extent the provisions of this Indenture conflict or are inconsistent with the Intercreditor Agreements, each
        Holder (by accepting a Security), the Trustee and the Collateral Agent consents and agrees that the Intercreditor Agreements will control.

       

      (b)          Notwithstanding anything to the contrary herein, in this Indenture or in any Security Document or any ABL Document (as such term is defined in the Intercreditor Agreements), the Issuer and the Guarantors
        shall not be required to act or refrain from acting (i) pursuant to this Indenture or any Security Document solely with respect to any ABL Collateral in any manner that would cause a default under any ABL Document, or (ii) pursuant to any ABL
        Document solely with respect to any Noteholder First Lien Collateral in any manner that would cause a default under this Indenture or any Security Document. For avoidance of doubt, and for the purposes of this paragraph only, the terms Security
        Document and ABL Document do not include the Intercreditor Agreements.

       

      

      
        119

        
          

      

      SECTION 12.16. Tax Matters.

       

      (a)          The Issuer has entered into this Indenture, and the Securities will be issued, with the intention that, for all tax purposes, the Securities will qualify as indebtedness. The Issuer, by entering into this
        Indenture, and each Holder and beneficial owner of Securities, agree to treat the Securities as indebtedness for all tax purposes.

       

      (b)          Each Holder or beneficial holder of Securities, by reason of its purchase of Securities, is deemed to have acknowledged (x) that, for U.S. federal income tax purposes, the Securities will be treated as
        indebtedness subject to the U.S. Treasury Regulations governing contingent payment debt instruments, (y) that such Holder or beneficial holder will report original issue discount and interest on the Securities in accordance with the Issuer’s
        determination of both the “comparable yield” and “projected payment schedule” for the Securities and (z) to be bound by the Issuer’s application of the U.S. Treasury Regulations that govern contingent payment debt instruments. For this purpose, the
        “comparable yield” and “projected payment schedule” for the Securities may be obtained by contacting the Issuer at the address set forth in Section 12.01. The Issuer shall file with the Trustee no later than the end of each calendar year (i) a
        written notice specifying the “comparable yield” and “projected payment schedule” for the Securities as of the end of such calendar year and (ii) such other specific information as may then be relevant under the Code. Upon the request of a Holder
        or beneficial holder of Securities, the Issuer shall inform such Holder or beneficial holder of the issue price of the Securities.

       

      (c)          The Issuer shall not be obligated to pay any additional amounts to the Holders or beneficial holder of Securities as a result of any withholding or deduction for, or on account of, any present or future
        taxes imposed on payments in respect of the Securities. The Issuer shall (or shall direct the Trustee in writing to) request the Securities to be coded as eligible for the “portfolio interest exemption”. Unless otherwise required by applicable law,
        if Definitive Securities are issued, so long as a Person shall have delivered to the Issuer a properly completed IRS Form W-9 or IRS Form W-8BEN, IRS Form W-8BEN-E, IRS Form W-8ECI or other applicable IRS form, claiming an exemption from
        withholding under FATCA and, in the case of a Person claiming the exemption from U.S. federal withholding tax under Section 871(h) of the Code or Section 881(c) of the Code with respect to payments of “portfolio interest”, the appropriate properly
        completed IRS form together with a certificate substantially in the form of Exhibit G, neither the Issuer nor the Trustee shall withhold taxes on payments of interest made to any such Person. Any such IRS Form W-8BEN or IRS Form W-8BEN-E shall
        specify whether the Holder or beneficial holder of Securities to whom the form relates is entitled to the benefits of any applicable income tax treaty.

       

      

      
        120

        
          

      

      (d)          If Definitive Securities are issued, (i) if any withholding tax is imposed on the Issuer’s payment under the Securities to any Holder or beneficial holder of Securities, such tax shall reduce the amount
        otherwise distributable to such Holder or beneficial holder, as the case may be, (ii) the Trustee is hereby authorized and directed to retain from amounts otherwise distributable to any Holder or beneficial holder of Securities sufficient funds for
        the payment of any withholding tax that is legally owed by the Issuer (but such authorization shall not prevent the Trustee from contesting any such withholding tax in appropriate proceedings and withholding payment of such tax, if permitted by
        applicable law, pending the outcome of such proceedings) and (iii) the amount of any withholding tax imposed with respect to any Holder or beneficial holder of Securities shall be treated as cash distributed to such Holder or beneficial holder, as
        the case may be, at the time it is withheld by the Trustee and remitted to the appropriate taxing authority. If there is a possibility that withholding tax is payable with respect to a payment under the Securities, the Trustee may (but shall have
        no obligation to) withhold such amounts in accordance with this Section 12.16. Nothing herein shall impose an obligation on the part of the Trustee to determine the amount of any tax or withholding obligation on the part of the Issuer or in respect
        of the Securities.

       

      

      SECTION 12.17. USA PATRIOT Act. The parties hereto acknowledge that in accordance with Section 326 of the USA PATRIOT Act, the Trustee, like all financial institutions and in order to
        help fight the funding of terrorism and money laundering, is required to obtain, verify and record information that identifies each Person that establishes a relationship or opens an account with the Trustee. The parties to this Indenture agree
        that they will provide the Trustee with such information as it may request in order for the Trustee to satisfy the requirements of the USA PATRIOT Act.

       

      SECTION 12.18. WAIVER OF TRIAL BY JURY. EACH OF THE ISSUER, EACH GUARANTOR, THE TRUSTEE AND THE COLLATERAL AGENT HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY
        APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS INDENTURE, THE SECURITIES OR THE TRANSACTION CONTEMPLATED HEREBY.

       

      SECTION 12.19. Limited Incorporation of the TIA. This Indenture is not subject to the mandatory provisions of the TIA. The provisions of the TIA are not incorporated by reference in
        or made part of this Indenture unless specifically provided herein.

       

      {Remainder of page intentionally left blank}

       

      

      
        121

        
          

      

      IN WITNESS WHEREOF, the parties have caused this Indenture to be duly executed as of the date first written above.

       

      
        	 	
                AQUESTIVE THERAPEUTICS, INC.

              
	 	 
	 	
                By:

                  

              	/s/ John Maxwell
	 	

              	
                Name: John Maxwell

              
	 	

              	
                Title:   CFO

              

         

        

        
          {Signature Page to the Indenture}

           

          

        

        
          
            

        

        
          	 	
                  U.S. BANK NATIONAL ASSOCIATION,

                
	 	
                  as Trustee

                
	 	 
	 	By:	
                  /s/ Allison D.B. Nadeau

                
	 	

                	
                  Name:  Allison D.B. Nadeau

                
	 	

                	
                  Title:    Vice President

                

           

          

          
            	 	
                    U.S. BANK NATIONAL ASSOCIATION,

                  
	 	
                    as Collateral Agent

                  
	 	 
	 	By: 

                    	
                    /s/ Allison D.B. Nadeau

                  
	 	

                  	
                    Name:  Allison D.B. Nadeau

                  
	 	

                  	
                    Title:    Vice President

                  

             

            

            
              
                {Signature Page to the Indenture}

                 

                

              

            

          

        

      

      
        
          

      

      APPENDIX A

       

      

      PROVISIONS RELATING TO SECURITIES

       

      1.            Definitions.

       

      1.1          Definitions.

       

      For the purposes of this Appendix A, the following terms shall have the meanings indicated below (and if not defined in this Appendix A, capitalized terms used herein shall have the meaning set forth in this
        Indenture):

       

      “Accredited Investor” means an “accredited investor” as defined in subclause (1), (2), (3) or (7) of Rule 501 that is not (i) a QIB or (ii) a Person other than a U.S. Person that acquires Securities in reliance on
        Regulation S.

       

      “Clearstream” means Clearstream Banking, S.A.

       

      “Definitive Security” means a certificated Security (bearing the Restricted Securities Legend if the transfer of such Security is restricted by applicable law) that does not include the Global Securities Legend.

       

      “Depository” means The Depository Trust Company, its nominees and their respective successors.

       

      “Euroclear” means Euroclear Bank S.A./N.V., as operator of the Euroclear System.

       

      “Global Securities Legend” means the legend set forth in Section 2.2(f)(i)(B) herein.

       

      “Global Security” means a certificated Security (bearing the Restricted Securities Legend if the transfer of such Security is restricted by applicable law) that includes the Global Securities Legend. The term “Global
        Securities” includes Rule 144A Global Securities and Regulation S Global Securities.

       

      “Purchase Agreement” means each Purchase Agreement dated July 15, 2019, between the Issuer and the purchaser(s) party thereto.

       

      “QIB” means a “qualified institutional buyer” as defined in Rule 144A.

       

      “Regulation S” means Regulation S under the Securities Act.

       

      “Regulation S Securities” means all Securities offered and sold outside the United States in reliance on Regulation S.

       

      “Restricted Period”, with respect to any Regulation S Securities, means the period of 40 consecutive days beginning on and including the later of (a) the day on which such Securities are first offered to persons other
        than distributors (as defined in Regulation S) in reliance on Regulation S, notice of which day shall be promptly given by the Issuer to the Trustee, and (b) the date of issuance of such Securities.

       

      

      
        A-1

        
          

      

      “Restricted Securities Legend” means the legend set forth in Section 2.2(f)(i)(A) herein.

       

      “Rule 144A” means Rule 144A under the Securities Act.

       

      “Rule 144A Securities” means all Securities privately placed with QIBs.

       

      “Rule 501” means Rule 501(a) under the Securities Act.

       

      “Rule 506” means Rule 506 under the Securities Act.

       

      “Securities Custodian” means the custodian with respect to a Global Security (as appointed by the Depository) or any successor person thereto, who shall initially be the Trustee.

       

      “Transfer Restricted Definitive Securities” means Definitive Securities that bear or are required to bear or are subject to the Restricted Securities Legend.

       

      “Transfer Restricted Global Securities” means Global Securities that bear or are required to bear or are subject to the Restricted Securities Legend.

       

      “Unrestricted Definitive Securities” means Definitive Securities that are not required to bear, and are not subject to, the Restricted Securities Legend.

       

      “Unrestricted Global Securities” means Global Securities that are not required to bear, and are not subject to, the Restricted Securities Legend.

       

      “U.S. Person” means a “U.S. person” as defined in Regulation S.

       

      

      
        A-2

        
          

      

      1.2          Other Definitions.

       

      
        	
                Term:

              	
                Defined in Section:

              
	 	 
	
                Agent Members

              	
                2.1(b)

              
	
                Regulation S Global Securities

              	
                2.1(b)

              
	
                Rule 144A Global Securities

              	
                2.1(b)

              

      

       

      

      2.            The Securities.

       

      2.1          Form and Dating; Global Securities.

       

      (a)          Issuance and Transfers. The Securities issued by the Issuer will be (i) privately placed by the Issuer pursuant to the Purchase Agreement and (ii) sold initially only to (1) QIBs,
        (2) Persons other than U.S. Persons in reliance on Regulation S and (3) Accredited Investors. Such Securities may thereafter be transferred to, among others, QIBs, purchasers in reliance on Regulation S and Accredited Investors.

       

      (b)          Global Securities. (i) Except as provided in clause (c) below, Rule 144A Securities initially shall be represented by one or more Securities in definitive, fully registered,
        global form without interest coupons (collectively, the “Rule 144A Global Securities”).

       

      Regulation S Securities initially shall be represented by one or more Securities in fully registered, global form without interest coupons (collectively, the “Regulation S Global Securities”), which shall be registered
        in the name of the Depository for the accounts of designated agents holding on behalf of Euroclear or Clearstream.

       

      The provisions of the “Operating Procedures of the Euroclear System” and “Terms and Conditions Governing Use of Euroclear” and the “General Terms and Conditions of Clearstream Banking” and “Customer Handbook” of
        Clearstream shall be applicable to transfers of beneficial interests in the Regulation S Global Securities that are held through Euroclear or Clearstream.

       

      The Global Securities shall bear the Global Securities Legend. The Global Securities initially shall (i) be registered in the name of the Depository, in each case for credit to an account of an Agent Member, (ii) be
        delivered to the Securities Custodian and (iii) bear the Restricted Securities Legend.

       

      Members of, or direct or indirect participants in, the Depository (collectively, the “Agent Members”) shall have no rights under this Indenture with respect to any Global Security held on their behalf by the
        Depository, or the Trustee as its custodian, or under the Global Securities. The Depository may be treated by the Issuer, the Trustee and any agent of the Issuer or the Trustee as the absolute owner of the Global Securities for all purposes
        whatsoever. Notwithstanding the foregoing, nothing herein shall prevent the Issuer, the Trustee or any agent of the Issuer or the Trustee from giving effect to any written certification, proxy or other authorization furnished by the Depository, or
        impair, as between the Depository and its Agent Members, the operation of customary practices governing the exercise of the rights of a Holder of any Security.

       

      

      
        A-3

        
          

      

      The Registrar shall retain copies of all letters, notices, Confidentiality Agreements and other written communications received pursuant to this Section 2.1 or Section 2.2 herein. The Issuer, at its sole cost and
        expense, shall have the right to inspect and make copies of all such letters, notices, Confidentiality Agreements or other written communications at any reasonable time upon the giving of reasonable written notice to the Registrar.

       

      (ii)          Transfers of Global Securities shall be limited to transfer in whole, but not in part, to the Depository. Interests of beneficial owners in the Global Securities may be transferred or exchanged for
        Definitive Securities only in accordance with the applicable rules and procedures of the Depository and the provisions of Section 2.2 herein. In addition, a Global Security shall be exchangeable for Definitive Securities if (x) the Depository (1)
        notifies the Issuer that it is unwilling or unable to continue as depository for such Global Security and the Issuer thereupon fails to appoint a successor depository or (2) has ceased to be a clearing agency registered under the Exchange Act or
        (y) there shall have occurred and be continuing an Event of Default with respect to such Global Security. In all cases, Definitive Securities delivered in exchange for any Global Security or beneficial interests therein shall be registered in the
        names, and issued in any approved denominations, requested by or on behalf of the Depository in accordance with its customary procedures.

       

      (iii)         In connection with the transfer of a Global Security as an entirety to beneficial owners pursuant to Section 2.1(b)(ii) herein, such Global Security shall be deemed to be surrendered to the Trustee for
        cancellation, and the Issuer shall execute, and the Trustee shall authenticate and make available for delivery, to each beneficial owner identified by the Depository in writing in exchange for its beneficial interest in such Global Security, an
        equal aggregate principal amount of Definitive Securities of authorized denominations.

       

      (iv)         Any Transfer Restricted Definitive Security delivered in exchange for an interest in a Global Security pursuant to Section 2.2 herein shall, except as otherwise provided in Section 2.2 herein, bear the
        Restricted Securities Legend.

       

      (v)          Notwithstanding the foregoing, through the Restricted Period, a beneficial interest in a Regulation S Global Security may be held only through Euroclear or Clearstream unless delivery is made in accordance
        with the applicable provisions of Section 2.2 herein.

       

      (vi)         The Holder of any Global Security may grant proxies and otherwise authorize any Person, including Agent Members and Persons that may hold interests through Agent Members, to take any action that a Holder
        is entitled to take under this Indenture or the Securities.

       

      (c)          Definitive Securities. To the extent that the purchaser of a Security is an Accredited Investor or otherwise cannot or opts not to hold a beneficial interest in a Global Security,
        then such Security shall be represented by one or more Definitive Securities.

       

      

      
        A-4

        
          

      

      2.2          Transfer and Exchange.

       

      (a)          Transfer and Exchange of Global Securities. A Global Security may not be transferred as a whole except as set forth in Section 2.1(b) herein. Global Securities will not be
        exchanged by the Issuer for Definitive Securities except under the circumstances described in Section 2.1(b)(ii) herein. Global Securities also may be exchanged or replaced, in whole or in part, as provided in Sections 2.08 and 2.10 of this
        Indenture. Beneficial interests in a Global Security may be transferred and exchanged as provided in Section 2.2(b) herein or Section 2.2(g) herein.

       

      (b)          Transfer and Exchange of Beneficial Interests in Global Securities. The transfer and exchange of beneficial interests in the Global Securities shall be effected through the
        Depository, in accordance with the provisions of this Indenture and the applicable rules and procedures of the Depository. Beneficial interests in Transfer Restricted Global Securities shall be subject to restrictions on transfer comparable to
        those set forth herein to the extent required by the Securities Act. Transfers and exchanges of beneficial interests in the Global Securities also shall require compliance with either subparagraph (i) or (ii) below, as applicable, as well as one or
        more of the other following subparagraphs, as applicable:

       

      (i)           Transfer of Beneficial Interests in the Same Global Security. Beneficial interests in any Transfer Restricted Global Security may be transferred to Persons who take delivery
        thereof in the form of a beneficial interest in the same Transfer Restricted Global Security in accordance with the transfer restrictions set forth in the Restricted Securities Legend; provided, however, that prior to the expiration of the Restricted Period, transfers of beneficial interests in a Regulation S Global Security may not be made to a U.S. Person or for the account or benefit of a U.S. Person
        (other than to a QIB in reliance on Rule 144A). A beneficial interest in an Unrestricted Global Security may be transferred to Persons who take delivery thereof in the form of a beneficial interest in an Unrestricted Global Security. No written
        orders or instructions shall be required to be delivered to the Registrar to effect the transfers described in this Section 2.2(b)(i).

       

      (ii)          All Other Transfers and Exchanges of Beneficial Interests in Global Securities. In connection with all transfers and exchanges of beneficial interests in any Global Security that
        is not subject to Section 2.2(b)(i) herein, the transferor of such beneficial interest must deliver to the Registrar (1) a written order from an Agent Member given to the Depository in accordance with the applicable rules and procedures of the
        Depository directing the Depository to credit or cause to be credited a beneficial interest in another Global Security in an amount equal to the beneficial interest to be transferred or exchanged and (2) instructions given in accordance with the
        applicable rules and procedures of the Depository containing information regarding the Agent Member account to be credited with such increase. Upon satisfaction of all of the requirements for transfer or exchange of beneficial interests in Global
        Securities contained in this Indenture and the Securities or otherwise applicable under the Securities Act, the Trustee shall adjust the principal amount of the relevant Global Security pursuant to Section 2.2(g) herein.

       

      

      
        A-5

        
          

      

      (iii)         Transfer of Beneficial Interests to Another Transfer Restricted Global Security. A beneficial interest in a Transfer Restricted Global Security may be transferred to a Person
        who takes delivery thereof in the form of a beneficial interest in another Transfer Restricted Global Security if the transfer complies with the requirements of Section 2.2(b)(ii) herein and the Registrar receives the following:

       

      (A)         if the transferee will take delivery in the form of a beneficial interest in a Rule 144A Global Security, then the transferor must deliver a certificate in the form attached to the
        applicable Security; and

       

      (B)         if the transferee will take delivery in the form of a beneficial interest in a Regulation S Global Security, then the transferor must deliver a certificate in the form attached to the
        applicable Security.

       

      (iv) Transfer and Exchange of Beneficial Interests in a Transfer Restricted Global Security for Beneficial Interests in an Unrestricted Global Security. A beneficial interest in a Transfer
        Restricted Global Security may be exchanged by any holder thereof for a beneficial interest in an Unrestricted Global Security or transferred to a Person who takes delivery thereof in the form of a beneficial interest in an Unrestricted Global
        Security if the exchange or transfer complies with the requirements of Section 2.2(b)(ii) herein and the Registrar receives the following:

       

      (A)         if the holder of such beneficial interest in a Transfer Restricted Global Security proposes to exchange such beneficial interest for a beneficial interest in an Unrestricted Global
        Security, a certificate from such holder in the form attached to the applicable Security; or

       

      (B)         if the holder of such beneficial interest in a Transfer Restricted Global Security proposes to transfer such beneficial interest to a Person who shall take delivery thereof in the form of
        a beneficial interest in an Unrestricted Global Security, a certificate from such holder in the form attached to the applicable Security,

       

      and, in each such case, if the Issuer or the Registrar so requests or if the applicable rules and procedures of the Depository so require, an Opinion of Counsel in form reasonably acceptable to the Issuer and the
        Registrar to the effect that such exchange or transfer is in compliance with the Securities Act and that the restrictions on transfer contained herein and in the Restricted Securities Legend are no longer required in order to maintain compliance
        with the Securities Act. If any such transfer or exchange is effected pursuant to this subparagraph (iv) at a time when an Unrestricted Global Security has not yet been issued, the Issuer shall issue and, upon receipt of a written order of the
        Issuer in the form of an Officers’ Certificate, the Trustee shall authenticate one or more Unrestricted Global Securities in an aggregate principal amount equal to the aggregate principal amount of beneficial interests transferred or exchanged
        pursuant to this subparagraph (iv).

       

      

      
        A-6

        
          

      

      (v)          Transfer and Exchange of Beneficial Interests in an Unrestricted Global Security for Beneficial Interests in a Transfer Restricted Global Security. Beneficial interests in an
        Unrestricted Global Security cannot be exchanged for, or transferred to Persons who take delivery thereof in the form of, a beneficial interest in a Transfer Restricted Global Security.

       

      (c)          Transfer and Exchange of Beneficial Interests in Global Securities for Definitive Securities. A beneficial interest in a Global Security may not be exchanged for a Definitive
        Security except under the circumstances described in Section 2.1(b)(ii) herein. A beneficial interest in a Global Security may not be transferred to a Person who takes delivery thereof in the form of a Definitive Security except under the
        circumstances described in Section 2.1(b)(ii) herein or Section 2.1(c) herein.

       

      (d)          Transfer and Exchange of Definitive Securities for Beneficial Interests in Global Securities. Transfers and exchanges of Definitive Securities for beneficial interests in Global
        Securities also shall require compliance with either subparagraph (i), (ii), (iii) or (iv) below, as applicable:

       

      (i)           Transfer Restricted Definitive Securities to Beneficial Interests in Transfer Restricted Global Securities. If any Holder of a Transfer Restricted Definitive Security proposes
        to exchange such Transfer Restricted Definitive Security for a beneficial interest in a Transfer Restricted Global Security or to transfer such Transfer Restricted Definitive Security to a Person who takes delivery thereof in the form of a
        beneficial interest in a Transfer Restricted Global Security, then, upon receipt by the Registrar of the following documentation:

       

      (A)         if the Holder of such Transfer Restricted Definitive Security proposes to exchange such Transfer Restricted Definitive Security for a beneficial interest in a Transfer Restricted Global
        Security, a certificate from such Holder in the form attached to the applicable Security;

       

      (B)         if such Transfer Restricted Definitive Security is being transferred to a QIB in accordance with Rule 144A, a certificate from such Holder in the form attached to the applicable Security;

       

      (C)         if such Transfer Restricted Definitive Security is being transferred to a Person that is not a U.S. Person in an offshore transaction in accordance with Rule 903 or Rule 904 under the
        Securities Act, a certificate from such Holder in the form attached to the applicable Security;

       

      (D)         if such Transfer Restricted Definitive Security is being transferred pursuant to an exemption from the registration requirements of the Securities Act in accordance with Rule 144 under
        the Securities Act, a certificate from such Holder in the form attached to the applicable Security; and

       

      (E)         if such Transfer Restricted Definitive Security is being transferred to the Issuer or a Subsidiary thereof, a certificate from such Holder in the form attached to the applicable Security;

       

      

      
        A-7

        
          

      

      the Trustee shall cancel the Transfer Restricted Definitive Security, and increase or cause to be increased the aggregate principal amount of the appropriate Transfer Restricted Global Security.

       

      (ii)          Transfer Restricted Definitive Securities to Beneficial Interests in Unrestricted Global Securities. A Holder of a Transfer Restricted Definitive Security may exchange such
        Transfer Restricted Definitive Security for a beneficial interest in an Unrestricted Global Security or transfer such Transfer Restricted Definitive Security to a Person who takes delivery thereof in the form of a beneficial interest in an
        Unrestricted Global Security only if the Registrar receives the following:

       

      (A)         if the Holder of such Transfer Restricted Definitive Security proposes to exchange such Transfer Restricted Definitive Security for a beneficial interest in an Unrestricted Global
        Security, a certificate from such Holder in the form attached to the applicable Security; or

       

      (B)         if the Holder of such Transfer Restricted Definitive Security proposes to transfer such Transfer Restricted Definitive Security to a Person who shall take delivery thereof in the form of
        a beneficial interest in an Unrestricted Global Security, a certificate from such Holder in the form attached to the applicable Security,

       

      and, in each such case, if the Issuer or the Registrar so requests or if the applicable rules and procedures of the Depository so require, an Opinion of Counsel in form reasonably acceptable to the Registrar to the
        effect that such exchange or transfer is in compliance with the Securities Act and that the restrictions on transfer contained herein and in the Restricted Securities Legend are no longer required in order to maintain compliance with the Securities
        Act. Upon satisfaction of the conditions of this subparagraph (ii), the Trustee shall cancel the Transfer Restricted Definitive Securities and increase or cause to be increased the aggregate principal amount of the Unrestricted Global Security. If
        any such transfer or exchange is effected pursuant to this subparagraph (ii) at a time when an Unrestricted Global Security has not yet been issued, the Issuer shall issue and, upon receipt of an written order of the Issuer in the form of an
        Officers’ Certificate, the Trustee shall authenticate one or more Unrestricted Global Securities in an aggregate principal amount equal to the aggregate principal amount of Transfer Restricted Definitive Securities transferred or exchanged pursuant
        to this subparagraph (ii).

       

      (iii)         Unrestricted Definitive Securities to Beneficial Interests in Unrestricted Global Securities. A Holder of an Unrestricted Definitive Security may exchange such Unrestricted
        Definitive Security for a beneficial interest in an Unrestricted Global Security or transfer such Unrestricted Definitive Security to a Person who takes delivery thereof in the form of a beneficial interest in an Unrestricted Global Security at any
        time. Upon receipt of a request for such an exchange or transfer, the Trustee shall cancel the applicable Unrestricted Definitive Security and increase or cause to be increased the aggregate principal amount of one of the Unrestricted Global
        Securities. If any such transfer or exchange is effected pursuant to this subparagraph (iii) at a time when an Unrestricted Global Security has not yet been issued, the Issuer shall issue and, upon receipt of a written order of the Issuer in the
        form of an Officers’ Certificate, the Trustee shall authenticate one or more Unrestricted Global Securities in an aggregate principal amount equal to the aggregate principal amount of Unrestricted Definitive Securities transferred or exchanged
        pursuant to this subparagraph (iii).

       

      

      
        A-8

        
          

      

      (iv)         Unrestricted Definitive Securities to Beneficial Interests in Transfer Restricted Global Securities. An Unrestricted Definitive Security cannot be exchanged for, or transferred
        to a Person who takes delivery thereof in the form of, a beneficial interest in a Transfer Restricted Global Security.

       

      (e)          Transfer and Exchange of Definitive Securities for Definitive Securities. Upon request by a Holder of Definitive Securities and such Holder’s compliance with the provisions of
        this Section 2.2(e), the Registrar shall register the transfer or exchange of Definitive Securities. Prior to such registration of transfer or exchange, the requesting Holder shall present or surrender to the Registrar the Definitive Securities
        duly endorsed or accompanied by a written instruction of transfer in form satisfactory to the Registrar duly executed by such Holder or by its attorney, duly authorized in writing. In addition, the requesting Holder shall provide any additional
        certifications, documents and information, as applicable, required pursuant to the following provisions of this Section 2.2(e):

       

      (i)          Transfer Restricted Definitive Securities to Transfer Restricted Definitive Securities. A Transfer Restricted Definitive Security may be transferred to and registered in the name
        of a Person who takes delivery thereof in the form of a Transfer Restricted Definitive Security if the Registrar receives the following:

       

      (A)         if the transfer will be made pursuant to Rule 144A, a certificate in the form attached to the applicable Security;

       

      (B)         if the transfer will be made pursuant to Rule 903 or Rule 904 under the Securities Act, a certificate in the form attached to the applicable Security;

       

      (C)         if the transfer will be made pursuant to an exemption from the registration requirements of the Securities Act in accordance with Rule 144 under the Securities Act, a certificate in the
        form attached to the applicable Security;

       

      (D)         if the transfer will be made to an Accredited Investor in reliance on an exemption from the registration requirements of the Securities Act other than those listed in subparagraphs (A)
        through (C) above, a certificate in the form attached to the applicable Security and a Transferee Letter of Representation in the form of Exhibit B to this Indenture; and

       

      (E)         if such transfer will be made to the Issuer or a Subsidiary thereof, a certificate in the form attached to the applicable Security.

       

      (ii)          Transfer Restricted Definitive Securities to Unrestricted Definitive Securities. Any Transfer Restricted Definitive Security may be exchanged by the Holder thereof for an
        Unrestricted Definitive Security or transferred to a Person who takes delivery thereof in the form of an Unrestricted Definitive Security if the Registrar receives the following:

       

      

      
        A-9

        
          

      

      (1)          if the Holder of such Transfer Restricted Definitive Security proposes to exchange such Transfer Restricted Definitive Security for an Unrestricted Definitive Security, a certificate
        from such Holder in the form attached to the applicable Security; or

       

      (2)          if the Holder of such Transfer Restricted Definitive Security proposes to transfer such Transfer Restricted Definitive Security to a Person who shall take delivery thereof in the form of
        an Unrestricted Definitive Security, a certificate from such Holder in the form attached to the applicable Security,

       

      and, in each such case, if the Registrar so requests, an Opinion of Counsel in form reasonably acceptable to the Issuer to the effect that such exchange or transfer is in compliance with the Securities Act and that the
        restrictions on transfer contained herein and in the Restricted Securities Legend are no longer required in order to maintain compliance with the Securities Act.

       

      (iii)         Unrestricted Definitive Securities to Unrestricted Definitive Securities. A Holder of an Unrestricted Definitive Security may transfer such Unrestricted Definitive Security to a
        Person who takes delivery thereof in the form of an Unrestricted Definitive Security at any time. Upon receipt of a request to register such a transfer, the Registrar shall register the Unrestricted Definitive Securities pursuant to the
        instructions from the Holder thereof.

       

      (iv)         Unrestricted Definitive Securities to Transfer Restricted Definitive Securities. An Unrestricted Definitive Security cannot be exchanged for, or transferred to a Person who takes
        delivery thereof in the form of, a Transfer Restricted Definitive Security.

       

      At such time as all beneficial interests in a particular Global Security have been exchanged for Definitive Securities or a particular Global Security has been redeemed, repurchased or canceled in whole and not in
        part, each such Global Security shall be retained and canceled by the Trustee in accordance with Section 2.11 of this Indenture. At any time prior to such cancellation, if any beneficial interest in a Global Security is exchanged for or transferred
        to a Person who will take delivery thereof in the form of a beneficial interest in another Global Security or for Definitive Securities, the principal amount of Securities represented by such Global Security shall be reduced accordingly and an
        endorsement shall be made on such Global Security by the Trustee or by the Depository at the direction of the Trustee to reflect such reduction; and if the beneficial interest is being exchanged for or transferred to a Person who will take delivery
        thereof in the form of a beneficial interest in another Global Security, such other Global Security shall be increased accordingly and an endorsement shall be made on such Global Security by the Trustee or by the Depository at the direction of the
        Trustee to reflect such increase.

       

      

      
        A-10

        
          

      

      (f)           Legends.

       

      (i)           (A)        Each Security certificate evidencing the Global Securities and the Definitive Securities (and all Securities issued in exchange therefor or in substitution thereof) shall bear a legend in
        substantially the following form (each defined term in the legend being defined as such for purposes of the legend only):

       

      NEITHER THIS NOTE NOR ANY INTEREST HEREIN HAS BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), THE SECURITIES LAWS OF ANY STATE OR THE SECURITIES LAWS OF ANY OTHER JURISDICTION, NOR IS SUCH REGISTRATION
        CONTEMPLATED. NEITHER THIS NOTE NOR ANY INTEREST HEREIN MAY BE ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED, SOLD OR OFFERED FOR SALE OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EXEMPTION FROM SUCH REGISTRATION THEREUNDER AND ANY OTHER APPLICABLE
        SECURITIES LAW REGISTRATION REQUIREMENTS. EACH PERSON OR ENTITY THAT ACQUIRES OR ACCEPTS THIS NOTE OR AN INTEREST HEREIN BY SUCH ACQUISITION OR ACCEPTANCE (1) REPRESENTS THAT (A) IT IS A QUALIFIED INSTITUTIONAL BUYER (AS DEFINED IN RULE 144A UNDER
        THE SECURITIES ACT) AND, IF SUBSEQUENT TO THE INITIAL ACQUISITION HEREOF, IS PURCHASING THIS NOTE IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A UNDER THE SECURITIES ACT, (B) IT IS NOT A U.S. PERSON AND IS ACQUIRING THIS NOTE IN AN OFFSHORE
        TRANSACTION IN COMPLIANCE WITH RULE 903 OR 904 OF REGULATION S UNDER THE SECURITIES ACT OR (C) IT IS AN ACCREDITED INVESTOR AS DEFINED IN SUBPARAGRAPH (a)(1), (a)(2), (a)(3) or (a)(7) OF RULE 501 UNDER THE SECURITIES ACT (AN “ACCREDITED INVESTOR”),
        HAS SUFFICIENT KNOWLEDGE AND EXPERIENCE IN FINANCIAL AND BUSINESS MATTERS TO BE CAPABLE OF EVALUATING THE MERITS AND RISKS OF THE PURCHASE OF THIS NOTE AND IS ABLE AND PREPARED TO BEAR THE ECONOMIC RISK OF INVESTING IN AND HOLDING THIS NOTE, (2)
        AGREES THAT IT WILL NOT OFFER, SELL OR OTHERWISE TRANSFER THIS NOTE OR AN INTEREST HEREIN, EXCEPT (A) TO THE ISSUER OR A SUBSIDIARY THEREOF, (B) FOR SO LONG AS THIS NOTE IS ELIGIBLE FOR RESALE PURSUANT TO RULE 144A UNDER THE SECURITIES ACT, TO AN
        ENTITY IT REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER THAT PURCHASES FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER, TO WHOM NOTICE IS GIVEN THAT THE TRANSFER IS BEING MADE IN RELIANCE ON RULE 144A UNDER THE
        SECURITIES ACT, (C) TO PERSONS OR ENTITIES OTHER THAN U.S. PERSONS, INCLUDING DEALERS OR OTHER PROFESSIONAL FIDUCIARIES IN THE UNITED STATES ACTING ON A DISCRETIONARY BASIS FOR NON-U.S. BENEFICIAL OWNERS (OTHER THAN AN ESTATE OR TRUST), IN OFFSHORE
        TRANSACTIONS IN RELIANCE UPON, AND IN ACCORDANCE WITH, REGULATION S UNDER THE SECURITIES ACT OR (D) TO AN ACCREDITED INVESTOR THAT IS PURCHASING THIS NOTE OR AN INTEREST HEREIN, AS THE CASE MAY BE, FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF SUCH AN
        ACCREDITED INVESTOR FOR INVESTMENT PURPOSES AND NOT WITH A VIEW TO, OR FOR OFFER OR SALE IN CONNECTION WITH, ANY DISTRIBUTION IN VIOLATION OF THE SECURITIES ACT AND (3) AGREES THAT IT WILL GIVE TO EACH PERSON OR ENTITY TO WHOM THIS NOTE OR AN
        INTEREST HEREIN IS TRANSFERRED A NOTICE SUBSTANTIALLY TO THE EFFECT OF THIS LEGEND; PROVIDED, THAT THE ISSUER AND THE TRUSTEE SHALL HAVE THE RIGHT PRIOR TO ANY SUCH OFFER, SALE OR TRANSFER PURSUANT TO CLAUSE (2)(D) OF THIS PARAGRAPH TO REQUIRE THE
        DELIVERY OF AN OPINION OF COUNSEL, CERTIFICATION OR OTHER INFORMATION SATISFACTORY TO EACH OF THEM. THE TERMS “OFFSHORE TRANSACTION”, “UNITED STATES” AND “U.S. PERSON” HAVE THE RESPECTIVE MEANINGS GIVEN TO THEM BY REGULATION S UNDER THE SECURITIES
        ACT. THE INDENTURE REFERRED TO HEREINAFTER CONTAINS A PROVISION REQUIRING THE REGISTRAR APPOINTED THEREUNDER TO REFUSE TO REGISTER ANY TRANSFER OF THIS NOTE IN VIOLATION OF THE FOREGOING RESTRICTIONS.

       

      

      
        A-11

        
          

      

      THIS NOTE IS ISSUED WITH ORIGINAL ISSUE DISCOUNT UNDER SECTIONS 1272, 1273 AND 1275 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED, AND IS SUBJECT TO THE RULES FOR DEBT INSTRUMENTS WITH CONTINGENT PAYMENTS UNDER
        TREASURY REGULATION SECTION 1.1275-4(b). FOR INFORMATION REGARDING THE ISSUE PRICE, THE AMOUNT OF ORIGINAL ISSUE DISCOUNT, THE ISSUE DATE, THE YIELD TO MATURITY, THE COMPARABLE YIELD AND THE PROJECTED PAYMENT SCHEDULE FOR THIS NOTE, YOU SHOULD
        SUBMIT A WRITTEN REQUEST TO AQUESTIVE THERAPEUTICS, INC., 30 TECHNOLOGY DRIVE, WARREN, NEW JERSEY 07059, ATTENTION: CHIEF FINANCIAL OFFICER & GENERAL COUNSEL.

       

      THIS NOTE MAY NOT BE RESOLD OR TRANSFERRED EXCEPT AS SET FORTH IN THE INDENTURE REFERRED TO HEREINAFTER, AND, IN ADDITION, EACH PERSON OR ENTITY THAT ACQUIRES OR ACCEPTS THIS NOTE OR AN INTEREST HEREIN BY SUCH ACQUISITION OR ACCEPTANCE AGREES TO
        COMPLY WITH THE TRANSFER RESTRICTIONS SET FORTH IN SUCH INDENTURE, AND FURTHER ACKNOWLEDGES AND AGREES TO THE PROVISIONS SET FORTH IN SUCH INDENTURE.

       

      (B)         Each Global Security shall bear the following legend:

       

      UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION, TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF
        CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (AND ANY PAYMENT HEREON IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE
        DEPOSITORY TRUST COMPANY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON OR ENTITY IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.

       

      TRANSFERS OF THIS NOTE SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF CEDE & CO. OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS NOTE SHALL BE LIMITED TO TRANSFERS MADE IN
        ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE INDENTURE REFERRED TO HEREINAFTER.

       

      

      
        A-12

        
          

      

      (g)          Cancellation or Adjustment of Global Security. At such time as all beneficial interests in a particular Global Security have been exchanged for Definitive Securities or a
        particular Global Security has been redeemed, repurchased or canceled in whole and not in part, each such Global Security shall be returned to or retained and canceled by the Trustee in accordance with Section 2.11 of this Indenture. At any time
        prior to such cancellation, if any beneficial interest in a Global Security is exchanged for or transferred to a Person who will take delivery thereof in the form of a beneficial interest in another Global Security or for Definitive Securities, the
        principal amount of Securities represented by such Global Security shall be reduced accordingly and an endorsement shall be made on such Global Security by the Trustee or by the Depository at the direction of the Trustee to reflect such reduction;
        and if the beneficial interest is being exchanged for or transferred to a Person who will take delivery thereof in the form of a beneficial interest in another Global Security, such other Global Security shall be increased accordingly and an
        endorsement shall be made on such Global Security by the Trustee or by the Depository at the direction of the Trustee to reflect such increase.

       

      (h)          Obligations with Respect to Transfers and Exchanges of Securities.

       

      (i)           To permit registrations of transfers and exchanges, the Issuer shall execute, and the Trustee shall authenticate, Definitive Securities and Global Securities at the Registrar’s request.

       

      (ii)          No service charge shall be made for any registration of transfer or exchange, but the Issuer may require payment of a sum sufficient to cover any transfer tax, assessments, or similar governmental charge
        payable in connection therewith (other than any such transfer taxes, assessments or similar governmental charge payable upon exchanges pursuant to Sections 3.06, 4.06, 4.08 and 9.04 of this Indenture).

       

      (iii)         Prior to the due presentation for registration of transfer of any Security, the Issuer, the Trustee, a Paying Agent or the Registrar may deem and treat the Person in whose name a Security is registered as
        the absolute owner of such Security for the purpose of receiving payment of principal of and interest on such Security and for all other purposes whatsoever, whether or not such Security is overdue, and none of the Issuer, the Trustee, the Paying
        Agent or the Registrar shall be affected by notice to the contrary.

       

      (iv)         All Securities issued upon any transfer or exchange pursuant to the terms of this Indenture shall evidence the same debt and shall be entitled to the same benefits under this Indenture as the Securities
        surrendered upon such transfer or exchange.

       

      (i)           No Obligation of the Trustee.

       

      

      
        A-13

        
          

      

      (i)           The Trustee shall have no responsibility or obligation to any beneficial owner of a Global Security, a member of, or a participant in, the Depository or any other Person with respect to the accuracy of
        the records of the Depository or of any participant or member thereof, with respect to any ownership interest in the Securities or with respect to the delivery to any participant, member, beneficial owner or other Person (other than the Depository)
        of any notice (including any notice of redemption or repurchase) or the payment of any amount, under or with respect to such Securities. All notices and communications to be given to the Holders and all payments to be made to the Holders under the
        Securities shall be given or made to the registered Holders (which shall be the Depository in the case of a Global Security). Except as may be otherwise permitted pursuant to Section 2.14 of the Indenture, the rights of beneficial owners in any
        Global Security shall be exercised only through the Depository subject to the applicable rules and procedures of the Depository. The Trustee may rely and shall be fully protected in relying upon information furnished by the Depository with respect
        to its members, its participants and any beneficial owners.

       

      (ii)          The Trustee shall have no obligation or duty to monitor, determine or inquire as to compliance with any restrictions on transfer imposed under this Indenture or under applicable law with respect to any
        transfer of any interest in any Security (including any transfers between or among Depository participants, members or beneficial owners in any Global Security) other than to require delivery of such certificates and other documentation or evidence
        as are expressly required by, and to do so if and when expressly required by, the terms of this Indenture, and to examine the same to determine substantial compliance as to form with the express requirements hereof.

       

      

      
        A-14

        
          

      

      EXHIBIT A

       

      {FORM OF SECURITY}

       

      NEITHER THIS NOTE NOR ANY INTEREST HEREIN HAS BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), THE SECURITIES LAWS OF ANY STATE OR THE SECURITIES LAWS OF ANY OTHER JURISDICTION, NOR IS SUCH REGISTRATION
        CONTEMPLATED. NEITHER THIS NOTE NOR ANY INTEREST HEREIN MAY BE ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED, SOLD OR OFFERED FOR SALE OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EXEMPTION FROM SUCH REGISTRATION THEREUNDER AND ANY OTHER APPLICABLE
        SECURITIES LAW REGISTRATION REQUIREMENTS. EACH PERSON OR ENTITY THAT ACQUIRES OR ACCEPTS THIS NOTE OR AN INTEREST HEREIN BY SUCH ACQUISITION OR ACCEPTANCE (1) REPRESENTS THAT (A) IT IS A QUALIFIED INSTITUTIONAL BUYER (AS DEFINED IN RULE 144A UNDER
        THE SECURITIES ACT) AND, IF SUBSEQUENT TO THE INITIAL ACQUISITION HEREOF, IS PURCHASING THIS NOTE IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A UNDER THE SECURITIES ACT, (B) IT IS NOT A U.S. PERSON AND IS ACQUIRING THIS NOTE IN AN OFFSHORE
        TRANSACTION IN COMPLIANCE WITH RULE 903 OR 904 OF REGULATION S UNDER THE SECURITIES ACT OR (C) IT IS AN ACCREDITED INVESTOR AS DEFINED IN SUBPARAGRAPH (a)(1), (a)(2), (a)(3) or (a)(7) OF RULE 501 UNDER THE SECURITIES ACT (AN “ACCREDITED INVESTOR”),
        HAS SUFFICIENT KNOWLEDGE AND EXPERIENCE IN FINANCIAL AND BUSINESS MATTERS TO BE CAPABLE OF EVALUATING THE MERITS AND RISKS OF THE PURCHASE OF THIS NOTE AND IS ABLE AND PREPARED TO BEAR THE ECONOMIC RISK OF INVESTING IN AND HOLDING THIS NOTE, (2)
        AGREES THAT IT WILL NOT OFFER, SELL OR OTHERWISE TRANSFER THIS NOTE OR AN INTEREST HEREIN, EXCEPT (A) TO THE ISSUER OR A SUBSIDIARY THEREOF, (B) FOR SO LONG AS THIS NOTE IS ELIGIBLE FOR RESALE PURSUANT TO RULE 144A UNDER THE SECURITIES ACT, TO AN
        ENTITY IT REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER THAT PURCHASES FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER, TO WHOM NOTICE IS GIVEN THAT THE TRANSFER IS BEING MADE IN RELIANCE ON RULE 144A UNDER THE
        SECURITIES ACT, (C) TO PERSONS OR ENTITIES OTHER THAN U.S. PERSONS, INCLUDING DEALERS OR OTHER PROFESSIONAL FIDUCIARIES IN THE UNITED STATES ACTING ON A DISCRETIONARY BASIS FOR NON-U.S. BENEFICIAL OWNERS (OTHER THAN AN ESTATE OR TRUST), IN OFFSHORE
        TRANSACTIONS IN RELIANCE UPON, AND IN ACCORDANCE WITH, REGULATION S UNDER THE SECURITIES ACT OR (D) TO AN ACCREDITED INVESTOR THAT IS PURCHASING THIS NOTE OR AN INTEREST HEREIN, AS THE CASE MAY BE, FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF SUCH AN
        ACCREDITED INVESTOR FOR INVESTMENT PURPOSES AND NOT WITH A VIEW TO, OR FOR OFFER OR SALE IN CONNECTION WITH, ANY DISTRIBUTION IN VIOLATION OF THE SECURITIES ACT AND (3) AGREES THAT IT WILL GIVE TO EACH PERSON OR ENTITY TO WHOM THIS NOTE OR AN
        INTEREST HEREIN IS TRANSFERRED A NOTICE SUBSTANTIALLY TO THE EFFECT OF THIS LEGEND; PROVIDED, THAT THE ISSUER AND THE TRUSTEE SHALL HAVE THE RIGHT PRIOR TO ANY SUCH OFFER, SALE OR TRANSFER PURSUANT TO CLAUSE (2)(D) OF THIS PARAGRAPH TO REQUIRE THE
        DELIVERY OF AN OPINION OF COUNSEL, CERTIFICATION OR OTHER INFORMATION SATISFACTORY TO EACH OF THEM. THE TERMS “OFFSHORE TRANSACTION”, “UNITED STATES” AND “U.S. PERSON” HAVE THE RESPECTIVE MEANINGS GIVEN TO THEM BY REGULATION S UNDER THE SECURITIES
        ACT. THE INDENTURE REFERRED TO HEREINAFTER CONTAINS A PROVISION REQUIRING THE REGISTRAR APPOINTED THEREUNDER TO REFUSE TO REGISTER ANY TRANSFER OF THIS NOTE IN VIOLATION OF THE FOREGOING RESTRICTIONS.

       

      

      
        A-1

        
          

      

      THIS NOTE IS ISSUED WITH ORIGINAL ISSUE DISCOUNT UNDER SECTIONS 1272, 1273 AND 1275 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED, AND IS SUBJECT TO THE RULES FOR DEBT INSTRUMENTS WITH CONTINGENT PAYMENTS UNDER TREASURY REGULATION SECTION
        1.1275-4(b). FOR INFORMATION REGARDING THE ISSUE PRICE, THE AMOUNT OF ORIGINAL ISSUE DISCOUNT, THE ISSUE DATE, THE YIELD TO MATURITY, THE COMPARABLE YIELD AND THE PROJECTED PAYMENT SCHEDULE FOR THIS NOTE, YOU SHOULD SUBMIT A WRITTEN REQUEST TO
        AQUESTIVE THERAPEUTICS, INC., 30 TECHNOLOGY DRIVE, WARREN, NEW JERSEY 07059, ATTENTION: CHIEF FINANCIAL OFFICER & GENERAL COUNSEL.

       

      THIS NOTE MAY NOT BE RESOLD OR TRANSFERRED EXCEPT AS SET FORTH IN THE INDENTURE REFERRED TO HEREINAFTER, AND, IN ADDITION, EACH PERSON OR ENTITY THAT ACQUIRES OR ACCEPTS THIS NOTE OR AN INTEREST HEREIN BY SUCH ACQUISITION OR ACCEPTANCE AGREES TO
        COMPLY WITH THE TRANSFER RESTRICTIONS SET FORTH IN SUCH INDENTURE, AND FURTHER ACKNOWLEDGES AND AGREES TO THE PROVISIONS SET FORTH IN SUCH INDENTURE.

       

      {Global Securities Legend}

       

      UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION, TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF
        CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (AND ANY PAYMENT HEREON IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE
        DEPOSITORY TRUST COMPANY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON OR ENTITY IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.

       

      TRANSFERS OF THIS NOTE SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF CEDE & CO. OR TO A SUCCESSOR THEREOF OR SUCH SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS NOTE SHALL BE LIMITED TO TRANSFERS MADE IN
        ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE INDENTURE REFERRED TO HEREINAFTER.

       

      

      
        A-2

        
          

      

      {FORM OF SECURITY}

       

      

      
        	
                
                  No.____ 

                  

                

              	
                $__________

              

      

      

      12.5% Senior Secured Note due 2025

       

      

      CUSIP No._____

      ISIN No._______

       

      Aquestive Therapeutics, Inc., a Delaware corporation (the “Issuer”), promises to pay to {Cede & Co.}{__________}, or its registered assigns, the principal sum {of $________ Dollars} {listed on the Schedule of
        Increases or Decreases in Global Security attached hereto}1 on or before June 30, 2025 as set forth in this Security.

       

      Payment Dates: March 30, June 30, September 30 and December 30 (each, a “Payment Date”)

       

      Record Dates: March 15, June 15, September 15 and December 15 (each, a “Record Date”)

       

      Additional provisions of this Security are set forth on the following pages of this Security.

      

      

      

       

        

      1 Use the Schedule of Increases or Decreases language if Security is in Global Form.

       

      
        A-3

        
          

      

      IN WITNESS WHEREOF, the undersigned has caused this Instrument to be duly executed.

       

      

      
        	 	
                AQUESTIVE THERAPEUTICS, INC.

              
	 	 
	 	
                By:

                  

              	

              	 
	 	 	
                Name:

                

              	 
	 	 	
                Title:

                

              	 

        

        

      

      
        A-4

        
          

      

      
        	
                
                  TRUSTEE’S CERTIFICATE OF

                  

                

              	
                 

              
	
                AUTHENTICATION

              	
                 

              
	
                 

              	
                 

              
	
                U.S. BANK NATIONAL ASSOCIATION,

                

              	
                 

              
	
                as Trustee, certifies that this is

                

              	
                 

              
	
                one of the Securities

                

              	
                 

              
	
                referred to in the within-mentioned Indenture.

              	
                 

              

      

       

      

      
        	
                By:

              	
                 

              	
                 

              
	
                 

              	
                
                  Authorized Signatory

                

              	
                 

              

      

      

      

      
        	
                Date:

              	 	
                 

              

         

        

      

      
        A-5

        
          

      

      12.5% Senior Secured Note due 2025

       

      
        
          	1.	
                  Interest and Payments of Principal

                

        

      

       

      (a)          Aquestive Therapeutics, Inc., a Delaware corporation (the “Issuer”), shall pay interest on the outstanding principal amount of this Security at the rate per annum shown above.

       

      (b)          The Issuer shall pay interest quarterly in arrears on each Payment Date, commencing on {September 30, 2019}, or on the succeeding Business Day if any such date is not a Business Day.
        Interest on this Security shall accrue on the outstanding principal amount thereof from the most recent date to which interest has been paid or duly provided for or, if no interest has been paid or duly provided for, from {July 15, 2019} until the
        principal hereof is paid or duly provided for. Interest shall be computed on the basis of a 360-day year of twelve 30-day months. The Issuer shall pay, during the continuance of an Event of Default, interest on the outstanding principal amount of
        the Securities at the rate borne by the Securities plus 4.00% per annum, and the Issuer shall pay interest on overdue installments of interest at the rate borne by the Securities plus 4.00% per annum to the extent lawful. All payments of interest
        shall be rounded to two decimal places.

       

      (c)          The Securities will mature on June 30, 2025.

       

      (d)          On each Payment Date, commencing on September 30, 2021, or on the succeeding Business Day if any such date is not a Business Day, the Issuer shall pay to the Holders an installment of
        principal of the Securities in accordance with the table below corresponding to the applicable Payment Date, where the applicable percentage is the percentage of (i) the initial aggregate principal amount of Original Securities issued on the Issue
        Date plus (ii) the initial aggregate principal amount of any First Additional Securities issued on their date of issuance plus (iii) the initial aggregate principal amount of any Second Additional Securities issued on their date of issuance minus
        (iv) the aggregate principal amount of Securities redeemed or repurchased pursuant to the Indenture prior to such Payment Date:

       

      
        	
                Payment Date

              	
                Applicable Percentage

              
	
                September 30, 2021

              	
                2.5%

              
	
                December 30, 2021

              	
                2.5%

              
	
                March 30, 2022

              	
                2.5%

              
	
                June 30, 2022

              	
                2.5%

              
	
                September 30, 2022

              	
                5.0%

              
	
                December 30, 2022

              	
                5.0%

              
	
                March 30, 2023

              	
                5.0%

              
	
                June 30, 2023

              	
                5.0%

              
	
                September 30, 2023

              	
                7.5%

              
	
                December 30, 2023

              	
                7.5%

              
	
                March 30, 2024

              	
                7.5%

              
	
                June 30, 2024

              	
                7.5%

              
	
                September 30, 2024

              	
                10.0%

              
	
                December 30, 2024

              	
                10.0%

              
	
                March 30, 2025

              	
                10.0%

              
	
                June 30, 2025

              	
                All remaining outstanding principal of the Securities at such date

              

      

      

      

      All payments calculated from the principal installment percentages set forth above shall be rounded to two decimal places.

       

      

      
        A-6

        
          

      

      
        
          	2.	
                  Method of Payment

                

        

      

       

      The Issuer shall pay interest on the Securities (except defaulted interest) and payments of installments of principal to the Persons who are registered Holders at the
        close of business on the Record Date immediately preceding the related Payment Date even if Securities are canceled after such Record Date and on or before such Payment Date (whether or not a Business Day). Holders must surrender Securities to the
        Paying Agent to collect principal payments (other than payments of installments of principal). The Issuer shall pay principal, premium, if any, and interest in money of the United States of America that at the time of payment is legal tender for
        payment of public and private debts. {Payments in respect of the Securities (including principal, premium, if any, and interest) shall be made by wire transfer of immediately available funds to the accounts specified by The Depository Trust Company
        or any successor depositary.}1 {The Issuer shall make all payments in respect of the Securities (including principal, premium, if any, and interest) at the office of
        the Paying Agent, except that, at the option of the Issuer, payment of interest may be made by mailing a check to the registered address of each Holder thereof; provided, however,
        that payments on the Securities may also be made, in the case of a Holder of at least $1,000,000 aggregate principal amount of Securities, by wire transfer to a U.S. dollar account maintained by the payee with a bank in the United States if such
        Holder elects payment by wire transfer by giving written notice to the Trustee or Paying Agent to such effect designating such account no later than 30 days immediately preceding the relevant due date for payment (or such other date as the Trustee
        may accept in its discretion).}2

       

      
        
          	3.	
                  Paying Agent and Registrar

                

        

      

       

      Initially, U.S. Bank National Association (the “Trustee”) will act as Paying Agent and Registrar. The Issuer or any of its domestically organized Wholly Owned Restricted Subsidiaries may act as Paying Agent or
        Registrar.

       

      
        
          	4.	
                  Indenture

                

        

      

       

      The Issuer issued the Securities under the Indenture dated as of July 15, 2019 (the “Indenture”) among the Issuer, the guarantors that may be party thereto from time to time, the Trustee and the
        Collateral Agent. The terms of the Securities include those stated in the Indenture. Terms defined in the Indenture and not defined herein have the meanings ascribed thereto in the Indenture. The Securities are subject to all terms and provisions
        of the Indenture, and the Holders are referred to the Indenture and the TIA for a statement of such terms and provisions. If and to the extent that any provision of the Securities limits, qualifies or conflicts with a provision of the Indenture,
        such provision of the Indenture shall control.

      
        
          
             

            

            
              

            	1	
                    Include in a Global Security.

                  

          

        

         

        
          
            	2	
                    Include in a Definitive Security.

                  

          

        

      

       

      

      
        A-7

        
          

      

      The Securities are senior secured obligations of the Issuer. This Security is one of the Securities referred to in the Indenture. The Securities are treated as a single class of securities under the Indenture. The
        Indenture imposes certain limitations on the ability of the Issuer and its Restricted Subsidiaries to, among other things, make certain Investments and other Restricted Payments, pay dividends and other distributions, incur Indebtedness, enter into
        consensual restrictions upon the payment of certain dividends and distributions by such Restricted Subsidiaries, issue or sell shares of capital stock of the Issuer and such Restricted Subsidiaries, enter into or permit certain transactions with
        Affiliates, create or incur Liens and Dispose of assets. The Indenture also imposes limitations on the ability of the Issuer and each Guarantor to merge, amalgamate or consolidate with or into any other Person or convey, transfer or lease all or
        substantially all of their property.

       

      To guarantee the due and punctual payment of the principal of and interest on the Securities and all other amounts payable by the Issuer under the Indenture and the Securities when and as the same shall be due and
        payable, whether at maturity, by acceleration or otherwise, according to the terms of the Securities and the Indenture, the Guarantors have, jointly and severally, irrevocably and unconditionally guaranteed the Guaranteed Obligations on a senior
        secured basis pursuant to the terms of the Indenture.

       

      
        
          	5.	
                  Optional Redemption

                

        

      

       

      The Issuer may redeem the Securities at its option, in whole at any time or in part from time to time, on any Business Day specified by the Issuer prior to July 15, 2021 (the “First Call Date”), on not less than 30
        days’ nor more than 60 days’ prior written notice delivered to each Holder, at a redemption price equal to 100% of the principal amount of the Securities being redeemed plus the Applicable Premium, plus accrued and unpaid interest, if any, to the
        redemption date (subject to the right of Holders of record on the relevant Record Date to receive interest due on the relevant Payment Date).

       

      The Issuer may redeem the Securities at its option, in whole at any time or in part from time to time, on any Business Day specified by the Issuer on or after the First Call Date, on not less than 30 days’ nor more
        than 60 days’ prior written notice delivered to each Holder, at the following redemption prices (expressed as a percentage of outstanding principal amount of the Securities being redeemed), plus accrued and unpaid interest to the redemption date
        (subject to the right of Holders of record on the relevant Record Date to receive interest due on the relevant Payment Date), for the following periods:

       

      	
              Period

            	
              Redemption Price

            
	
              From and including the First Call Date to and including July 14, 2022

            	
              112.5000%

            
	
              From and including July 15, 2022 to and including July 14, 2023

            	
              106.2500%

            
	
              From and including July 15, 2023 to and including July 14, 2024

            	
              103.1250%

            
	
              From and including July 15, 2024 and thereafter

            	
              101.5625%

            

      

      

      
        A-8

        
          

      

      “Applicable Premium” means, with respect to any Security (or portion thereof) to be redeemed on any redemption date, the greater of (i) 1.0% of the amount of principal of such Security to be redeemed and (ii) the
        amount, if any, by which (a) the present value at such redemption date of (1) the redemption price of the amount of principal of such Security to be redeemed on the First Call Date (as stated in the table above) plus (2) all required interest
        payments due on the amount of principal of such Security to be redeemed through the First Call Date (excluding accrued but unpaid interest, if any, to the redemption date), computed using a discount rate equal to the Treasury Rate in respect of
        such redemption date plus 100 basis points, exceeds (b) the amount of principal of such Security to be redeemed. The Trustee shall have no duty to calculate or verify the calculation of the Applicable Premium.

       

      “Treasury Rate” means, in respect of any redemption date, the yield to maturity as of such redemption date of United States Treasury securities with a constant maturity (as compiled and published in the most recent
        Federal Reserve Statistical Release H.15 that has become publicly available at least two Business Days prior to such redemption date (or, if such Federal Reserve Statistical Release H.15 is no longer published, any publicly available source of
        similar market data)) most nearly equal to the period from such redemption date to the First Call Date; provided, that if the period from such redemption date to the First Call Date is less than one year,
        the weekly average yield on actually traded United States Treasury securities adjusted to a constant maturity of one year will be used.

       

      Notice of any redemption may, at the Issuer’s discretion, be revocable and be subject to one or more conditions precedent, including the receipt by the Trustee, on or prior to the redemption date, of money sufficient
        to pay the principal of, and premium, if any, and interest on, the Securities being redeemed.

       

      
        
          	6.	
                  Notice of Redemption

                

        

      

       

      Written notice of redemption pursuant to paragraph 5 will be provided at least 30 days but not more than 60 days before the redemption date to each Holder of Securities to be redeemed. Securities in denominations
        larger than $1,000 may be redeemed in part but only in whole multiples of $1,000. If money sufficient to pay the redemption price of and accrued and unpaid interest on all Securities (or portions thereof) to be redeemed on the redemption date is
        deposited with a Paying Agent on or before the redemption date and certain other conditions are satisfied, on and after such date, interest ceases to accrue on such Securities (or such portions thereof) called for redemption.

       

      
        
          	7.	
                  Sinking Fund

                

        

      

       

      The Securities are not subject to any sinking fund.

       

      
        
          	8.	
                  Repurchase of Securities at the Option of the Holders upon Apomorphine Disposition

                

        

      

       

      Upon the occurrence of any Apomorphine Disposition, each Holder shall have the right, subject to certain conditions specified in the Indenture, to require the Issuer to repurchase all or any part of such Holder’s then
        outstanding Securities at a repurchase price in cash equal to 112.5000% of the principal amount thereof, plus accrued and unpaid interest, if any, thereon to the repurchase date (subject to the right of the Holders of record on the relevant Record
        Date to receive interest due on the related Payment Date), as provided in, and subject to the terms of, the Indenture.

       

      

      
        A-9

        
          

      

      
        
          	9.	
                  Repurchase of Securities at the Option of the Holders upon Change of Control

                

        

      

       

      Upon the occurrence of a Change of Control, each Holder shall have the right, subject to certain conditions specified in the Indenture, to cause the Issuer to repurchase all or any part of such Holder’s Securities at a
        repurchase price in cash equal to 101% of the principal amount thereof, plus accrued and unpaid interest, if any, to the repurchase date (subject to the right of the Holders of record on the relevant Record Date to receive interest due on the
        related Payment Date), as provided in, and subject to the terms of, the Indenture.

       

      
        
          	10.	
                  Security

                

        

      

       

      The Securities will be secured by the Notes Collateral on the terms and subject to the conditions set forth in the Indenture and the Security Documents. The Collateral Agent holds the Notes Collateral in trust for the
        benefit of the Trustee and the Holders, in each case pursuant to the Security Documents and the Intercreditor Agreements. Each Holder, by accepting this Security, consents and agrees to the terms of the Security Documents (including the provisions
        providing for the foreclosure and release of Notes Collateral) and the Intercreditor Agreements as the same may be in effect or may be amended from time to time in accordance with their terms and the Indenture and authorizes and directs each of the
        Trustee and the Collateral Agent to enter into the Security Documents and the Intercreditor Agreements, and to perform its obligations and exercise its rights thereunder in accordance therewith.

       

      
        
          	11.	
                  Denominations; Transfer; Exchange

                

        

      

       

      The Securities are in registered form, without coupons, in denominations of $250,000 and any integral multiple of $1,000 in excess thereof. The registration of transfer of or exchange of Securities shall be done in
        accordance with the Indenture. Upon any registration of transfer or exchange, the Registrar and the Trustee may require a Holder, among other things, to furnish appropriate endorsements and transfer documents and to pay any taxes required by law or
        permitted by the Indenture. The Registrar need not register the transfer of or exchange any Securities selected for redemption (except, in the case of a Security to be redeemed in part, the portion of the Security not to be redeemed) or to transfer
        or exchange any Securities for a period of 15 days prior to a selection of Securities to be redeemed.

       

      
        
          	12.	
                  Persons Deemed Owners

                

        

      

       

      Subject to Section 2.14 of the Indenture, the registered Holder of this Security shall be treated as the owner of it for all purposes.

       

      
        
          	13.	
                  Unclaimed Money

                

        

      

       

      If money for the payment of principal or interest remains unclaimed for two years, the Trustee and a Paying Agent shall pay the money back to the Issuer at its written request unless an abandoned property law
        designates another Person. After any such payment, the Holders entitled to the money must look to the Issuer for payment as general creditors and the Trustee and Paying Agent shall have no further liability with respect to such monies.

       

      

      
        A-10

        
          

      

      
        
          	14.	
                  Discharge and Defeasance

                

        

      

       

      Subject to certain conditions set forth in the Indenture, the Issuer at any time may terminate some of or all its obligations under the Securities and the Indenture if the Issuer deposits with the Trustee money or U.S.
        Government Obligations for the payment of principal and interest on the Securities to redemption or maturity, as the case may be.

       

      
        
          	15.	
                  Amendment; Waiver

                

        

      

       

      Subject to certain exceptions set forth in the Indenture, the Indenture, the Securities, any Security Document or any Intercreditor Agreement may be amended with the written consent of the Holders of a majority in
        principal amount of the Securities then outstanding (voting as a single class). Subject to certain exceptions set forth in the Indenture, without the consent of any Holder, the Issuer, the Collateral Agent, the Guarantors and the Trustee may amend
        the Indenture, the Securities, any Security Document or any Intercreditor Agreement (i) to cure any ambiguity, omission, mistake, defect or inconsistency; (ii) to provide for the assumption by a Successor Company of the obligations of the Issuer
        under the Indenture and the Securities in accordance with the terms of the Indenture; (iii) to provide for the assumption by a Successor Guarantor of the obligations of a Guarantor under the Indenture and its Guarantee; (iv) to provide for
        uncertificated Securities in addition to or in place of certificated Securities; provided, however, that the uncertificated Securities are issued in registered form
        for purposes of Sections 871(h)(2)(B) and 881(c)(2)(B) of the Code and United States Treasury Regulation Section 5f.103-1(c); (v) to add additional Guarantees or co-obligors with respect to the Securities in accordance with the terms of the
        Indenture; (vi) to add to the covenants of the Issuer for the benefit of the Holders or to surrender any right or power conferred in the Indenture upon the Issuer in accordance with the terms of the Indenture; (vii) to comply with any requirement
        of the SEC in connection with qualifying or maintaining the qualification of the Indenture under the TIA (to the extent any such qualification is required); (viii) to make any change that does not adversely affect the rights of any Holder; (ix) to
        add additional assets as Notes Collateral to secure the Securities; (x) to provide for or confirm the issuance of Second Additional Securities; (xi) to release a Guarantor in accordance with the provisions of the Indenture, the Security Documents
        and the Intercreditor Agreement or to release Notes Collateral from the Lien pursuant to the Indenture, the Security Documents and the Intercreditor Agreements when permitted or required by the Indenture, the Security Documents or the Intercreditor
        Agreements; or (xii) to modify the Security Documents or the Intercreditor Agreements (a) to secure additional extensions of credit and add additional secured creditors holding First Priority Lien Obligations so long as the Incurrence of such First
        Priority Lien Obligations and related Liens are not prohibited by the provisions of the Indenture, (b) as provided for in provisions comparable to Section 2.11(b) of the form of Intercreditor Agreement attached as Exhibit D to the Indenture, (c) to
        add the Issuer or any Guarantor as a party to any Intercreditor Agreement to the extent such party Incurs any Secured Indebtedness that constitutes First Priority Lien Obligations in accordance with the terms of the Indenture or to remove the
        Issuer or any Guarantor as a party to any Intercreditor Agreement to the extent such party ceases to be bound by any and all First Priority Lien Obligations or (d) to accommodate and implement the Liens permitted by clause (19)(z) of the definition
        of “Permitted Liens”.

       

      

      
        A-11

        
          

      

      
        
          	16.	
                  Defaults and Remedies

                

        

      

       

      If an Event of Default (other than an Event of Default relating to certain events of bankruptcy, insolvency or reorganization) occurs and is continuing, the Trustee or the Holders of at least 25% in principal amount of
        outstanding Securities by notice to the Issuer may, and if such notice is given by the Holders such notice shall be given to the Issuer and the Trustee, declare that the principal of, and the premium, if any, and accrued but unpaid interest on, all
        the Securities is due and payable. Upon such a declaration, such principal and interest shall be due and payable immediately. If an Event of Default relating to certain events of bankruptcy, insolvency or reorganization occurs, the principal of,
        and the premium, if any, and accrued but unpaid interest on, all the Securities shall ipso facto become and be immediately due and payable, without any declaration or other act on the part of the Trustee or
        any Holders. Under certain circumstances, the Holders of a majority in principal amount of the Securities may rescind any such acceleration with respect to the Securities and its consequences.

       

      Except to enforce the right to receive payment of principal, premium (if any) or interest when due, no Holder may pursue any remedy with respect to the Indenture or the Securities unless (i) such Holder gives the
        Trustee written notice stating that an Event of Default is continuing, (ii) the Holders of at least 25% in principal amount of the then outstanding Securities make a written request to the Trustee to pursue the remedy, (iii) such Holder or Holders
        offer to the Trustee security or indemnity satisfactory to it against any loss, liability or expense, (iv) the Trustee does not comply with such request within 60 days after the receipt of the request and the offer of security or indemnity and (v)
        the Holders of a majority in principal amount of the then outstanding Securities do not give the Trustee a direction inconsistent with such request during such 60-day period. Subject to certain restrictions set forth in the Indenture, the Holders
        of a majority in principal amount of the Securities may direct the time, method and place of conducting any proceeding for any remedy available to the Trustee or of exercising any trust or power conferred on the Trustee. The Trustee, however, may
        refuse to follow any direction that conflicts with law or the Indenture or, subject to the Indenture, that the Trustee determines is unduly prejudicial to the rights of any other Holder or that would involve the Trustee in personal liability. Prior
        to taking any action under the Indenture, the Trustee shall be entitled to indemnification satisfactory to it in its sole discretion against all losses and expenses caused by taking or not taking such action.

       

      
        
          	17.	
                  Trustee Dealings with the Issuer

                

        

      

       

      Subject to certain limitations imposed by the Indenture, the Trustee under the Indenture, in its individual or any other capacity, may become the owner or pledgee of Securities and may otherwise deal with the Issuer or
        its Affiliates with the same rights it would have if it were not Trustee.

       

      

      
        A-12

        
          

      

      
        
          	18.	
                  No Recourse Against Others

                

        

      

       

      No director, officer, employee, manager, incorporator or holder of any Equity Interests in the Issuer or in any Guarantor, as such, shall have any liability for any obligations of the Issuer or the Guarantors under the
        Securities or the Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder of Securities by accepting a Security waives and releases all such liability.

       

      
        
          	19.	
                  Authentication

                

        

      

       

      This Security shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the certificate of authentication on this Security.

       

      
        
          	20.	
                  Abbreviations

                

        

      

       

      Customary abbreviations may be used in the name of a Holder or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants by the entireties), JT TEN (=joint tenants with rights of survivorship and not as
        tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act).

       

      
        
          	21.	
                  Governing Law

                

        

      

       

      THIS SECURITY SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAW (OTHER THAN SECTIONS 5-1401 AND 5-1402 OF THE
        NEW YORK GENERAL OBLIGATIONS LAW).

       

      
        
          	22.	
                  CUSIP Numbers; ISINs

                

        

      

       

      The Issuer has caused CUSIP numbers and ISINs to be printed on the Securities and has directed the Trustee to use CUSIP numbers and ISINs in notices (including notices of redemption) as a convenience to the Holders. No
        representation is made as to the correctness of such numbers either as printed on the Securities or as contained in any notice and reliance may be placed only on the other identification numbers placed thereon.

       

      The Issuer will furnish to any Holder of Securities upon written request and without charge to the Holder a copy of the Indenture, which has in it the text of this Security.

       

      

      
        A-13

        
          

      

      ASSIGNMENT FORM

       

      To assign this Security, fill in the form below:

       

      I or we assign and transfer this Security to:

       

      

      
        	
                 

              

      

      (Print or type assignee’s name, address and zip code)

      
        
           

          

          	
                   

                

           

        

      

      (Insert assignee’s soc. sec. or tax I.D. No.)

       

      and irrevocably appoint ________________ agent to transfer this Security on the books of the Issuer. The agent may substitute another to act for him or her.

       

      

      
        	
                
                  Date:

                  

                

              	
                 

              	
                 

              	
                Your Signature:

              	 	
                 

              

      

      

      

      Sign exactly as your name appears on this Security.

       

      
        	
                
                  Signature Guarantee:

                

              	 	 

      

      

      

      	
              Date:

            	 	 	
              

              

            
	
              Signature must be guaranteed by a participant in a recognized signature guaranty medallion program or other signature guarantor program reasonably acceptable to the Trustee

            	 	
              Signature of Signature Guarantee

            

       

      

      
        A-14

        
          

      

      CERTIFICATE TO BE DELIVERED UPON EXCHANGE OR

        REGISTRATION OF TRANSFER OF RESTRICTED SECURITIES

       

      This certificate relates to $_________ principal amount of Securities held in (check applicable space) ____ book-entry or _____ definitive form by the undersigned.

       

      The undersigned (check one box below):

       

      
        
          
            	
                    ☐

                  	
                    has requested the Trustee by written order to deliver in exchange for its beneficial interest in the Global Security held by the Depository a Security or Securities in definitive, registered form of authorized denominations and an
                      aggregate principal amount equal to its beneficial interest in such Global Security (or the portion thereof indicated above);

                  

          

          

          

          
            
              	
                      ☐

                    	
                      
                        has requested the Trustee by written order to exchange or register the transfer of a Security or Securities.

                      

                    

            

          

          

          

        

      

      In connection with any transfer of any of the Securities evidenced by this certificate occurring prior to the expiration of the period referred to in Rule 144(d)(1) under the Securities Act, the undersigned confirms that such Securities are
        being transferred in accordance with its terms:

       

      CHECK ONE BOX BELOW

       

      	
              (1)

            	
              ☐

            	
              to the Issuer or a Subsidiary thereof; or

            
	 	 	 
	
              (2)

            	
              ☐

            	
              to the Registrar for registration in the name of the Holder, without transfer; or

            
	 	 	 
	
              (3)

            	
              ☐

            	
              pursuant to an effective registration statement under the Securities Act of 1933; or

            
	 	 	 
	
              (4)

            	
              ☐

            	
              inside the United States to a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act of 1933) that purchases for its own account or for the account of a qualified institutional buyer to whom notice is given
                that such transfer is being made in reliance on such Rule 144A, in each case pursuant to and in compliance with Rule 144A under the Securities Act of 1933; or

            
	 	 	 
	
              (5)

            	
              ☐

            	
              outside the United States in an offshore transaction within the meaning of Regulation S under the Securities Act in compliance with Rule 904 under the Securities Act of 1933 and such Security shall be held immediately after the transfer
                through Euroclear or Clearstream until the expiration of the Restricted Period; or

            
	 	 	 
	
              (6)

            	
              ☐

            	
              to an “accredited investor” (as defined in Rule 501(a)(1), (2), (3) or (7) under the Securities Act of 1933) that has furnished to the Trustee a signed letter containing certain representations and agreements and, if applicable, an
                Opinion of Counsel; or

            
	 	 	 
	
              (7)

            	
              ☐

            	
              pursuant to another available exemption from registration provided by Rule 144 under the Securities Act of 1933.

            

       

      

      
        A-15

        
          

      

      Unless one of the boxes is checked, the Trustee will refuse to register any of the Securities evidenced by this certificate in the name of any Person other than the registered Holder thereof; provided, however, that if box (5), (6) or (7) is checked, the Issuer or the Trustee may require, prior to registering any such transfer of the Securities, such legal
        opinions, certifications and other information as the Issuer or the Trustee have reasonably requested to confirm that such transfer is being made pursuant to an exemption from, or in a transaction not subject to, the registration requirements of
        the Securities Act of 1933.

      

        	
                
                  Date:

                  

                

              	
                 

              	
                 

              	
                Your Signature:

              	 	
                 

              

      

       

      

      
        
          	
                  
                    Signature Guarantee:

                  

                	 	 

           

          

        

      

      
        	
                Date:

              	 	 	
                

                

              
	
                
                  Signature must be guaranteed by a participant in a recognized signature guaranty medallion program or other signature guarantor program reasonably acceptable to the Trustee

                

              	 	
                
                  Signature of Signature Guarantee

                

              

      

       

      

      
        A-16

        
          

      

      TO BE COMPLETED BY PURCHASER IF (4) ABOVE IS CHECKED.

       

      The undersigned represents and warrants that it is purchasing this Security for its own account or an account with respect to which it exercises sole investment discretion and that it and any such account is a
        “qualified institutional buyer” within the meaning of Rule 144A under the Securities Act of 1933, and is aware that the sale to it is being made in reliance on such Rule 144A and acknowledges that it has received such information regarding the
        Issuer as the undersigned has requested pursuant to such Rule 144A or has determined not to request such information and that it is aware that the transferor is relying upon the undersigned’s foregoing representations in order to claim the
        exemption from registration provided by such Rule 144A.

       

      
        	
                Dated:

              	
                 

              	 	
                

                

              	
                

                

              
	 	 	 	
                NOTICE: 

              	
                To be executed by an executive officer

              

         

        

      

      
        A-17

        
          

      

      {TO BE ATTACHED TO GLOBAL SECURITIES}

       

      SCHEDULE OF INCREASES OR DECREASES IN GLOBAL SECURITY

       

      The initial principal amount of this Global Security is $______________. The following increases or decreases in this Global Security have been made:

       

      	
              
                Date

              

            	 	
              
                Amount of decrease in Principal Amount of this Global Security

              

            	 	
              
                Amount of increase in Principal Amount of this Global Security

              

            	 	
              
                Principal amount of this Global Security following such decrease or increase

              

            	 	
              
                Signature of authorized signatory of Trustee or Securities Custodian

              

            
	 	 	 	 	 	 	 	 	 

      

      

       

      
        A-18

        
          

      

      OPTION OF HOLDER TO ELECT PURCHASE

       

      If you want to elect to have this Security repurchased by the Issuer pursuant to Section 4.06 (Asset Sales) or Section 4.08 (Change of Control) of the Indenture, check the
        appropriate box:

       

      
        	
                Apomorphine Asset Sale Offer

                

              	
                ☐

              	
                 Change of Control Offer

              	
                ☐

              

      

      

      

      If you want to elect to have only part of this Security repurchased by the Issuer pursuant to Section 4.06 (Asset Sales) or Section 4.08 (Change of Control) of the Indenture,
        state the amount ($1,000 or any integral multiple of $1,000 in excess thereof): $____________________

       

      
        	
                
                  Date:

                  

                

              	
                 

              	
                 

              	
                Your Signature:

              	 	
                 

              
	
                

                

              	
                
                  
                    
                      
                        
                          
                            
                              
                                
                                  
                                    
                                      
                                        
                                          
                                            
                                              
                                                
                                                  
                                                     (Sign exactly as your name 

                                                    appears on this Security)

                                                  

                                                

                                              

                                            

                                          

                                        

                                      

                                    

                                  

                                

                              

                            

                          

                        

                      

                    

                  

                

              

      

       

      

      
        	
                
                  Signature Guarantee:

                

              	 	 

         

        

      

      Signature must be guaranteed by a participant in a recognized signature guaranty medallion program or other signature guarantor program reasonably acceptable to the Trustee

       

      

       

      

       A-19Exhibit 4.2

    

     

    

    
      THIS COMMON STOCK PURCHASE WARRANT AND THE SHARES THAT MAY BE PURCHASED HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
        AMENDED, OR UNDER APPLICABLE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. THIS COMMON STOCK PURCHASE WARRANT AND THE SHARES THAT MAY BE PURCHASED HEREUNDER MAY NOT BE SOLD OR OFFERED FOR SALE IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION
        STATEMENT UNDER THE SECURITIES ACT OF 1933 AND REGISTRATION OR QUALIFICATION UNDER ANY OTHER SECURITIES LAWS OF ANY APPLICABLE STATE OR OTHER JURISDICTION OR (B) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT OR SUCH LAWS.

       

      AQUESTIVE THERAPEUTICS, INC.

       

      COMMON STOCK PURCHASE WARRANT

       

      WHEREAS, capitalized terms used herein shall have the meanings ascribed to such terms in Section 9 hereof;

       

      WHEREAS, the Company and the Holder have entered into that certain Purchase Agreement (as amended, modified or supplemented, the “Purchase Agreement”)
        pursuant to which the Company will issue to the Holder the Company’s 12.5% Senior Secured Notes due 2025 (the “Senior Notes”);

       

      WHEREAS, in connection with the issuance of the Senior Notes to the Holder, the Company also wishes to issue this Warrant to the Holder; and

       

      WHEREAS, the Company and the Holder desire to set forth herein the rights and obligations of the Company and the Holder both prior to and following the
        exercise of this Warrant;

       

      NOW THEREFORE, in consideration of the mutual covenants and agreements contained herein and other good and valuable consideration, the receipt and
        sufficiency of which are hereby acknowledged, the Company hereby issues this Warrant to the Holder, and the Company and the Holder hereby agree as follows:

       

      
        	
                Issue Date: July 15, 2019

              	
                Certificate No. [●]

              

      

       

      

      THIS IS TO CERTIFY that [●] and its permitted transferees, successors and assigns (the “Holder”) is the holder of this Warrant (this “Warrant”)
        entitling the Holder to purchase from Aquestive Therapeutics, Inc., a Delaware corporation (the “Company”), at the price of $4.25 per share (the “Exercise Price”), at any time after the date hereof (the “Issue Date”) and
        expiring on June 30, 2025 (the “Expiration Date”), up to [●] shares of the fully paid and non-assessable common stock, par value $0.001 per share, of the Company. The maximum number of shares of Common Stock that may be purchased pursuant to
        this Warrant is referred to herein as the “Aggregate Number”. The Aggregate Number and Exercise Price set forth above shall also be adjusted under certain conditions specified in Section 5 hereof.

       

      
        
          

      

      
      SECTION 1.       This Warrant; Transfer and Exchange.

       

      (a)          This Warrant. This Warrant and the rights and privileges of the Holder under this Warrant may be exercised by the Holder in whole or in part as provided herein, shall survive
        any termination of the Purchase Agreement and, as more fully set forth in Section 1(b) hereof and Section 6 hereof, may, subject to the terms of this Warrant, be transferred by the Holder to any other Person or Persons who meet the
        requirements set forth herein at any time or from time to time, in whole or in part, regardless of whether the Holder retains any or all rights under the Purchase Agreement.

       

      (b)          Transfer and Exchanges. The Company shall initially record this Warrant on a register to be maintained by the Company and, subject to Section 6 hereof, from time to time
        thereafter shall reflect the transfer of this Warrant on such register when surrendered for transfer in accordance with the terms of this Warrant and properly endorsed, accompanied by appropriate instructions, and further accompanied by payment in
        cash or by check, bank draft or money order payable to the order of the Company, in United States currency, of an amount equal to any stamp or other tax or governmental charge or fee required to be paid by the Company in connection with the
        transfer of this Warrant. Upon any such transfer, a new warrant or warrants shall be issued to the transferee (and to the Holder for the balance of the Aggregate Number in the event this Warrant is only partially transferred), and the surrendered
        warrant shall be cancelled. This Warrant may be exchanged at the option of the Holder, when surrendered at the Principal Office, for another warrant or other warrants of like tenor and representing in the aggregate the right to purchase a like
        number of shares of Common Stock.  Any attempt to transfer this Warrant in violation of the provisions of this Section 1(b) shall be null and void and the Company shall not register or effect any such transfer.

       

      SECTION 2.       Exercise.

       

      (a)         Right to Exercise. At any time after the Issue Date and on or before the Expiration Date, the Holder, in accordance with the terms hereof, may exercise this Warrant, in whole at
        any time or in part from time to time, by delivering this Warrant to the Company during normal business hours on any Business Day at the Principal Office, together with the notice of exercise in the form attached hereto as Exhibit A and
        made a part hereof (the “Notice of Exercise”), duly executed, and payment of the Exercise Price per share for each share purchased, as specified in the Notice of Exercise. The aggregate amount (the “Aggregate Exercise Price”) to be
        paid for the shares to be purchased (the “Exercise Amount”) shall equal the product of (i) the Exercise Amount multiplied by (ii) the Exercise Price. If the Expiration Date is not a Business Day, then this Warrant may be exercised on the
        next succeeding Business Day.

       

      (b)         Payment of the Aggregate Exercise Price. Payment of the Aggregate Exercise Price shall be made to the Company in cash or other immediately available funds or as provided in Section
          2(c) hereof or a combination thereof. In the case of payment of all or a portion of the Aggregate Exercise Price pursuant to Section 2(c) hereof, the direction by the Holder to make a “Cashless Exercise” shall serve as accompanying
        payment for that portion of the Aggregate Exercise Price.

       

      
        2

        
          

      

      (c)          Cashless Exercise. If the Company shall receive written notice from the Holder at the time of exercise of this Warrant that the Holder elects to make a “Cashless Exercise” of
        this Warrant, the Company shall deliver to the Holder (without payment by the Holder of any Exercise Price in cash) that number of Warrant Shares computed using the following formula:

       

       

      where

       

      
        
          	

                	X =	
                  the number of Warrant Shares to be issued to the Holder;

                

        

      

       

      
        
          	

                	Y =	
                  the number of Warrant Shares purchasable under this Warrant (at the date of such calculation) or, if only a portion of this Warrant is being exercised, the number of Warrant Shares purchasable under the portion of this Warrant being
                    exercised (at the date of such calculation);

                

        

      

       

      
        
          	

                	A =	
                  the Fair Market Value Per Share; and

                

        

      

       

      
        
          	

                	B =	
                  the Exercise Price (as adjusted to the date of such calculation).

                

        

      

       

      (d)          Issuance of Shares of Common Stock. Upon receipt by the Company of this Warrant at the Principal Office in proper form for
        exercise, and accompanied by the Notice of Exercise and payment of the Aggregate Exercise Price as aforesaid, the Holder shall be deemed to be the holder of record of the shares of Common Stock issuable upon
        such exercise, notwithstanding that certificates representing such shares of Common Stock may not then be actually delivered. Within 10 Business Days after such surrender of this Warrant, delivery of the
        Notice of Exercise and payment of the Aggregate Exercise Price as aforesaid, the Company shall cause its transfer agent to issue the Warrant Shares so purchased to the Holder in book-entry form. Any reference in this Warrant to the issuance of a
        certificate or certificates representing the Warrant Shares shall also be deemed a reference to the book-entry issuance of such Warrant Shares.

       

      (e)          Fractional Shares. The Company may, but shall not be required to, deliver fractions of shares of Common Stock upon exercise of this Warrant. If any fraction of a share of Common
        Stock would be deliverable upon an exercise of this Warrant, the Company may, in lieu of delivering such fraction of a share of Common Stock, make a cash payment to the Holder in an amount equal to the same fraction of the Fair Market Value Per
        Share.

       

      (f)          Partial Exercise. In the event of a partial exercise of this Warrant, the Company shall issue to the Holder a Warrant in like form for the unexercised portion thereof that has
        not expired.

       

      (g)          Deemed Automatic Exercise. If, on the Expiration Date, this Warrant remains unexercised (in whole or in part) and the Fair Market Value Per Share is greater than the Exercise
        Price, then this Warrant shall (automatically and without any action on the part of the Holder) be deemed exercised in full in a “Cashless Exercise” in accordance with Section 2(a) hereof, Section 2(b) hereof and Section 2(c)
        hereof.

       

      
        3

        
          

      

      SECTION 3.      Payment of Taxes. The Company shall pay all stamp taxes attributable to the initial issuance
        of shares or other securities issuable upon the exercise of this Warrant or pursuant to Section 5 hereof, excluding any tax or taxes that may be payable because of a transfer involved in the issuance or delivery of any certificates for
        shares or other securities issued or delivered upon exercise of this Warrant in a name other than that of the Holder. The Company shall not be required to issue or deliver Warrant Shares to any Person or Persons other than the Holder unless and
        until the Person or Persons requesting the issuance thereof shall have paid to the Company the amount of any such tax or shall have established to the satisfaction of the Company that any such tax has been paid.

       

      SECTION 4.       Replacement Warrant. Upon receipt by the Company of evidence reasonably satisfactory to the
        Company of the loss, theft, destruction or mutilation of this Warrant, and, in the case of loss, theft or destruction, of an affidavit of loss and indemnity undertaking by the Holder to the Company in customary form, and, in the case of mutilation,
        upon surrender and cancellation of this Warrant, the Company shall issue and deliver in exchange and substitution for and upon cancellation of the mutilated Warrant, or in lieu of and in substitution for the Warrant lost, stolen or destroyed, a new
        Warrant of like tenor and representing an equivalent right or interest.

       

      SECTION 5.       Adjustments to the Aggregate Number and the Exercise Price.

       

      (a)          The Exercise Price shall be subject to adjustment from time to time as provided in this Section 5 (without duplication, but in each case after taking into consideration any
        prior adjustments pursuant to this Section 5) upon the occurrence of any of the following events:

       

      (i)          The issuance of Common Stock as a dividend or distribution to all holders of Common Stock, or a subdivision, combination, split, reverse split or reclassification of
        the outstanding Common Stock into a greater or smaller number of shares of Common Stock, in which event the Exercise Price shall be adjusted based on the following formula:

       

        
          	
                  E1 = E0  x

                	 	
                  N0

                	 
	 	
                  N1

                	 

        

         

        where:

        

        

        
          
            	

                  	E1 =	
                    the Exercise Price in effect immediately after (i) in the case of a dividend or distribution, the start of business on the first date on which the Common Stock can be traded without the right to receive such dividend or
                      distribution (the “Ex-Date”), or (ii) the consummation of the transaction in the case of a subdivision, combination, split, reverse split or reclassification;

                  

          

        

        

        

        
          
            	

                  	E0 =	
                    the Exercise Price in effect immediately prior to (i) the start of business on the Ex-Date in the case of a dividend or distribution or (ii) the consummation of the transaction in the case of a subdivision, combination, split,
                      reverse split or reclassification;

                  

          

        

        

        

        
          
            	

                  	N0 =	
                    the number of outstanding shares of Common Stock (including any shares issuable on exercise or conversion of outstanding options, warrants and convertible securities, but excluding any shares held by the Company or any of its
                      subsidiaries) (together, “Common Stock Deemed Outstanding”) immediately prior to (i) the start of business on the record date in the case of a dividend or distribution or (ii) the consummation of the transaction in the case of
                      a subdivision, combination, split, reverse split or reclassification; and

                  

             

            

          

        

        
          4

          
            

        

        
          
            	

                  	N1 =	
                    the number of shares of Common Stock equal to (i) in the case of a dividend or distribution, the sum of the Common Stock Deemed Outstanding immediately prior to the start of business on the record date for such dividend or
                      distribution plus the total number of shares of Common Stock issued pursuant to such dividend or distribution, or (ii) in the case of a subdivision, combination, split, reverse split or reclassification, the shares of Common Stock
                      Deemed Outstanding immediately after such subdivision, combination, split, reverse split or reclassification.

                  

          

        

         

        Such adjustment shall become effective immediately after (i) the start of business on the Ex-Date in the case of a dividend or distribution or (ii) the consummation of the transaction in the case
          of a subdivision, combination, split, reverse split or reclassification. If any dividend or distribution or subdivision, combination, split, reverse split or reclassification of the type described in this Section 5(a) is declared or
          announced but not so paid or made, the Exercise Prices shall again be adjusted to the applicable Exercise Prices that would then be in effect if such dividend or distribution or subdivision, combination, split, reverse split or reclassification
          had not been declared or announced, as the case may be.

        

        

        (ii)          The issuance as a dividend or distribution to all holders of Common Stock of evidences of indebtedness, securities (including convertible securities) of the
          Company or any other Person (other than Common Stock), cash or other property (excluding any dividend or distribution covered by clause (i) above), in which event the Exercise Price will be adjusted based on the following formula:

         

          	
                  E1 = E0  x

                	 	
                  P-FMV

                	 
	 	
                  P

                	 

        

         

        

        where:

        

        

        
          
            	

                  	E1 =	
                    the Exercise Price in effect immediately after the start of business on the Ex-Date for such dividend or distribution;

                  

          

        

        

        

        
          
            	

                  	E0 =	
                    the Exercise Price in effect immediately prior to the start of business on the Ex-Date for such dividend or distribution;

                  

          

        

        

        

        
          
            	

                  	P =	
                    the Fair Market Value Per Share as of immediately prior to the start of business on the second Business Day preceding the Ex-Date for such dividend or distribution;

                  

          

        

        

        

        
          
            	

                  	FMV =	
                    the Fair Value of the portion of such dividend or distribution applicable to one share of Common Stock as of the start of business on the date of such dividend or distribution.

                  

          

        

         

        Such decrease shall become effective immediately after the start of business on the Ex-Date for such dividend or distribution. In the event that such dividend or distribution is declared or
          announced but not so paid or made, the Exercise Price shall again be adjusted to be the Exercise Price which would then be in effect if such dividend or distribution had not been declared or announced.

        

        

        (iii)         The payment in respect of any tender offer or exchange offer by the Company for shares of Common Stock, where the cash and Fair Value of any other consideration
          included in the payment per share of Common Stock exceeds the Fair Market Value Per Share as of the start of business on the second Business Day preceding the expiration date of the tender or exchange offer (the “Offer Expiration Date”),
          in which event the Exercise Price will be adjusted based on the following formula:

         

        
          5

          
            

        

        
          	
                  E1 = E0  x

                	 	
                  (N0 x P) - A

                	 
	 	
                  (P x N1)

                	 

        

        

        

        where:

        

        

        
          
            	

                  	E1 =	
                    the Exercise Price in effect immediately after the start of business on the Offer Expiration Date;

                  

          

        

        

        

        
          
            	

                  	E0 =	
                    the Exercise Price in effect immediately prior to the start of business on the Offer Expiration Date;

                  

          

        

        

        

        
          
            	

                  	N0 =	
                    the number of shares of Common Stock Deemed Outstanding immediately prior to the expiration of the tender or exchange offer (prior to giving effect to the purchase or exchange of Common Stock);

                  

          

        

        

        

        
          
            	

                  	N1 =	
                    the number of shares of Common Stock Deemed Outstanding immediately after the expiration of the tender or exchange offer (prior to giving effect to the purchase or exchange of Common Stock);

                  

          

        

        

        

        
          
            	

                  	A=	
                    the aggregate cash and Fair Value of any other consideration payable for the shares of Common Stock purchased in such tender offer or exchange offer; and

                  

          

        

        

        

        
          
            	

                  	P =	
                    the Fair Market Value Per Share as of the start of business on the second Business Day preceding the Offer Expiration Date.

                  

          

        

         

        An adjustment, if any, to the Exercise Price pursuant to this clause (iii) shall become effective immediately after the close of business on the Offer Expiration Date. In the event that the
          Company or a subsidiary of the Company is obligated to purchase shares of Common Stock pursuant to any such tender offer or exchange offer, but the Company or such subsidiary is permanently prevented by applicable law from effecting any such
          purchases, or all such purchases are rescinded, then the Exercise Price shall again be adjusted to be the Exercise Price which would then be in effect if such tender offer or exchange offer had not been made. Except as set forth in the preceding
          sentence, if the application of this clause (iii) to any tender offer or exchange offer would result in an increase in the Exercise Price, no adjustment shall be made for such tender offer or exchange offer under this clause (iii).

        

        

        (iv)         If any single action would require adjustment of the Exercise Price pursuant to more than one subsection of this Section 5(a), only one adjustment shall be
          made and such adjustment shall be the amount of adjustment that has the highest absolute value relative to the rights and interests of the Holder.

         

        (v)          Notwithstanding this Section 5(a) or any other provision of this Warrant, if an Exercise Price adjustment becomes effective on any Ex-Date, and a Warrant
          has been exercised on or after such Ex-Date and on or prior to the related record date resulting in the Person issued Common Stock being treated as the record holder of such Common Stock on or prior to the record date, then, notwithstanding the
          Exercise Price adjustment provisions in this Section 5(a), the Exercise Price adjustment relating to such Ex-Date will not be made. Instead, such Person will be treated as if it were the record owner of such Common Stock on an un-adjusted
          basis and participate in the related dividend, distribution or other event giving rise to such adjustment.

         

        
          6

          
            

        

        (b)          Adjustments to Aggregate Number. Concurrently with any adjustment to the Exercise Price under Section 5(a), the Aggregate Number will be adjusted such that the
          Aggregate Number in effect immediately following the effectiveness of such adjustment will be equal to the Aggregate Number in effect immediately prior to such adjustment, multiplied by a fraction, (i) the numerator of which is the Exercise Price
          in effect immediately prior to such adjustment and (ii) the denominator of which is the Exercise Price in effect immediately following such adjustment.

         

        (c)          Certain Distributions of Rights and Warrants.

         

        (i)          Rights or warrants distributed by the Company to all holders of Common Stock entitling the holders thereof to subscribe for or purchase the Company’s securities
          (either initially or under certain circumstances), which rights or warrants, until the occurrence of a specified event or events (a “Trigger Event”):

         

        (1)          are deemed to be transferred with such Common Stock;

         

        (2)          are not exercisable; and

         

        (3)          are also issued in respect of future issuances of Common Stock,

        

        

        shall be deemed not to have been distributed for purposes of this Section 5 (and no adjustment to the Exercise Price or the Aggregate Number under this Section 5 will be made)
          until the occurrence of the earliest Trigger Event, whereupon such rights and warrants shall be deemed to have been distributed and an appropriate adjustment (if any is required) to the Exercise Price and the Aggregate Number shall be made under
          this Section 5 (subject in all respects to Section 5(d) below).

        

        

        (ii)          If any such right or warrant is subject to events, upon the occurrence of which such rights or warrants become exercisable to purchase different securities,
          evidences of indebtedness or other assets, then the date of the occurrence of any and each such event shall be deemed to be the date of distribution and record date with respect to new rights or warrants with such rights (subject in all respects
          to Section 5(d) below).

         

        (iii)        In addition, except as set forth in Section 5(d), in the event of any distribution (or deemed distribution) of rights or warrants, or any Trigger Event or
          other event (of the type described in clause (ii) above) with respect thereto that was counted for purposes of calculating a distribution amount for which an adjustment to the Exercise Price and the Aggregate Number under this Section 5
          was made (including any adjustment contemplated in Section 5(d)):

         

        
          7

          
            

        

        (1)          in the case of any such rights or warrants that shall all have been redeemed or repurchased without exercise by the holders thereof, the Exercise Price and the Aggregate Number shall
          be readjusted upon such final redemption or repurchase to give effect to such distribution or Trigger Event, as the case may be, as though it were a distribution under Section 5(a)(ii), equal to the per share redemption or repurchase
          price received by a holder or holders of Common Stock with respect to such rights or warrants (assuming such holder had retained such rights or warrants), made to all holders of Common Stock as of the date of such redemption or repurchase; and

        

        

        (2)          in the case of such rights or warrants that shall have expired or been terminated without exercise by the holders thereof, the Exercise Price and the Aggregate Number shall be
          readjusted as if such rights and warrants had not been issued or distributed.

        

        

        (d)          Stockholder Rights Plans. If the Company has a stockholder rights plan in effect with respect to the Common Stock, upon exercise of the Warrant the Holder shall be entitled to
          receive, in addition to the Common Stock, the rights associated therewith under such stockholder rights plan, unless, prior to such exercise, such rights have separated from the Common Stock.

         

        (e)          Restrictions on Adjustments.

         

        (i)           Except in accordance with Sections 5(a) and 5(b), the Exercise Price and the Aggregate Number will not be adjusted for the issuance of Common
          Stock or other securities of the Company.

         

        (ii)          For the avoidance of doubt, except as otherwise provided in Sections 5(a) and 5(b), neither the Exercise Price nor the Aggregate Number will be
          adjusted:

         

        
          
            	

                  	(1)	
                    upon the issuance of any shares of Common Stock or other securities or any payments pursuant to any equity incentive plan of the Company;

                  

          

        

         

        
          
            	

                  	(2)	
                    upon any issuance of any shares of Common Stock pursuant to the exercise of the Warrant;

                  

          

        

         

        
          
            	

                  	(3)	
                    upon the offer and sale of shares of Common Stock by the Company in a primary offering;

                  

          

        

         

        
          
            	

                  	(4)	
                    upon the issuance of shares of Common Stock or other securities of the Company in connection with a business acquisition transaction; or

                  

          

        

         

        
          
            	

                  	(5)	
                    upon the issuance of any shares of Common Stock or other securities of the Company in any financing transaction with a third party.

                  

          

        

        

        

        (iii)        No adjustment shall be made to the Exercise Price or the Aggregate Number for any of the transactions described in Section 5(a) if the Company makes
          provisions for participation in any such transaction with respect to the Holder of this Warrant without exercise of the Warrant on the same basis as with respect to the shares of Common Stock issuable hereunder with notice that the Company’s
          board of directors determines in good faith to be fair and appropriate

         

        
          8

          
            

        

        (f)          Certificate as to Adjustment. As promptly as reasonably practicable following (i) any adjustment of the Exercise Price or the Aggregate Number or (ii) the receipt by the
          Company of a written request by the Holder, but in each case in any event not later than ten Business Days thereafter, the Company shall furnish to the Holder a certificate of an executive officer certifying the Exercise Price then in effect and
          the Aggregate Number or the amount, if any, of other shares of stock or other securities or assets then issuable upon exercise of the Warrant, which certificate shall, in the case of clause (i) above, set forth in reasonable detail any adjustment
          and the facts upon which it is based.

         

        (g)          Treatment of Warrant upon a Cash Change of Control. In the event of a Change of Control in which the consideration to be received by the Company’s stockholders consists solely
          of cash (a “Cash Change of Control”), if this Warrant is outstanding immediately prior to such Cash Change of Control, then (i) if the Fair Market Value Per Share is greater than the then applicable Exercise Price, this Warrant shall be
          automatically exchanged without exercise for the same amount of cash as the Holder would have been entitled to receive upon the occurrence of such Cash Change of Control if this Warrant had been exercised in full pursuant to Section 2(c)
          hereof immediately prior to such Cash Change of Control, and (ii) if the Fair Market Value Per Share is less than or equal to the then applicable Exercise Price, this Warrant will expire immediately prior to the consummation of such Change of
          Control. If this Warrant is exchanged in accordance with clause (i) above, the Company shall pay or deliver to the Holder the cash so contemplated promptly following the consummation of the Cash Change of Control.

         

        (h)          Treatment of Warrant upon Any Other Change of Control. If, at any time while this Warrant is outstanding, the Company consummates a Change of Control that is not a Cash Change
          of Control, then:

         

        (1)          if the cash consideration (if any) per Warrant Share is greater than the then applicable Exercise Price, this Warrant shall be automatically exchanged without
          exercise for the same amount and kind of cash, securities or other property as the Holder would have been entitled to receive upon the occurrence of such Change of Control if this Warrant had been exercised in full pursuant to Section 2(c)
          hereof immediately prior to such Change of Control, it being understood that if this Warrant is exchanged in accordance with this subclause (1) above, the Company shall pay or deliver to the Holder the cash, securities or other property so
          contemplated promptly following the consummation of the Change of Control; or

         

        (2)          if the cash consideration (if any) per Warrant Share is less than or equal to the then applicable Exercise Price, the Holder shall have the right thereafter to
          receive, upon exercise of this Warrant (in whole at any time or in part from time to time), the same amount and kind of securities, cash or property as the Holder would have been entitled to receive upon the occurrence of such Change of Control
          if it had been, immediately prior to such Change of Control, a holder of the number of Warrant Shares then issuable upon such exercise of this Warrant (the “Alternate Consideration”); in such case, appropriate adjustment (in form and
          substance reasonably satisfactory to the Holder) shall be made with respect to the Holder’s rights under this Warrant to insure that the provisions of this Section 5 hereof shall thereafter be applicable, as nearly as possible, to this Warrant in
          relation to any securities, cash or property thereafter acquirable upon exercise of this Warrant (including, in the case of any Change of Control, an immediate adjustment in the Exercise Price to the value per share for the Common Stock reflected
          by the terms of such Change of Control transaction, and a corresponding immediate adjustment to the number of Warrant Shares exercisable upon exercise of this Warrant, if the value so reflected is less than the Exercise Price in effect
          immediately prior to Change of Control). If this subclause (2) shall be applicable, the Company shall not effect any such Change of Control unless, prior to or simultaneously with the consummation thereof, any successor to the Company, any
          surviving entity or the Person purchasing or otherwise acquiring such assets or other appropriate Person shall assume the obligation to deliver to the Holder such Alternate Consideration as, in accordance with the foregoing provisions, the Holder
          may be entitled to receive and the other obligations under this Warrant.

         

        
          9

          
            

        

        SECTION 6.       Transfers of this Warrant and the Warrant Shares.

            

         

        (a)          Generally. Subject to compliance with applicable U.S. federal and state securities Laws and the restrictions set forth in this Section 6, the Holder may transfer this
          Warrant and the Warrant Shares in whole or in part to any Person, and, upon the reasonable request of the Holder, the Company agrees that it shall use commercially reasonable efforts to promptly assist the Holder in making any such transfer in
          compliance with any applicable U.S. federal and state securities Laws. This Warrant has not been, and the Warrant Shares at the time of their issuance may not be, registered under the Securities Act. For a transfer of this Warrant as an entirety
          by the Holder, upon surrender of this Warrant to the Company, together with the notice of assignment in the form attached hereto as Exhibit B duly completed and executed on behalf of the Holder, the Company shall issue a new Warrant of
          the same denomination to the assignee. For a transfer of this Warrant with respect to a portion of the Warrant Shares purchasable hereunder, upon surrender of this Warrant to the Company, together with the notice of assignment in the form
          attached hereto as Exhibit B duly completed and executed on behalf of the Holder, the Company shall issue a new Warrant to the assignee, in such denomination as shall be requested by the Holder, and shall issue to the Holder a new Warrant
          covering the number of Warrant Shares in respect of which this Warrant shall not have been transferred.

         

        (b)          Representations by the Holder. The Holder, by its acceptance of this Warrant, represents and warrants to the Company as follows:

         

        (i)          this Warrant has been acquired by the Holder, and any Warrant Shares to be acquired by the Holder will be acquired, for the account of the Holder for investment
          purposes for its own account and not with a view to or for sale in connection with any distribution or reselling thereof in a transaction that would violate the Securities Act or the securities laws of any state of the United States or any other
          applicable jurisdiction;

         

        (ii)          the Holder is an “accredited investor” within the meaning of Rule 501(a) of Regulation D under the Securities Act;

         

        (iii)          the Holder is experienced in evaluating and investing in companies engaged in businesses similar to that of the Company;

         

        
          10

          
            

        

        (iv)          the Holder understands that investment in this Warrant (and any Warrant Shares that the Holder acquires) involves substantial risks;

         

        (v)          the Holder has such knowledge and experience in financial and business matters so as to be capable of evaluating the merits and risks of its investment in this
          Warrant (and any Warrant Shares that the Holder acquires) and is able to bear the economic risk of that investment; and

         

        (vi)          the Holder understands that this Warrant is, and the Warrant Shares may be, characterized as “restricted securities” under the U.S. federal securities Laws
          inasmuch as they are being (or may be) acquired from the Company in a transaction not involving a public offering and that under such Laws this Warrant and the Warrant Shares may be resold without registration under the Securities Act only in
          certain limited circumstances and, accordingly, the Holder represents that it is familiar with Rule 144, as presently in effect, and understands the resale limitations imposed thereby and by the Securities Act.

         

        (c)          Transfer Restrictions Regarding This Warrant. This Warrant (or any warrants represented hereby) may only be sold, in whole or in part, (i) pursuant to an effective
          registration statement covering the resale by the Holder of this Warrant under the Securities Act or (ii) pursuant to an exemption from registration under the Securities Act and, if reasonably required by the Company, upon delivery to the Company
          of a customary opinion of legal counsel (which may rely on customary certificates and representations), certifications or other evidence to establish that such registration is not required under the Securities Act.

         

        (d)          Transfer Restrictions Regarding Warrant Shares. If the Warrant Shares are not registered at the time of issuance, then any Warrant Shares may only be sold (i) pursuant to an
          effective registration statement under the Securities Act or (ii) pursuant to an exemption from registration under the Securities Act and upon delivery to the Company of a customary opinion of legal counsel (which may rely on customary
          certificates and representations), certifications or other evidence as may reasonably be required by the Company in order to determine that such registration is not required under the Securities Act. The Holder acknowledges that the Company may
          place a restrictive legend on any Warrant Shares issued upon exercise in order to comply with applicable securities Laws, unless such Warrant Shares are sold pursuant to an effective registration statement or are otherwise freely tradable under
          Rule 144.

         

        SECTION 7.       Covenants. Until the later of (i) the Expiration Date and (ii) the date as of which this
          Warrant has been exercised in full, the Company hereby covenants to the Holder as set forth in this Section 7.

         

        (a)        Validly Issued Shares. All shares of Common Stock that may be issued upon exercise of this Warrant, assuming full payment of the Aggregate Exercise Price, shall, upon delivery
          by the Company, be duly authorized and validly issued, fully paid and non-assessable, free from all stamp taxes, liens and charges with respect to the issue or delivery thereof and otherwise free of all other security interests, encumbrances and
          claims (other than security interests, encumbrances and claims to which the Holder is subject prior to or upon the issuance of the applicable Warrant Shares, restrictions under applicable U.S. federal and/or state securities Laws and other
          transfer restrictions described herein).

         

        
          11

          
            

        

        (b)         Reservation of Shares. The Company shall at all times reserve and keep available out of the aggregate of its authorized but unissued Common Stock or its authorized and issued
          Common Stock held in its treasury, free of preemptive rights, such number of its duly authorized shares of Common Stock as shall be sufficient to enable the Company to issue the shares of Common Stock issuable upon exercise in full of this
          Warrant.

         

        (c)          Affirmative Actions to Permit Exercise and Realization of Benefits. If any shares of Common Stock reserved or to be reserved for the purpose of the exercise of this Warrant,
          or any shares or other securities reserved or to be reserved for the purpose of issuance pursuant to Section 5 hereof, require registration with or approval of any Governmental Authority under any U.S. federal or state Law (other than
          securities Laws) before such shares or other securities may be validly delivered upon exercise of this Warrant, then the Company covenants that it will, at its sole expense, secure such registration or approval, as the case may be (including,
          without limitation, approvals or expirations of waiting periods required under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended).

         

        (d)         Integration. The Company shall not, and shall use its commercially reasonable efforts to ensure that no
            Affiliate of the Company shall, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of this Warrant in a
            manner that would require the registration under the Securities Act of the sale of this Warrant to the Holder or any assignee of the Holder.

         

        SECTION 8.       Registration Rights

         

        (a)          Registration of Warrant Shares.

         

        (i)          No later than sixty (60) days after the Issue Date, the Company shall prepare and file with the Commission one registration statement on Form S-3 (or, if the
          Company is not then eligible to use Form S-3 to register the resale of the Warrant Shares, on such form of registration statement as is then available to effect a registration therefor) (the “Registration Statement”) covering the resale of
          the Warrant Shares.  The Holder shall not be named as an “underwriter” in the Registration Statement without the Holder’s prior written consent.  Such Registration Statement also shall cover, to the extent allowable under the Securities Act and
          the rules promulgated thereunder (including Rule 416), such indeterminate number of additional shares of Common Stock resulting from stock splits, stock dividends or similar transactions with respect to the Warrant Shares.  Such Registration
          Statement shall not include any shares of Common Stock or other securities for the account of any holder other than the Holder without the prior written consent of the Holder; provided that the Registration Statement may include securities to be
          registered pursuant to (i) that certain Registration Rights Agreement, dated as of June 24, 2018, among the Company, Aquestive Partners, LLC, and the other parties named therein (as such agreement is in effect on the date hereof) (the “Bratton
            RRA”), and (ii) the shares of Common Stock issued or issuable upon exercise of the other warrants dated the date hereof, each by and between the Company and each other holder party thereto.  The Registration Statement (and each amendment or
          supplement thereto, and each request for acceleration of effectiveness thereof) shall be provided to the Holder and its counsel prior to its filing or other submission.

         

        
          12

          
            

        

        (ii)         The Company shall use reasonable best efforts to have the Registration Statement declared effective within ninety (90) days after the Issue Date.  The Company
          shall notify the Holder by facsimile or e-mail as promptly as practicable, and in any event, within twenty-four (24) hours, after the Registration Statement is declared effective, and shall simultaneously provide the Holder with a number of
          copies of any related prospectus reasonably requested to be used in connection with the sale or other disposition of the securities covered thereby.

         

        (iii)        For not more than thirty (30) consecutive days, and for not more than an aggregate of sixty (60) days in any twelve (12) month period, the Company may suspend the
          use of any prospectus included in the Registration Statement contemplated by this Section in the event that the Company determines in good faith that such suspension is necessary (A) to delay the disclosure of material non-public information
          concerning the Company, the disclosure of which at the time would be, in the good faith opinion of the Company, materially detrimental to the Company, or (B) to amend or supplement the affected Registration Statement or the related prospectus so
          that such Registration Statement or prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the case of the prospectus in
          light of the circumstances under which they were made, not misleading (an “Allowed Delay”); provided that the Company shall promptly (x) notify the Holder in writing of the commencement of and the
          reasons for an Allowed Delay, but shall not (without the prior written consent of the Holder) disclose to the Holder any material non-public information giving rise to an Allowed Delay; (y) advise the Holder in writing (including via e-mail) to
          cease all sales under the Registration Statement until the end of the Allowed Delay; and (z) use commercially reasonable best efforts to terminate an Allowed Delay as promptly as practicable.

         

        (b)         Piggyback Rights. Without limiting Section 8(a), the Company agrees that it shall notify the Holder in writing at least 10 days prior to the filing of any registration
          statement under the Securities Act for purposes of a public offering of Common Stock of the Company (including, without limitation, registration statements relating to secondary offerings of securities of the Company, but excluding any Special
          Registration Statement) that would be filed at any time during which this Warrant is still outstanding and/or the Holder continues to hold any Warrant Shares, and the Company will afford the Holder an opportunity to include in such registration
          statement all or part of the Warrant Shares subject to the provisions hereof (such registration statement, the “Piggyback Registration Statement”). If the Holder desires to include in any such Piggyback Registration Statement all or any
          part of the Warrant Shares held by it, the Holder shall, within seven days after the above-described notice from the Company, so notify the Company in writing and shall thereafter furnish the Company with such information as the Company
          reasonably requires to effect the registration of such Warrant Shares. The Company will use its commercially reasonable efforts to cause such Warrant Shares as to which inclusion shall have been so requested to be included in the Piggyback
          Registration Statement. The Holder shall be entitled to sell the Warrant Shares included in a Piggyback Registration Statement in accordance with the method of distribution requested by it; provided that,
          if the Piggyback Registration Statement relates to an underwritten offering, then (i) the Company shall be entitled to select the underwriters in its sole discretion and (ii) the Holder must sell all Warrant Shares included on the Piggyback
          Registration Statement in such underwritten offering pursuant to an underwriting agreement containing terms and conditions that are customary for secondary offerings.  The Company may withdraw a Piggyback Registration Statement prior to its being
          declared effective without incurring any liability to the Holder and shall not be required to keep a Piggyback Registration Statement effective for longer than the period contemplated by the intended manner of distribution for the securities of
          the Company to be sold by the Company as described in the prospectus included in the Piggyback Registration Statement. The piggyback registration rights provided for in this Section 8(b) shall not apply to securities which may be sold
          pursuant to Rule 144 under the Securities Act without volume or manner-of-sale restrictions and without the requirement for the Company to be in compliance with the current public information requirement under Rule 144(c)(1).

         

        
          13

          
            

        

        (c)          Underwriter Cutback.  In the event the managing underwriter shall be of the opinion that the number of such securities, when taken together with the Warrant Shares requested
          to be included in an offering pursuant to Section 8(a) or (b), alone or taken together with the equity securities of the Company to be included therein, would adversely affect the marketing of such offering (including the price at
          which the securities of the Company may be sold), then the number of securities to be included in such underwritten offering will be reduced (an “Underwriter Cutback”), with the securities to be included in such offering based on the
          following priority: (w) first, in the case of a registration under Section 8(b), the number of securities that the Company seeks to include in the offering, up to the number that, in the opinion of the managing underwriter, would not
          adversely affect the marketing of the offering (including the price at which such securities of the Company may be sold); (x) second, if such underwritten offering is a Demand Registration (as defined in the Bratton RRA), to the Demand Holders
          (as defined in the Bratton RRA) and Other Priority Holders (as defined in the Bratton RRA) as set forth in the Bratton RRA; (y) third, the number of the securities of the Company requested to be included by the Holder and any other Person(s) who
          has (have) elected to include securities pursuant to written agreements with the Company, in each case, up to the number that, in the opinion of the managing underwriter, would not adversely affect the marketing of the offering (including the
          price at which the securities (including the Warrant Shares) may be sold); and (z) fourth, the number of securities of the Company requested to be included by (1) the Company, in the case of a registration pursuant to Section 8(a) and (2)
          any other Person(s) in the offering with the permission of the Company, up to the number that, in the opinion of the managing underwriter, would not adversely affect the marketing of the offering (including the price at which the securities of
          the Company may be sold). The Underwriter Cutbacks described in the immediately preceding clause (y) shall be allocated pro rata among the participating Persons, including the Holder, on the basis of the number of securities requested to be
          included in such registration by such Persons.

         

        (d)         Expenses.  The expenses of any such registration under Section 8(a) or (b) above (other than any underwriting discounts, selling commissions and stock transfer
          taxes applicable to the sale of Warrant Shares, and the fees and disbursements of counsel for the selling security holders, other than one special counsel for the selling security holders in any offering) shall be borne by the Company. If the
          Holder decides not to include all of its Warrant Shares in any registration statement thereafter filed by the Company, the Holder shall nevertheless continue to have the right to include any Warrant Shares in any subsequent Piggyback Registration
          Statement or Piggyback Registration Statements as may be filed by the Company with respect to offerings of its securities, all upon the terms and conditions set forth herein.

         

        
          14

          
            

        

        (e)          Incorporation of Other Provisions.  To the extent not duplicative of or inconsistent with the terms hereof, the provisions of Sections 4, 6, 7 and (to the extent necessary to
          permit interpretation) 8 of the Bratton RRA shall apply to the registration rights provisions and related obligations in this Section 8, mutatis mutandis.

         

        (f)          Listing of the Warrant Shares. To the extent applicable, the Company shall promptly secure the listing of the Warrant Shares on whichever market is at the time the principal trading exchange or market for the Common Stock, based upon share volume, after such time as the Warrant Shares are no longer required to
            contain the legend referred to in Section 6 hereof, and the Company shall provide to the Holder evidence of such listing.

         

        (g)         Compliance with Rule 144. The Company shall timely file (or obtain extensions in respect thereof and file
            within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act. As long as the Holder owns any Warrant Shares, if the Company is not required to file reports pursuant to
            such laws, the Company will prepare and furnish to the Holder and make publicly available in accordance with Rule 144 such information as is required for the Holder to sell Warrant Shares under Rule 144. So long as the Warrant Shares are not
            registered under an effective registration statement, the Company further covenants that it will take such further action as the Holder may reasonably request and is within the Company’s control, all to the extent required from time to time to
            enable the Holder to sell such Warrant Shares without registration under the Securities Act within the limits of the exemptions provided by Rule 144.

         

        SECTION 9.       Definitions.  As used herein, the following terms
          shall have the following meanings.

         

        “Affiliate” means, with respect to a specified Person, another Person that directly, or indirectly through one or more intermediaries, controls, is controlled by or is under common control
          with the Person specified.

         

        “Aggregate Exercise Price” has the meaning set forth in Section 2(a) hereof.

         

        “Aggregate Number” has the meaning set forth in the preamble hereto.

         

        “Allowed Delay” has the meaning set forth in Section 8(a) hereof.

         

        “Alternate Consideration” has the meaning set forth in Section 5(h) hereof.

         

        “Bloomberg” means Bloomberg Financial Markets (or a comparable reporting service of national reputation selected by the Company and reasonably acceptable to the Holder if Bloomberg
          Financial Markets is not then reporting sales prices of the Common Stock).

         

        “Bratton RRA” has the meaning set forth in Section 8(a)(i) hereof.

         

        
          15

          
            

        

        “Business Day” means a day (other than a Saturday or Sunday) on which commercial banks are not authorized or required to close in New York City.

         

        “Cash Change of Control” has the meaning set forth in Section 5(g) hereof.

         

        “Change of Control” means any of the following, whether directly or indirectly and whether in one or a series of related transactions: (i) the sale, assignment, transfer, conveyance or
          other disposal of all or substantially all of the assets or all or a majority of the outstanding voting shares of capital stock of the Company, other than to any of the Permitted Holders, (ii) a purchase, tender or exchange offer accepted by the
          holders of a majority of the outstanding voting shares of capital stock of the Company or (iii) a “person” or “group” (as these terms are used for purposes of Sections 13(d) and 14(d) of the Exchange Act) is or shall become the “beneficial owner”
          (as defined in Rule 13d-3 under the Exchange Act), other than to any of the Permitted Holders, directly or indirectly, of a majority of the voting power of the capital stock of the Company including pursuant to any merger, consolidation or other
          business combination, other than any of the Permitted Holders; provided that for purposes of Section 5(g) any of the foregoing references to “a majority” of the voting power of the capital stock of the Company or “a majority” of
          the outstanding voting shares of capital stock of the Company shall be deemed to refer to “100% of” such voting power or voting shares, as the case may be.

         

        “Commission” means the Securities and Exchange Commission, or any Governmental Authority succeeding to any of its principal functions.

         

        “Common Stock” means (i) the Company’s common stock, par value $0.001 per share, and (ii) any other capital stock into which such common stock is reclassified or reconstituted.

         

        “Common Stock Deemed Outstanding” has the meaning set forth in Section 5(a)(i) hereof.

         

        “Company” has the meaning set forth in the preamble hereto.

         

        “Ex-Date” has the meaning set forth in Section 5(a)(i) hereof.

         

        “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission promulgated thereunder.

         

        “Exercise Amount” has the meaning set forth in Section 2(a) hereof.

         

        “Exercise Price” has the meaning set forth in the preamble hereto.

         

        “Expiration Date” has the meaning set forth in the preamble hereto.

         

        “Fair Market Value Per Share” means as of any date: (i) the last reported sale price or, if there are no sales, the last reported bid price of the Common Stock on the Business Day
          immediately prior to such date on the New York Stock Exchange, the NYSE American LLC, the NASDAQ Global Market, the NASDAQ Global Select Market or the Nasdaq Capital Market (or any of their respective successors) as reported by Bloomberg; (ii) if
          clause (i) above does not apply, the last sales price of the Common Stock in the over-the-counter market on the pink sheets or bulletin board for such security on the Business Day immediately prior to such date as reported by Bloomberg or, if
          there are no sales, the last reported bid price of the Common Stock on the Business Day immediately prior to the date of exercise as reported by Bloomberg; or (iii) if fair market value cannot be calculated as of such date on the basis of either
          clause (i) or clause (ii) above, the price determined in good faith by the Company’s board of directors or upon the advice of an independent investment banking, financial advisory or valuation firm or appraiser as selected by the Company’s board
          of directors.

         

        
          16

          
            

        

        “Fair Value” means the fair value of any securities or other distributed property determined as follows:

         

        (i) in the case of securities listed on any United States national or regional securities exchange, the volume weighted average price (“VWAP”) of a single unit of such security in
          composite trading for the principal exchange on which such securities are listed for the 20 trading days ending on, but excluding, the date of valuation (or if the security has been listed for fewer than 20 trading days, the VWAP for such lesser
          period of time); or

         

        (ii) in all other cases, the fair value as of a date not earlier than 10 Business Days preceding the specified date as determined in good faith by the Company’s board of directors or upon the
          advice of an independent investment banking, financial advisory or valuation firm or appraiser as selected by the Company’s board of directors;

         

        provided, however, that notwithstanding the foregoing, if the Company’s board of directors determines in good faith that the application of clause (i) of this definition
          would result in a VWAP based on the trading prices of a thinly-traded security such that the price resulting therefrom may not represent an accurate measurement of the fair value of such security, the board of directors at its election may apply
          the provisions of clause (ii) of this definition in lieu of clause (i) with respect to the determination of the fair value of such security.

         

        “Governmental Authority” means any nation, government, branch of power (whether executive, legislative or judicial), state, province or municipality or other political subdivision thereof
          or any entity exercising executive, legislative, judicial, monetary, regulatory or administrative functions of or pertaining to government, including, without limitation, regulatory authorities, governmental departments, agencies, commissions,
          bureaus, officials, ministers, courts, bodies, boards, tribunals and dispute settlement panels, and other law-making, rule-making or regulation-making organizations or entities of any state, territory, county, city or other political subdivision
          of the United States.

         

        “Holder” has the meaning set forth in the preamble hereto.

         

        “Issue Date” has the meaning set forth in the preamble hereto.

         

        “Laws” means, collectively, all international, foreign, federal, state, provincial, territorial, municipal and local statutes, treaties, rules, regulations, ordinances, codes and
          administrative or judicial precedents or authorities, including the interpretation or administration thereof by any Governmental Authority charged with the enforcement, interpretation or administration thereof, and all applicable administrative
          orders, directed duties, requests, licenses, authorizations and permits of, and agreements with, any Governmental Authority.

         

        
          17

          
            

        

        “Notice of Exercise” has the meaning set forth in Section 2(a) hereof.

         

        “Offer Expiration Date” has the meaning set forth in Section 5(a)(iii) hereof.

         

        “Permitted Holders” means, at any time, each of Mr. Douglas Bratton, Bratton Capital Management L.P., MRX Partners, LLC, Monoline R.X., L.P., Monoline II R.X., L.P. and Monoline III R.X.,
          L.P.

         

        “Person” means any individual, corporation, company, voluntary association, partnership, limited liability company, joint venture, trust, unincorporated organization or Governmental
          Authority or other entity of whatever nature.

         

        “Piggyback Registration Statement” has the meaning set forth in Section 8(b) hereof.

         

        “Principal Office” means the Company’s principal office as set forth in Section 14 hereof or such other principal office of the Company in the United States
          of America the address of which first shall have been set forth in a notice to the Holder.

         

        “Purchase Agreement” has the meaning set forth in the recitals hereto.

         

        “Registration Statement” has the meaning set forth in Section 8(a) hereof.

         

        “Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule 144 may be amended from time to time, or any similar rule or regulation hereafter
          adopted by the Commission having substantially the same effect as such Rule 144.

         

        “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations of the Commission promulgated thereunder.

         

        “Senior Notes” has the meaning set forth in the recitals hereto.

         

        “Special Registration Statement” means (i) a registration statement relating to any employee benefit plan; (ii) with respect to any corporate reorganization or transaction under Rule 145
          promulgated under the Securities Act, any registration statement related solely to the issuance or resale of securities issued in such a transaction; (iii) a registration statement related solely to stock issued upon conversion of debt
          securities; (iv) any registration statement filed under Rule 462(b) promulgated under the Securities Act; or (v) any registration statement on Form S-4 or Form S-8 not contemplated by clauses (i) – (iv) hereof.

         

        “Trigger Event” has the meaning set forth in Section 5(c)(i) hereof.

         

        “Underwriter Cutback” has the meaning set forth in Section 8(c) hereof.

         

        “Warrant” has the meaning set forth in the preamble hereto.

         

        “Warrant Securities” means, collectively, this Warrant and the Warrant Shares.

         

        
          18

          
            

        

        “Warrant Shares” means (i) the shares of Common Stock issued or issuable upon exercise of this Warrant in accordance with its terms and (ii) all other shares of the Company’s capital stock
          issued with respect to such shares by way of stock dividend, stock split or other reclassification or in connection with any merger, consolidation, recapitalization or other reorganization affecting the Company’s capital stock.

         

        SECTION 10.     Survival of Provisions. Upon the full exercise by the Holder of its rights to purchase
          Common Stock under this Warrant, all of the provisions of this Warrant shall terminate, other than the provisions of Sections 6-21 hereof, which shall expressly survive such exercise until the later of (a) the Expiration Date and (b) the
          time when the Holder no longer holds any Warrant Shares.

         

        SECTION 11.     Delays, Omissions and Indulgences. It is agreed that no delay or omission to exercise any
          right, power or remedy accruing to the Holder upon any breach or default of the Company under this Warrant shall impair any such right, power or remedy, nor shall it be construed to be a waiver of any such breach or default, or any acquiescence
          therein, or of or in any similar breach or default thereafter occurring, nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. It is further agreed that any
          waiver, permit, consent or approval of any kind or character on the Holder’s part of any breach or default under this Warrant, or any waiver on the Holder’s part of any provisions or conditions of this Warrant, must be in writing and that all
          remedies under this Warrant, by Law or otherwise afforded to the Holder shall be cumulative and not alternative.

         

        SECTION 12.     Rights of Transferees. Subject to Section 6 hereof, the rights granted under this
          Warrant to the Holder shall pass to and inure to the benefit of all subsequent transferees of all or any portion of this Warrant (provided, that the Holder and any transferee shall hold such rights in
          proportion to their respective ownership of this Warrant and the Warrant Shares) until extinguished pursuant to the terms hereof.

         

        SECTION 13.     Captions. The section headings and other captions appearing herein are included solely for
          convenience of reference and are not intended to affect the interpretation of any provision of this Warrant.

         

        SECTION 14.    Notices. All notices, requests, instructions, directions and other communications provided
          for herein (including any modifications of, or waivers, requests or consents under, this Warrant) shall be given or made in writing delivered to the applicable addresses specified below or at such other address as shall be designated by the
          Company or the Holder, as applicable, in a notice to the other. Except as otherwise provided in this Warrant, all such communications shall be deemed to have been duly given upon receipt of a legible copy thereof, in each case given or addressed
          as aforesaid.

         

        
          19

          
            

        

        (a)          If to the Company:

         

        Aquestive Therapeutics, Inc.

        30 Technology Drive

        Warren, New Jersey 07059

        Attention: Chief Financial Officer & General Counsel

        Facsimile: 908-561-1209

         

        with a copy to:

         

        Dechert LLP

        1095 Avenue of the Americas

        New York, New York 10036

        Attention: David Rosenthal

        Facsimile: 212-698-3599

        

        

        (b)          if to the Holder:

         

        [●]

        [●]

        Attention: [●]

        Facsimile: [●]

         

        

        with a copy to:

         

        Pillsbury Winthrop Shaw Pittman LLP

        31 W. 52nd Street

        New York, New York 10019

        Attention: Jeffrey Delaney

        Facsimile: 212-858-1500

         

        SECTION 15.    Successors and Assigns. This Warrant shall be
          binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns, provided, that the Company shall have no right to assign its rights, or to delegate its
          obligations, hereunder without the prior written consent of the Holder. The Company shall not require the Holder to provide an opinion of counsel if any transfer by the Holder is to an Affiliate of the Holder; provided,
          that any such transferee is an “accredited investor” as defined in Regulation D promulgated under the Securities Act and the Holder and such transferee each complies in all respects with the applicable transfer procedures set forth in Section
            6 hereof.

         

        SECTION 16.     Amendments. Neither this Warrant nor any term hereof may be amended, changed, waived,
          discharged or terminated without the prior written consent of the Holder and the Company to such action.

         

        SECTION 17.     Severability. If any provision hereof is found by a
          court to be invalid or unenforceable, to the fullest extent permitted by applicable Law the parties hereto agree that such invalidity or unenforceability shall not impair the validity or enforceability of any other provision hereof.

         

        
          20

          
            

        

        SECTION 18.     Governing Law. This Warrant and the rights and obligations of the Holder and the Company
          hereunder shall be governed by, and construed in accordance with, the Law of the State of New York, without regard to principles of conflicts of laws that would result in the application of the Laws of any other jurisdiction; provided, that Section 5-1401 of the New York General Obligations Law shall apply.

         

        SECTION 19.    Entire Agreement. This Warrant, together with the Purchase Agreement and the other documents
          contemplated thereby, are intended by the parties as a final expression of their agreement and are intended to be a complete and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter
          contained herein.

         

        SECTION 20.    Rules of Construction. Unless the context otherwise
          requires, “or” is not exclusive, and references to sections or subsections refer to sections or subsections of this Warrant. All pronouns and any variations thereof refer to the masculine, feminine or neuter, singular or plural, as the context
          may require.

         

        SECTION 21.    No Effect Upon Lending Relationship. Notwithstanding anything herein to the contrary,
          nothing contained in this Warrant shall affect, limit or impair the rights and remedies of the Holder or any of its Affiliates in its capacity as a lender to the Company pursuant to any agreement under which the Company has borrowed money from
          the Holder or any of its Affiliates, including, without limitation, the Purchase Agreement and the Senior Notes. Without limiting the generality of the foregoing, neither the Holder nor any Affiliate of the Holder, in exercising its rights as a
          lender, including making its decision on whether to foreclose on any collateral security, will have any duty to consider (a) its status or the status of any of its Affiliates as a direct or indirect equity holder of the Company, (b) the equity of
          the Company or (c) any duty it may have to any other direct or indirect equity holder of the Company, except as may be required by commercial Law applicable to creditors generally.

         

        {Remainder of Page Intentionally Left Blank}

         

        
          21

          
            

        

        IN WITNESS WHEREOF, the Company has caused this Warrant to be issued and executed in its corporate name by a duly authorized officer as of the date first
          written above.

         

        	 	 	 	
                AQUESTIVE THERAPEUTICS, INC.

              
	 	 	 	 	 
	 	 	 	
                By:

              	 
	 	 	 	 	
                Name:

              
	 	 	 	 	
                Title:

              
	 	 	 	 	 
	
                Accepted and agreed:

              	 	 	 
	 	 	 	 
	
                [HOLDER]

              	 	 	 
	 	 	 	 	 
	
                By:

              	 	 	 	 
	 	
                Name:

              	 	 	 
	 	
                Title:

              	 	 	 

         

        

        
          {Signature Page to Warrant}

           

          

        

        
          
            

        

        
        EXHIBIT A

         

        Form of

        NOTICE OF EXERCISE

         
          	
                  To:

                	
                  
                    Aquestive Therapeutics, Inc.

                  

                
	 	
                  30 Technology Drive

                
	 	
                  Warren, New Jersey 07059

                
	 	
                  Attention: Chief Financial Officer & General Counsel

                
	 	
                  Facsimile: 908-561-1209

                

        

        
          
            
              

              

            

          

        

        1.           The undersigned, pursuant to the provisions of the attached Warrant, hereby elects to exercise this Warrant with respect to __________ shares of Common Stock (the “Exercise Amount”).
          Capitalized terms used but not otherwise defined herein have the meanings ascribed thereto in the attached Warrant.

         

        2.           The undersigned herewith tenders payment for such shares in the following manner (please check type, or types, of payment and indicate the portion of the Exercise Price to be paid by
          each type of payment):

         
          	 	
                   

                	
                  Exercise for Cash

                
	 	 	
                  Cashless Exercise

                

        

        

        3.           Please issue a certificate or certificates representing the shares issuable in respect hereof under the terms of the attached Warrant, as follows:

         

        	 	 
	 	
                (Name of Record Holder/Transferee)

              

        and deliver such certificate or certificates to the following address:

         

        	 	 
	 	
                (Address of Record Holder/Transferee)

              

         

        

        4.          The undersigned represents that the aforesaid shares are being acquired for the account of the undersigned for investment purposes and not with a view to, or for resale in connection
          with, the distribution thereof and that the undersigned has no present intention of distributing or reselling such shares.

         

        5.           If the Exercise Amount is less than all of the shares of Common Stock purchasable under the attached Warrant, please issue a new warrant representing the remaining balance of such
          shares, as follows:

         

        	 	 
	 	
                (Name of Record Holder/Transferee)

              

         

        

        and deliver such warrant to the following address:

         

        	 	 	 
	 	 	
                (Address of Record Holder/Transferee)

              
	 	 	 
	 	 	 
	 	 	
                (Signature)

              
	 	 	 
	 	 	 
	
                (Date)

              	 	 

         

        

        
          A-1

          
            

        

        EXHIBIT B

         

        Form of

        NOTICE OF ASSIGNMENT

         

        FOR VALUE RECEIVED, the Holder (the “Assignor”) hereby sells, assigns and transfers all of the rights of the undersigned Assignor under the attached Warrant with respect to the number of
          shares of common stock of Aquestive Therapeutics, Inc. (the “Company”) covered thereby set forth below, to the following “Assignee” and, in connection with such transfer, represents and warrants to the Company that the transfer is
          in compliance with Section 6 of the Warrant and applicable U.S. federal and state securities laws:

         

        	 	 
	
                (Name of Assignee)

              	 
	 	 
	 	 
	
                (Address of Assignee)

              	 
	 	 
	 	 
	
                (Number of Shares)

              	 
	 	 
	 	 
	
                (Dated)

              	 
	 	 
	 	 
	
                (Signature)

              	 

        

        

        ASSIGNEE ACKNOWLEDGMENT

         

        The undersigned Assignee acknowledges that it has reviewed the attached Warrant and by its signature below it hereby represents and warrants that it is an “accredited investor” as defined in Rule
          501(a) of Regulation D promulgated under the Securities Act of 1933, as amended, and agrees to be bound by the terms and conditions of the Warrant as of the date hereof, including Section 6 thereof.

         

        	
                By:

              	 	 
	 	
                Name:

              	 
	 	
                Title:

              	 
	 	
                Address:

              	 

        

        

        

        

        B-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00297-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00297-of-00352.parquet"}]]